>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 1; Drug: Control Apo 0.5 然
bLibLgLsLsmbLsLsmbLibLibLhbLsbLiRsbLibLgbLsLsmbLgbLsbRsbLibLgRsbLcbRsb
LiRsRsmbLsbLsLsmbLgbLibLgbLsbLsbLsLsmbLhbLibLiRsbsbLgbLibLsbLibLibLjbL
gbLibLgbLgLsbLiLsbLcbLcbRcbLoLsmbLcbLobLhbLcbLcbLjbLcbLcbLobLebRibLibL
iLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 2; Drug: Control Apo 0.5 然
bRiRsmbLsbRibLgbRgbRgbLcbLsbLsbLsbLsbLgbLsbLibLibRcRgRsmbLobsbLcLsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 3; Drug: Control Apo 0.5 然
bRsbLhbRgbLcbLcLsRsmbLgbRibRcbLsbRibRsbLhbLibLobLsbRibLibRibRibRibRgbL
gbLgbRjbRibLcbReRsmbLcLsmbRcbRgRgbRgbRsbRgbRgbRibRgbLhbRiLsbRgbLibLhbR
ibLhRsbRibLgbLsLeb

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 4; Drug: Control Apo 0.5 然
bsbRobLhbLibLgbLsbLjbLebLhbLibLcRsbLibLgbRhbRibLibLibLsRsbLgbLgbRobRcb
RcbLgbRcbRob

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 5; Drug: Control Apo 0.5 然
bLgbLgbLibRgbRsbRsbRcbRobRsbRgbRjRcbRiRobLsbRgbRsbRjbRsbsbLibRibRsRsmb
LcbRoRsRsmmbRgbRgRobLgbRobRsbLibRgbLsbLhbRibRib

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 6; Drug: Control Apo 0.5 然
bsbLcbLcbLjbRcbLcLsmbLiLsbRjbLiLsbLebRcb

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 7; Drug: Haloperidol 1 然 Apo 0.5 然
bLsbLsbLsLgbLcbLsbRsbRsbLjbLibLgbLgLsbLgbLgbLiLsbRsbRibLibLcLsLsmmbRsb
sbRgbRhbRcbRsbLgbRiRsmbRibRibRcbRsbsbRibLjbRsLsRsbLsbRsbsbLcbRjRsmbLib
LsLsmbLsbLsbLgLsLsmbRsRsLsmbLiLsbRcRsmbRjbRgbRgbRjRsmbRib

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 8; Drug: Haloperidol 1 然 Apo 0.5 然
bRibLgbRsbRobLsbRibRibRiRiRgRsmbRgbRgbRibRgLsbRgRsmbsbLsbRgbRgRsmbRhRs
mbRgbRgbLsbRibRibRgbLgbRoLsbRibRiRsmbRibRebRibRibRgLsbRibRgbRibRcbRgbR
sbRgbRgbRebRibRhbLgbRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 9; Drug: Haloperidol 1 然 Apo 0.5 然
bRsbRgbLjbLibLgbLibLgbLgbLsbLgbLgbLgbLgbRgbRgbLsbLcbLgbLsbLgbLgbLgLsbL
sbRgbLibLcbLibLcbLibLibLibLgbsbLjbLibLgbRibLibLibLhbLgbLibLsbLgbLsbLgb
LgbRsbLgbRobLjbLgbRcbLgbLgbRsbRgbRcbLibRgbRgbRsbRsbRsbRsbRsbRsbRsbRgRs
mbRsbRsbRsbRsRsmbRgbRsbRgLsbLsbLgbRibRgbLsbRgbLsRsRsmbRhbLjbRhbLsbLjbL
gbRibRgRsmbRsbRsbRsbRsbRhbRsbRgbLsbRgbRgbRsRsmbRgRsmbRsbRibRsRsmbRsbRg
bRgbRsbLsbRgbRgbRsbRsbRibRgbRgbRgbRsbLgbRibRgbRsbRibRgbLsbLsbRiRsmbRib
RjRsmbRibLgbRibLsbRibRcbRsbRsbRibRibLjbLjbRhbRibRiRsmbRhRsmbRsbLibRibR
ibRibRiRsmbRsbLgbLiLsbRobRebLcbLgbLsbRsbRsbLgbRibRcbRgbRibRgbRsbLjb

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 10; Drug: Haloperidol 1 然 Apo 0.5 然
bLgbLgbLibLsbLgbLsRsRsmbRgbsbRgbRgbRgbLsbRsLjbRgbRsbRsbRgbRsbRgbRsRsmb
RsRsmbRgbRsLsbRgbRgRsmbRsbRgbRgbLgbRgbRsRsmbRgRsmbRgbRsbRsbRsbRsRsmbLs
bRgbLsbRibLsbRgbRgbRsbRsbRsbRgRsmbRsbRgbRsbRsbRsbRgbRsbRgLsbRsbRgbRsbR
sbRsbRsRsmbRsbRjbRiLsLsmbRiLsbRibRgbRsbRsbRsbRjbRgRsmbRgbRgRsmbRgbLjbR
iRsmbRgbRgbsbLsbRgbRgLsbRgbRgbRgbLgbReRsmbRcRsmbRsbRsLsbRsbRsRibLsbRgb
RgbRgbRsbRsLsbLsbLsbRsRsmbRsbsbsbRgbLsRsLsbRsbRsbsbRsbRiRsRsmmbRgRsmbL
gbLgbLsbRibLjbRibLsbRgRsmbRsbLoRsbLsbLsbLgbRgbRsbLibLibsbRgbLibLgbLgLs
bLgbRgbRsbRgRsmbRgbRgbLsbRsbRgbRgbRgbLsbRgbLsLsmbRsLsbLibRibRcbRsRsmbR
gbRsbLsbRgRsmbRgbLgLsLsmbLjLsmbLcbLjLgbLsbRgbLgbLsbRgbLibLgLsbLsRsbRsb
LibLgbLsLsmbLgLsbLsLsLsmmbLgbLsbLsLsmbLgbLgbLsRsbRsbLgLsbLgbLgbLgbLgbL
sbLgLsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 11; Drug: Haloperidol 1 然 Apo 0.5 然
bLibLcbLgbLgbLgbLcbRibLgLsbLgbLgbRgRsmbLoLcbRibLgbRsRsmbRgLsbRgbRgLsbL
sbRgbRsRsmbRsbRgbRgbRgbRsbLsbRsLsbRgbRsbRgbRsbRebLibRibLgbLsbLibLgRsbR
sbLgbRgbLgLsbLgLsbLgbRobRibRibRgLsbRgbRsRsmbRsbRgbLsbLsbRgLsbRgbLgbLeb
LibRsbLgbLsbLgbRsLsRsbLgLsbLgLsbLgbLgbLgbLgbLsRsbRsbLgbRsbLgRsbRsbRsbL
gbLgbLgRsbLobRibRgbLobRcbLibLobLjbLcbLibRgbLjLsmbRiRsmbLibLjLsmbRgbLgb
LgbLcbLibLgbRgbRiRsmbRjRgRsmbLgbLsbRjRsmbRcbRjRsmbRsRsmbRibRib

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 12; Drug: Haloperidol 1 然 Apo 0.5 然
bRcbRsLsbLibLobLebLsRsbLsbLibLgLjbLsbsbLgRsbLsLiRsbLsbLibLgbLgbLgLsLsm
bLsbLgbLgbLgbRobLsbRgbRsbRgRsmbLcbLiLsbRgbsbLsbLibRjbRobLjLsmbRcbRjbRc
RsmbLjbRcbRgLsbLsbRgbRgbRgbRsbRgbLsbsbRsbLjbLobLgbLgbLsLsmbLgLsLsmbRib
LsbRobRibLsbRgbRibRgbRgRsmbRgbRsRsmbRgbLgbRgbRoRsRsmmbLgbLsbRgbRibRibR
gRsmbRgbLsbLobLcLsmbRgbLibRgbLiRsbLsbLgbRibLebRgbLsbLhLsbRsbLoLsLsmmbL
ibLgbLgbRibLhbLibLibLibLsbRgbLjbLsbsbRsLsbRcbLcLsmbLibsbRsbLsLsmbLsLiL
sbRsbRsbLebRsRsmbRgRsmbLcbRgbLhbLgbRgRsmbLsbLibLsLsmbRcbRcbLsLsmbLibLs
bRibLgbRibRiRsRsmmbLobLsLiLsbLsbLsbLgbLsbLgLsbLgbLsbsbLibLgbLsbLsbRsRs
mb

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 13; Drug: Haloperidol 3 然 Apo 0.5 然
bRsbRgRsmbRgbLhbLibLhbLhbLgbRibRcbRibLgbLsbRcLsbRhbRcbRoRsLsmbRcbRcbLh
bLcbRiRsmbLsbRjbRobRhbRibRibRibLebRiRsmbLcbLcbRjbLibLgbRhbRgbRibRjbsbR
sbLsRsbRgbRgbLsbRgbRgRsmbRgbRgbRsbLcbLiLsbRsbLibLgbLgbRgLsbLiRsbLsbLsb
sbLibRsbLibLsbLsbLsbRsbRsbLgRsbsbLibRcbRibLibRcbRibRsbRsLsbRsbLsbLebLi
bRibRebRibLsbRgRsmbLsRsbRgbRgbRsLsbRgbLsbRgbRjbLcbRhbLjbLhbRgbLgbRjbRi
RsmbRiLsbLjbRgbRgbLsbLgbLjbLsbRhLsRsbLjbRiRsmbLsRsbRgbRsbLsbLebLiLsbLs
bRgLsbLibLjbRcbRcRsLsmbLsLsmbLebLsLsmbLsbLsbLsbLgbLsbLgbsbsbLgRsbLgbRs
bLgbRsbLsLsmbRsbRsbRjbLsLhbRgbRcbRibRsbRgRsmbRibRibRsbRgbRgRsmbRsbLcbR
sLsbLibLsLsmbRsLsbRsbLibRebRibRsbRgbLgbRibLsbRsbRgbRsbLsbLsbRgbLibLibR
jbLcRsbRgbLsbLibLgLsbRsbLgLsbRcbRiLsbRibRsbRgbLgbRgbRcbLibLgbLhbLibRgb
LsbLcbRsRsmbRcbRsRibRgLsbLjLsRsmbLhbLibLibRhbRibLjbLjbRjbLiLsbLgLsbRsb
LgbRsbLibRgbLibLsbsbRsbLsLsLsmmbLgbRsRgbLsbLsbLsbLgbLgbLgbLgbLiLsbRsbL
gbLsbLiRsbRsRsmbRebLjLsmbRhbRibRgbRgbLjbRebLhbRhbRgbRgbRibLsbRgbRgbRgL
sbRgRsmbRgbLsbRgbLjLsmbRcbRjbsbLebsbLiLsbRcbRcLsbLjbLebLibRsRsmbsbLhLs
bRgbLgbLhbRsbLcbLibLgbRsbRcbRcbRibLsbLcbRgRsmbLcbLibRgbRsLibLibRibRcbL
cbLgbLsLsmbLsLsmbLsLsmbLjbsbLsbsbLgbLgLsbLgRsbLgbRjbLhbLibRgbLgbsbsbLi
bRgbsbLsbRibRibRiLsbLjbRhbRhbRsbRibRcbLgbLgbRgLsbLgbRcbRgbRibLibRcbLhb
LcbLsbRjRsmbRebLebLibLgLsbLgbRjbLcbLsbLsbRiLsbRcbLsbRcbRsRsmbLsbRibRib
RsRsmbLebLiLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 14; Drug: Haloperidol 3 然 Apo 0.5 然
bLsbLjbRgbRgbRsbLobRsbRgbLsbLjbLjbLibLibRsbLcRsbLgbReRsmbRsbRgbLjbLhbR
eLsbRibLgLsRsbsbRibRibRibLgbsbRgbRsbRgbsbRsbRgbRgRgbRgbRgbLsbRgbRsRsmb
LsRgbRsbRgbRgbRsbRsbRgRsmbRgbRgbRgRsmbRsRsmbRgbRgbRsbRsbRsbRgbLgbRgbRi
bRibLgbLjbLibRibRibRebRhbLgbRgbRgbRjbRibLsLjbLcRsbLgbRcbRibLsbRibLsbRg
RsmbRjLsLsmbRgbRibLgbRibRsbRcRsmbRibRibLgbLgLsbRgRsmbLsbLcRsRsmbLgbRob
RgRsmbRgbLcbLibLgbRgbRibRhbLgbRgbLgbRibLcbLgbLibRgbRgbLibLgbLgbLgbRgbR
hRsmbRgbRgbLsbRgbLsbLsbLeLsbLibLsbRjbLibLibLgbRibLjLsmbRgbLibRgbRjbRjb
RibRgbLsLsmbLgbRsbRibRiRsmbRsbLsbRibRgbLgbLsLsmbRibRgbRgbLjbRgbRgbLgbR
ibLsbRsbRjRsRsmmbRsRsmbRsRsmbRsbRibLgbRgbRgbRgbRgbLjbRgbRgbLgbRgbRibRg
RsmbRsbRsbRsbRgbRsbRgRsmbRgbRgbRgbRgbRsbRibLsbLsbRibRibRsRsmbLsRsbRsbR
ibLgbRiRsmbRgbRibLsbRjbRibRgbRgbRgbRgbRgLsbRgbRiLsbRgbRsbLsbRsbLsbRsbR
gbRgbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 15; Drug: Haloperidol 3 然 Apo 0.5 然
bLsbLsbLgLsbLcbRgbLibRsbRsbLgbLsRsbLiLsLsmbRsbLgbRsbLibLgbLsLsmbRsbLib
LgbLgbRsbLgLsbRgbLgLsbRsbLsbLgLsRsbLgbLgbLgbRjbRcLsbRibRgLsbRibRgbRgLs
bRgRsmbRsbsbRgbRgbRgbRgbRgRsmbRgbsbRsbRsbRsbRgRsmbRgbRgLsbRgbRgbLsRsbR
gbRgbLsbLjbLibLibLgbLibLgbRjbRibRhbLcbLhbLibRibRgbLiLsbLsLsmbRsbLsbLgb
LibLgLsbLsbLibLibRsbLiRsbLgbLcbLgbRiRsmbLsbRgbRsRsRsmmbRgLsbRgbRgbRsbs
bRgbRgRsmbRsRsmbRgbRsRsmbRsbRsbRsbRiRsmbLgbLsbLobRsLsbRcbLhbsbRsLibLgb
LgbLgbLsbLibLgLsRsbLsLsmbLiLsLsmbLsbRsbsbLiLsbLgbRsbRgbLiLsbRjbLhbLibL
gLsbLsbLgLgLsbLsbLsbLeLsbLsRoRsmbLjbLibRsbLsLsmbRsbLsbRsbLsbLsLibLsbLi
bLgbRibLiRsbRgbLhLiLsbLibLgLsLsmbLibsbLsLsmbLgbLgbLibLibRsRsmbLibLibLi
LsbLsbRsbLsbsbLgLsbLgLsbLsbLgbLsbRsbsbLgbLsbLsbLsRsbLibRibLsbRebRibLsb
LhRsbRgbRcbsbsbsbsbsbLsbsbsbsbsbsbsbsbLsLsmbRibsbsbsbLsbRsbsbRgbLcbsbL
sbRsLsLsmbLsbRsbLsbLgbRsbLobLoLsmbLibRjbRobRoLsLsmbLsLsmbLibLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 16; Drug: Haloperidol 3 然 Apo 0.5 然
bRibLsbLcLsmbLsLsmbLsbRsbLsbLsbLsbLsLsmbLgLsbLsbLsbLsLsmbLgRsbReRsmbLi
bLgbRgbLgbLibRgbsbLgLsbLgbRsbLgbLsbLsRsbLibsbRgbLgLsbLsbLgbLgbLsLsmbLs
bLsbRsbLsLsmbRsbLgLsLsmbLgbLsLsmbLgbRsbLsLsLsmmbLsbLgbLsLsmbLjbLsbLgbs
bLsLsmbLgbLsbLgbLsbLsLsmbLsbLsbLsbLsbLgLsbRsbLsbRsbLgbLsbLsbLgbLsRsbsb
LgbLsbLgbLsLsmbLiRsbRsbLsbLsbLsRsLsLsRsRsmmbLsRsRsmbsbLsLgbLsbLsLsmbLg
bLsbRsbLsbLgLsbRsbLgLsbRsLsbLgbLsbRgRsRsmmbRsbsbLibLibLsbLsLsmbLsLsmbL
gLsLsmbLgLsbRsbLgbRsbLsbLsbLjbLsbLjbsbRsLsLsLsmmbRsLsbLsLsRsmbLebLsLsm
bLsbsbLsLsmbLiLsLsmbsbsbLsRsLsbRibRgbRgbRgbRgRsRsmmbRsbLsRsbRibLjbLhbL
sLsmbsbRsLsRsLsLsmbLsRsbLoLsLsRsmmbRsbLobRgbRsbLobLibLsbLsbLsbLgLsbRjb
LsbLgbLgbRsRsmbsbLibLgbLgbRsbRgRsmbRgbRsbLgbsbLsbLiLsbRsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 17; Drug: Haloperidol 3 然 Apo 0.5 然
bRgbRgbRgbRsbRgbLjbRibRsbRgbRsbRgbLsbRgbRgbRsbRgbRsbRsbsbRibRibsbRibLg
bLgbRiRsmbLgbLgbLibRjLsbRjbRjbsbRgRsmbRsLsbRsbRgbLsbRgbLjbRibLsbRibRsb
RgbRgbRgbRgbLsbRibLgbRibRibRibLgbRibLgbRibLsbRibLjbsbsbRcbLibLsbRibRgb
RgbRsRsmbRgbRsbRsbRgbRgbRgbRibRgbLsbRibLgbLjbLgbLgbReLsbLcbLsRsbsbRcbR
sbRsRsRsLsmmbRsbLsRsbRsbLsbRibRsRsmbRsRsmbRgbRsbLsbsbsbLgbRibRsRsmbsbs
bRibRsbRsbRgbRiRsLsmbRsbRsbRgbLsbRgbRgbLsLsmbRibLgbRibRibLgbRibLcbLibL
gLsbLgbRcbLsbRgRsmbLsbRgRsmbRgbRgRsmbRgRsmbRgbRibLhbRibRsbRgbRgbRgbRgb
LsbRibLsbRibLsbRgbRibLgbRibLibRiRsmbRgbRgbRgbRgbLhbLibRibLgbLgbLsbLsbR
jbRhbRcbRsLsRsbsbLibRgbLsLsRsLsRcmbLsbLgbRjbRibRsbsbRgRsmbRsbRibLjbRsb
LsLsmbRsLsbsbRjRgRsmbLjbRsbLsbRjbRgbLsbRjbRjbsbRsbRsbRgbLjbRibRgbLsbLj
bLjLsLsmmbsbRjbLjbLgbLibsbRgLsLgLsbLsLsmbRsbRjRsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 18; Drug: Haloperidol 3 然 Apo 0.5 然
bLeLsLsmbLiLsLsmbLsbLcbLhLsbLjLsLsmmbLiLsbLgbLsbRsbsbLsbLsbsbLsbLiLsbL
gbLgbLgbLgLsLsLsmmbLgbLobLhLsbLcbLhLsbLcbLhbRibLibLgbLgbRsbLsLcbRgbRcb
RhbRiRsmbRgbRsbRgbRsbRjRsmbRhbRsbRsbLibLibLgbLgbLgbLsbRiLsRsbLiLsbLibR
sLiRsbLsbRsLibLsLcRsbLgLsbLgbRgbLjbLibRsbLcbLiLsbLibLgbLeLsbRgLsbLobRs
LsLsLsmmbRsbRiLsbRibRsRsmbLsbRgbRgbLsbRgRsmbRgbRsRsmbLsbRsbRsbRgbLsbLs
RsbsbLjbLcbLiRsbLcLsmbRsbRgRsRsmmbRjbRgbRiRsmbLjbLjLsmbLibLibRsRsmbLib
LgbRibRjbLjLsmbLibRjbLibLiLsbLgLsbLgbLsbLsbLjLsmbLgbLsbLiLsbLsbLibLgLs
bLgLsbLgbLgbLibLgbLgLsbLibLgbRgbLcbLgbRhbRcLsbLjbLiLsbsbLsbRsbsbLibRsb
sbLsbLgbLgbRsbRsLsbLsbRsbLibRgRsmbLsbLibLgbLgbLsbLiLsbLgbLgLsbLibRsbLs
LobLsbLcbLcbLiLsbRgbRcRsmbLibRhbLjbRibLjbRibRsLjbLcLsmbLjLsLsmmbLiLsbL
gbLgbLgLsbLgbLibLgbLsbLiLsbRsLsbLgbsbLiLsbLjbRsLsbLsbRgbLsbLsLsmbLsbLs
bLsbLgbsbLibLsLsLsmmbsbLibLsbRsbRgbLsbsbLsbsbLsLsmbLsLsmbLgbLsLsmbLgbL
sLsmbLgbLsbRsbRsbRgbLsbLcbRsLsLsRsmbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 19; Drug: Haloperidol 10 然 Apo 0.5 然
bRsLsbRsLsbRjbRsbRgRsmbRsbRsbRsRsmbRsbRsbRgbRsbRsbRgbLsbRsRsmbLsbLibLg
bLsRhbRgbLsbLsbRgbRsbRsbRsbRsbRsbLjbLcbLibLgbLjbLibLgbLsbLsbLsbsbLsbLs
bLgbLgbLsbLsbsbLibLgbLibLsbLsLgLsLsLsmmbRebLjbLebRsLsbRsLsbRsLsbLsbLsb
LsbRsbRsLsbRibRsbRsbRsbRsbRsbRgbRsRsmbRgbRsbLiLsbLgbLgLsbLsLsmbLsbsbsb
RsbsbRsbLsbRsbsbLsbsbRsbLsbLsbRgRsmbLsbRsbRgRsmbRsbLsbRsbRsbRsRsmbRgLs
bRsRsmbRsbRcbLsbLsLsmbLsbLsLsmbLsLsmbLgLsbLsbLgbLgbLsbRsbLgbRsbLsRsbLs
bLsbLgbLsLsmbLsbLsbLsbLsLsmbLsbRsRsmbRjbRibRjbRsbRsbRsbRsRsmbLsbRjbLsb
LsRsbRsbRsRsmbRgbLibLsbLgbLsbLsbLsbLgbRsbLgbRsLsbLsbLsbLgbLsbLsLsmbLsL
smbLsbLsLsRsmbLgLsbLgbLgbLsbRgbLgbLsbLsbRsbRjbRsbRsbRsbRjRsmbRgbRsRsmb
RgbRsbLsbLsbRgbRgbRgbRgbRsbRgbRgbRgRsmbRsbRsbRsbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 20; Drug: Haloperidol 10 然 Apo 0.5 然
bsbLgbLsbLgbsbLgLsbLsLsLsmmbLgbsbsbRjbRhbRgbLsRsbRsRsmbRsbLsbRsbsbLjbL
sLibLibRsbLibsbLsLsmbsbsbLsbRsbLibLgbLgRsbLsbLsLsmbLsbRsbLsbRsbLcbLgRs
LgbLibLibLibRsbLibLibLobRgbRsbRobLebLcbLhbLcbLgbLeLsbLiLsbLibLiLsRsbLs
bLibRsbRsRsRsmmbLhb

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 21; Drug: Haloperidol 10 然 Apo 0.5 然
bRsbLsbLibRibRgbLsLsLsmmbRsbRsbRsbRsbRgbLjbLibLsbsbsbLsbLsbLsbLsLsmbLs
bLgbLgbRjRjbRibRgbRsbRsRsmbRsbRsRsmbRsbRsRsmbRsbRsbLobLgbLsbLsbRsLsLsm
bLsbRsbRgbRgbRsbLsRsbRsbRsbRsbRsRsmbsbRsbRsbRgbRsbRsbRgbRsRsmbRsbRsbRg
bRsRgRsmbRsbRsbRsLjbRebRibRsbRgbRsbLibLibLibLsbLsbLsbLsRsbRsbRsbLgbLgb
LgbRsLsbRibsbRsbRsbRsbRsbRsbRsRsmbRgbRsRsmbsbRsRsmbRsbRsLsbRsbRsbRsbRs
LsbRsbRsRsmbLsbRsbLsbRsbRsRsRsRsRsLsmmmmbLsbLsRsbRsbLgbLibLibLsbRsbRsb
RsbRsbReLgbRsbLgbLgbLsLsmbLsbLgbLsbLsbLsbLjbLgbLgbLsRsbLgbLsbLsbLsbLgb
LibLsbLsbLgbLgRsbLgbLsbLgLsbLgbLgbLsbLsbLsbRibRgbRsbRgbRsbRsbRsRsmbLsb
RsbRibRgbLsbRsbRsbRsbRsbRsbLsLsmbLsbRsbRsRgbLsbRgbRgbRgbRsRsmbLsLsLsLs
LsmmmmbLgbLsbLsbLgbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 22; Drug: Haloperidol 10 然 Apo 0.5 然
bLgLsLsmbLgbLsLsmbsbsbLgLsbRjbRcbLjbLjbLcbRjbRjbRgbLiRgbLsbLsbLsLsLsmm
bLgbRebLebRibRcbRebReLsbRsRsmbRgLsbRjbLcbRebRgbRsbLsbLsbLsLsmbsbLsLsmb
LsbLgbRsbLsLsmbLsbLsbsbRsbRsbsbLsbLsbsbRsbLsLsmbLgLsbLgbLgbLsbLsbRsLsb
LgbLsbLsbsbLsbLgbLgLsbLsbLsLsmbLgLsbLgbLgbLgbLsbLsbLibsbLsRsbRsbsbsbLs
LsLsmmbLgbLsbLgbLgbLgbLgLsbLgLsbLgbLgLsLsmbRgbRcbLjbRsRsmbLsRsbLsbLgLs
bLgLsbLsLsmbRsbLsbRsbLgRsbLjbRsbLibRgbsbRsbRebRsbRgbRiRsmbRgLgRgbRgbLc
bRjbLgbRgbRibLsbRcbRgRsmbRgbRsbRgbRgbRgbRsbRgbRibRsRsmbRgbRsbRsRsmbLgb
LgbLsbLgbLsbLsbsbLsbLsbRsbLsbLsbLgLsbLgbLgbLgbLgbLgLsbLgLsLsmbLsLsmbLs
bsbLsbsbsbRsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 23; Drug: Haloperidol 10 然 Apo 0.5 然
bRsRsmbRibLsLsRsmbRgbRsLsbRgRsmbLsLsmbLsbRsbLgbLsbLsbRgbRcbRsbRgbLhbRs
bLgbLgbLgbLgbLgbLgbLsbLgbLgbRibLibLgbLgbRsbRsLsbRsbRsbLsbsb

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 24; Drug: Haloperidol 10 然 Apo 0.5 然
bRgbLsRsbLsbRjbRibRgbRsRsRsmmbLsbLsbLsbRgbLsbLsLsmbLgbRgbRgbLsbRgbLsbR
gbRsLsbRgbLsbLjbLcLiLsLsmbRsbRsbLgbLibLiLsbsbRgbRsLsbRsbLcbLiLsbsbLiLs
bLibsbRhbRibRgbsbRgbRsbsbRsbLobLibsbLgbRibLsbRhbRiRsmbRgbLgbsbRcbRsRsm
bLgbLibLgLsbRsbLsbLsLsmbLsbLibRsbLsbLsLhbRibLibRgbLsbLgbRsRsmbLgbsbLgb
LsbLgbLsbLsbLgbLhbRibRebRibRgbRsLsbRibLsbLebLgbLibRsRsLsmbRgRsmbLibRgb
LibLiLsRgbLibLgbLjLsmbLgbLgbRgbRgbLgRsbLsbLsRsbRgLsbRgbRgbRgbRibRiLsbR
ibRgRsmbRgbLsbsbLcbLcbLsbLhbLsbLibLibRibLsbRsbRibRgbLsbRibRgbLgbRgbLib
RsbsbRsbLgLsbRsbLibLibRibLobLgbLgRsRsmbLibRsbRjbRjRsmbLsbRsbsbLsRsbRgb
sbLsbRgLsbRgbRsbRsbsbLsRsRsmbsbRibRgbRgbRsbLsLsmbRsbRgLsRsbRsbLcbRibLg
LsbLsbLgbsbsbsbLgbRsLsbLsbRgbRjRsmbLgLsbRgLsbRgbLsbLgbLsbRsbRjbLsRsbLi
bLobLcbRibRsbRsbLsbLsbLgbLgLsbRsbLgbLsbLgbRgbLsbLibRgbLsbRsbLsbLibLgbR
gbRsbLiLsbRibRsbRgbsbLibRsbLgbRsbRsbRgbLsbRjLsbRsRsmbRsbRgbRsRsmbRsbLs
bRsbLibRsbLcbLibRgbLcbLibRsLsbRsbRsRsmbLgbRgbLsLsmbRsbLgbLgbLsbLsbLibR
gbLsLsmbLiLsbLsbLsbLibLgbLjbLsbRhRsmbLobLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 25; Drug: Control Apo 0.5 然
bRjbRibRgbRhbRibRibRgbRgbRgbLobRjbRhbRhbRobRibRjbRgbRibLobLgLsLsmbLibL
ibRibRgbRibRgbRsbRgbRobRobRibRibRcRiLsbLhbLcb

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 26; Drug: Control Apo 0.5 然
bRiRsmbRgRsmbRsbLibRgbRibRgbRgbRgbRibRgbRsbLibLibRsbLgRsbLiLsRsbLhbLsb
LgbLibRjRgbLjbLgbLibRibRibRcbLcbLgbLhbLsbLibLgbRcRsmbRibLjLsmbRibLibRg
bLgbRgbLjLgLsbRsbLgbLoLsmbLcbLiRsbRibRgbRjbLiLsbLibRobLiLsbLjbLsbRsbRs
b

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 27; Drug: Control Apo 0.5 然
bLjbRibRcbRgLsbRsRhbRebRhbRibLjRsbLebRibLsRcbRhbRibRebRcbRibRibRgbRibR
cRsmbLibLibRcbRjLsbRibRiLsbRibRjRjbRjbRjRsRsmmbRcbRjRgbRjbRhLsbLjbRcbL
jLcbLhbLjRsbLibRiRsmbRjRsmbRcbRsbRobReRsmbRhbRjRsmbRsbRcRsmbRcRsmbRcbR
gbRcbLsReRgbRjbRjbLjbRcRsLsmbRgLsbRibRebRcRsmbRobRcbRsbLjbLcLsmbLhbLeb
LjbRjRhbLcbLjbLjRsbLibLcbLcbLjbLjRsbLsLibLibLcbLcbLibLcbLcbLobLcbRobRc
bLcb

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 28; Drug: Control Apo 0.5 然
bLhbLgbLgLsbRiRsmbLcbLiRsLsbLcLsmbLiRsbRsbLibRgbLibRsbRsbRcbRibRhbRgbL
gbRhbRhbRjbRobRsLsbRgbRgbRgbRgbRiRsmbRsbLhbLjRsbLobRiLsbRcbLcbLcRsbRob
RgbRsbRcRsmbRsbRjbRgbLhbRobLjbRobRibRjRgbRcbLsRsbLsbRsbLsbRsbLcbLsbRsb
LhLibRob

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 29; Drug: Control Apo 0.5 然
bLgbRibRibRibRgbRsbRgbRgbRsbRsLsbRibRgbRgbRgbLibLcbRcbRibLsbLjbLibLibL
gbRjbRhbRobLibLhbRhbRibRibLsbRebLjbLibRobRobLgbRibRcb

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 30; Drug: Control Apo 0.5 然
bRcRsRsmmbLgLsbRgbLoLiRsRsmbRibRhRsmbRsbLoLiRsbRibLcbLsbLsbLgbLibRgbLh
bLiRsbLsbLsLcbLgLsbLsbRibLibRjbLibRgbLgbLsbLgRsbRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 31; Drug: Haloperidol 1 然 Apo 0.5 然
bLgbLjbLibRjbRobRhbRcbRgLsbRibRgbLibLibLgbLjLsmbRcbLibLgbRibLgbLibLibL
gbLcbLibRsbLsLsmbLcbLgbLgbRsbLibLgbLhbLsbLsbLgbLjRsbRjbLjbRiRsmbRibLgL
sbLjbLcbLgbRjbLgbLgbRjbLibLcbRibLgbLgbLjbLibRgbLibRgbLsbLiRsLsbLcbRsbR
obRibRcbLgLsLsmbRgbLjbRoLsbRibRibLgbLebLoLsmbLibLgbLjbLgbLgbLsbLgLsbLg
bLcbLcbRgRsmbRsLsbRibRgbLsLsmbRibRgbRobLsbLibLsbLibLcbLgbLgbLibRjbRobR
ibRibRcbRibLibLsbLgLsbLibLgbLjLibLibLibLjbRiRsmbLgbLjbRhRsmbLibRcLsbLi
bRjbLibLcbLibLjbLcbLsRsbLsLsmbLjbLjLsmbLibLsbLhbLjbLibLsbRcLsbLsbLibLj
LsmbLiRsbRjRsmbLibRhbRjbLibLsbLibLcbLhbLebLiLsbLjbLjbLcbLcbLhbLjLsmbRj
bLhbLjbRibLhbLcbLcbLib

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 32; Drug: Haloperidol 1 然 Apo 0.5 然
bLsbLgbRsbRcRsmbRgRsmbRibLgbRgRsRsmmbLjbLhLsbLiLsLsmbRibLibLibRgbLgLsb
LgbRsLsbLgLsbLgbLsLsmbLibsbRsbRgbsbLgbLgbLgLsbLibLgbLibRibLgbLgbRsbLsb
LsRsbsbLsbLgbLgbLgbLgLsbLsbLgbRsLsbLgbLgbsbLgbLgbLgbRobRibLiRsbLibLgbL
gbLsbLibRgbLsbLsbLgbLsbLgbLsbLgLsbLgbRgbRjRibRibRhbLjRsbLjbLiLsbLsbLsb
LibLibLibRjRsmbLgbLgLsbRsbRsbLgbLibRibLgLsbLibLgbsbRsLsbLgLsbLgRsbsbLg
bLibLsLsmbLsbLsbRsbRgbLgbLsbLgbRsbLsbLjLsmbLgbLsLsmbRgbLgbLsbLsbRsRsmb
LiLsbLjLsmbLgLsbLgbLsLsmbLgbLibLgbLgbLibLibLibLibLgbLsbsb

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 33; Drug: Haloperidol 1 然 Apo 0.5 然
bLibRsbRsRsmbLgLsbLgLsbRsbRsbLgLsbRsLsbLibRsbLsbLsbLgbLjbsbLgbRsLsbRsb
LgbRsbLjbRibLgbLsbRsbLgbLgbLgbRsbLgbLgbRgbLsbLgLsbRgbLgLsbRsLsbLsbLgbL
gbLgbLgbRgbLgbLgbRsbLgbRgbLgbRsbRsLgbLsbLgbLsbsbRsbLgbLsbLgbRgbRsbLiLs
bRsbLgLsLsmbLgbLsbLgbRgbLsbLibLgRsbRsbLsbLsbLgbRgbLibRgbLsbLgbLsRsbLsb
LsbLsLsmbLsbLgbLgbLgbRsLsbLgbLgbRgbLgbLgbRgbLgbRsbLgbLgbLsbLsbLgbLsbLg
bLgbRsRsmbsbLgbRsbLgbLgbLsbRsbLgbLsbLgbRsbLgbLsbLsbLgLsLsmbLgbRsLsbLgb
LsbLsbLsbLsbLsRsbLgbLgbRsLsbLgbRgbLgbRsbLgbLgbLsbLsbLsbLgbLsbLgbsbRgLs
bLgbLsbLsbLgbRgLsbLgLsbRsbLgLsbLsbLgbLgLsbRgbLgbLgbRsbLgbRsbLgbLgbRsLs
bRsbRsbLgbLgbLgbRsbLgbRsLgbRsbLsLsmbLsbLgbLsbLgbLsbLsbLgbLsLsmbRsbLgLs
bLgLsbLgbLgbLiLsbRgbLgbLsbLsbLgbLgbRsbLgbRsbLsbLgbRsbLgbLsLsmbRgbLgbRs
bLsbLgbRsbLjbLsbRsbLsbLgbRsbLgbLgbLsbLgbLsbLiRsbLibRgbLsbLsbLgLsbLgbRs
bLgbLgbRjbRcbRhbLjbRibLgbLjbRcbRhbRibLibRsbLsLsmbLsbRibRhbLibRcbRibRsb
LgbLsbRibLgbLjbLhbLsbRsbRibLiLsbRgbLgbRsbLgbRsbLgbRsbRsbLsbLgLsbRgbRsb
LibLibLsbLibRibLibLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 34; Drug: Haloperidol 1 然 Apo 0.5 然
bLiLsbLgLsbLebLgLsLsmbLiLsbRsbLsbLibLsLsmbLsbLgbRsbRsbLgbLsbRsbRgbRsbL
ibLsLsmbLsbLibLibLhbLiLsLsmbLgLsbLsLsmbLjLgLsLsmbLsLsLsmmbLgbLgbLgLsbL
gbLsbRsbLgLsbLgbLgbLgRsbLsLsmbLgLsbLsbLsbRcLsbLibLsbLgbLsbLibRcbRcbRgb
LsbLcbRsbLiLsbLsbLsbLgbLsbLsbLsbLsbRsLsbLhbLibLibLsbLsbLibLsRsbLibLsbL
gbLibLgbLibLgbLgbRsbRsbLcRsbLsbLiLsbLhbRibLsbRsbLgbLsLsmbLibLgbLcbRibL
sbLibLibLsbLgLsbLgbRjRsRsmmbLhbLsbLgbLsLsmbLgbLsbLgLsbRsLsbLsLsmbLibLh
bRgbLibRsbLsbRsbLibLibRjbsbLibLibLgbLsLsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 35; Drug: Haloperidol 1 然 Apo 0.5 然
bLoRsbLcbsbRsbRjbRibRibRgbRibRgbRgRsLsmbLgbLiLsbRibRibRcLsbRcbRibRgbRh
bRiLsbLjbRcbLcbLoRsbRibRibRobLibLibLcRsbRgbLgbLhbRgbRgbLsbLsbRcLsbRcbR
ibLgLsbRgbRsbRsbRsbRgbLcbRsbRsLsbRgbRsRsmbRsbRsbRsbLcbLibRjbRcbLcbLjLs
mbRobRibRsbLgbLibLcbLibLcbRgbRcbRgbLsLsmbRgbRgbLsbRibLjbLcbLcbRhbRsbLj
bRcbRjbLjLsmbRjbRibRsbRsbsbRjbLjbLjbRgbLcbLibsbRiRsmbLcbLcbLgbLsRsbLjL
smbLcbLobLibLibLibLgbRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 36; Drug: Haloperidol 1 然 Apo 0.5 然
bRjLsbLibRsRsmbLibLsbLgbLsbLgLsbLcbRibLibLgbLgbRsLsbLgbRjRgbRgbLjbRsbL
iRsbLibRhbLeLsbRebLhLsbLibRjbLhbLibLibRjbRjbLibsbRhRsmbLcLsmbLoRsbRsbL
gbLiLsbsbRebLebLibLsbsbRcbRcbLebLjLsmbLgLsbLgbLibsbLsbRsbRsbLgbLsbRsbL
gbLibLgbLgLsbLgbRjbRhbLibRjbLjbLgbRcbLgbLhbLobRiRsRsmmbsbRsbsbLsbRibLi
bLgbLsbRsbLgbLgbLsLsmbRsRsmbLsbRsbLsbLsbRsbLsbLsbRgbLsbLsbLsbLgbLgbLiL
sbRibLjbLjbRibRjRsmbRsLsbRjbRgbsbLgbLsbLibRjRsmbLgLsbRjbLjbRhbReRsmbLc
bRjbRsbRjbLjbRgbLjLsmbLjbLcbLhbLjRsbLiLsbRgbRibLibRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 37; Drug: Haloperidol 3 然 Apo 0.5 然
bRgbRgbRsRsRsmmbRsRsRsRsmmmbRsRsRsmmbsbRgbLgbRgbLsbRgbLsLsmbRibRcbRgRs
mbLsbLeRsbRibLsbRibRgbRgbRsbLsbRibLibRibRibLsbRhbRsbRsRsmbRibRgRsmbRgb
RgbRsRsRsmmbRgbRsLsRsbRgRsmbRgRsmbRgRsmbRgbRsbRgbRgRsmbRsRsmbRgbLsbLeb
LibRgRsmbLibRgLsbLibLsbLgbLgbLsbLiRsbLgRsbLgLsbLgbLgLsbLgbLsbRgbLibLsL
smbRgRcbRiRsRsmmbLsbRgbRgbRsRsmbRsRsmbRgbRibLibLsbRhbRibLgbRibLgLsbRib
RsLsbLgLsLsmbRibLsbRsRsmbLgLsbLsbRoRsmbLibRcbRibRsbRgbLsbLgbRgbRsbLobL
hbsbRsbsbRibLhbLcbLsbLgbLgbRjbRcbRibRibRgbLgbLgLsbLjbLibLiLsbLsLsmbLsb
LsLsLsLsmmmbLgbLgLsbLcRsbLsRsbLgbLsbLgbLsbRcRsRgmbRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 38; Drug: Haloperidol 3 然 Apo 0.5 然
bLsbRgbRiRsLsmbLjbRiRsmbRgbLsbRgbRgbLeLsbLiLsbLsLsmbLibLsbLgbLsbLgbLgb
LsbLgbLgbLgRsbLgRsbRgbLgbRgbLsLiRsbRgLsRsbLhbLsbLibLgLsbRgbLibRgbLibLs
LsmbLgbLgbLgbLgbLsbLiLsbRibLcbRibLsRsLsbLcRsbLgLsbRibLcbRjbLcLsmbLsRgb
LibRsbLgbLgbRgbLibRgbLiLsbLgbRgLsbLgLsbLibLibLsbLiRsbRsbLgLsRsbLgbRgbL
ibRsbLgbLibRgRsmbLibLsbRcbLibRibLibRgbLibLgbLgLsbLgbLibRibLcLsmbLibLib
LgbLibRsbLiLsRsbLgbRgbLibLibLgbLsbLgbLgbRhbsbLeLsbLobRgbLcRsbLgbLgbRsb
LibRgbLgbLiLsbLibRsbLibRcbLcbRsLsLsmbLiLsbLgbRobRgbLibRibLiLsbLgbRsbLh
bRjbLcbRgLsbLibRgbLcbLibRgbRgbRiLsbLsbRibLgLsbRsbRibRsbRgLsbRibRoLsbLi
bRsbRgbLibLiRsbLgbRibLibRgbLibLibLsbLsbRibRcbLsRsbLjbLcLsRsmbLibLsbLgb
LibLsbLgbLgbRjbRcbLeRsbLiLsbRiLsbLibRgRsmbRgbLebLibRgbLcbLibLgbRcbRcbR
gbLibLcbRsRsmbLibLibRgbLsbRgbRsbLibRgbLgLsbLiLsbLhbLiLsbLiRsbLgbLiLsbL
gLsbLgbLgbRobLgbLib

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 39; Drug: Haloperidol 3 然 Apo 0.5 然
bLhbLsLsmbRsLsbLibLgLsbLsbRcbRibRgbRiRsmbLibRgbLibLcbLibLibLgbRgbLsbLi
bRgbLibLsbLhbRjbLibLgbLsRsbLsLsmbLgbRsLsbLsbLsbLsbLgbRsbRgbLibLsbLgbLg
bLgbLsbLgbLgRsbRsbLibLsbRsRcbRibRibLgbRhbLgLsRsbLjbLibRjRsmbRiRsmbLgbR
ibLjbRibRsbRiRsmbRgbLsbRibLsbRiRsRsmmbLgbRgbRgbRgLsbRgbRgRsmbLsbRibRgb
LsbRgbRgRsmbRsbRgbRgbRgRsmbRgbRgbRibRgbRgbRgbRsRsmbRgbLsbLcbLhbLcbLgbR
gbLibLibRjbRcbLibRibRibLcbLhLsbLhbRgbLhRsbLcLsmbLiRsbRgRsmbLjbLcbRcbRi
bLgbRibLsbRibRgbLcbRjbRibRiRsmbRibRgLsbsbsbsbsbRsbsbsbRsRgLsbRsbRsbRgb
RgRsmbRgbRgbRiRgbRgRsmbRgbLsLsmbRibLsbLobLibLhLsbRibLcbLhLsbRsbLgbRibL
sbLibLgbLgLsRsbRgbLsbLibRsbLibLsbLibLibLibRgbLibRgbRsbRibRiRsmbLcLgbLs
bLibRgRsmbLibRsbLgbLibLibRgbLhbLiLsbRsbLcLsRsmbLgbLsLsmbRcbRsbLsbRibLi
bLibLcLsmbRsbLgbLhLsbRsbLiLsbLgbLibRsbLibRsbRcbRhbRgbLgbRibRgbLsbRibRg
bLsbRgbLsbRibLgbRibLsbRibRgbRiRibRgbRiRiRsRiRimbRgbRgbRgbRibLsbLsLsmbL
gbLibLsbLcbLibLgbLgbLgbLgbLiLsbRgbLib

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 40; Drug: Haloperidol 3 然 Apo 0.5 然
bLibLibRsbRsLsbLsbLsbLibLgLsbsbRsbLibRgbLgbLgRsLsbLsLsmbLgbRsbRsbRsbRs
bRsbLibLgbRsRsmbLsbLgbLsbLgbRsLsbLgbLgbLsLsmbLgbRsbLgbLibLgbLgbLsbRsbs
bRsLsbRsbLsLsmbRsRsmbLgbLsbLcbLibLsbLgbRgbRgbRhbRebLsLsmbLsbRsbRgbRgbR
cbLsbLgbRgbLsbsbsbsbsbsbRcbLiLsbLsbRsbRibRhbRgbLsbRsbsbLoLsmbLibLsLsmb
LsbRsbRsbLgLsbLgRsbRsbLgRsbRsRsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 41; Drug: Haloperidol 3 然 Apo 0.5 然
bRsLsbRiLsbLjbRibLcbLcLsmbLgLsbRsLsbLgbLsbLsbLiLsbLhbLsbLgbRsbRsbLibLh
LsbRgbLsLsmbRibRibRhbRgbRgbRsbRgbRcLsbLgbRsbRiLsbRgbRsbLgbLebLibRsRsmb
LibLibLsbRsbLsbRsLsLsmbLiLsbRsLsbRiLsbLgbLsRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 42; Drug: Haloperidol 3 然 Apo 0.5 然
bLsbRibRibRsbRibRsbRgbRgbRsbRgbRgbRgbLsbRgbRgbRsbRsbRgbRgbLcRsbLobLobL
ibRsbLgbRobLsbLoRsbLsbLgbLsbLibRjbRcbRcbLibLgbRhbRgbsbLsbRcbRcRsmbLibR
sbLiLgRibRjbRibRgbRgRsmbRgbRgbLgbRsbRgbRgbLhbLcbRhbLcbRjRsmbRhbRgbLjRs
bRhLsbLgbRibRsbRgbRibLjbRgbRgbLsbRgbRgbRgbRgbRhbLebRgbLibLgLsbRjbRhbRg
bRibLibRgbLibRcbRsbRsRsmbRgbLsbLgbRgbRgbLsLsmbLsbsbLsLsLjmbLsLsLsmmbLc
bRgRsmbRgbLobLjLsmbRjRsRsmmbRsbLcbLgbRsRsmbLsbLibLgbLgbRgbLibRjbsbRsbs
bLjbsbsbRjbRgbRhbLhbRoLsbRcbRgRsmbLibRgbRibRgbRgbRgbRsbRgbRibLebLibLcR
sLsbRibLcbLibLcbRcbRobLgbRgRsmbLibRcLsbRhRsmbLgLsbLgLsRsbLgbLhbLcbRsRs
mbLibRgbLibRsRsmbRjRsmbLhbRsbLibLgRsbRsLsbLibRjbLcbLgbRibLibRjbRcbRibR
ebRibLiLsbLibRibLibLgLsbRcbRibLcbLcLsmbLcLsmbLgbRsLsbRgbLcbLibRiRsmbLi
bRebRibLibRjRsRsRsmmmbRjRsmbLibLibRsRsmbRgbRgbRgbLibLjLsmbRjbRsRsmbLjL
smbRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 43; Drug: Haloperidol 10 然 Apo 0.5 然
bRsLsbLsbLsbLgbLsLsLsLsmmmbLgLsbsbLsLsmbRsLsbLsLsLsLsLsmmmmbRsbLgbRsLs
bLgbLsbLsbLsLsLsLsmmmbRsRsmbLgbLsbLsLgbRsbLgbLgLsbLgLsLsmbRgbRibLsbRib
RsbRsLsbLsbRsbLsbsbLgbRgbRsbRsbRsbRsbRsbRsbRgRsmbRgRsmbRsRsmbRgbRsLsbL
sRsRsmbLsbRgRsmbRgRsmbRsRsmbRgRsmbRgbLsbRsbRsbRsbRgbRsbRsbRsbRsbRgRsmb
RsbLsbLsRsbRsbRsbRsbRsbLsRsRsmbLsRsbRgbRgbRgbRsbRsbLsbRsbRgbRsLsbRsRsm
bRsbRsbRgRsmbRgbRgbRgRsmbRgbRgRsmbRsbRgbRgbRgbRgbRgRsmbRsLsbRsbsbRsbRs
bLsbRsbRgbRgbRsbRsbRsbLsbLsbRsbRgRsmbRsbRsbRsbRsbRsbRsbRsbRsRsmbRsbLsb
RsbRsbsbLsbLsRsbRsbRgbRsbRsbRsbRsbRsbRsbRsbRsRsmbRgbLsbLsLsRsLsRsRsmmb
sbsbsbsbRsLsRsRsmbRgRgRsmbRjbLjRsbLcbsbLsbLsLsmbLsbLsbLgbLiLsbLjbRhbRg
LsbRgRsmbRsbRibRgRsLsRsRsmmbRsbRibLjbLcbLibLgbLibRgLsbRsbRsRsmbRgbRsbL
sbLgbLgbLsbLgbRgbRgbLjbLsbLsbLsbLgLsbRsbLgbsbLsLsmbRsLsbRsLsbLsbLsbLsb
LgbLsbLsbLsRsbRsbLsbLsLsmbLsbLsbLsbLsbLsbLsbLsRsLsbLgRsbLsbLsbLsbLgbLs
RsLsLsLsmmbsbLsLsLsRsRsmmmbLsRsbLgbLsbRsbLsbLsbLgbLsbRsbLsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 44; Drug: Haloperidol 10 然 Apo 0.5 然
bLsLsRgmbLsbLsLsmbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 45; Drug: Haloperidol 10 然 Apo 0.5 然
bRgRsmbRgbRgbRgbRgbRgbRsbRgbRgbRgbRsbRsbRgbRsbRgbLsbRsbRsbRgbRsLsbRgbL
sbLsbRgbRgbRgRsmbRsRgbRsbRsbRgLsbRsLsbRsbRgbRsbRsbRsbRgbRgbRsbRsbRhbRi
RsRsmmbRgbRsbRsRgbLcRsbRsLiLsbLibRebRgbRgbRsbRgbRgbRgbRsbsbRgbRgbRsbRs
bRgbRgbLsbRgbRsbRsbRgbRsbLsbRsbRgbRgbRebLsRsbRsLsRsRsmbRgbRsbLsRgbRsRs
mbRibLsRsbsbLjbLsbLoLsmbRgbRibLgbLgbLsbLgbRsbLibLsbLgbLeRgbLeLsLsmbLgL
sbLgbLgRsbRsbLgbRsbLgbLgbLgbLgbLgbLiLsbLgbLgbLgbLgbLsbsbsbsbsbLsbLhRsb
LsbLibLibLibLgbLgbLsLsmbLgbRjbLsbsbLsbRibRsbLsbRjbsbsbsbRsbLsbRsbsbLsb
sbRgbRsLebLobLsbLsbLgbLgbLsbLibRsbLsbLgbRsbRsbLeRsbRgbRgLsLsRsmbLjbRjb
LsRsbLjbLsLsmbsbRsRsmbRjbRgbLsbRjbRgbRgbRgbRgbRgRsmbRsbRgbRgbRsbRgbRsb
LsbRgbRsbRsbLsRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 46; Drug: Haloperidol 10 然 Apo 0.5 然
bLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 47; Drug: Haloperidol 10 然 Apo 0.5 然
bLsbLcbLgbLhbsbRgRsRsmmbLibLibLgbLgbLsbLsLsmbLgbRsbLhbLcbLcbLcLsmbLcbR
gbRiRsmbRiLsbRgbRgRsmbRgbRiRsmbLgbRgbRsbRgbLsbRibLgRsbRibRsbLsbRiLsLsR
sRgmbRibRibLsLsmbLcbLebLsbRobRibsbRsbRibLsbLsbRsRsLsmbLsbLcbLgbLgLsbRs
bRsbLcbRibRsbRsbRibRsRsRgmbLsbRsbRgbRsRsRsRgRgmmbRgRsmbRsRsRgRgmbRgbRi
bRgbRgRsLsmbRibLibLjbLgbLibLsbLibLibLebRgRsmbRibRjRgbRgbRgbLibLibRsbLi
LsbRgbLgbLgbLsbLgbLgbLgRsbLhbRsbLcbLgbRgbLsRsbLibLgbLgLsbLsbLsbRcbRibL
sbRgRsRsRsmmmbLsRsRsmbRgRsmbRsbRiRsmbRgRsmbRgbRibLsbLsbLibLibRsbLibLgb
RsRgRsmbRsRsmbLibLsbLiLsbLsbRjbsbRibRgRsmbRsbRiRsmbRgbLsbRiRsmbRgbRsbs
bRsbLsLsmbRsRsRsmmbLsbLsbLgbRcbLsbLsbRsbsbRsRsmbRgRsmbRgbRsbRgbRsbRsbR
gbRibLsbRgbRiRsmbRsRsRsmmbRgbRgRsmbLsRsbRgbRsRgRsmbRgbRsRsmbRgbRgbRgbR
iRsmbRgRsmbRgRsmbRsbRsbRsbLsbRsbLsRsbLsbRsLsbRsRsmbLsbLsbRsbRibRgbRsRs
mbRsRsmbLsbLsbsbsbsbLibLgbLibRsbRibRibRsbRsbRibRgbLsRsbLsbLcLsmbLgbLgL
sRsbRsbsbRsbLsLsLsmmbLsbRsRsRsmmbLibRsbsbsbLsbLsRsLsbLsbRsbsbsbLsbsbsb
LsbLsbLibRsbsbsbsbLsbLsbLsLsmbLsLsmbLgbLsbRgLsbRsLsbRsbLsLsmbLsbRsLsbL
sbLsLsmbLsLsmbLsbLsLsmbLsLsmbLsbLsbLibLsLsmbLgLsbLiLsLsLsmmbLibLibLsbL
cbsbsbLsbsbLibLgbRsLibLsbsbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 152952; End: 153452;
Recording: 1-1; Individual: 48; Drug: Haloperidol 10 然 Apo 0.5 然
bRsbLgbLgbLsbLsbLsbLsbLsLsmbLsLsmbLsbLsbLsLsLsmmbLgLsbLsbLsbLsLsmbLsbL
sRsbLsbLsRsbLsbLibLsbLsbRsbRsRgbLcbLsLsmbLsRsbLsLsmbLgbLgLsbRsbLgbLsbL
gbLsLsLsmmbLgbLsbLsbLgLsbLsbLsLsmbLsbLgbLsbLsbLsbLsbLsbLsLsmbLgbLsbLsb
LgbLgLsbLiLsbLiLsRsLsbLibLibLgbLiLsbLgLsbLgLsbLgbLiLsbLsbLsbLgbLgRsbLs
RsbLgbRsbLgbRebLobRibRebRiLsbLgbRibRgbRsbRgRsmbRibReRsmbRiRsmbLjLsmbLh
LsbLgbLgbLgbLgbLibLgLsbLgLsLsmbLgbLgbLgbLhbLjLibRcbLgbRsbLsbLsLsmbLgbL
sbLsbLsbLsLsmbLgbLsbLsbLsbRsbLsbRsbRsbLgbLgbLgbLsLsmbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 1; Drug: Control Apo 0.5 然
bLibRcbLibLgRsbLcbLibLcRsbLcbLibLibLjbLgbLibLobLgbLibLibLibLjRsbLibLcb
LcbLhbLiLsbLobLcbLobLibLcbLebLibLibLibLsbLgbLsLsmbLsLsmbLgbLibRobLcbLh
b

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 2; Drug: Control Apo 0.5 然
bLcRsbLsLsmbLiLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 3; Drug: Control Apo 0.5 然
bRgbLsLeLcbLcRsbLcbLcbLebLsLsmbLjbLcbLibLibRsbLibLcbLcbLibLibRjbLcbRib
Rib

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 4; Drug: Control Apo 0.5 然
bRoRsmbRib

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 5; Drug: Control Apo 0.5 然
bRcbRjbRoLsRsbRgbLebLsbLibLgbLgbLibLgbLgbRibRobRobRgbRibLgbRgRsmbLcbLi
bLcbLobRiLsbRgbRsbRoLsLsmbRsbRobLgbReRsmbRibRgbRjRsmbRsLsbRsbRhbRiRsmb
LibLgbRgbRsbRjbLcb

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 6; Drug: Control Apo 0.5 然
bLibLcbLjbRobRcb

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 7; Drug: Haloperidol 1 然 Apo 0.5 然
bLebLgbLeLibLsbLcLsLsmmbLsbLcbLibLgbRgbLgRsbRhbLsbRibRjbRhRsmbLoLsLsmm
bLsbRsRsmbRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 8; Drug: Haloperidol 1 然 Apo 0.5 然
bRjRsmbRsRsRsmmbsbsbLsbLgLsbLgbLgbRsbRsRsmbLhbLhbLibLcbRibLibRibLgbLjL
sLsmmbRibLgLsbLgRsbLgbRibRsbRebRibLcbLhbLsbLsbLibRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 9; Drug: Haloperidol 1 然 Apo 0.5 然
bLibRiRsmbRibRgbRsbRibRsbRsbRgbRgbRjRsmbRibLsbRiRsmbRgRsmbLgbLiRsbLcbL
cbLibLgbLgbsbLgbLgLsbLsbLgbLibRgbRibLibLibRcRsmbRibLsbRsbRibLiRsbLgbRi
bRibsbRgbLsbRgbRgbRobLibRcbRgbLsbRgbRgbRibRibRgRsmbRgbLibRebRhRsmbRibR
ibRgbLjbRibRsLsbRsRsmbRsbRibRibRibLgbRsbRcbRgLsbLsbRibRibRgbRsbRibRgbR
ibRibRibRibRgRsmbLgbLgLsLsmbRibRcbRsbRgbRsbRhbRsbRibRsbLsbReRsmbRgRsRs
mmb

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 10; Drug: Haloperidol 1 然 Apo 0.5 然
bLgbRibRibLebLsbLgLsbLgLsbLsbLsbLsbRsbLsbRsRsmbLsbRcRsmbRgbLgbRcbRgbLs
LsLsmmbLsbRibLsbRsbLgbRibRgbRoRsmbRsLsbLibLibLibRsbRsLsLsmbRgbLiLsbLgb
LiLsbLsbLibLgbLjbLjbRibLgRsbRgRsmbRebLgbLsbLgLsbLebLibLibLibLibLgbLgRs
bRjbLiLsbLcbLhbLibLgbLibLgbLgLsbLcbLibLjbLibLsbLsbLgbLibLibRsbLgbRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 11; Drug: Haloperidol 1 然 Apo 0.5 然
bRsbRjRsRsmmbRibLsLsmbLibLibLhbRsbRebRgbsbsbRsRsmbRgbRibRcRsmbRgbRgbRs
bRcbRibRgbRsbRibRsbRgbRgbRibRgbRsbRgbRsbsbRsbRsRsmbLsbRoRsmbLoLsmbRgbL
gLsbLhbsbLsRsLsRsRsRsLsmmbRsbRsbsbsbLsLsmbsbLsbLsbRsbLsLsmbRsbRsbRsLsL
smbsbRsbLjLgRsbRsRsmbLiRsbRsRsRsmmbRsbLibRjbRoLsbLsbsbLgbLcbRsbRjRcbRs
RsmbRibRsbRjLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 12; Drug: Haloperidol 1 然 Apo 0.5 然
bLsbLgbLsbLsLsmbRsbRgbRsbLgbsbLsbRsbLeLsbLsbLsbLiLsbLsbLsbLsbRjbRgbRib
RiLsbLgbRjRsmbRhbRebLsbLsbLhLsLsmbLsbRsbLhbRoRsmbLsbLsbLebLibRjbLibLsb
LibLjRsRsmbRsbRibLcRsbLhbLiLsbLsbReRsmbLcbLibRibRjbRhbRgRsmbRobRsRiRsm
bRhbRoRsmbLsbLibRcbRibRsbRiRsmbLjbLcbLgbRgbLcbRjbRjbRibLsbLsRsbRjbLsbR
jRsmbRgbRibLsbLsbLiLsbLsLsmbLiLsRsLsbLibLibLibLgbRgbLsbsbRgbRibLcbRobR
ibLjbRsbRjRsmbLsbLsbRibLjbRgbRibRsLsbRgRsmbRgbRibLjbRhbLcbLcRsbLsbLsbR
gbLib

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 13; Drug: Haloperidol 3 然 Apo 0.5 然
bLsbLsbLobLcbRibLsbRhLsbRgbLsLsmbRsbLjbRcbLjbRjbLcbLcLsmbLcRsbRsbRsbRi
bLsbRcRsLsmbRibRgLsbLibRsbRcbLjbRibRgbRsRsmbRsbRgbRgbLsLsmbLibLjLsmbRe
bRibRsbRibRgbLgbLibRhbLebRjRsRsmmbRiLsbRibRibLibLebRjbLcLsmbLibLsbLsbR
jbRibLcbLibRsbLcbLcbLibLgbLsbLcbRsLsbLcbLcbLsbLsLsmbLgLsbLjbLgbLibRsLs
bRjbRibRcbLcbLeLsbLjLsLsmmbLcbLibLiLsbLsbLsbRcbLebLebRsbRjRebLcbRcbLsb
LibLsbRhbRcRsmbRgLsbRgbRsbLcbRsbRibRcbRibsbRgbRsbRcbLsLsmbLhbLcbLsbLsb
RjbRcbRsbRgLsbLcbLebLsbLjLsmbLgLsLsmbLsbRsRsRsmmbLsbLebRsRsmbLiRsbLgLs
bLsLsmbLsbLebLsbRoLsbLsLsmbRcRsLsmbRsbRsbRiLsbLgbRibLsbRgLsRsbLsbRgbLs
bLcLsmbLsLsmbLibRgLsbLcb

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 14; Drug: Haloperidol 3 然 Apo 0.5 然
bRibRsbLgbRsbRgbLsbRgbRibLsbLgbRibRebRhbRiRsmbRgbRiRsmbRgbRgbRgbRgbLgb
RgbRgbRiRsmbLgbRsbRibLibRjLsbRibRsRsRsmmbLsLsmbRsbRsbRgbRsbRibLsLsmbLs
bLibLibLcLsmbRgLsbRibLibRiLsbRsbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 15; Drug: Haloperidol 3 然 Apo 0.5 然
bRjbRibRibLsbLsbLhbLibRobRsbLgLsRsbLibRoLsbRsbRgbLsbsbRsLsLsmbRgRsmbLs
LsmbLsbRgRsmbRebLcbLcbRjbLibRcbLsbRsbLjbRjbRsbRsbRsbLibRgbLgbLsLsmbLgb
RgbLgbRsbRgbLhbRsRsmbLsbRsbLsRsLsLsmbLsbRsRsmbRsbLsLsmbLgbLgLsbLsRsbLs
bRsbLgRsRsmbsbLjbLcbRibLgRsbRibsbRobLjbLgbLjbLiRsbRibLsbLsRsbRsbLsbRsR
smbsbRcbLcbRsbLsbLsbLobLsbLsbLibRjbRebLjbLcbRobRibLgLsbRjbLobLgbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 16; Drug: Haloperidol 3 然 Apo 0.5 然
bLsbLgLsbRsbLsbLsbLjbLgbRgbLsbLgbRsRsmbsbRsbLibRsbLsbLgbLgLsbRibsbLgbL
sLsmbLgbLgbLobRsRsmbRsbLsbLsbsbRsRibRsbLgbRsLsbsbLsbsbLsbRsLsbLsbRsbsb
RsLsRsLsRsRsLsmbRsLsbsbLsbLsbRsbRsbRsRsmbLsbRsbRgbRsbLgbRjbRhbRoRsRsmm
bLcLsmbsbRsLsbLibRiRsmbRjLsbRhbLsbRgbRgbRgbRgRsmbRsLsRsbLjbRgRsmbRibRs
LsbRsbLgbLjLiLsbLibLibLhbLsbLsbLgbLgLsbLgbLsbLibRgbRcbRgbReRsmbRibRibR
ibRcbRibRiLsLsmbRibRibRsbLsbLeLsbLoLsmbRebRcRsmbLsbRibRhRsmbLsbRiRsmbL
gbLibLhbRgbRhbRgbRiRsmbRgbRcbLsbRgbRjbRgbRiLsbRcRsmbRhbRgbRgbRgbRsbLcb
LiLsbLsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 17; Drug: Haloperidol 3 然 Apo 0.5 然
bLjbRsbsbsbsbRcbRibRsbRsbLjbLsbsbsbRsbLcbsbRsbLoRgbRsbRgbLibLsbLgLsbLs
bLgbLsbRsbLhbRcbLsbRibRiRsmbRgbRsbRsbLsbLsbRsLsbLsLsmbsbsbsbsbLsRsbsbR
ibRgbRsbRibRsbLgbRiRsmbRsbRjbRgbReRsLsmbRsbLgbRsbRjbRhRsmbRibRsbRsbRgb
RibRibRsRsmbLcbLcbLebRsbLibRsbLibLsbLgbLgbLibLibLibRibLsbLsbRiRsmbLsbL
jbLcbLsbLcbLgbRsbRibLsbLibRjRsmbRibRsRsRsmmbRibRsbRibRgbLhbRsbLsbLgbLs
bLiRsbRgbLsbLcbRibLsbRibsbLjbLib

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 18; Drug: Haloperidol 3 然 Apo 0.5 然
bsbLsRsbLsbLsRsbLsRsbLgLsbLsbRsbsbLgbLsbLsLsmbLgbLsbLsLsmbLsbsbsbLsbsb
LsbLgbLsbRsbLsLsLsmmbLsbsbLgbRgLsbRsLsbsbLsRsbLsLsmbsbRsbLsbsbLgLsbLsL
smbRsbRsbRsbLsbLsbLsbLgbRsLsbLsbRsbsbsbLsbLgLsbRsLsbLsbsbLsbLsbLsbLsbs
bLsbLsbLsbLsbLsbRsLsbLgbRsbLsRsLsbRsbRibLgLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 19; Drug: Haloperidol 10 然 Apo 0.5 然
bRgbRsRsRgRgmbRsbRsbRsbRsbLsRsRsmbRsbRsbRgbRgRsmbRsbRsbRibsbRsbRsbLsbL
sbsbRsbRsbLsbRsbsbsbLhbLgbLsLsmbRsbLsbLsLsmbsbRsbLsRsbLgRsbLgbLsbLsbLs
bLgbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 20; Drug: Haloperidol 10 然 Apo 0.5 然
bRsbLsbLjbLiLsbLsbLgbLgbRsRsRsmmbLgbsbsbRsLsLsmbLgbRgbRsbLibLgbLgbsbLg
bLsbLsbLsLsmbRgbRsbRgbLsbLsbRebRebLiLsbLibsbsbLgRebRsbRjbLgbLibLcbRsbL
sbRibRgRsmbRjbLsRsbLsbsbLsbLsbsbRsRsmbLsRsbRjbRoRsmbLjbRebRcbRgRsRsRsm
mmbRgRhbRjbLgbRhbLgbLhbLiRsbRsbRhbRibsbRgbRgbLcbLibLgbRsbRsbRsbRsbLgbL
sbRhbRgbRgbRgRgbLcbLcbLcbLgLsbLibLjbLiRsbRjbsbRsbsbsbsbsbRsbsbLjbsbsbR
gbLsbsbRsbRjbRibsbRsbsbRgbLsbLjbRjbsbRoRgbLsbLsbLsbRsbLjRsLjbsbRgRsRsm
mbLjbLjbLsLsmbRsbRgbReRsRsmmbLgbLiLsLsmbLsbLsbRsRhbsbsbRsbReRsmbLjLsmb
sbLibsbsbsb

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 21; Drug: Haloperidol 10 然 Apo 0.5 然
bLsLsmbLsLsmbsbRsRsmbLsbRjbRjbRcbLiRsbLgbLsbLsLsmbLsbLsLsLsmmbLgbLgbLg
bLgbLgbLsbLsbLsRsbLsLsmbLsLsRsmbLsLsmbLsbLsLiLsbLsbLsbLsLsmbLsbLsbLsbL
sbLsbLsbLsRsbLsbLsbLsbLsbLgbLgbRsLsbRgbLcbRhb

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 22; Drug: Haloperidol 10 然 Apo 0.5 然
b

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 23; Drug: Haloperidol 10 然 Apo 0.5 然
bRob

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 24; Drug: Haloperidol 10 然 Apo 0.5 然
bLgbRiRsmbRsbRibsbLgbRjbRibRsRsmbRgbRsbRgRsmbRgbLgbLcbLsbLgbRcbRsbRibL
sLsRsmbLibLgbLgbLsbLgbRsbRjbLibsbRsbRsbLgLsbLibLibLibRsbLsbRgbRjbLsbsb
RjbRsRsmbRgbLgbRibLjbLcbLgbLsLsmbLsbRjbRebRibRgbsbRsbRsbRobRhbLcbRsLsb
sbRjbLgbRebLsbRiLsbRsbLcbLibRsbRsbLgbLgbLsbLgbRsbRgbLsLsRsmbRjbLhbRgbR
ibLsbLibLsbRsbLibLibRsbLsbLsLsmbRgbLiLsbRjbRjbRhbRsbLgLsbLibRsbLsbLgbR
gRsmbLsbsbLgbLgbLgbLgbRsbLgbRsLsbLjbRcbRibRibsbRsbRgbRsRsmbRsbLgbLcbLs
bLsbLibLsLsmbRsRsmbRsbRsbRsbLiLsbRgbLgbLgbsbRjbRsbRgbLcbLsbRobRibRsbsb
RibLibRgbRsbRsbRgbLcbLhbRjbRjbLjbLibLibRsbsbLibRebLibLibRjbRibLjbLibRs
bRsbLiRsbLsbLsbRgbRjbRsbLgbLsbLsLsmbLsbLsLsmbLsLsmbLgbLsbLsbLsbLgbLsbL
sbsbRcbRibRibRgbLsRsbRoLsbLibLibLsbLsbLibLsbLgbRjbRcbRibLsLsmbRsLsRsbR
gbRgbRebRsLsbLsbRsbRgbLhLsbLgbLgbLjbLgRsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 25; Drug: Control Apo 0.5 然
bRibRsLsbLgbRobLoRsbRcRsLsmbRoLsbLgbRhbRcbRgbLsRebRsbRsbLsbRsbRsbRgbRo
LsbLob

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 26; Drug: Control Apo 0.5 然
bRsbRsLibLgbLgLsbLsLsmbRsbRgRsmbLhbRjRsRsRsmmmbRsbLibRsRsmbRgRsmbLjbRg
bRibLsRsRsmbLgbLsbLhbRjbLsbLgbLgbRgbLjbRsLcRsbLcbLcLsRsmbLsRibRhbLsbLg
bLcbRibRibLiLsbRibLgRsbRjbLobRibRibRsRsmbLjLsLsmmbRib

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 27; Drug: Control Apo 0.5 然
bRjLsbRjbLcbLobLibRcbRhbLcbLcbLcLsmbLibLhLsbRiRsmbRibRobRjbRcRsmbRgbRj
RgLsbRibRjbRibLibRsbRibRjb

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 28; Drug: Control Apo 0.5 然
bRobRobRjbRjbRjRjbLobLobLcbLoLsRsmbRobRsbRebRobRjbLhLsbLsbRsbRibRjRsRs
mmbLibRsbRsbRhbLobLjbLgbLcbRcbLsbRsbRsbRobLoLsmbRsbRsRsmbRjbRobLcRsbLi
bLibLcbRcbRjbLobLobLcbLcbLcbLobLcbLjRsRsmbLgbLcbLjbLoLsmbsbLsLsmbRsbRs
bsbLsRsbRsLsbRsbLsRsLsRsRsRsmmbRsLsRsbLsRsbRsbLsbLibLcbLgbRobLgbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 29; Drug: Control Apo 0.5 然
bRgbRibRiRsmbLgbRiLsbRgbRgbRcRsmbLgbRibRsLsbRiLsbRiRsmbRjbLibLcLsmbLiL
sbRibRibLhbLhRsbLebLibLgRsbLcbRibRcbLcbRgbRhbLibLibLibLiRsbRib

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 30; Drug: Control Apo 0.5 然
bLibRsRsmbRjbRgbLhbRibRhbLcbRgbRgbLcRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 31; Drug: Haloperidol 1 然 Apo 0.5 然
bLebLcbLcbLibLsbRgbLcbLibLjbLebLhbLibLcbLjbLibRcbLjLsmbRjbLjbLjbLjbLcb
LcbLsbLcbRsbRebLsbRobLsbRibRjbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 32; Drug: Haloperidol 1 然 Apo 0.5 然
bLgbLgbLsbLgbLibLgbLgbRcRsmbRgbRgRsmbRgbRgRsmbRhRsmbsbRsRsmbRgRsmbRibL
ibLsbLgbLsbLibLgbLibRgbRgbRsbLgbRsRsmbLobLsbLgbLibRcbLsLsmbLibLibLgbRs
bRsbLibRsbLgbLibLsbsbRgbRgbLibRibLhbLibRgbLsbRhbRsbRsRsmbRcbRoLsbLcbLi
bLibRobLgbLgbRcLsbRgbRobLibLgbLsbRoLsbLgbRcbLsbLsbLjb

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 33; Drug: Haloperidol 1 然 Apo 0.5 然
bLsbRgbRsbRjbRibRsbRibRsbRibRgbRibRsbRibLibRgbLibLibRcbLiLsbRcbRsbLgbL
sbRibRsbLsbLgbLgbRgbLgbLgbRsbRsbLgbLsLsLsmmbLsbLsbRsbRgbLgLsbLgbLsbLgb
sbRgbLibRcbLebLgbLgbRgbLsbLsbLsbRsRsRsmmbLibRgbLgbLsbLgbLibRsbLsbLgbLs
bLgbLibLibRsbRsbLsLgbLsbLgbLgbLgLsbLgbLsbRsbRsbLsbLgbLibLgbLsbLgbLsbLg
bLgLsbLsLsmbLsbLsLsmbLsLsmbLibLibLgbRsbRsbLsbRgbLcbLibRgRsmbRgbLsbLgbR
gbLsbLgbLgbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 34; Drug: Haloperidol 1 然 Apo 0.5 然
bLgbLsbLsbLgbLsbLsbLgbLgbLsbLobLsbRibLhbLibLibRibLcbRibLcbLibLsbRibRjb
LcbLebLebLsbLsbLsbLcRsbRgbLobRjbRcbLsbLsLsmbRsLebLhbLiLsbLgLsbLibRsbLg
bLgbLgbRgbLhbLibLsbLsbLsbLhbRsbLsbRsbLsbLsbLsbLhbRsbLibLsbLsbLgbLgbLgb
LsLsRsmbLsbLibLgbLsLsmbLsLsmbRsbLsbLiLsbRsbLibLgbRsbLsRsbLibLgbRsRsmbL
sbRjbLibLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 35; Drug: Haloperidol 1 然 Apo 0.5 然
bRsbRsbRgbsbLgbLjbLcbLsLsmbLcRsbLibLgbLgbLgbLsLsmbLgbRobRjRsmbLgbRjbLi
bRiLsLsmbLjRsbLcRsbLjbLsbLgbRsbRoLsRsbRjRsmbRibRgbRsbRgbLcbRgbRjbRgbsb
Rsb

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 36; Drug: Haloperidol 1 然 Apo 0.5 然
bLibRcb

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 37; Drug: Haloperidol 3 然 Apo 0.5 然
bRgbRcbRibRibsbLgbRcRsmbLibLibLsbLgLsbLsbLgLsbLsbLgbRsbLgbLgbLgbLsbLgL
sbLsbLgbRsbLsLsmbLibLgbLsbLsLsmbLgbRgbLibRsbLgLsbLgbLgbLgbLgRsbRcLsbRh
bRgbRgLsbRgbRgbRgbRsRsRsmmbRgbRgbRgbRsbRsbRgbRsbRibRibRgbRsbLibLgbRibR
gbRcRsmbLgLsbRjRgbLibRgbRhRsmbLcbRsRsRsmmbLcRsRsmbRgbLgbRgbLsbLsbLibLs
bRgbLcbRsbLibRsbLsLsmbRgbLibLgbLgbLsbLsbLsbLgbLsLsmbRgbLgbLgbLsbLsbLsb
LsLsmbLibRjbLhLsbLibLcLsmbLhbLgbRsbLsbLgLsbLgbLjRsbsbRibLcbLibLibRsRsR
smmbRiRsmbLcbLiLsbLhbRsbRsbRiRsmbRsbLgRsRsmbRcbLcbLibRibLcbLhbLsbRjRsR
smmbLibLsbLjLsmbLsbLsLsmbLsLsLsmmbLobRibLibLgbLibLgbLsbLgbLgRsbLsbRibL
iLsbLgbLsLsmbRgbLiLsbRcbRibLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 38; Drug: Haloperidol 3 然 Apo 0.5 然
bLjbLgRsbLibLsbLibLibLibLibRibRgRsmbRiLsbLsReRsmbRcbRgbLsbLibLsbLgbRib
LgbLcLsmbLibLcbLibLibLibRcbRgbRibLiLsRsbRibRcbLibLhbLhRsbLsbLgbRcbRhbL
gbLcbLoLsLsmmbLsbLhbLibRgbLjLsmbLgbRcbLsbsbRjbLcbRobRjbRhbLjbRibRibLcb
LiLsbLgLsbRhbRobRiLsbLsbLsbLebLobRcLsbLebLoLsmbLibLibRhbLiLsbLsbLcLsmb
LibLibLibLhbRcRsmbLsbRibLgbRjRsmbRib

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 39; Drug: Haloperidol 3 然 Apo 0.5 然
bLgbLsbLjLgbLsbsbLjLsmbLsLsmbLgbRsbLibLsbLibRgRsmbLibLibLsbRsLsRsbLgbL
gbLsbRjbLobLgbRgbLgbLibRsbLcbLibLibLibLgbsbLibLsbLgbLibLsRsbLsbLgRgbLg
bLsbLibLsLsmbLsLsLsmmbLgbLsbLibRsRsmbLgbLsbLgbRsbLgRsbRgbLgbLibLibLiLs
bLgbLibRsbLgbLgbLibLgbLgbLsbLgLgLsLsLgmbLgbLeLibLiLibLibRgbLiLsbLsbLgb
RgbLgLsbLgbRsbLgbLsbLgbLsbLgbLgbLgLibLgbLiLsbLgbLibLgRsbLsLgbRgbLibLib
Lib

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 40; Drug: Haloperidol 3 然 Apo 0.5 然
bRsLsbRsbLsLsmbRsbLiLsLsmbLgLsbLsbLsbLsLsmbRsbLjLsLsmmbLgbLgbRsbLibLsb
LgLsbLgbRsbLsbLiLsbLcLsmbRgbLsbLgbLhbLsbRsbLibRsbLsbRsbRcbRhRsmbLgRsbR
ibRsbLsbRsbRgbRhbRibLgLsbRsbLgLsbsbLgbRsbLhbLgbRsbRsbLsbLsbLgbLibsbRgb
LsbLibLsbLgbLsbLgbLgbLsbLsbLsbRsbLsLsmbRsbLhLsRsbLsLsmbLgLsbRcRcbRsLsR
sbRgbRsbRgLsbRobLgbLiLsLsmbsbLgbLsbRsRsmbsbLsLiLsbRgbRsbLibRsLsbLsLsmb
LgRsLsbRgLsbRsbLibRsbLgLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 41; Drug: Haloperidol 3 然 Apo 0.5 然
bLgbLsLsmbLsbRsRsLsmbRsLsbRsbLiLsbLibLibLgbLsbLcbLgbLgbLsbLiLsbLibLibL
gbLgbRsbLibLgbRsbLgbRsbLibLiLsbLgbLgbRgbRsbLibLiLsbLsbLgbRgbRjbRsbLgbL
sbLgbLibLibLgLsbLgLsbLgbRsbLsbLsbLiLsbLgLsbLjbLgbRjbLsbLibRsbLgLsbLsbR
gbRibRibRibRgbRgbLgbLgbLibRjbRcbLhbRgbRobRgbLiLsbLgbLsbLgbLsbLsbLgbLsL
smbLsLsmbLgbLsbLsbLgbRsbLgRsbLgLsbLsbLgLsbLsbLgbLgLsbRsbLgLsbLgLsbLgbL
gbLsRsbLsLsmbLibLsbLgLsbRgbLibLibLgbLiLsRiRsmbRiRsmbRgbLobRsbRsbRgbRsR
smbRsbRhbRgbLgbLgbLsbLsbLcRsRsmbRsbRgbRhbLobLgRsbLoLsmbLsbLgbLgbLibLib
RgbLebRsbRiLsbRiRsmbLsRgbRgRsmbLobLgLgbLgLsLsmbLsbLgLsRsbLsLsmbLsbLgbR
sbLgLsbLgLsbLsLsmbLgbLgbLsLsmbLgLsbLsbLgRsbLsbLsbLgLsbRsbLgbRsbRsLsRcb
LsRcRsLsmbLsbRibReRiRsLsmbLsbRibRgRsRsRsmmmb

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 42; Drug: Haloperidol 3 然 Apo 0.5 然
bRsLsbsbRsRsLsmbsbsbsbLsbRsRsmbLsLsmbLsbRsbLsbLsbRcbRgbRibRebLcLsmbLib
RcbRcbRhbRhbRsRsmbRgbRcbRcbLiRsbRibRgbRibLsbLoRsRsmbRsbRcbRhLsbRoRsmbR
sRsmbRgbRsbsbRsbLsbRcbRobLgbRjbRcbRsbLcbLiLsbRjbRcbRibRgbLcLsmbLgLsbLo
bRobLobLsbLibLcbRsbRhbRsbRcbLgbLobLobRsbLobRgbReRsmbRibRsbRibRcbLibRcL
sbLcbRobRgbLibLibRebRcbLibRcbRobLhbRebRcbLobLebRgLsbLcRsRsmbRsRsmbLcbL
sRsbLjbLiLsbRebLib

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 43; Drug: Haloperidol 10 然 Apo 0.5 然
bLsbLgbLgbLgbLsbLsLsmbLgbLsbLsbRsbLjb

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 44; Drug: Haloperidol 10 然 Apo 0.5 然
bRsbLcbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 45; Drug: Haloperidol 10 然 Apo 0.5 然
bRgLsbRsbLsbRgbRsbLsbRsbLsbRgbsbRsbRgLsbRgLsbRsbRsbRsbRiLsbLsbRsbLobRg
bRgbLsbRiRibLsbLiLgLsRsbRsbRsRsmbLsbLebLiLsbRgRsmbRsbRsbRsbRgbRsbRsRsm
bRsbRsbsbLsbsbsbsbsbsbsbsbLsbLsLsmbLsbLsbsbsbLsRsbRsbsbRjbLsbRjbRsbRgR
iRsRgRgmbRgbRsRsmbsbLsbRsRsRsmmbRgRsmbRgbLsRsbsbsbsbLsbsbRsbsbLsbLgbLg
LsbRsLgbLgbLgbLgbLgbLgbLgbLgbLgbLgbsbRsbsbsbRsbsbsbRsbRsbsbLsRsbRsLsbL
sLsmbsbsbLsbRsbRsbRsbRsbsbRsbLsLsmbRsbLsbLsLsLembRsbLsLgRsLgLgLgLgLiLi
bRsRsLgmbLgRsRsLsmbLgbLsbLgbLsLsmbLgbLgbLgbLsbLgbLsLsmbLsbLgbLsbLgbRsR
smbLsbLgbLhRgbLsbLsLsmbLgLiLsbRsbLeLsRgRsmbsbLebLgLsLsmbRsLsLsmbLgbLgb
RsbRgbLeLsLsRsmbRgbLgbLgbLsbLgbLsbLsbLgLsbLsLsmbLsbsbLebRobLgLsbLgbRsb
LsLsmbLsLsmbRsbLsbLcb

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 46; Drug: Haloperidol 10 然 Apo 0.5 然
bLgbRsbRsbRjRsmbRjbRcRiRsmbRsRsRsmmbLsRsbRsRsRsRemmbRgRgRgbLoRsRsmbLsR
ibLsRsbRibRgbRgbRgbRsbRgRsmbRgRsRgRgRsmmbRgRsmbRsRsmbRsRsRsmmbRgbRsbRi
LsbRgRsRsmmbRsbRgbLcbRebRibRcbRiLsbLsbLgbLgLibLsbLeRgbLgbRsbLsbRibRsRs
RsmmbRsbRgRsRgmbRgRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 47; Drug: Haloperidol 10 然 Apo 0.5 然
bLiLsbLsbLsbLsbLsLgbLsLsLsmmbRsLsLsmbsbLsbLiRsLsbLsLsmbLiLsbRsbLibLsbL
sbRsbRjbRiRsmbRgbRibRgbRgbLsbRiRsmbLsbRiRsmbLgbLcbLibLsbLiLsLsmbRsbLhb
RsbRsbLjLsmbLibLiRsbRsbRsbLibsbsbsbRsbLsbLiLsbLsLsmbLibRsbsbLsLsLsRsmm
bLsbLgbLgbLsbLgLsbLgbRsbLsLsLsmmbLgLsbLgbLibLsRsRsmbsbsbLibRsbsbLsbLcb
LibRsbLibLibRsbLibRgbLsbLhbLibRsbRsRsLsmbsbRsbsbLibLsbLibRsRsmbLgbLsbR
sbLgbLibsbLsLsmbRsbLsLiLsbLibRsbRgbLsbRsbLhbLsLsmbsbLibLsbLsbRsLsbLsLi
LsLsmbRsbLibRsLsbLiLsbLsLsmbRsbLibLsbLsLsmbLgbLsLsLsmmbLgRsbLgbLgLsbRs
bLsbLgbLgbLgbLgbLsbLiLsbLiLsLsmbRgbRsbLjbLcRsbRsbLgbsbLsbLhLsbLgbRsbLs
LsmbLsbLgbRsbLibsbsbLgLsbLsbRsbLibLsRsbRgbLibLibLibLibLsbLibLsbsbLsbLs
bRsLsbsbRsbLiLsbLsbLiLsbLsbLibLsbsbsbLgbRsLsbRsLsLsmbRsbLibLibRsRsmbLs
bLsRsbLibLsbRsbLsLsmbRsbLgbLibLibLiRsbRgbLibLiLsbLiLsbLsbsbLgbLsLsRsmb
LsbLib

>ZF Recording 2016-07-04; tW: 300s; Start: 153453; End: 153953;
Recording: 2-1; Individual: 48; Drug: Haloperidol 10 然 Apo 0.5 然
bLsRsbRobRsbLsbLsLsmbLgLsbLsbLsbLgbLgbRsbLgbLsbsbLsbLjbRsbRibRsRgbRsRs
mbRsbRgbRgbRsbRsbRgbRgLsbRgRsmbRgbRsRsRsRsmmmbRibLobLcRsbRjbLsbLgbRsbL
sbLibRgbRsRsmbsbRsbRsRsmbRsRsRsmmbLsbRsbRsbRgbRsbRsbLsbRsbRgbRsbLsRsLs
bRsRsmbRsbRsbRsbLsbRgbRgbLsRsRsmbRsRiRsmbRsLsbRgbRjbRsbLsbLibRcbRibRiL
sbLgRsbRsRsRgRgRsmmbRsbRsbRsbLibLhbLsLsRsmbLsLgbLgbLgbLsbLsbLsRsbLsbLi
RsbLibLsbLsLsLsmmbLsbLgbLsbRhbRiLgbLgbLgbRsRsmbLsbRibRsbLsRsbRgbRgRsmb
RsbRsRsmbRgbLsbRsbRgbRgbRgbLsbRsbRsbRgbRiRgRsmbLibRibRibRgbRsbRgbLgbRs
RsmbRhbRgbRsRgbRsbRcbRibLcbLsLsLsmmbLgLsRsRsmbRsRsmbRsRsmbRsbRgRsmbRgb
RsbRgbRgbLsbRgbRgRsmbRgbRsbRgRsmbLsbLsbRsbRsbLjbLibLgbRsLsbRgbLgbLsbLe
bRgbLgbLsbLsbLsbRsbLsbRsbLsbLgbLsbRsbLgbLgRsRsmbLsLsmbLgRsbLsbLsLsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 1; Drug: Control Apo 0.5 然
bLiLsbLibRibLobRjbRhbLiLsbRebRcbLcbLcbLibLebLob

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 2; Drug: Control Apo 0.5 然
bLobRgbRgbRgbRcbRgRsmbRsbRsRsmbLcbLib

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 3; Drug: Control Apo 0.5 然
bLibRgLsbRhbLoRsbRgbRoRsmbLcbRebRibRgbRsLsbRjbLibRobLobLsRsbLgbRjRcbRs
bRibRobRgbLobRsRsmbRibLgbLoRsbRob

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 4; Drug: Control Apo 0.5 然
bRobLcbRjRsRsmmbLjRsbReb

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 5; Drug: Control Apo 0.5 然
bRgbLobLsLsmbRsbLoRsbLcbLjbLoLsmbLcRsRsmbRcbRoLsbRgbRgbRgbRebRobRibLgb
RhbRibRgbRgbRhbLibRsRsmbRib

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 6; Drug: Control Apo 0.5 然
bLgbRhbLibLcbLcbLibRsbRcLsbRcbLsbRsRsmbRgbRib

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 7; Drug: Haloperidol 1 然 Apo 0.5 然
bLgLsbLgbLjLgbLsbRhbRibRobRiRsRsmmbLobLsbRjRcRsmbRibRiLsLsmbLgbRjbRsbR
sRsmbRsbRgRsmbRsbRgRsmbRibLsbRibLgbRibRgbLobLsbRsbLoLsmbRsbRhbLsbRcbRi
bRgbRgbLjLgbLcbLibLgbLeLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 8; Drug: Haloperidol 1 然 Apo 0.5 然
bRcbRobRsRsmbRgbRgbRgbRgbRsbRhRsmbRsRsmbRsbRibRsbRgbRibRgbRgbLsbRsbRgL
sbRibRsRsmbRgbLgbRobRibRibRsbRsbRibRgbRsbRsbRgbsbLgLsbLgbLgbLsbRiLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 9; Drug: Haloperidol 1 然 Apo 0.5 然
bRibRiRsmbRibRsRsmbRiRsmbRsbRgbRsbRgbRibRibRibRhRsmbRibRibRsbRibLgbRcb
RsbRsbRibRibRsRsmbLjLsmbRsbRsbRgbRsbRgbRsRsmbRgRsmbRibRsbRibRibRsbRsbL
gbRgbRibLgLsbRibRibLsLsmbRgbLsbRibRibsbRgbRgbRgbLgbsbRibRsRsmbLgbLsLsm
bRibRgbRsbRsbRgbRibRibRiLsbLgRsbRibRhbRsbRibLjbRgbRsbRgbRibRibLsbRibRg
bLgbRcRsmbRhbRjb

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 10; Drug: Haloperidol 1 然 Apo 0.5 然
bRhbLibLgbRjbRgbRgbRcbLgLsbRcLsbRgbRsRsmbLibRibRebRobLcbLibLiRsbRebRcR
smbLibLcbLsbLibLgbLgbLib

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 11; Drug: Haloperidol 1 然 Apo 0.5 然
bLibRibRsbRsbLgbLgbLiLsbLgbLgbLgbLgbLgLsbLiRsbLhbLsLgbRsbLsLsmbLsbRsRs
mbLsbLsLsmbRsRsmbLsLsmbLsLsmbLsbRibRsbLsbRgbRsbRsRsmbRgbRsbLcbLobRsbLi
bRgLsbLgbLgbLsbRsbLgbLgLsbLsbRsLsbRsbLgbLgbRsRsmbLgbLsbLgRsbLobRsbRiRs
mbRibRsRsmbLsbRjLsbLgbRgRgbLsLsRsmbLsRsLsRsbRgbRgbLsLsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 12; Drug: Haloperidol 1 然 Apo 0.5 然
bRjbReb

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 13; Drug: Haloperidol 3 然 Apo 0.5 然
bLsbLsLsLsmmbRebRibRsRsmbLsbRsbRcbLgbLsbRobRsbRibRgbRgbLibRgbRibRsbRgb
LjbRibRibRsbRsbRsbLobRsbLcLsRsmbLsbLjLgbLsLsmbRcbLibLibLebRcbLsbLsbLsL
sLsmmbLcbRsRgRsmbRgLsbLcbRsbLgLsbLsLsmbLiLsbLsbRcLsLsLsmmbLcLsmbRsbLsb
RsbLcbLsLsmbRibRcbLgbRcbRcbLibLjLsLsmmbRgbLsLsmbLsLsmbLsLsmbLibRsbRjbR
cRsmbLcbRcbRibsbRsRsmbRsLsbRjbLjbRobRhbsbRsbLiLsbLeLsbLsbLobRsbLcbLgLs
bLgbLsbLibLsbLsbLhbLsbLgLsbLiLsbLsbRgbRcbRibRibLgbLjLibLiLsLsmbLsRsbLg
bLcbRsbRcLsbLsRsbLsLsRsmbRcbLgbLsbRobLsLsRsmbLibLsbRcbRibRibRibLsbLebL
cbRsLsbRibLhbRjbLibLjLsmbRgRsmbLiLsbRsbLgbLibRsLsbLiRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 14; Drug: Haloperidol 3 然 Apo 0.5 然
bLgbLsbRcLsbLsbRgbRgbRgbRsbRsbRsbRsRgbLjbRsRsmbRgbRgbLsbRgbRgLsbRibLib
sbRcbRsbLjbRsRhbRsbLsbLgLsRsbRsbRsLsbLsbRsRsmbRgbRsbRsbsbRgbRgbLsbRgbL
gbRiLsbLsRsbRgLsbLgbRibRibLgbsbRib

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 15; Drug: Haloperidol 3 然 Apo 0.5 然
bLebLiLsbsbsbLsbsbsbRsbLsRsbsbsbLgbRjbRcbRcbLsbRhbLjbRjbRibRsbLsRsbLhb
LgbLgRsLibRjbRhRsmbLibLjbLsLsLsLsmmmbsbsbsbRjbLhbLsbLsbsbsbsbsbsbsbsbs
bsbLgbLsbRsbsbsbsbRsbLgRsbLgRsbRjRsmbRjRsmbRibLsbRibRhLsbLibLcLsmbLib

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 16; Drug: Haloperidol 3 然 Apo 0.5 然
bRibRsbRgRsRgRsRgmmbLsbsbRgbRibRcRsmbLsbLsbRgbLjLsmbLobRebRoLsbsbRibRi
bLgbRibRsbRibLsbRsbRebRgbLibRgRsmbRsRsmbRcbRiRsmbRibLgLsbLebRhbRebLgbR
ibLsRsbRhbRgbRsbRiRsmbLgbRibRgbRiRsmbRgbLjbRibRibRibLgbLsbLsbRcbRsbRsb
RibLsbRibLgbRcbRsbLsbRgbRgbRcbLsbRibLsbLiRsbRebRibLibRsRsmbRhRsmbLsbRg
bRgbLibRiRsmbLgbRsbRcbRsbLibRgbLebLibRsRsmbRgbRcRsmbLgbLibRjLsbLobLgbR
gbLgbLsbLgbLgLsbLcLsmbLcbLsbLibLibLsbLsLsmbLhLsbRsbLsbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 17; Drug: Haloperidol 3 然 Apo 0.5 然
bRsbLgbLibRsbLsbLgbLibLgbRsbLgbRsbRgRgbRgbLgbRsRsmbLsbsbRsRsRcmbLsbLsb
RjRsmbLjbLibLsbLgbLgbLsbsbLibLgbRgbLibLsbLiLsbLgbLsLgbLgRsbRibLebLsbLi
bLhRsbLobLsbLobRibLcRsbLibRgLsbLgbLobLgbRgbLcRsbLsLsmbLsbLsLsLsmmbLsRs
bsbLsRsbsbsbLsbLgbRsbsbsbsbLsLsmbLsbsbLsbsbsbsbsbsbLgbLsbRsbLgbLsbLsbL
sbsbRsbLiRsbRcbLsbLobLsbLsbLibLsbRoRsmbRsbRgbRibRibLibLcbLgbLgLsbRsbLg
bLjbRcbLibLibLgLsLsLsmmbLibLsLsmbLsbLsbLsbLsbLgbRsbLgbLgbRsbLgbLgLsbRg
bLgbLsbLgbLgbLibRibLhbLgbLgbLsbLgLsbLgbLgbRsbLgbLibLsLsmbLsLsmbLgbLgLs
bLsbLgbLibRgRsmbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 18; Drug: Haloperidol 3 然 Apo 0.5 然
bLgbRsbLsLsmbLgbRsLsRsbLgbLsLsmbLsbLsbLgbLgbsbLgbLgLsLsmbLsLsmbLgbLsbL
gbLsbLgbLsLsmbLgbLgbRsRsmbLgbLsbLgRsbLibRsbsbLsLsmbLgLsbLgbLsbLgbLgbLg
bLsbLsbLgbLsbLgbLgbLgbLsbLgbLsbLgbRsbLibRsbLibLibRsRsmbLgbLibRgbRcbRib
RibRgbLsbLsbRsbsbLsbLgbLjbLibLcLsmbLibRsbLsRsbLsbLibLiLsbRsbLibLgbLibL
ibRgLsbLoLsmbLcbLgbLhbLcLsmbLgbLhbLibRsbRsLibLgbLsbLsbLsbLsbLhbLibLcbL
iLsbRsbsbsbsbLsbLcbRsbLsbLgLsbLsLsmbLsbLgbRsbLjRsbRsbRsbLibLgbLiLsbRsb
RibLhbLcbLcbLgbLibLsLsmbLgLsbLsbRgbLsbLibLgLsbLsLsmbLsbLsLgbRsbLgRsbLg
bLsbLgbRjbRsbLiLsbLibRgbLibLibRsbLiLsbRsLsbLgbLsbsbLjbLgbRgbsbLsLsmbsb
sbsbsbsbRsbLsbLsLsmbLsRsbLsbLsbLgbLgLsbLgbLsbLgRsbLsRsbRgbLjbLsbLsbLsb
RsbLibRsbLibLibLibLhLsbLgbLjbLibLgbsbsbsbLjbLsbRsLsbRsbLsbLgbLsLsmbLgL
sbLsbLsbLgLsbLsLsmbLgLsbLsLsmbLsbsbsbLibLsbRsbRjbLhbLibRsbRgbLsbRgbLgb
LsLsmbLsbLgbLgbLsbLgbLsbLsbRgbLsbRjbLsbRsRibRiLsbRibLcbLsbRsbRsRsmbLiR
sbLsbLibLsbLgbRsRsmbLib

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 19; Drug: Haloperidol 10 然 Apo 0.5 然
bRsbLiLsbRsbLgLgRsLsbLsbLgRsbLsRsbRsbLsbLgbLgLsLsmbLsbLgbLgbLgbLsLsmbR
sbLgLsbRsbLgbLgbLgbRsbLsbRsbsbRsbRsbLsbRsbLsbRsbLsbLsbLsbRiRsmbRsbRsbL
sLgLsRsbRsbLgLsbLsLsmbLsbRsbLsbRibRhRsmbRsbLsLgRsbLgbLgbLgbRsbsbLsbLsb
LsbRsbsbLsbLhbLhbRgLsbRsRsRsmmbRsRsRsmmbRgRsmbRsbRsbRsbRgbRsbLsbLsbLib
LiLsbLibLgbLgRsbLsbLgbLgbRsbLgbLjbLsbLjbsbLsbLgbLsbLgbLsbLsbLgbLsbLsbL
sbLgbLsbLsbRsbLsbLsbLsbLgbRsbLgbLsbLgbRsbLgbLgbLsbLgbLsbRsbLsbLsbLsbLg
bLsbLsbLsbLsbRsbRgbRsbRsbLsbRsRsmbRsbRsbRsbRsbRgbRsbLsbRgbRgbRgLsbRsbR
sbRsbRgRsRsmmbRsbRsbRsbRgbRsbRsbRsbRsbRsbRsbLsRsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 20; Drug: Haloperidol 10 然 Apo 0.5 然
bRsbRsbRgbRsRsmbsbRsbRibRsbRsRsmbRgRsmbLgbsbLgbsbRgbRsLsbLgbsbLsbsbsbL
ibsbsbLgbLibRjbLsbsbLsbLjbsbsbsbsbsbsbRibRibRsRsmbRgbRjbRsbsbLsbRsRsmb
LgbRgbRsRsmbsbRsRsLsmbsbLgbLsbRsbLsbLcLsmbLgbRsLsLsmbLsbLibLiRsbLiLsbL
gbRsbLjbsbRgbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 21; Drug: Haloperidol 10 然 Apo 0.5 然
bReRsmbRsRsmbLsbRgbRsLsbRgbRiRsmbLsbLsbRsbLgbRsbRsbLsbLsbLibLgbLsbLsbR
sbRjbRsRsmbRsbRsbRsbRsbRsLsbRsbRsRsmbRsbRsRsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 22; Drug: Haloperidol 10 然 Apo 0.5 然
bRgLsbRsbRibRhbRibRibRiLsRsbLhLsbLibLgbLsLgbLibLcbLsbLsbLsbLibLibLsbLs
LsmbLsLsmbsbLgLsbLgbLgLsRsbLgbLgbLsbLgbRsbsbRsLsRsbsbLgbRsbLsbLsbLgbLg
LsLsmbRsLsbLiLsLsmbLiLsLsmbLsbLgLsbRsLsbLsbRjbRibRibLsbRsbRsbRiRsmbLsb
LgbLjLsmbLibLsbLgLsbLgLsbLsLsmbLsLsmbRsLsLsmbRsbsbRsbsbLgLsbLgLsbLiLsb
LsbLgLsLsmbLgLsbLsLsmbRsbRebRgRsLsmbsbsbsbRgbRgbLgbRsbLsbRebRibRiLsbLs
bLsbLgbLibLgbRsbRjRcLsLsmbRibRgLsbLsbLsbsbLsbRsRsmbRgbLsbLsbLsbRgLsbRg
RsmbRgbRibRgbRgbRsbRgRsLsRsmbRsbRgbRgRsmbRgbRgLsbRgbRgbRgbRibRibRibLsb
LsbLsbLgbLgbLgbLibLgbLsbLsbLsbRsbRsbRsbRjbRibRgLsbRgbLsbLsbRsbRibRgbRs
bRsbLibLgbLgbLsLsRsmbLgbLgbLgbLgbLgbLgbLsbLsbLgbLsbLgbLsbRsbLsbRsbLgbR
ibRibRsbRsbRgLsbRsbRgbRsbRgbRsbLibLibLgbLgbLsLsmbLgbRsbLsLsmbLgLsbLgLs
bLsbLgbLsbLsbLgbLgbLsbLsRsbLsLsmbLsbLsbRsbRjbRibRibRgbRsbRgRsLsmbRibRi
bRibRjbRiLsRsbRibRgbRgbRgbRsRsmbRgbLsbLsbLgbLgbLgbLgbRebLsbRgbRgLsbRsb
Rgb

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 23; Drug: Haloperidol 10 然 Apo 0.5 然
bRsbLsbRjbRjbRsbRjbRobLsbLsbRsLsbRobLsbRsbRsbRsbLsbLsLsmbLsbLjbLgbLgbL
sbRsbRsbRcbRcbRsRsmbLsbLsbRsLiLsbLcbRib

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 24; Drug: Haloperidol 10 然 Apo 0.5 然
bsbLsbLcbLgLsbLibRsbLsbLsRsbLgbRsLgbsbRsbRsbLibsbLsbLsRiRsmbRebRibLsbR
sRsmbRgbRgbRsRsmbRsLsbRgbRgbRsLsRsbRsbRsbRgbRgbRgLsRsbRsbsbLgbLcbLiLsb
RsbRibLcbLhbRsbLgbLgbLsRsbLgRsbRsbRgLsbsbRgbLsLsmbLgbLsbRgbRcbRgbRgbRg
bsbRgRsmbLgbRgbsbLgLsbLsbRsLsbLgbRsRibLsbRgbRsbRgbRgbRsbRsbRsRsmbRsbLi
bRhbRiLsbLibRjbLibLsbLibLsLsmbLgLsbLsLsmbLiRsbLiLsbLjbLgbRgLsbRsbRibLh
LsbLibRsbLsbLcbLgbRgbLsbRsbRhbRsbRsbLsbLgbRsbLcbLgbLsbRsbLsbsbLgbLsbRs
bRgbLsLsmbRsbRsRjRsmbRsbsbRibRjbLsbLsbLsbsbsbRgbLsbRsbLjbLjRsbRcbRgbRs
RsmbRsbRgbRsRsmbRsbRsRsmbRsbsbRsbRsRsmbRsRsmbRsbLgRsbRsbRibRsRsmbRgLsb
LsbLsbLsLsmbRjbLcbLiLsbLgLsbRgRsRsmmbLcbLsbRjbRjbLiLsbLgbLgbRiRsmbRibL
ebLcbRgbLsbLsbLiLsbLsbLsLsLsmmbLsLsLsLsLsmmmmbLgbLibLiRsRsmbRgbRsbRsbR
sbRsbRibRibLsbRsbRsbRsbLsbsbLsLsmbRsLsbsbRsbRibLsbsbLsbLsbLsbsbRsbRsbR
sbLsLsmbRsbRcRsmbLsLsmbLjbsbLibLsbRsbLiLsbRsRsmbRsbLgbLsLsmbsbLgLsbRjb
RsRjbRjbsbLobRcbLsbRsbLcbRsbRgbLsbLgbRhbRibLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 25; Drug: Control Apo 0.5 然
bLsbLobRsbRobRgbLebRcbRgbLsRsbLjbRibRgbLgbRcbLgbRibRibRgbRgbRibRjbRsbR
cRsmbRobRiRsmbLsbLibRcbRgbRsbRgbRgbLgLsbRibRibRhbRibRibRiRsmbRcbLcbRib
RjbLhLsbRibRobRiLsbRibRibRcbRiLsbRsbRgbLcLsmbRsbRibRibRoLsbRibRibRgbRj
bLsbRibRiRsmbRjbRcb

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 26; Drug: Control Apo 0.5 然
bRibLsLcLsmbRhbRibLibRibsbLibRibLgbLcRsbRibLsRsbLgbRsbLgLsbRgbsbLgRsbR
sLsbRgbsbsbRsbRibRiRsmbLjbLcbLcRsbLcRsbLgLsbLsRsbRibLib

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 27; Drug: Control Apo 0.5 然
bLibLibLgbLjbLibLsbRjb

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 28; Drug: Control Apo 0.5 然
bRgbRcbLhbLcbLsbLibLibRhbLcbLjbRsbLcbLobLoLsmbLjbLhRsbLsbLhbLcbLobLobL
obLobLcbLcbRgbsbLobRsbRibLjbLcbLsbLjbLoLsmbLsLsmbLsbLsbRobLoLsmbLcbLcb
Rhb

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 29; Drug: Control Apo 0.5 然
bLiLsbRsLcLsmbLibLiRsbLibLiRsbRibRiRsRsmmbLiRsbRhbRjbLhbLibLibLcbLibLc
RsbRsLgbRcLsbRjbRjbRiLsbRibRibLoRsRsRsmmbRsbRgRsmbRib

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 30; Drug: Control Apo 0.5 然
bRgbLhLsbLoRsbRcbLibLsbLgbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 31; Drug: Haloperidol 1 然 Apo 0.5 然
bsbRobRsbLjLsmbRjbRobLsLsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 32; Drug: Haloperidol 1 然 Apo 0.5 然
bLgbLcbLibLjbRibRsbLibLsbLiLsbLibLibLhbRgbRoLsbLibRhbLsbLgbRobRibLibRo
LsbLibLibLgbRsbRsbLjbRibRsbLgbLjbRoLsbLgbRibRsbRiRsmbLsbLoRsbLiLsbLsbR
cbLjbLgbRsbRoLsLsmbRsbRsbLhbLibRsbLsbRsbRsbLibLgbLibRcRsmbRgbRcbLgbRjR
smbLgbRibsbLjbLiRsbRgbLjbRobLgbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 33; Drug: Haloperidol 1 然 Apo 0.5 然
bRgbLcLsmbLgbLgbRsbRsbLsbRsbLgbLgbRsRsmbsbsbsbRsbsbsbLsLsmbLibLsbLgbLs
LsmbLsbRsbLgbLibLsLsmbLsbLgbLibRsbRcbLsbRcbLgbRsbLgbLsbLgLsbRgbLsbsbLs
bsbRsRsmbsbLjbsbsbsbsbLibLiLsbLgLsbLgLsbLibLgbRsbLcLsmbLsbLsLsmbLsbRgb
LsbLsbRgbRsbRsRsmbLgbLsRsbRsbLjbRsRsLsmbsbRsbRsLsbLsbRsLsbRsbRsbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 34; Drug: Haloperidol 1 然 Apo 0.5 然
bLgbRsRsmbLsbLgbLgbLsLsmbLibLibRsLsbLsbLgbLibRsbRibLibRgLsbLgbLibRsbRg
bLgbLsbLgbLsbLgbLgbLsbLsbLsbLibLsbLsbLsbLgbLiLsbLgbRsbRsbLjbLgbLgbRsbL
sLsLsmmbLibLobLsbRsbLgbLgbLgbLsbLgLsbLsbLsbRgbLeLsLsmbLsbsbRsbLibLhbLs
bRgbRsbLibLsbLsbRibLgbLiLsbLsbLgbRsbLgbLhbRsbRgbLjbLcbRhbLibLsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 35; Drug: Haloperidol 1 然 Apo 0.5 然
bLjbRibRgbRhbLgbLibLcbLcbRobRibRsbRsbRsbLoRsbLsLsmbLjbLjbRcbRgRsmbRsRs
mbRhLsbLsbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 36; Drug: Haloperidol 1 然 Apo 0.5 然
bLsLebRjbsbsb

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 37; Drug: Haloperidol 3 然 Apo 0.5 然
bRibRibRhLsbsbLgLsbLsbsbRoLsbLjbRgbRgbRcbRhbRgbLibLcbLsbRjRsRsmmbRibLc
LsmbLibLsbLsbLibRiLsbLcbLibRjbLibLsLsmbLsLsLsmmbLsbRibLibLsbLsLsmbLiLs
bLhbLibLiLsbLgbRsbRsbLiLsbLsbLibLcbLibRsbRcbLgbRibRsbRsbRcbLibRsbLgbLi
LsbRibRjRsmbRiRsmbLibRjRsRsmmbLsbRsbRcLsbRsbLcLsmbLiLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 38; Drug: Haloperidol 3 然 Apo 0.5 然
bLcLsmbLobLjLsmbLgLsbRsbLibLiLsbLsbLobLibLhbRgbRcbLhbLcbLibLhLsbRgbLiL
sbLgbRsbLgbRhbLcbLcbLiRsbLsbLsbLgbRhbRcbLibRsbRsLsLsmbRgbRsbRcbRcbLjLs
mbLgbLcbLhRsbLgRsbRsLsbLsbLoLsmbRsbRsbLcbLsbRsbLcRsbLibLiLsbLsLsmbLgbL
cbRsbLgbLibRgLsbLgbLsbRcbRoRsRsmmbLsLsmbRcbLcbLibLsbRsbLsbLhbRsbLcbLhb
RsbLcbLoLsmbRibRibLibLsbLibLcbRiRsmbRsbLibLibRibLcbLgbLsbRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 39; Drug: Haloperidol 3 然 Apo 0.5 然
bLcLsmbLhLsbRjbsbsbsbLgLhbRsbRsRsRsmmbRjRgRsmbLjbLcbLgLsbLibLsLsRsLgmb
LsbRibRcbLjbLibRebRsRsmbLsbLsbRsbLsbLsbLsRsbLsbLsbLsbLjbRsbRsbLsbLsbRg
bRgbRjbRhbRcbRgbRsbLsbRsbLcbLjLsmbLibLsbRgbRgLsbsbLjbLibLgbRsbLsLsmbsb
LcLgbLibLhbRsbLsbLsbLiLsbLibLsbRibsbsbLibRsbRsRsmbLsbsbLiLsbLcbLgbLgbL
sbLgbLibLiLibLiLsbLsbRcbRibRsbRsbRgbLsbRgbLjbRiRsmbLjbRibRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 40; Drug: Haloperidol 3 然 Apo 0.5 然
bRsRsmbLsbLgLsbLsbLsbLgbRsbRsLsbsbRsbRsbLibRsRsmbLsbLsbLsbLsbLgbLgbLsR
sbLsbLsbRsbLiLsbLsbLsbLsbLsbLsbRsLsbRsbLibRsRsmbLgRsbLibLsbRsRsmbLgbLs
LsmbLgbRsbRsLsbLsbRsbLgbRsLsbLsbRsbLsLsLsmmbRsLsbLsbRsbLsRsbLgLsbRsbsb
LibLhbLibLsbRgbLgbLgLsbLsbRjbRcbLgbRibRsbRsbsbsbsbRsbsbLjLsmbLcLsmbRsR
smbLgbRsbRibLsbRiRsmbLsLsmbLsbLgbLsbLsbLsbLsbLgbLsbLsbLsbRjbRcRsmbLsbs
bRsbRgLsbLgbRibLgRsbRgbLgbRsRsRsmmbRsRsmbLsRsbLsbRsRsmbLgbLibRibRsRsmb
Rsb

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 41; Drug: Haloperidol 3 然 Apo 0.5 然
bsbsbRibLgRjbRgLsbRsbLoLsmbRsbLsLsmbLiLsbLibLiRsLsbLgRsbRgbLgbLjbLcbLg
bRsbRibRsbLcbLiLsbLsbLsbLgbLsbRsbLjbLobLiLsbLjbRjbLjLsmbLgbLgLsbLgbLsb
LgLsbLgbLgbLgbLgbRgLsbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 42; Drug: Haloperidol 3 然 Apo 0.5 然
bLhbLobRgbLgbLhbRcbLibLhbLiRsbRcRsmbLebLcLsmbRsRsRsmmbLjLsmbLjLgbsbLob
RcbRsbRcbLiRsRsmbRhbsbsbRsbRebLiLsbLgbLcLsmbLiLsbLibLgbRibLsRsbLebLsLs
mbRsbsbsbRibLhRsbLobRibLcbLgbRjbRcRsmbLsbRsbLjLgLsbRobsbRiRsmbRsbLebLj
bRjRsmbRsRsmbRjbLcbRibLobsbRjb

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 43; Drug: Haloperidol 10 然 Apo 0.5 然
bRsLsLgLsLsmbLsLsmbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 44; Drug: Haloperidol 10 然 Apo 0.5 然
bRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 45; Drug: Haloperidol 10 然 Apo 0.5 然
bLsbLsbLsbRgbRgbLsbRsbLsLsmbRgbRgbRsbRsbRgbRgbRsbLsbLibLgbLgbLgbLgLjbR
gRgRsmbRgRgRgbRsbLsbRibRgbRjbLgbRgbRgbRsbRgbLsbLsbRhbRgbRgbRgbRgbRgbRs
RsmbRsRsRsmmbRsRsRsLsmmbRgbRgbRgbRsRsRsmmbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 46; Drug: Haloperidol 10 然 Apo 0.5 然
bLebRobLobLebRobRobLibRcbLibRgbLebLobLebRobLcbLcbRebRcbLibLebRobLgbLcb
RibLebRcbRobRgbRobLgbLobLobLobRhbLebLebRobLobRobLebRcbLobRobRobRobRobL
sbRobRobLobRsbLobRobRibRsbRobRobLcbRobLjbLebLobLsbLebRobRibRibRcbRebLo
bRebLobLobRcbRibLobRcbLobLcbLebRobRcbRgbLebLcbLobRobRobLobLobLcbLhbLob
RobRebLcbLebLobRobRcbRobLibLobRhbRobRcbRebLibLobRebLebLobRobRobLobRobR
ebLebRgbLcbRcbRobRobRobLobLgbRcbRobRcbRobRobLebRebLobLobLobRobRhbLhbRi
bLobLebRibRsbLobLcbLcbRebRobRebLobLobLobLobLgbRebRebRcbLebRgbRobLcbReb
RobRcbRobLcbRjbLcbLobLcbRcbLcbLobLobLebLebLebRobLibRobLhbLobRobRobLobR
obRobLobRebRobLebRcbLobRobLcbRebLobRobRibRsbLobLgbRobRobLcbRebRebRhbLc
bLibLcbLebRcbLobLsbRgbLobLobRobRobLebRobRibRobRebLobRcbRobRobRebRobLob
LsbLobLobRcbRhbLobLebRebRobRebRebRsbLobRebRobRcbRobLobLgbLgbRebRcbRobL
obRcbLsbLhbRobRebRobRcbLebRebLebLebLsbLobLobRhbRobRebRebRobRobRsbLcbRe
bRibRebRobLibRobRobLobLgbLobRcbLobLebLobLebLebLebLsbRebLebLebRibRobReb
RobRhbLebRobLobLgbRobRebRobRcbRobRibRcbRobLobLobRebLobRcbRobLobLebLobL
obLobLobLebRebRebRsbLobLebLebRobRebRebRobLebRobRebRcbRobLcbLcbRebLgbRo
bLibLobLebLebLobRcbRgbRobLobRobRjbRcbRibLebRebRsbLcbRibLgbRobRcbRobRob
LebRebLebLebLebRobLsbRsbLsbLobRgbRhbRobLsbRibLgbRobRcbRibLcbLobLobLobR
obRcbLobRcbLcbRobRobLebLcbRibLhbLobRcbLobRebRgbLcbLebLobRcbLobLobLobRc
bRobLobRibRobRobLebLobLibLobRebLobLjbRobLebRobLebLibRibLobLobLobRcbRob
RebRcbRcbLcbRibRcbLebLobLebRobLobRebLobLebRcbRobLebLebRobLebLsbLcbLebL
obLcbLobLobLebLcbRobLhbRibRcbRibLcbLcbLebLgbLebRcbLgbRobRibRcbLobLobLo
bRebRebRobLjbRgbRibRcbRibRobRsbLibRobLcbLgbRebRobLebLgbRobLcbLgbRobLeb
LobLebRobRobRebLgbLebRibLibLobLobRobLebLebLhbRebRobLgbLobLobRgbRebRcbR
obLobRobRobLcbRcbLobRobRobLibLobLobLobLgbLibRcbRobLobLcbRobLibRobRobLo
bLebLebLebLgbLobLobRebLobRibRebLobLebLsbLebLebRhbLgbLcbRibRsbRebLsbRob
RebLobLcbRibLobLobLobLhbRobLebLobLobLobRobLcbRebRobRebRcbRcbRobRibLebL
obRibRobLcbRobRebRsbRobRebRibLobRobRcbLobRcbLcbLobLobLebLobRebLobLobLo
bRhbRobLobRcbRebRebLobLobRcbLcbRobLcbRibRobLcbRobLebRebRcbRobLobRobRob
LebRgbRobRobLobLobLcbRebRebLcbLobLcbRebRibRobLobLibRebRobRobRgbRgbRebR
ebLcbLsbLobLgbRobLcbLsbLobLcbLibLgbRobLibRcbRobRobLebRobRebRobRebLcbRc
bLobRcbRobLobLebLebLobRobRebLobRebRebLibLebRobLobRcbRcbRobLcbLgbRobLeb
RebRobRibLobRobRobLibLebLcbRobLibLebRobRebRobLobRcbLobLebLobRcbRebLebR
ebLobRobLsbRobLcbLobRgbRobRobRgbLobLebRobRgbRobLobRsbLobLibLsbLobRebRo
bLobRebRebRobLcbRgbRobRobLobRcbRebRsbLcbRebLibLebLobRsbLgbRebRjbLobLcb
LobRobLcbLhbRobRsbLcbLhbRcbRcbLobLobLobLobRcbRobLobRebLcbRebLobRebRobL
ebLibLhbRebLobRsbRebRobLobRobRsbRcbRsbRobLhbLebLjbLobRcbRobRebLcbLobRo
bLhbRobRebRhbRcbLibRebRobRcbRobRebLobLobRgbLibRobRsbRebLobRobRcbLebLob
LebRobRcbLebLobLebLobLgbLebRibRobLebLebRobLobLebRobRobLobLebLibRibRcbR
ebRebLobRibRebLobLobLobRibLebLebRgbLebRobRcbRobLebRebRebLobLebLgbLhbLg
bLobLcbRcbLibLobLobRcbLebRobRcbRebRsbRobLebRob

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 47; Drug: Haloperidol 10 然 Apo 0.5 然
bLsbLsLsmbLsbLsRsRsmbLgbLsLsmbLiLgbRjbLsbLsbLibLgLsbLgbLibRjbLsLsmbLhb
RsbLgLsLsmbLsbLsRsbLibRsbRjRsRsmmbRibRsbRiLsbRsbRibRsbsbRhbLsbRiRsmbRs
bRjRsmbLsbRsbRibRgbLsbRgbRibRibLsbLjbLcbLsbRsLsbLiLsbLsbLsbLsbLgLsbLgb
LsbRsRsmbLjLsmbRsRsmbLgbLgbRsLsbRsLsbLgLsbLgbLgbLsbLibRsbRsbLsLgbLgbLg
LsLsmbLgbLsRsbLsLsmbRsRsmbRsbRibRsbLebLiLsLsmbLobLsbRsbRhRiRsmbRibRsRs
mbRgbRgRsmbRgbRsbRgbRgbRsbRsbRibRsbRsbRibRgbRobLsLsLsmmbLibLhbLsRsbLgb
RsbLgbLiLsbRsbLibLibLsbsbRsbRibRgbLsbRibLjbLhbLibLcbLibRsbLcLsmbLibRsR
gbLibLsbLcbRsRsRsRsmmmbRsbLsLsLsmmbLibRsbLibRsbRsbRiLsbRgbLsbLjbLcbLhb
LibLibRsbLcbRsbRsbLgbLibRsRsRsmmbRebRsbRgbRsbRgRsmbRsbLsRsbLjbsbRibLjb
LhbRsbLibsbLsRsbRsbLsLsmbRsbLsbLgbRsbRsbLgbRsbLsbLgbLgbLibLsbLcbLsbLgb
RsLsbLibsbLiLsbLsLsmbLibRgbLoRsRsmbLibRsbLibLsLsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 153955; End: 154455;
Recording: 3-1; Individual: 48; Drug: Haloperidol 10 然 Apo 0.5 然
bLsbLsbLsbLsbRsLsbLsbLsbsbLsbLsbLsLsmbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 1; Drug: Control Apo 0.5 然
bLibRcRibLibLibLibLgbLsbLsbLibLsLsmbLgbLcbLibLcb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 2; Drug: Control Apo 0.5 然
bLibLiLsbRibLebLiRsbLiRsRsmbRsRsRsmmbLgbLsRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 3; Drug: Control Apo 0.5 然
bLcbRiLsbLgLsbLibRobLiLsbLcbLjbRgLsbRgLsbLgbLjLgLsbLcbLsbsbLobRgRsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 4; Drug: Control Apo 0.5 然
bRobRcbRobLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 5; Drug: Control Apo 0.5 然
bLibLibRjLsbRiRsmbRibLgbLgbRcbRibLcbRiRsmbLhb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 6; Drug: Control Apo 0.5 然
bRhbRsbRsbRsbRsbLhLsbLgbLhbRhbRsbRibRsRsmbLsbLibRiRsmbLiLsLsmbLibRoRsm
bsbLibsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 7; Drug: Haloperidol 1 然 Apo 0.5 然
bsbsbRsbLsRsbRsRsmbLsbLgbRsbRcbRibLgbRgbLjbsbLsbLgbRgbRgbRiRsmbRcRsmbL
sRsbRsRsmbLgbLgbRsbLgbLgbLibLibLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 8; Drug: Haloperidol 1 然 Apo 0.5 然
bLobRibRsbRgbRcbRoLsbRhbRib

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 9; Drug: Haloperidol 1 然 Apo 0.5 然
bLgbRibRibLsbLsbRiRsRsmmbRsRsmbRibRsbRgbRibRibRgbLsbRoLsbRibRsbRibRsbR
jLsbRiRsmbRibRsbRsbRibRibLsbLgLsbsbRhbRebRgbRgbRibLiLsbLgLsLsmbLibLsbL
ibRsRsmbLibLsbRsbLgbLgbLsbRobRjLsbRgbLgbLsRsbRhbRiLsbLgbRibRsbRibRhb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 10; Drug: Haloperidol 1 然 Apo 0.5 然
bLebLebLeLsbLiRsLsbLibLgbLobLsbRibRgLsbLgbRobRibRibLcbLibsbLiRsRsmbLib
RjbRsbRgbRgbLsbLobLsLsmbLgbLsbLgbLibLibLjLsmbsbsbLibLibLhbLibLibLobLib
RsbLsbLibLhbLibRib

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 11; Drug: Haloperidol 1 然 Apo 0.5 然
bLjbLibsbRsbLgbLcbRibRsbRsbLibLobRiRsmbRsbLsbRsRsmbRiRsmbLcbRobRiRsmbL
obRjRibRhbLsbLsRsbRibRgbRhbLgbLsbRsbLsbRsbRjbRgbRcbLsbRsbLgbRcbRcbLsbL
sbRgbRsbRgbRsRsmbRgbRgbLcbRibRsbLsbLobRiRsmbLsRsbRgbLsLsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 12; Drug: Haloperidol 1 然 Apo 0.5 然
bLcLibLoLsmbLsbLgbLibLhbRcbRibRcbLsbLobLgbRjbRoLsRsbRibRcbRibLibLibLjb
LibLhLsbRcbLibRiRsmbRsbLobRhbRjbLobRhRsmbRsbRgbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 13; Drug: Haloperidol 3 然 Apo 0.5 然
bLgbRsbRsbRsbLjbLsLcbRgbLibLeLsbRsbRsbRibRibRgLsbLsRgRsmbRibLsbLgbRibL
ibLibRjbRcbLgbLcbLibRgbLibLibRgbLiLsbLsbLgLsLsmbRsbLsbLibRsbLebRgbRhbL
hbLibLibLibRgRsmbLgbLgLsbLsbRcbRiLsbLsLsmbLsRsbLsbLibLsbRjLsbRsRsmbRhR
smbLibLcbLcbLsbRjbRiRsRsmmbRsLsbRsRsmbsbRsRsmbLsRsbLsbLcLsmbRjbRiRsmbR
sbLcbLjLgbLsbRcRsmbRibLhbRobRiRsmbLsbLjLsmbRhRsmbRgbRsbRsLsbLgbLcRsbLi
bRsbRsRsmbLsbLgbLsbLsbRjbRcbRjRsmbLhbLebLsbRgbLibRsRsmbLgbRjbLjLsmbLib
LgbRjbLsLsmbLsbLsLsmbLgbLgbLgRsbLhLsbRsLsbRgbRsbLeLsbLsRsbLcbRsLsRsbRs
bLibLgLsbLgLsbLsbsbLgLsbLsLsmbRjbLjRsbRsbRjbRjbRibRcbLib

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 14; Drug: Haloperidol 3 然 Apo 0.5 然
bLsbRcbRgRibRgbRibRgbRgbRiRsRsRsRsmmmmbRibRgbRsbRsbRsbRgbRgbRiLsbRsRsm
bLsbRgbRgLsbRsbRgbRsbLsRsbRgbRsRsLsmbRgbRgbRjbLsbsbLsbLgbRgLiRsbRhbRib
RsbRsbRhbRjRgbLibRgbLibLsRsbRcbRobLib

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 15; Drug: Haloperidol 3 然 Apo 0.5 然
bLgbLjLsmbsbRsbsbsbLsbLsLsmbRgRsRsmmbRcbLgbRsbLsbLcbLsbLiRsbsbRsbLibLs
bRoRsmbRobLiLsbRsbsbLgRsbLsbsbLgbRjbRcbRsRsmbLcLsmbRjbLsbRsLsbLcLsmbLg
RsbRsbRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 16; Drug: Haloperidol 3 然 Apo 0.5 然
bRibRgLsLsmbLibLcbRsRsmbsbLsbLibLsbLibRsbLgLsbRsbRsbReRsmbRibRsbLcbLib
RsbLibRibReRsmbRsbRsbLsbLsbsbLsbRhbRsbRsRsRsmmbLsbRsbLcbLibLsbLcbLiLsb
LibLebRsbsbsbsbsbsbRsbLsbLibRsLsbLsbLsLsmbRsRsmbRsbLsLsmbLgLsbLgRsbLsb
LibLhbLibLibRsRsmbLgbLiLsbLgbRsRsmbLsbLsbLhbLsbLcbRsLgbLsbLgLsbLsbLgLs
bLibLgbLgbLsbLgbLgbLcLsmbLgbLhbLiLsbLiLsbLgbLibLsbLibLibLgbRsLsbLibLhb
LiLsbLsLsmbLcb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 17; Drug: Haloperidol 3 然 Apo 0.5 然
bLgbLgbLibLsbLgbLgbLgbLgRsbRsbLsbLgbLsbLgbRsbLgbLgbLsbRsbsbsbsbsbsbsbs
bsbsbsbsbsbsbsbRsRsmbLibRsbRsbLgbLgRsbLgbRsbLsbLhbRgbRsbLobLgbRsbRibRg
bRsbLgbRcbRibLibLibLibLibLsbRsbRhbLgbLjbLgbLibRsbRobRgbRgbsbLgbLjbRibR
jbRgbLsbRibLsbRsbRsbRsbRibRgbRibRibLibRibLebLibLhbRsbRcbRibLjbLjbLsLsm
bRsRsmbRsLiLsbLiLsbRsbLhbsbsbLsLsRsmbRoRsmbsbsbsbLsbRebRibRibRsRsmbRgb
RsbLibRcbRgbRjbRibRsbRsbLcbLibRgbLgbRhbRibRsbRgRsmbRsbRsRibRsbRibLjbRg
bLsbRibRgbLjbRsbRgbRibRibRibRibRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 18; Drug: Haloperidol 3 然 Apo 0.5 然
bLibLgbLcbLibLgLsbRsLsbRsLcbLibLsbRsbLgbLcbLiLsbLhbLhbLgLsbLgbLibRsbLs
LsRsRsmmbLsbRsLsbRgLsbLhbLgbLhbLibLsbLgbRibsbRoLsbLebLibLsbLgbLgbLgbLs
bRsbLibLsbLgbRgbLiLsbLgbLibLsbRsbLsbLcbLgbLgbRgbLsbLsbLsbLgLeLsbLoLsmb
LgbRsbRgLsbLsbLjLsmbLibLibRsRsmbLibRgbLibLiLsLsLsmmbLibLhbLsbRsRsmbRgb
LsbsbRsbRsRsRsmmbsbLgbLibLgbLgbLibRsbLsLhbRsbsbLsLsRsmbRsbsbLibLsbsbLg
LsbLgbRsbLibRjbRibRibLsbLgbRcbRsbLgbRibLsbLgbLjbLhbLibLsbsbRsbsbRsbRsb
LibLsbLsLsmbLsbLgbLsbLibRsbRsbsbRgLsbLiLsbRsbLsbLibsbLsbRsLgRsbReRsmbL
sbLcbLibLibLibLgbLgLsbRjRsmbRobRsbLibLiLsbLsbLgbLibLsLsmbLsbLsRsbLibLs
bLgbRjbsbsbsbsbsbLgbLsbLsLsmbLgbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 19; Drug: Haloperidol 10 然 Apo 0.5 然
bRsbRsbRsbRsbRsbRsbRgbRsRsmbRsbLsbRgRsmbRsbsbLgbLsbRsbLsbLgLsbLgLsLsmb
LsRsbRsbLjbsbLgbsbsbRsbRebRebRsbRsRsmbRgbRsbRsRsmbRsbRsRsmbLsbRsbLjbLi
bLsbLgbLgbLsbLgbLsbLsbRsbLgbLgbLsbLgbLgbLgbLsbLgbLgbLsbLsbLsbLsRsbLsbL
sbLgbLsbLsbLgbLgbLgbLgbLsbLsbLsbLgbLgbLsbLgbLgbLgbLgbLgbLsbLsbLsLsmbLs
bLsbLsRsbLsLsmbLgbLgbLsbLsbLsbLsbLgbLsbLsbLgbLsbLsbLsbLgbLgbLsbLgbLgbL
gRsbLgbLsbLsbLgbLgbLsbLsbLsLsmbLsbLsbLsbLsbLsbLsbLibRsLsbLsRsbRsLgbLgb
LibRsLsbLsbLgbLsbLsRsbLgLsbsbLsbLsLsmbLsLsmbLsLsmbLsLsmbsbLsbsbsbsbsbs
bLsbLsbsbRsbLsbsbsbLsLsLsLsmmmbLsbLsRsbLsRgbLsbRsbLsbLsbLsbLgbLgbLsRsb
LsbRsbLsRsbLsbLsLsmbLsbLsbLgLgbLsLsmbLgbLsLsLsLsmmmbLsbLgbLsLsmbLgbLgL
gbLsbLsbLsbRjbRgbRgbRsbRgbRsbRsRsmbRsRsmbRgbRsRsmbRsbRsbRsbRsbRsbRsbRs
RsmbRgbRsLsbRgRsmbRgRsmbRsRsmbRsbRsLsRsbLgbRgbRgbLsbLsbRcbLhbLibLgbsbR
sbRsbRsLsbRsbRsbRebLgbLhbLcbLebLsLsmbLsbLsbRsbRsbLsLgLsLsmbLsbsbLsbLsL
smbLsbRjbLsbLebLibLgLsbRsbRsLsbLgLsLsRsLsmbLgbLsbLsbLsbRsbRsLgbsbsbsbL
sbLgbLsLsmbRsbLsLsmbRsLsbLibLiRsbLsbLsbRsbLgbRgbLibLibLcbLsbLgbLsbLgbL
sbLsbLsLsLsLsmmmbLsbLsbLsbLgbLsbLsbLsbLgbLsbLsbLsbRjbRiRsmbRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 20; Drug: Haloperidol 10 然 Apo 0.5 然
bLsbLgbLgbRsbLiLsbRsbRsbRgbLgbsbLsbLibRsbRgbRgbRgbLiLsbRgbRiLsbRsRsLsm
bLgbLibRsbRgbRsbRsbsbLsbsbsbLibLsbLibLsLgbRoRgbRibLsbRgbLsbRsRsmbRiRsm
bRibRibLsbRsbRsbLebLjbLsbLibLgLsbLsbsbsbsbsbsbsbRsbLsLsLsmmbsbRgbLsbsb
LsLiLsbRsbLibRsbsbLibLsbLsLsmbReLsbsbRgRsmbRsbRibsbRgbRgbLibLsbRsbsbsb
sbRsbRgbLsbLsbRibRsbRsbsbRsbLsbRsbsbsbsbLsLsmbRgLsbLgLsbRebRsbRibRgbRs
bRsbLsRsbLsbLibRiRsmbRibRsRsRsRsmmmbRgbRgRsRsmmbRgbRiRsRsRgmmbRgbRsbRg
bRgLsbRgLsRsbRsbsbRgbRsbsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 21; Drug: Haloperidol 10 然 Apo 0.5 然
bRsbLsbLjbLhbRebRiLsLsmbLsbLgbLgbLsbsbsbRsbLsLsLiLsmbLsLsLsmmbLsbLsLsL
sLgmmbLgbLsbLsRsbLsbLsLsLsmmbLsbLsRsbLgbRsbLsbRsbLibLhbLcbLiLibLsbLsLs
LsRsmmbLsRsbLsRsbRsLsbLjbLjbLsbRibRsbRgbRsbLsLsmbLsbLsbRsbRsRsRsmmbRgR
iLsRsbsbLsbLsbRgbRgbRsRsmbRgbRsRsmbRsbsbRsbRsbRsbRsbRsbRsbRsbRsbLsbRgb
RsRsRsmmbRsRsmbRsbRsbRsRsmbRgbRibRsbRgbRgbRsbRsbRsbRgbRsbRsbRgbRsbRsbR
gbRsbRgbRsbRgbRsbRsbRsbLsbRsbRsbRsbRsbRgbRgbRgbRsbRsRsmbRgRsmbRsbRsbRg
bLsbRsbRgbLsbsbRgbRibRgbRgRsLsmbRsbRsbRsbRsbRsbRsbRsbRsbRsbLibRsbRsLsb
RgbRsbRsbRsbRsbRsbRsbLsLsmbLsbRsbRsbRsbRgbRsbRgbRsbRsbRsbRgbRgbRsbRgbR
sbRsbRgbLebLgbLsbRsRsmbRgRsmbRgbRsRsmbRsbRsRsmbRsRgbRsbRsbRsRsmbRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 22; Drug: Haloperidol 10 然 Apo 0.5 然
bRsbRgbRgbRibRibLsLsmbRibRibRsbLsbRebLgbRsRsmbRebLhbLjLsLsmmbRgbRsbRsb
RsRsmbRsbLsbLsbRgbLsbRsbRgbLgbRiRsmbRsRsmbRebRjbRsLsbLibLsLsRsmbRgLsbR
sRsmbRgbRsbRgbRgbRgbRjbsbRsbRgbRsbRsLsLsmbLsbRgbRsRsRsmmbRsRsRsRsmmmbR
sRgbLsbRsbRjbLsbLsbRoLsbLsLsmbRsRibRsRsmbRsbRsbRsbRgbRsbRsbRsRsmbRsbRs
bRgLsbRgbRsRsLsmbRgbRsbRsLsbRsbRoRsmbLjbLebRjbRibRsbRsRsmbRgRsmbRsbRsR
smbRsbRsbLsbRsRsmbRsRsmbRsRsmbRgbRgbRsLsbRsbRsbRgRsmbRgbRgbRgbRsbRsbRs
bRsbLgbRsRsRsmmbRgRsmbRsbRgRsLsmbRsRsmbRgRsmbRgbRiRsRsmmbRgbRgbRgbRgbL
sLgbLsbRjbLsLsmbRsbRsLsbRsLsRsbLgbRebLgbRgLgbLebRsLsbRsbRibRsbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 23; Drug: Haloperidol 10 然 Apo 0.5 然
bLsbLibRsbRgbRgbRjbRcbLgbRcRsmbRiRsmbLgbLgLsbLjbLebLibLsbLibLsbLgbRsbL
sbLsbLibLjbLgbRsbLsLgLsbRsbLsbLsLsmbLgLsLsLsmmbLsbRsbLsbRsbLobRobLjbLg
bLsbRobRgLsbLsbLsLsmbLsbLsLsmbLsbLsbRgbLsbRsRsLsmbRsLsbsbLsbLsbsbLebRs
bLgbRsbLjbRjbLhbRhbLgbRsbRsRsRsRsmmmbLsRsbsbRgRsRsmmbLsbLibLsLsRsLsmbL
gbLsLsLsLsmmmbLsLsmbRsbRsLsbLgbRsbRsLsbLsbRsLsbRsLgbLsbLsbRsbRsbLsLsmb
LsbLgbLgbLsbLsbRebLjbLhbRcRsmbLibRcRsRsmmb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 24; Drug: Haloperidol 10 然 Apo 0.5 然
bRiLsbLsbLgbLjbLcbLsbRsbRhbRsbLsbLcbLsLsmbLsbLibRgbRhbRsbRhbLsLsmbLgbR
iRsmbRgbRsbRsbRsbLsbRsbLsLsmbLgLsbLgbLsLsmbLgbLgbLgRsbRjbLgLsbLsbLcbsb
LibsbRgLsbRsbLsbRgbLsbLsbRsbsbRjbRibRibRsbLjbLhbRsbRsbRsbRgbLsLsmbLjbs
bLsbRsbLsbsbLsbLsLsmbLsbLsbLgbLsLsmbLsLsmbLgbRsbLgbLsbLsLsmbLgbRsbLgbL
sbLsbRjRsmbLjbLsbRgbRsbRsbRgbRcbRsbRsLsbRsbRiLsbLsbLibRsLsbsbsbsbLsbLs
LsRsmbsbRsbLsbsbRsbLibsbLsRsbRsLsLsRsRsmmbRjbRebLjLsmbRjbRibLsbLsbLjbL
ibLsbLgbLsbLgbLsLcbLsLsmbLibRgbLsbLsbLibsbRsbLsbRibLsbLsLjbRsbRsbLhRsb
LsbRsRsmbLibLsbLibRsbLsbLsLsmbLgbRsbRgRsmbLgbLgbLsLsmbLsbRcbRibLsbLsbR
gLsbRcLsbLsbLgbLsbRsLsbRsbRgbLgLsbRibLsbRjbLsbRsbLsbLsbLibRgbLhbRsbLgR
eRsmbRsLsbLsbLgbLsLsmbLsLsmbLgbLgLsRsbRsbsbRsRsmbLib

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 25; Drug: Control Apo 0.5 然
bLgbRgLsbRebRob

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 26; Drug: Control Apo 0.5 然
bLibLgbLibRibLsbLsbRcbLcbRiRsmbRjRsmbLcbRibRgbRjbRobRjbRsbRsbRsbRobLob
RgbRgbRgbRjLsbLjbLjbRsbLgLsbLgbLgRsbLobLibLoRgbRibRjbLsbLsRsbRsbRsbRiL
sbRsbRgbRgbRsbRsbRsbRgbRgbRgbRgbRsLsbRsbRsbLsRsbRsbRsbRsbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 27; Drug: Control Apo 0.5 然
bRcbRgbRobLoLsmbRcbLiRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 28; Drug: Control Apo 0.5 然
bRsbRoRsRsmmbRobLsbRsbsbsbLhbRobRcbLebLcbLcbRibLcbRcbRsbLsbLsbLsbLiRsb
LjbLcbLcbLjbLibLsbRgbRoRsmbLibLsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 29; Drug: Control Apo 0.5 然
bLgbRcbRjbLgbLiRsbLcbLibLsbRgLsbRgbRcbRiLsbRibRibRibRebRcRsmbRgbRibRiR
smbRjbRebLobRgbsbLsRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 30; Drug: Control Apo 0.5 然
bLjRsbRjb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 31; Drug: Haloperidol 1 然 Apo 0.5 然
bRgbRiRsmbRibRgbLibLhbRsbRsbLsbLgLsbLcbLibLibLjLsmbLibLsbRsbRsbRsLsbRc
bReLgbRcLsbLsLsmbRhbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 32; Drug: Haloperidol 1 然 Apo 0.5 然
bLjbLiLsbRsbRibRcLsbLgbRobRgbsbLhbLgbLeLsbLhbRgLsbLgbLibLsbRsbLibLibLi
bRjRsmbRcbLibLibRjbLibLsbLibLsbLjLgbLgbLgLsLsmbLsbLgbRjRgbLsRsbLgbLsbR
sbRsbRibRsbLobLhbLgbLhLsbLgbRobRibLsbLcbLoRsbRjRsRsmmbLibLibLgbRsbRsbL
iRsbRsbRsbsbRgbLgbLsbRibLgbLobLoRsbRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 33; Drug: Haloperidol 1 然 Apo 0.5 然
bsbsbRgbLjLsmbLjbRgbRsbLgbLgbLgbLsbLsbRsbLsbLsbLsbLibLibLsLsmbLsbLsbLi
bRsbRsbLgRsbLsbLsbLsbRsbLsbLsbLsbLiLsLsmbLsbRsbRcbRgbRsbRsbRibRsbRobRg
bLsbLsbLsbLsbLsLsmbLsbLsbRcbLsbRgbRsbLsbRsbLsLsmbLgbRsbRgbLsbRsbRgbRsb
LsLsmbLgbRib

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 34; Drug: Haloperidol 1 然 Apo 0.5 然
bRsbRibLobLgbLsbLsRsbRgbLsbRiRsmbLsbLcLsmbLiLsbLsLsmbLsbLcbRibLgbLsbLi
bRibLsbLibLsbRsbLsbRsbLsbRsbLsbLsLsmbRsbRsbRsLsbRsbLiLsbLsbLiRsLsbLsbL
sbLsbLoLsRsmbRibRibRobLsbRgbRsbRibRsbLgbRgbRsbLhbLsbLiLsbLgbLsbRgbLiLs
bLsbLsbLgbLsbLibLsbLsLsmbRgbLsbLibLsbRgbLgbLiLsbRgbLibRsLsbLgbRcbRjbRi
bRsbLsbLcbRjbRcRsmbLjbLcbLsbRgbLcbLsbRgbLibLsbRgbLiLsbLsbLsbLsbLcbRsLs
bLsRsbLsRsLsbRibLsbRsbLsbLhbLsbLsbLibLsbRsbLsbLgbLgbLsbRsbLibRsLsbLcbR
sLsbRsbLsbLsbLgbLibRsbLsbLsbLsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 35; Drug: Haloperidol 1 然 Apo 0.5 然
bLibLsbLsbLjbLsbLgbLobLibRsbLcbsbsbLjbLsbLiLsLsmbRsbLcLsmbRsbLibLsLsmb
LobLsbRoLsbRgbRgbRcb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 36; Drug: Haloperidol 1 然 Apo 0.5 然
bRjbLsbLgbRibLiLsbRibRebsbsbsbLsLsmbRsRsLsmbRsLsRsRsmbsbRjbLjbRjbRjbRj
bRjRsmbRjRjb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 37; Drug: Haloperidol 3 然 Apo 0.5 然
bLgbLgbsbLsbLsLsmbLsbLobLgLsbLibLgbLhLsbRjbRcLsbLgbRcbsbRgbRsbRiRsmbLg
bLibLobsbLsbLsbLgRsbLgbRjbRcbRibsbLibLibLhbRjbRibLobRgbRgRsmbRgbRibsbs
bsbsbLsRsbLsbsbLsbsbRgbRgbLsbLjbRibRibLjLsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 38; Drug: Haloperidol 3 然 Apo 0.5 然
bRgbLibLsbLibLibRcLsLsLgmbLiLsbLsbLgbLibRhbLibRcbLobRgbLibLcLsmbRgbRib
LibLibRgLsbLibLiLsbRibRoRsmbRibRsLsbLobLsbLgLsbRsbLobLiLsbLibLcbLhLsbL
ibRgbRhbRcbLhbLsRsbLebLsbLibLsbRgbLibLsbLibRsbLibLibLiRsbRibRsbLgbLibR
ibRcbLibRcbLibRibRiLsbLgbRhLsbLiLsbRibLjbRcbRiLsbLiLsbRibRsLsbRoLsbLgb
LsbLjbLiLsbLgLsbLiRsbRgbLhbRibLibLgbLsbRcRsmbLibRhbLebLsbLhbRsbRhbRsbL
hbLiLsbRgbRhbRhLsbRibLgbLgbLsbLcbLhbLhbRsbLibLiLsbLeLsbLiRsbLibLsbLibL
ibRgbLiLsbLibLsbRcRsmbRibRsbLjbLcb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 39; Drug: Haloperidol 3 然 Apo 0.5 然
bRsbRsbRgbRgRsmbRsbRgbRsbRgbRgbRibRibRsbRgbRsbRgbLgbLsRibRgRsmbRibLjbR
ibRgbRgbRsbsbRgbRsRsmbRsRsmbRgLsbLjbRjbRsbRsbRgbLsbRiLsbRsbRibRibRsbRi
bRiLsbRibLcbLcbRibLcbLsbReLsbLjbLcbLgbLcbsbLibRjbLsbRsbsbLjbRgbsbLsbRc
bLjbLibLibRgbRjbRjbRibRibRibLibLjLsmbRsbLsbLsLiLsLgRsbLibRsbLgLsbLhbLi
bLgLsLsmbLiLsbLjLsmbLibLiLsLsmbLjLsmbRibLsRsbsbLsLgLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 40; Drug: Haloperidol 3 然 Apo 0.5 然
bRgbRsbLsRsbsbRsbLsRsbRgbLsbRsbRsRsmbsbsbsbLsLsmbRiRsmbLsbLgbRsbRsbRgL
sbLgbsbLsLsmbRsbRsbLsbRsbsbLgbRsbLsbRebLsLsmbRgbRsbRsRsmbRebRsbRsbLsbR
ibRsbLgbsbRsbsbsbRsbLsbsbsbRsbRcRsmbRgRsRsmmbLjbRjbLibLsbRhbRsbLgbRsbR
gbRgbLsbLsbLsRsRsRsLsmmbRsbRgbRsbRsbRsbRsbRgbRgRsmbRgbRgbsbRsbLsbRgbRs
bLsbRsbRcbLgbLsbRibRsbRgbLsRsbRibRgRsmbRsRgbRsRsmbRsRsmbRsbRsbRgbRgbRs
LsbRsRsRimbRgRsmbRsbRiRsmbRgRsRsRsmmmbRsRibRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 41; Drug: Haloperidol 3 然 Apo 0.5 然
bLgbLsbLgbLgbLsbLsLsmbLsbLgbLgLsbLgbLgbLsbLgbLgLsbLgbLgbLsbLgLsbRsbLgb
LgbLgRsbLgbRsbLgbRsbLgbLgbRsLsbLjRsLsbLsbLgbsbLgbRgbRgbLgbRgbRsbRgbRgR
smbRsbRgbRsbRgbRsbRgRsmbRgRgbRiRsmbLsbRgbRsbRgbRsbsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 42; Drug: Haloperidol 3 然 Apo 0.5 然
bLibLjLsmbLibRcbLsbLjbLcbRsbRsRsmbRsbRibRsbRcbLsbRjRsmbRsbRgRsmbRjRgRs
mbLjLsmbLsbRsLsbRibRibRsbRsbRsbLsbRgbRhbLobRcRsmbLsLsRsRsLsmmbRsbLsbRs
bsbLsbLsbsbsbRsbLsbsbRsbLsbLsbRsbsbRsLsbsbRsbRsRsLsRsmbsbsbsbRsbRsbRsb
LsRsbRsbLsRsbRsLsbRsbLsbsbRsRsmbsbsbsbsbRsbsbsbRsbLsbRsLsRsbsbLsLsmbLi
LsRsbRsRsmbsbLibRsbLcbLiLsbRgLsbLobRsbRibLsbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 43; Drug: Haloperidol 10 然 Apo 0.5 然
bLibLsbLsLsmbLsbRsLsRsbLgbLsbLsLsmbRsLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 44; Drug: Haloperidol 10 然 Apo 0.5 然
bRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 45; Drug: Haloperidol 10 然 Apo 0.5 然
bsbRsLsbsbLsbsbsbLsbsbsbsbsbLsbsbLsbRsbLsRebLobRgRsmbLgbRsbRsbRjbLjbRs
bLsbLsbRsbLsbRjbLsLsmbRsbRsbLsbLsbsbsbsbsbsbsbsbsbsbsbLsbRgbLsLsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 46; Drug: Haloperidol 10 然 Apo 0.5 然
bRsRsmbRsbReRsRgRsLsmmbLibLibRgbLsbRebReRsmbRiRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 47; Drug: Haloperidol 10 然 Apo 0.5 然
bLsbLiLsLsmbLsbsbLsLsRsmbsbLsLsLsmmbLsLsLsmmbLsbLsbLgLsLsmbRsbsbLsbLsb
LsbLsLsmbLsbLgbLhRsbRsbLhbLgbLiLsLsmbLgbsbLibRsLsLsmbLsbLsbLsbLsbLgRsb
RsRsmbRsLsbLgRsbLsRsRsLsmbRsRsRsmmbLgbLsRsbRsbRsLsbLsbLsLgbLibRgbsbLib
RsLsbLsbsbsbLsbLibLsbLsbLcbLiLsbLsLsmbLiRsbLsbLhbLsbLsbsbLgbLibRsRsmbR
sRsmbLibsbLsbLsLsmbLiLsbLsbLiLsLsmbLibRsRsRsmmbLsLsLsmmbLgbLibLibRsRsm
bLsbsbRsbLibLsbRsLsLsmbLgbLsRsbLgbLsbLsbLsbLibLibLsbLibRsbRsbsbLsLsmbL
sLsmbLibRsRsmbRsRsmbLgRsbRsbReLsbLjbRibRcbLsbLibLibsbLiRsbLibRgbLsbLsL
gbLsbLgbLsLsLsmmbLsbRsbLgbLibsbRsbsbLsRsbLsLsmbsbRjbRibRibRsbRibRsbLsb
RiRsmbRgRsmbRsRsmbRsLsbRgRsmbLsbLgbLhLsbLgbLgbsbsbsbsbLsLsmbRsRsLsmbLs
bLsbRsLsbRsbsbLsbRsbLsLsmbRsLsbRsbsbLsLsmbsbsbLsbLsbLibsbRsRsmbRsbRsbR
ebLsRsbLsbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 154457; End: 154957;
Recording: 4-1; Individual: 48; Drug: Haloperidol 10 然 Apo 0.5 然
bLiLsbLibRgRsmbRsLsLsmbLgbRebLcRibLsbLebRibLgbLsbLobRgbLgbLgbLgbLsbLsb
LgbLgbLsbLgbLgbLsbLgLsbRsbLgbLsLsmbLsbRsbRsLsRsbLsRsbLsbLsbLsbLsbRsbLs
LsmbRsbRsbRsbLgbsbRjbRsbRsRsmbRgbRsbRsbRsbRgbRsbRgbRgbRsbsbRsRsmbRsbRs
bRsbRibRsbRsbRsbRgbRgbRsbRsbRsbRibLsbRsLsbRsbRsbLebLebRgbRgbRsbRsbRsLs
LgbLibLsbLhLsLgbLgLsbLgLsbLgbLgLsbRsbRsbRsbLgbLgbRsbLgLsbLgRsbRsbLsRsL
gLsRsbLibLgbLgLsLgLsbLsbLgLsbLgLsRsbLgLsbLsbLgLsbLgLsbLgLsbLsbLsbRsbLs
LsmbLgbLgbLsLsmbLsbLsLsRsmbLgbLsLsmbRsbLsbLgbLgbLgLsbLgLsLsmbLgRsbLgbL
sbLgLsbLsbLsbLgLsLsmbLgbLgLsbLsbLsbLgbLsbLgbLsbRsbLgbLgbLsRsbLgLsbLgbL
gLsLsmbLgbLgbLgbLgbLgbLgbLgbLsLiRsbRgbRiRsmbRgRsRsmmbRgRsmbRgLsbRgLsbR
sRsmbRgRsmbRsbLsbRgRsmbLebLeRsbRhbLcRsbLibLibLhbRiRsmbRiRsmbLcbRsbLsbL
gbLgbRsbRsbLsbLsLsmbLsbRsbLsbLsbLeRsLsbRcbRjbLibRiLsbRibRibRgbRsbRsbRs
RsmbRsRgRsmbRsbRgbRiLsbLgRsbLgbLjbRsbLsbLsbLsbLobRebLgLgLsbLsLsmbLgbLs
LsmbLgLsbLibLibLgLsbLsLsmbLsbRgRgRgRgbRgbRgRgRgRgbLsbLsbLibLgbRsbLsbLs
bLsLsRsLsmbRsbLsbRgbRgbLsLsmbLsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 1; Drug: Control Apo 0.5 然
bLgbRobLgbRjbLobLcLsLsmmbLoRsbLcbRiLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 2; Drug: Control Apo 0.5 然
bsbRsbRsbLsbsbLsbsbsbsbLsbsbsbLsbsbRsbLsRsbsbsbsbLsbRsbsbsbRsLsbsbLsbL
sbsbsbsbRsbsbsbLsbsbsbRsbsbRsbLsbsbsbsbRsbsbsbLsbRsbsbsbsbsbsbsbsbsbsb
sbRsbLsbLsbLsbRsbsbLsbRsbLsbsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 3; Drug: Control Apo 0.5 然
bRgbRgbRhbLcbRsRsmbsbRibRobRebRobLcbRobsbRobLsbLgbLcRsRsmbRcLhbLjbLsbR
gbLibLoLsmbLsbLgbRjbLjbRgbRsRsLsmbLsRsLsRsbRsbLsLsLsmmbsbsbsbsbsbsbsbs
bLsLibRgbsbsbLsbLsbsbLsRsbLsLsRsmbLsRsLibLjbLsLjbsbRgbRibLsbRcRsLsRsmb
LsbLgbRibLibRobLhRjbRjbReRsmbLobReLgbsbsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 4; Drug: Control Apo 0.5 然
bsbRoRsmbRgbLoLsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 5; Drug: Control Apo 0.5 然
bLgbLibRgRsmbRcbRibLobLgbLgbLcbRcRhbRsRsmbRsbRgbRjbLsRoRsmbRjbLcbLobLo
LsmbRibLjbLcRsbRgbLjbLjLsmbLcRsbRsbRsbLcbRgRsmbRgbRibLobRiLsRsbRjRsmbR
gb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 6; Drug: Control Apo 0.5 然
bLgbLjLsmbRcb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 7; Drug: Haloperidol 1 然 Apo 0.5 然
bLibRsLsbRsRsmbLcbLibLsbLiLsbLsbRsbLibLiLsbLgbLgLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 8; Drug: Haloperidol 1 然 Apo 0.5 然
bRjRsmbLsbLsLsmbLjLsmbRibRjbRgbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 9; Drug: Haloperidol 1 然 Apo 0.5 然
bLgbRhbRsRsmbRibLsbRgbLibRcbLgbLsRgbRibRsRsmbRgbRibRgRsmbRsbLibLgbRcbL
jbLobLsbLsbLiLsbRjbRcbRcRsmbLgbRiLsbLsLsmbRgbRibRibLgbRgbRiRsmbRsbRibR
ibRgbRibRibRgbRibRgbRsbRgbRibLibRibRibRebRsRsRsRsmmmbRhbRibRibLsbLhbRi
bLgbLjRsRsmbRjbLiLsbLeb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 10; Drug: Haloperidol 1 然 Apo 0.5 然
bRibLcbRgRsmbsbsbLjbRhRsLsmbRsbLibRgbLjbRibLiRsbLsbRiRsmbLibRsRhbLibRi
bLgbLiLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 11; Drug: Haloperidol 1 然 Apo 0.5 然
bLgLsbLcbsbLsbLsbLibLibLgbRsLsbRsLsbLibLsbRsbLsbRoRsmbRsbLgbRjRjbLobRs
bRsbRsbLsbLgLsbLgLsLsmbLsLsmbLibRsbLgbRcbLibRjRibRcbLjbRoRsmbRibLcLsmb
LgbLgLsbLsbLsLsmbRsbLgbLsbLgLsbLsbRsbRgbRiRsmbRcbLsbRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 12; Drug: Haloperidol 1 然 Apo 0.5 然
bRebRebRcbRgbLsbRibLsbLhbRgLsbLgbRgbLibLibRjbRobRgRsmbRgbLibLcbRjbRjbR
obLsbLeLsbLibRsbLjbLgbLsbLcbLsLsmbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 13; Drug: Haloperidol 3 然 Apo 0.5 然
bRcbLgbRibRcLsbLibLcbLibLiLsbRsbRsbLsbLgbLiRsbRgbRjbRibRibRibLjLgbRcbL
gLsbLsbLgbLcbLibRsbRsbRcRsmbRibRibLiLsbLibLgbLgbRjLsbLibRibLibLibLsbLs
LsmbLsbRsbLibLgbLibRgRsmbLsbLhbLsLsmbRoLsbRibRgbLjLsmbLiLsbLibLeLsbLsb
LgRsbLsbLiLsbRsbLibRiLsbRjRsmbLibRcRsmbsbLibLibLsbLsLsmbLsbLsLsmbRibRh
bRgLsbLgbLcbLjLsmbLsLsmbLgbLgbRgLsbLibLsbLsbRcbRhLsRsbLjbLibLiLsLsmbLg
bLsbLsbLhLsbRsRcbLibLgbRsRsmbLsLiLsbRsbRsbLiLsbRjbRcbRhLsbLgbLsbLcbLjL
smbLsbRsbRgbLjLsmbLgbRsbLsRsbLsLsmbLhbRsbRobLgbLcbLibLsLsmbLibRsLsbRsL
sbLgLsbLibsbLsbLsbLibLsLsmbRjbRcbRgbRcbLibLgLsbRcRsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 14; Drug: Haloperidol 3 然 Apo 0.5 然
bRsRsmbRsbRgLsbRsLsbRgbRgbLgbRibsbRsbLsbRsbLsbRgbRgbRgbRgbRibLsbLgbRjb
RgbRibRsbLsbRibRsRsmbRgbRsbRjbRiLsbLibRebLcLsmbRgbRcbRgRsmbRgbRsbLsbRs
bRgbRsbRgbRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 15; Drug: Haloperidol 3 然 Apo 0.5 然
bLsbLsbLsbRjbRhRsRsmmbRcbLibRjRsmbRibRjbLiLsLsmbLgLsbsbsbLsbLgLsbLgbRs
bRsbLiLsbLibLibRsbLgbLsbLgbRsbRebRobLjbLobReRsmbLcbLobLsbLibRsbRgbLjbs
bLsLsmbLsbLgbRcbLsLsLsmmbRgRibLjbLcbLsRsbLibLibRsbLibRcLsbRhLsLsmbRsLs
bRhbLsLsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 16; Drug: Haloperidol 3 然 Apo 0.5 然
bLiRsbRsbLgbLgbRsbLcbRibRiRsmbsbLcbLiLsbRjRsRsmmbLcbLiLsbLhbRsbLgLsbLi
LsbLibLsbLgbLibLgbRsbLiLsbLgbLibLsbLibLibLsbLsbLsbLsbRsRsRsmmbLcRsbRsb
LcbRcbRoLsbLsbRsbLebLcRsbLsLsLsmmbLgbLgLsbLcbLsbLgbLgbRgbLibLsbLibLebL
ibLiLsbLgbRsbLsbLgbLsbLiRsLsbLgbRsLsbRsbLibLiLsbLsbRsbLsbLsbLeLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 17; Drug: Haloperidol 3 然 Apo 0.5 然
bLibRsbLjbRsRsmbLibLibLjLsRsmbLsbRibRsbRgbsbLgLsbRgbRibRsbRibRiLsbLsLs
mbRgbRibLcbLibRsbLjLsmbRjbRcbRgbRiRsRsmmbRibRgbLgbLjbLcbRjbRgbRsRsmbLi
bRsbsbsbsbLcbRsLsbLsbsbLjLsLsmmbLgbRjbLsbLjbLsbRsLsbsbsbLsbLibRsbLibRs
bRjbRhbLgbRhbRgbRiLsbLsbRjRsmbRibRsbRibRsbRsLsbRsbLsbRgbsbsbsbsbsbsbsb
RgbRsbRsbLjbRjbRibRsbRgRsmbRsRsmbRibRhLsbLibRsbRobLgbRcbRsbRgbRiRsmbLe
b

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 18; Drug: Haloperidol 3 然 Apo 0.5 然
bLsbRsbLibRsRsmbLgbRsbRsbLsbRsbLgbLgbLsbLgbLsbLgbLsbRsbLgbsbLsbRsbRsLs
bRsRsRsmmbLsbLcbLoRsbLgLsbRibRgbRcbLoLsmbLcbLibLsRsbLhbLgLsbLsRsbLgbLi
bsbLsbRsbRsbLibLiLsbRsLsbLgbLibLsbRgbRsbRsbRobLsbLeLhbRsbLcLsLsmmbLcLs
mbLgbLsLsmbLgbsbLsbLsbLsLsmbLsbLgbRsbLsLsmbLsbLgLsbLsRsLsbRsbLsbRgbRsb
sbLgLsbLsLsmbLibLibLsbLsbLsbLsRsRsLsmbRsbLgRsLsbLibLsbLibLsbLibRsbRibL
jbLgbRsbsbLgbRsbRgbRsLsbLibLsbLsLsmbLsbLibLibRsbLibLsbLsbLgLsbLsLsmbLg
bLsbLgbLsbLhLsRsRsmbLhbLibLsRsbLiLsbLsbLgbLsLsmbRsbLsLsmbsbLsLibRsbLiL
sbRsbLobRgbLjbRsRsmbLsLgbLiRsbLgLsbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 19; Drug: Haloperidol 10 然 Apo 0.5 然
bRjbRsbRsbRsRsRsmmbRsbRsbRsbRgbRsbRgbRgbLgbLebLibLgbLgbRsbRgbLsbLsbLsb
LgbLiLsbsbLgbLsbRsbLsbsbLgbLgbLiLsbLjLsmbRsbLgbLibLibRcbLcbLcbLebLsLib
RsbRgbRsbRsRsmbRsbRsRgbLsbLsbRiLsbLsbLsbLgbRsRsRsmmbLsbRjbRgRsRsRgmmbR
sRsRsmmbRgRsmbLgbRsbRibRgbRsbLsRsbLsbRsbRgRsmbRsbRsRsmbRsbLsbLsRsbRsbR
sbRsbRsRsRsmmbRgbRgRsmbRsbRsbRsbLsRsbRsRsmbRsbsbLsbsbRsbRsbRgbLsbLsLsm
bRsbRsbRsRsmbRsbRsbRsbRjRsmbRgbRsbLobRjbRsRsmbRsRsmbRgbRsbRsbRgbLsbRgb
LsbLsbLibRjRsmbLsbLibLsbRsbLgbLsLsmbRsbRsbLsbLgbLgLsbLgbLsLsRsmbLgbLsb
LgbLiRibRsRsRsmmbLsLgbLsLsLsmmbLsRsbLsbLsbLsbLgLsbLgbLsbsbLsRsLsbLgbRs
bRibRibLgbLgbLsLsmbLsLsmbLsLsmbLsLsmbLsbLsbLsRsbLsLsmbLsbLsbLsLsmbLsbL
gLsbLsbLsbRsLsbLsbRsbRsbLsbLgbLiLsbLsbLsbLgLsLgLibLgbLgRsbLgbLgbsbRsbs
bsbLsbLebLhbRgbRsLsbLsbLsbLgLsLsmbLsbLgbRsbLsbRsRjbRgbRgRsLsmbLhbRgbLs
bLgbLgLsbLsbLsRsbLsbLsbRsbRsbLsRsbLsbLgbsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 20; Drug: Haloperidol 10 然 Apo 0.5 然
bLsbRsbRsLsbRsbRsbLsbLsLsmbRsbLjbLibLgbLgbLgLsbLiLsRsRsmbLsbRjbLgbLsbR
gbLiLsLibLgRsbLibLebLiLsLibLcLsRimbRjbRibLsbRgbLsLsRsmbLsbLsbLjRibRsbL
jbRibRjbRsbLsbRsbLsbLobsbRsbLibRsLsbRsLsLgbLsLsmbRsbRsbLiLiLsRsbRgRsmb
RgbRsbRgbLgbRsbLebLobRcbLsRsbLsbRgLsbLsbRgbRibRjbLebLcbLgLsLsRsmbRsLsL
smbRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 21; Drug: Haloperidol 10 然 Apo 0.5 然
bRsbRgRsmbRsRsRsLimmbRgbRsbRgbRebLibLibLsbLgbRsbRsbsbRgbRsbRsbRsbRgbRg
bRsbRsRsmbRsbRsbRsRsmbLsLjbLsbLsbLgLsbLgbRgRsmbRgbRsbRsbRsbRsbRsbRsbRs
bRsbRsbLsRsbRsbRsRsmbLgbLsbLsbRibLgLsbLsbLgbLsbLsLsmbRsbRsbLsbLgLsLsmb
LsbLsbLgbLgRsbLsbLsbLsbLgbLgbLgbLgLsbLgbLgbLsbLsLsmbLsbRsbRgbRgbRsbRsb
LsbRsbRsbRsRsRsmmbRgbLsbRsbRsbRsLsbRsbRsLsbRsbRsRsmbsbsbLsbLsbRsbRsbsb
RsbRsbLsbRsbRsbRsbRsbRsbRibLsLsLsRsmmbLgbLsbRsbRsRsRsLsmmbRsbLsRsbsbRs
bLsbLsbRsbRsbRsbRsbRsbLsbLsLsmbLgbLjbLgbRsRsRsRsRsmmmmbRsbLjbLibLsbRsb
RgbLgbRebLsbRgRsRimbRgRsmbRsbLsbLsbRsbLsbRoLsbLsbsbsbLsLsmbLsbLsbRsbLs
LsmbLsLsmbLgbLgbLjbRsbLsbLsbRsbRsbRgbRgbRsbRsbRsbRsbRsbsbRsbRsbRsbRsRg
LsbRgLsbRgLgLsLgbLsbLsbLgbLsbLsbLsbLsbLsbRjbLsRsbLsbRsLsbsbLsbLsbLgLsb
RsbLsbRsLsbLibLgbLgLsbLgLgbLgbLgbLibLsbLsbLsbLsbLsLsmbLsRsbRgbRgbRgRsm
bRsRsmbRob

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 22; Drug: Haloperidol 10 然 Apo 0.5 然
bRgRsmbLgbLgLsbRgbRgbRsbRsbRsRsmbRsbRgbRsbLibRgbRsbRsbRgbRgbRgbRsRsmbR
gbsbRsLsbRsbLsbRsbLsbLsbRsbsbLsbLsbRsbLsbRgbRsbRsbsbLsbRsbRsbLsbRebRsb
RsRsRsmmbRsbLsbLsbRsRsmbLsbRgbRibRgbRsbLgbLebRsbRsbRsbsbRsRsRsmmbReLsL
smbLsbLsbRsLsLsmbRsRsmbRgbLsbLgbLgbsbLsbLgbLgbLsbLsbLsbLsbLsLsmbLsbLsR
sbLsbLgbLsbLsLsmbLcbRobLsRsbLsbRgbLsbRsbRsbRsbRsbLsbLobRebLgbLsbLebLjb
RsbRgRsmbLsRsRsmbRsbRsRsmbRsLsbRsbRsRsmbRsbRjbLgbRsRsmbRsbRsRsmbRsRsRs
mmbRsbRsbLjLibRgRsLsRsmbRsRsmbRsLsbRsbRsRgbRgbRgbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 23; Drug: Haloperidol 10 然 Apo 0.5 然
bLgbLgbRsbRsbRsbRsLsbsbRibLsbRgRsmbRgLsRsRsmbLgbLsLsmbLgbLsbLgbLsLsmbL
gbLsbLsLsRsmbLgbLsbLgbLsbLsbLsbLgLsLsmbRsLsbLgbLsbLsLsLsLsmmmbLsLsLsmm
bLsLsmbLsbRsLsLgbRsbLsbRsLsRsbLsRsbLjLsmbLsLsLsmmbLsRsRsmbLsLsLsmmbLsL
sLsmmbLsLsmbLsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 24; Drug: Haloperidol 10 然 Apo 0.5 然
bsbRsRsmbLsbLsbLgLsbLgbRsLsbLsLsmbsbLgbLsbRibRibLgbLsbRibRsbRobLibLibR
sbLhbRgbLgbLgLsLsmbLsLsmbLsbLsbLsbLsLsmbLsbLsbLiRgbLsbLibRsbLsbRsbLsRj
bLcbLgbLgLsbLsbLgbRiLsLsmbLgbLsbLjbLsbRsbRsbRobRibRjbLibRgbLsLiRsbLsbR
sbLjbRsLsbsbLgLsbRsbLhbRsbLibRsbRsbLsbLibLgbLsbRsbsbLgbRiLsbLsbRjbRsbR
ibRhbLsbLjbLjbLsbLgbLgbLsbLibRsbRsbsbLgbsbLsLsmbLgbsbLgbLsbLsbLsbLsLsm
bRgbRsbLgLsbLgbLsLsmbLsbLsLsmbLgbLsLsmbLibRsLsbLibLgbLibLsbLiRsbRsRsmb
RhRsmbRsbRsbRgbRjbRibLgbLgbLiLsbRsbLsbLsLsmbLgbRsbLgbRgbRsbRibRibRgbRs
bLsbRgLsbRgLsbLgLsbRgRgbLebLgRsbLsbLsbLsbLsLsmbLsbLsLsmbLsLsLsmmbLsRsb
LgbRsbLibRjLsbLsbLgLsbLsLsLsmmbLsbsbLsbLsbRgbLgbLsLsmbLibLsLsmbLgLsbLj
bLsbLsbLsbLsbLsbLsbRgbRsRsmbLibLiLsbLgbRsRsLsmbLsLsmbLsLsmbLsRsbLgbLgb
RobRoLsbLsLsLsmmbLsbRibRgbRgbRsbRgbLgbLgLsbLgbRsbLgRsRsmbRsbLgbLgbRibL
gbLgbLsLsmbLsLsmbLsbLgLsbLsbLsLsmbLsbsbsbLsbLgbsbRgbRsbsbLibRsbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 25; Drug: Control Apo 0.5 然
bRjbRcb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 26; Drug: Control Apo 0.5 然
bRgbRgLsbRsbRgbRsRsmbRgbRgbRgbRsbRgbRsbRgbLgbRsbRhbLgbLgbLsLgbRsRsmbRj
bLibRgbRgRsmbRgbRibRobRgbLgbLibRibLcbRjRsmbLobLobLhbLhbLib

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 27; Drug: Control Apo 0.5 然
bRgbRsbLobRiLsLsmbRjbLcLsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 28; Drug: Control Apo 0.5 然
bLsbLgbRhRsmbLobLhbLsLsmbRcbLcbLcbLibRcbLsLsmbLsbLsbLsbRibRgbRcLgLsbRc
bRcbRsbRcbLsbRibLcbLsbLcLsmbRobLgLsbLcbLsbLsbLgbLobLiRsbLsbLsbLsbLcbLs
bLsbLsbRoLsbLib

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 29; Drug: Control Apo 0.5 然
bRsbLgRsbRgbRgbRiRsmbLcRsbRcbRhbLgbRgbLeb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 30; Drug: Control Apo 0.5 然
bRsRsRsmmbLibRibsbLibRcRsRsmmbRsbRsbLcRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 31; Drug: Haloperidol 1 然 Apo 0.5 然
bLcLsmbLgbLsbLgbRobLcbLibLeLsbLibLsbRsbLsbLgbLsbLiRsbLhbLgbRibRsbRgbLj
bRgbRiLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 32; Drug: Haloperidol 1 然 Apo 0.5 然
bLibRgbRgRsmbLibLgbLjbRiRsmbLgbLcbLibLibLsRsbLibLoLsmbLgbRsbLhbLjLsmbL
ibLgbLjLsmbLsRsbRsbLgbLgbLsbRibRsbLibLsbLsbLgLsbLgbLsbLcRsbLsRsbRsbLgb
RcbRsbRcbLsbLsbRhbRsbRibLsbLsbLgbsbRcbsbRobLcbRsbRiRsmbLibLgbRobLgbRiR
smbLsbsbRiLsbRsLsbRjRgbRjRsmbLgbLgbLgbRcbRcbLsbsbLibLibLgbsbsbRsbLhbLs
Lib

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 33; Drug: Haloperidol 1 然 Apo 0.5 然
bLgbRgbLsbRsbRcbRsRsmbLsbRjbRjRjbLgbLibLsbLsbRcbLsbRjbRgbLiLsbRobLsbLi
bLgbLsbLiLsbLsbRgbLsLsmbLibLhbLsbLsbRsbLsbLgbLgbLsbLgbRsbLsbRsbLsbsbLh
bRsbRsbLgbRsbsbsbRsLsbLibLsbRsbRsbRsbLgbRsbRsbLsbLgbLgbLgLsbLsbRgLsbLs
bLsbRgbLsbLgbLsbLsbLcbLsbRgbRsLsbRgbLebLibLsbRsLsbLsbsbRsbRcRsmbRgbRsb
RgbRgbLsbRsbLsbRgbRgbRsbRsbLsbsbRjbLjbRhbLsbLib

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 34; Drug: Haloperidol 1 然 Apo 0.5 然
bLsbLgbLgbLgbLsbLsLsLsmmbLsbRobLjbRcbRgbRcbLgbRebRjbRsbRiRsmbRgbLsRsbL
sbLcbLibLsbRjbLibLgbRgbRsbLsLsmbLibLibRibLsbLgbLsRjbLibLsbLgbLsLsmbLhb
LsbRjbLgbLgbLsRsbLsbLsbLsbLsbLsbLgbRsbLcbRibLgbLsbRgbLsbLgbLibRgbLibLg
bLsbLsbRobLjbLebRsbLibLgRsbRgbLsbLgbLibLsbLsbLgbRsbRgbRjRsmbLibRsbLgbL
ibLsbLiLsbLgbLsbLsbLsbLgbLsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 35; Drug: Haloperidol 1 然 Apo 0.5 然
bLjbLibRsRsmbLcbLjbLobLcbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 36; Drug: Haloperidol 1 然 Apo 0.5 然
bLjbRgbRgbRcbRcbRgRsRsmmbRjbRibLjb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 37; Drug: Haloperidol 3 然 Apo 0.5 然
bRhbRhbRgbRibRsRsRsmmbRgbRsbLsbRgRsmbRsLhbLhbLsLsLsmmbLsLsmbLibLjbLibR
ibRjRsmbLiLsbRhRsmbLiLsbLibLcbLsbRobRhbRsRsRsLsmmbRibRsRcbLgLsbLsLsmbR
iLsRsbRibRibLjbRibLgbLebLibLhbRobRgbLgbRiRsmbLsbLsbRibRibLgRsbsbRsbRgb
RibLibLcbRgbReRsmbRoLsLsLsmmbRsbLcbRjbRcRsmbRcbLgbLibLcbLsbRiRsLsmbLsb
LoRsbLsLsmbRiRsmbRsRsRsmmbRsRjRsmbLhbLcbLibLsbRgbLiRsbLsLsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 38; Drug: Haloperidol 3 然 Apo 0.5 然
bLiLsbRjbRibRibLebLibLibRgbRgbLibLgbLsbLibRibRobLgbLibLcbLhbLhbLsbRgbR
gbLsbRebLcbLgLsbRjbRcbLjbLibRcbRebRsLsbRsbLibLgbLiLsbRsbLgbLibLgLsbLgb
LibLibRcbLibLhbLibLgbLsbLhRsbRsbLhbLebLsbLcbLiRsbLsbLsbRsbLibLgLsbLgbL
ibRgbLibLibLsbLiLsbLgbLsbLsbLhbLgbLibLsbLibLgbRsbLibRjRsmbLibRibLibLsb
LibLsbRjbRjbRiRsmbRsLsbLsbRhbLcbLibLsbLgbRsbLsLsmbLsbLgbLcbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 39; Drug: Haloperidol 3 然 Apo 0.5 然
bLgbLgLsbLsbLgbLibRgbsbRsLsRsbLsbLgbLsLsmbLhLhLsLsmbLgbsbLhLsbLibRsbLs
LgbRsbLgbRsbLgbLsLsmbRjbLsbRsbLsbsbRsbLsRsbRsLsRsRsRsmmbRsLsLsmbLgbLgb
LgLsbLgbRsbRsbRsbLgbLsbLibLcbLiLsbLibLcbLcbRsbLsbLgbLgbRsbRgbReRcbLgbR
ibLcLsmbRsbLgLsbRsLsbsbRsRsmbRsLsbRsbLgbLgbRsbLsbLgbRsLsbLgbLgbLsbRsLs
bLgbLibLgbRsbRjbRobLibLcbLiLsbRsbLjLsmbLsbRiLsbRjbRebLgbRsbRib

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 40; Drug: Haloperidol 3 然 Apo 0.5 然
bRgbLgbLcbRsbRsbsbLsbLiLsbLjbLgbLjbLibLiLsbLsLsmbLgbLsbLgbLsbRsRsmbLsb
LgbLgbLsbRsbLgbRibRibRsRsmbRgbRsRsmbRsbLgbLgbLjLgbLsLsmbLibLgbRsbLsbLj
bRsbRsbLgLsbLgbLsbLgbLgbRsbRgbRsbRsRsmbRgbLibLsLsmbLgbLsbLgbLsbLsbRsbL
gLsbRsRsmbLgbLsbRsRsmbLgbLibRibLjRsbLibLsbLsbLgbLsLsLsmmbLibLgbRsRsmbR
sbLgbLibLsRsbLgbLsbRsbLgRsbRsbRgbLgbLibLsbLgbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 41; Drug: Haloperidol 3 然 Apo 0.5 然
bRgbRgbRsbLebRsbLjLhbRsbLgRsbRsRsRsmmbLibLgbRibLgbLibLsbRgbLsbRobRhbLc
LsmbLibLsbLgbRsLsbLsbLibRsbLgbLgLsbLgbLsLsmbLsbRsLsbRsbLgLsbLgbLsbLsbL
gbLsbLsbLgbLgbLsbLgbRgbRcbLcbRiRsmbLcbLgbLgLsbRgLsbLgLsbLsbLgbLsbLgbLs
bLsLsmbLsbLgbLgbLgbLgbLsbRgbLgbLiLsbRebRoLsbRibLsLibLgbRsLsbLgLsbLsbLg
bLgbLsbLgbLsbRsLsbLgbRcLsbRcbRsRsRsmmbLsbLsLsmbLgLsbLgbLgbLgbLsbRsLsbL
gbRsLsLsmbRsRsmbLgLsLsLgmbLgbLgbLgbLgbLsbLsbLgbRsbLgLsbLibLsbRsRsmbLsL
sLsLsLsmmmmbRsbLsbLiLsLsmbLsLsmbLiLsbLgbLgbLgbLgbLgbLgbRsbRebRgbLgbLcb
LibLgbRsLsbLgbRsbRsbLibRsLsLsmbLsbRhbRhbRebRsbLgbLsLgbLsLsmbRsbLjbLobL
eb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 42; Drug: Haloperidol 3 然 Apo 0.5 然
bsbRsRsmbLiLsbRsbRcbRibRcbRsbLjbRibLsbLobLsLhLsbLcbRsbLsRobRgRsmbRsRsm
bsbLsLsmbRgRsmbLsbLibRgbLoRsbRibRobLsLsmbRsbRibLgbRcbRsLsbLsbLjbRgbRsb
LsLsmbRcbRsRsmbLjbRsLsbRhRsmbLgLsbRjRsRsmmbLsRsbRsRsRsmmbLgLgLsbLibLsb
RobsbRibRibRgbLsbsbsbRibRibRoLsRsbRcbRgbRgbRsbRgbRsRsmbRsRsmbRgbLsbRgb
RcbRgbLhRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 43; Drug: Haloperidol 10 然 Apo 0.5 然
bLibLobRsbRcbLobRgbRcbRgbLcbRebLibLobLobRebRebLebRebLobRobLsbRobLobRcb
LgbRobLgbRebLibLebLibRobRebLebLcbLobLobLobRobLcbRibRcbRobRgbLibLobRcbL
obLjbRsbLobRcbRebRobLobRsbRcbLcbLebRobRgbLgbRcbRebRibLebRobRobLebLobLe
bRibRobLobRebLobRibRobRcbRobRobLobLebRcbRebRebLebLebLebRsbLebLobLobLcb
LobLcbLobRobRhbRobRebRebRhbLebRobRcbLobLebRobRebLobRebRebRobLebLobRobR
obRgbRobRebLobRebRobLobRcbLebRobLibLobLobRcbLgbLebRibLhbLcbLcbLobRobRg
bRobLcbRobRobLobRebRgbLebLjbRcbLibLobRobLobRgbRcbLobRobRebRgbLebLcbLib
RebRebRobRebLcbRebRobLobLcbRebLobLobLobLsbLibRebLsbRebRjbLcbRibRobRcbL
obRibRobRobRcbLebRsbLebLebLebLobLobRobLcbLobRebLobLgbLobLobRobRobRcbRo
bLhbLobRibRcbLebLhbRcbLibLibLobRobLebRobLcbRobRobRcbRobLebRebRgbLcbLsb
LhbRebRibRhbRcbRcbRcbRcbRcbRobRgbRobRcbLobLobRcbRebRobLobRcbRibRgbRobL
obRcbRsbRebLcbLobLcbLsbLibRobLobLebRhbLcbRobLobRebLobLobRgbLebRobLobLo
bLebRhbLcbRobRcbLobRobLebLobLebLcbRobLobLebLcbRobLobLsbRobRobLibRobLgb
LobRcbRebRcbRobLibRgbRibRebLobRebRobRebLgbRobRcbRobRobRibLobLobRhbLobR
obLibRobLsbLobLobLebRobLibRcbLobLobRebLcbLibLobLobLibLibLobLobLcbLobRo
bLebLibRcbRcbRhbRobRgbLebLobRobRgbLibRobRobRgbLcbLgbRobLcbRcbRobRcbLeb
LebLhbLobRobRcbLcbLibRebRebRcbLibLhbLebRebRebRobRcbLobRgbLobLobLcbLsbL
obRobRcbLobRebLobRebLobLobLcbRobLibLobLobRhbRebLebLebLobRcbRobLobLobRo
bLebRebRobRcbLgbRobRobRibLcbRcbRobLebLobRcbLobLhbRobRcbRibRgbLebRcbLcb
RebLebLgbLcbLobLobRebRgbRobLcbRibLibLcbRgbRobLgbRobLobLobRobRibLobRobL
ebLobRebRibRcbLobLebRobRcbLibRibRcbLebLgbRibLsbRobRibLebRebLobLobLsbRo
bRgbLcbLobLobLibLgbLebRobRibRobLcbRebRibRcbLebLobRibRobRobRobRobLebLeb
LebRobRcbLebRgbLebRobLibLobRobLjbRobLobRebRcbRobLsbRcbLibRebLobRgbLobR
obRgbLcbLobRhbRhbLcbRcbRobLobRhbLobRobRebLebLgbRsbRibRcbRibLobRhbRebLi
bRcbLibRgbLibRebLebRgbLobLcbRobRobLibRobLsbLgbLcbLebLobRcbLcbLcbLgbRcb
RibLobLobLcbRhbRobRebLebRobRobRcbRcbLcbLgbLobRibRsbLobRobRebLobLebRobL
cbLobLobLcbLebLobLebRobRobRobLebRibRobLobRobRibRebRgbLobRobRebRgbLgbRo
bRebLsbLgbRgbLsbRobRebRebLebLobLcbLebRibRcbRcbLibRobLebRibRebLebRobRob
LibRobLsbRgbLgbLobLebLibRobRebLibRobRebRcbLibLebRsbRobLgbLebRcbRibRcbL
ebRibRebRibRobLibRebLebRebRibLobLsbRcbLobLobRcbLebLsbLibLibLcbRgbLebRe
bRcbRebLcbRobRobRobLgbRgbRgbLgbLobRebLebLibLobLobLebLobLobRcbRebLgbRcb
RhbLobLobRgbLobLobLobLebRobRcbLsbRgbRsbLobLebRhbLobRobLebLobLobLobRcbR
ebLsbRobLcbLobRhbRebRcbLobLebLcbRobRobLobLcbRobRibRobLebLgbRibLebRobRe
bRobLcbRobLobLebLobLcbLobLcbLebRcbLobLobLcbRcbRebRobRobRobLobLobRobRib
RcbLobLobRsbLsbLobRcbRobRgbLobRobRobRobLibRhbRobRcbRobLobRibRobRebLobL
cbLibRobLcbRcbRobRobLcbLgbRobLobLobLobRobLebRebRebRibRibRebRsbLobRcbLc
bRobRobRobLibRibRobLebRebLobLebRebRebLebRobRcbLebRobLobRcbLcbLibRebRcb
RebRobLgbLobRebLobLebRobRobLcbRsbRibLobRobRcbRibLibLobRebRhbRcbRhbLibL
ebLebLcbLebLcbRobRebRobRobLebRgbRcbRcbRobRjbRebLobLobLcbLobLcbRobLobRe
bLebLobRgbRobRebLobRebRobRebRebLgbRobRibRibLobRcbLcbRebLobRebRobRcbLeb
RobLobLcbRobRcbRobRebReb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 44; Drug: Haloperidol 10 然 Apo 0.5 然
bLsbRsLsRjbRib

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 45; Drug: Haloperidol 10 然 Apo 0.5 然
bLibRjLsbRsbRsbLibRjbLebRiLgRjbRjbRsbRobsbLibRsRsmbRebLsbRiRsmbRgLsbRc
bLsLsRsLsRsLsmbLsbLsLsmbRcbRsbRsRsmbRsRsmbRsbLsLsLsmmbRsbLsbLsbLsbRsLs
ReLsLsmbLsRsLsbLsbLsRsbLsbRsbRsRsmbLgbRsbRsbRgbRgbLsLgRgLsRsbLsLsmbsbR
sLsRsbLhbRsbLebRibLgRsRsRgmbRsLsbRsbRsbRjbRibRgbRsbRsbRsbRgLsbLsbRsRsm
bReLsbLobRsbLjbLsLsRsRsRgmmbRgbRsRgbRibRgRsRsmmbRsRsmbRsbRsRsmbRgbRsRs
mbRsbRsbRsRsmbRibRsbRiLsbRiRsRsLsmmbRiLsbLgbRsRsRsRgmmbRsRsmbRgbRsbRgb
RsbRgbRgbRgLsLsRsRsLsLsLsmmmmbLsbRsbLsRsbsbsbRgbRgRsmbLsbRsRgbRgLsbLgb
RsRgbRgRgLsbRgbRgbRgbRgbLjbLgbLcbLhbLsbLsbLsbLsLsmbLsbLsbLsbLsbLebRobR
gbLgbsbLsbRsLsbLsbLgbLgLsbLgbLgbLgbLsLsmbLsbLsLsmbLsbLsbRsbRjbRsbRgbRg
bRsbRgbRgbRgbRsbLsbRsbRsbRgbRsbLebLsbLgbLgLsbLibLgbLgbLjbLgbLsLsmbLgbL
gbLgLsbLsbLsbRsbLsbRsbRgbLsbLsRgbRibLsLgLgRsLsbRsbRebRjbLsLsmbRsbLsbLs
bLsLgbLsLsmbLgLsbLgLsbRsLjbLsLsmbLiLsRsbLsbLsbLsbLsRsbLsbRjb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 46; Drug: Haloperidol 10 然 Apo 0.5 然
bLgbLgLsRsLsbRsbLsbLgbLibRsLgRgbLgbLgLsbLgLgLsbLgbLsbRgbLebLsLgbLsRsbL
sbRsbLgLiLsbLsbRgbLgbLsbRibRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 47; Drug: Haloperidol 10 然 Apo 0.5 然
bLhbLsbLsbLgbLibLsbLgbLgbLgbLibRgbLcbRgbRiRsmbRibRgbRibLsbLgbsbsbLhbLi
bRsbLsLsmbLsbLsbLsbLsLsmbRsRsmbRibRibRsbsbLsRsbRcbLgbLjbLibRsbRiLsbRib
RsbRsRsmbRsLsLsRsRsRsmmmbsbLsbLsLsLsRsmmbsbsbRgRsmbRsRsmbRsRsmbRsRsmbL
sbRobRsbLsbLibLgLsbRsbRsbLsLsmbLsbLgRsbLibRgbLiRsbLibLsbLsLsmbLibLgbRs
bRgbLgbLibLsbLsbLiRsbLibRsbLhbRibRsbRsbLsbRsbLgLsbLsbRsbLsLgLgbLiRsLsR
sbRsbRgbsbRsbLsbLsbLgbLgbLsbRsbRsbRsbRsRsLgmbLibLsbLsbRsbRsRsmbLjLsmbL
gbLiRsbRsbLibLsLsmbRsbRsbLsbsbRibRsbRiRsmbRgRsmbRsRsmbRsRsmbRsbRsRsmbR
ibRsbRsbLsRsLsbRsbsbRgbRgbRgbRsbRsLcbLiRsbLibLsLsmbLibRsRsmbLgbsbLsLgb
LsLsmbLsbRsbRsRsmbRsbLsLgbLgbLsbRgbRsbRebRgRsmbRsbLsbRcbLsRsbLcbLsbLib
LsbLsbRsRsmbLsbRsLsbLsbLsbRsLsRsbRsbLsbLsRsLsbsbLsbLsbLsbLgLsbRgRsmbLi
LsbRsbLibRsRsmbRsRsRsmmbRgbLsbLgbRgRsRgmbLsbRibRgbLibRebRgbRsbRsbRsRsm
bLsRsbRsRsmbRsRsmbRsbLsbLsbRgbRsbLsbLjbLsbLgbLibLsbLgbLsRsbLsLsmbRsbRs
bLsbLsbRsLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 154958; End: 155458;
Recording: 5-1; Individual: 48; Drug: Haloperidol 10 然 Apo 0.5 然
bRsbLsLsRsmbLsbRsLsbLsbLsLsmbLsbLsbLjbRjbRsbLsbRsbLsRsbLsLsmbRsbLsbRsb
RsbLsbLsbRgRsmbRiRsLsLsmmbLsbRsRsmbRsbLgbRsbRsRsmbRiLsbRjbRsLsbLsLsmbR
sbRsLsbRsbRibRsRgRsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 1; Drug: Control Apo 0.5 然
bLhbLiRsbLibLobLgbLsbRsbLoRsbLjRsbLcbLcbLhbLibLeLsbLiLsbLcbLoRsRsRsmmb
LsLjbLhb

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 2; Drug: Control Apo 0.5 然
b

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 3; Drug: Control Apo 0.5 然
bsbLjbsbsbsbLcRsLsRsbLebLsbsbLsbRebRobLobLjbLcbLjbLobRobLibRsbRjbLebRe
bRsbRsbLsbLobLobRsbRsbLsbRcbRsbLcbRobRobRjLobRjbRjbLjbRsbRobRibRcbRjbL
sbLgbLobLobLjbRcbRobRebLjbRjbLebRsbLsRsbLsbLgbRsbRsbRjbLsbLsbRsbLsbLsb
LsbRsbRjbLgbLjbRsbLebLobRsbRgbLebLebRsbRsbRsbLjbLsbRsbLsbRsbRjbLjbRsbR
sbRsbRjbLobRibRjbRjLsbLjbsbRjbRsbRsbLjbLsbLsbRebRsbRsbLgbRsbLsbRsbLsbL
sbRsbLsbLsbRsbLsbLsbRibLjbRgbLsbLsbLjbLsbLsbLsLjRjbLsbRsLgbLgbLebRsbRs
bRsbRibRsbRjbRjbRsbLsbRgLsRsbLebLsbRsRebsbsbLsRsRsmbRsbRobsbLibRjLsRsb
RiLjbRsRebLobRjbLgbLobLebLeLsbLobLsbLobLibRjbLsLgbRsRebRoLgbLebLsLsmbL
sbRobRobRsbRsbRebRsbRibRobRobLobLebRjbRsbRsbLsbLsbLsbLhbRhRsmbLobRjbLc
bLjbLsLsLsmmbLgbLoRsRsRsmmbRcbRhLsbLsLsmbRgbLebRgLoRjLibsbLcbRebLobsbs
bsbLob

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 4; Drug: Control Apo 0.5 然
bLgbLob

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 5; Drug: Control Apo 0.5 然
bLibLibRoLsbLsbLgbLoRsbRsbRcbRobRobRoLsbRgRsRsmmbRhbRobRobRjbRsbRhbLib
RgbRsbRsbLhbRgLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 6; Drug: Control Apo 0.5 然
bLcbLcb

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 7; Drug: Haloperidol 1 然 Apo 0.5 然
bReRibRoLsLsmbRgbRibRjbRibRgbRcbLgbLibRgbRsbLgbLcbLibLgbLgbLibLibRsbLc
Lsmbsb

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 8; Drug: Haloperidol 1 然 Apo 0.5 然
bLsLibRhbRcbLcbRibLgRsbRcbLobRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 9; Drug: Haloperidol 1 然 Apo 0.5 然
bLcbsbRiRsmbLgbRgbLsbLgbRgbRgbRiRsmbRsbRcbRsRsmbRibRibLsbLobLgbLsbLsbR
cbRgbRhbLsbRibLgLsbRsbRebRcRsmbRsbRibLsbRsRsmbLgbLibLibRsbRjbLgbLcbLgb
LjLgbRgbRgbLsRsbRcbLsbLhbLsbRgbLsbRjbLsbLcbLsbRgbLsbsbLsbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 10; Drug: Haloperidol 1 然 Apo 0.5 然
bLgbsbLibLgbLobLibLgbLobLsbLobRibLebLgLsbLiRsbLibRhbLibLcbLcRsbLiRsbLi
LsbLibLhLsbRhbRsbLibLgbRjbLobRjbLiLsbRebLcbLcbLsbLibLibLibRib

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 11; Drug: Haloperidol 1 然 Apo 0.5 然
bRjRgbLcbLebLibLsbLsbLgbRiRsmbLsbRibRsbRsbRsbLsbLcbLibLiRsbRsbLsbRsbLi
bRsbLgbLibLgbRsbRsbLgLsLsmbLgbLsbRsbRsbLoRsbLgbRibLsbRsbLgbLiLsbRoRsmb
LsLsmbLsbRibRsLsbRgbRsbLsbRsbRhbRsRsmbRsbRjRgbRgbRsRgbLsbRsRsLsmbLsbLg
LsbLsbLgLsbLobRsbRib

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 12; Drug: Haloperidol 1 然 Apo 0.5 然
bRgbLgbRibRgbRsbRgbRgbLsbLsbRgbRgbRobRiLsbLsRsbLiLsbRsbLgLsbLgbRsbLsLs
mbLgbRsbLsbLgbLsbsbLsbLsbLsLsmbLgbLsbLgbLgbLsbLgbLsbRsbRsLibLsbLsRsbLs
bLiRsbRsbLibLoRsRsmbRgbRibLjbLoRsbLsRsbRgbLhbRgbLibRsbLgLsbLgbLsbLsbLc
bLhbLgbRsRsmbRgRsmbRiRsmbLcbLibRgbLgbLibLhbLsbRibLcbLibLibRibLhbLsRsbL
sLsmbLsbLeLsbLsbLsbLcLsmbRgbRsbLibLsbLgbLibLibLjbLcbRjbRhbRobLhbRgbLgb
LibRsbLebLcb

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 13; Drug: Haloperidol 3 然 Apo 0.5 然
bLcbLibRgbLhbRcbRibLeLsbLibLsbLsbRcbRiLsbRiRsmbRsRsmbLsbLsbRcLsbLgbLib
RibRcbsbRibsbLsbRibLebLiLsRsbLgbLgbLsLgbLsbLsbLsbLibRgbLcbLoLsmbRsbRsb
RsbRhbLsbLsRsRsmbRhbRgbRhbRsbLsbLsbLcbLcbRgRsLsmbRsLsbRsLsbLsbLibLsLsm
bLgbLsbRebRhbLsLibLcbRsbLeLsbLiLsbLibLsLsmbRsLsbLibRsLsbLcbLgbRobRgRsm
bRibLsbRibRsbRgbLebLibLiLsbRgbLibRsRjbRgbLcbLiLsbRsbLibRgbLsRjbRcbRcbR
cbLiRibLibRcbRgRsmbRibLjbRsLsbLibLsbLsLibLcbRgLsRsbRgLsbLhLsbLiLsbLeLs
bRgbRebRibLjbRgRsmbRibRsbRgbsbRgRsmbLsbLsbRhbRiRsmbRgbRsbRgbRgbRgbRjLs
bLgbRibLsbRgRsmbLgRsLsbLhbLcbRcb

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 14; Drug: Haloperidol 3 然 Apo 0.5 然
bRibRgRsmbLsLsmbsbRibLjbRsbRsRsmbRibRgLsRsbRsLsbRibLcbLcbRsbLgLsLsmbLs
bRgbLibRgbRcbLsbLsbLsbRsbRibRibRsbRgbRsbRgbRgbRgbRsLsbRsbRsbRibLsbLgbL
gbLgbRgbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 15; Drug: Haloperidol 3 然 Apo 0.5 然
bLibLhLsbRjbRcbLsbLsbLjLsmbRsbsbRsbLibsbLsbLsbLsbLsbLsbLsLsmbLsbRsLsLg
bLsbLsbRcbLcbLcbLcbRsbsbRibRsbRsbRhbRsbsbsbRsbLsbRobRjbLgbLsbRsbRsbRcb
LsbLgLsbRoRsmbLsRcbsb

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 16; Drug: Haloperidol 3 然 Apo 0.5 然
bLgbRiLsbLhbLsbLgbLsbLsbLgbLiLsbRsbLgbLiLsbLibsbsbsbLibLsbLibLsbLibLgb
LibLsbLcbLgbLgbLiLsbLiLsbRsbRsbLsbLhbLiLsbLsLsLsmmbRjbRsbLebLibRsbLsRs
bLibLcbLsbLsbLibLcbLibRibLsbLhbLsbLibLsbLibLsbLsbLiLsbLibLiLsbLibLgbLi
bLsbRcbRsbRgRsRsmmbLsbLcbLobRsbRgRsRsmmbRsbLjbLibLcbRsbLsbLiLsbLsbLsbL
ebLhLsbLgbLibLsbLsbLiLsbLsbLsbLhbRsbLsbLibLgLsLsLiLsLiLhLsLiLgmbRobRib
LsbLsbRgRsmbRibLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 17; Drug: Haloperidol 3 然 Apo 0.5 然
bLsLsLsmmbLgbsbRiLsbRjbRsbsbLsbLsbRsLsRsbRsbRiLsbRsbRsbRibLsbRibRsbRgb
LsbRibRgbRgbLiRsbRcbRgbRhbRsbLgbRsbRgbRsbRibRiRsmbRiRsmbLibRsbLsbLsLsm
bRgbLobLsbRibLhbRgbRhbRibRgbsbLjRsbLjbsbLcbLsRsbsbRsRsRsmmbLsbRsbRjbsb
RsbRsbRsRsmbLsbRsbsbLsbLcbLsbRsbRcbRibRsbsbRgbRsLsbLjbLjbLgbLhbRsbRibR
jbRibRgbLgbRsbRibRsbRibRsbLcbLibLsbRsbRcbRibLcbRsbsbsbsbsbLcbLgbsbsbsb
sbLsLsmbsbsbRsbLsbRsbRsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 18; Drug: Haloperidol 3 然 Apo 0.5 然
bLibLgbLsbRsbLgbLgbRsbsbLgbLsRsbLsbLsbLgbLgLsbLgbLgbLsbLsbLsbLsbLibLsL
sLsmmbLsbLsbLiLsbLsbLgbRibLgLsbLgbLsLsmbLsbLgbLsbRgbLiLsbLgbRsbRsbsbRs
bRsRsmbRgbLsbRsbRsbLsbRsbLgbLsLsmbLsbRsbRsLsbLsbLsLsmbLcbLsRsbLsbRcLsb
RsbLsLsRsmbLsLsmbsbsbRsbLebsbsbLcLsmbLgbLgbLibLibLgLsbLsLsmbLsbLibLsbR
sbLsbLsbLsbRsRsLsmbLsLsmbRsbsbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 19; Drug: Haloperidol 10 然 Apo 0.5 然
bLsbLsbLgbRsRsmbRgbRhbRsbRsbLsbLibLebLgbRsbLsbLsbLsbRsbLsbLsbRsbRsbRsb
LsbLsbLsbLsbLsbLsbLsbLsbRsbLsbLgbLibLjbLobLcbLcbRsbRsbRsbRgbLsbRsLsbRs
bRsbRgbRsRsmbLsRsRsmbRsbRgRgbRsbRsRsRgRgmbRibRsRsmbLjbLiRsbLgbLsLsmbLg
bLsRsbLsLibLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 20; Drug: Haloperidol 10 然 Apo 0.5 然
bsbRgbRsbRgbRsbLsbRsbLsLsmbRsRsmbLsbsbLsbLsbLcLsLsmmbLsRsbLgbLgRgbLgbL
obLgLsLsmbRsLsbRjbRsbLoLsLsLsLgRsLsmmmbLiLsbRsLgbLgRgbLiRsbLgbRsRsRsRs
mmmbsbLobRibRiLgbLsRsbLsbRhbRibLgbLgbRiRsRsmmbLjbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 21; Drug: Haloperidol 10 然 Apo 0.5 然
b

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 22; Drug: Haloperidol 10 然 Apo 0.5 然
bRsRsmbRsbRsbLsRsbRgbLsbRobLebRsbRsLsbLibLsLibRsbLsbLsbRsbRibLsRsbRsbR
gbRibRsbRsbLgbRiRsLsmbRsbRgbRsbRsbRgbRgbRgRsmbLsbRgRsmbRsbRsLsbLibLsbR
sRsRsLsmmbsbRsRsmbRsbRsRsmbRsbRsRsmbLsbRgRsmbRgbRibRgbRsbRsbsbRgbRsbRs
bRsRsmbRsLsbLobLsbLgbsbRgbRhbLjbRsRsRsRsLsmmmbRsRsLsmbRsRgbRsbRsRsLsRs
mbRsRgRsRsmmbRsRsmbRsbRsbRgbLebRgRsmbRgbRsbRsbRgbRgbRgbRsbRgRsLsmbRgbR
sbRsbRsRsRsmmbRsRsmbRsRsmbLsLsmbLsbRgRsmbRgbRsbRgbRsLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 23; Drug: Haloperidol 10 然 Apo 0.5 然
bLsLsLsLgLsmmbLsRsLsbRsbLsRsLsbRsbRjbRsbLsRsbRsRsmbRsbRsLsLsmbRsbsbRgb
RsbRsRsmbRgLsbRgbLsRsLsbRsRsLsRsLsmbRsbRsbRsbLsRsbRsbRgbRibRsLsbRsLsbL
sbRibRsLsRsRsmbRsLsbRsbLsLsmbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 24; Drug: Haloperidol 10 然 Apo 0.5 然
bLgLsbLibLibLibsbRsbRsbLgbLiRsLsbLiLsbRsRsmbLgLsbsbLsbLsbLsRsLsbLsbLsL
smbLsbLgbRsLsbLsbRsbLsRsbLsbRjbRsbLsbRsbLgbsbLsbLibLjbLibsbLsbLsbRjbRc
bRhbsbsbRsbsbLcbLibsbLsbRjbLibRjbRibLgbsbRsbsbLhbLsbLsbRjbRebLsbLsbRgL
sbRsbRgbLsbRibRsRsmbRsRsmbLsbLsbsbsbRgbRgbRsbLsbLoRsbLgbLsbsbRsLgbLgbL
ibRsLsbLsbLeLsbRcbRsbLsbLgLsbLsbLsbRiRsmbRibRgbRsRsmbLsbRgbRsbRgbLsbLs
bRsbLcLsmbRsRsmbRgRsmbLsbRsbLsbRgbRgLsbRgbsbRgbRsbRgbsbRsbRsbRgbLhbLib
RjbRibLibLibRjbRgbsbRjbLibLsbLsbRsbLibLibRjLsbRhbLsbLibsbsbsbLsbRsLsbL
gbRgLsbRcbRjbLhbsbLsbLsbLsbRsbLsbLsbLsbLsbLjbLsbRsbLgbRsLsbLsbLsbLsbLs
bLjbLsbLibLsbLsLsmbLgLsbLsbLgbLsbLsLsmbLsLsmbLgbLgbLgbRebLjbLibRsbRjbR
jbLsRibRsRsmbRgbRgbRgLsbRsRsmbRsbRgbLiRsbLjbRjbRibRgbRgbRgbLsLsRsmbLsb
sbRsRsmbsbsbLcbLsbLhRsbRsbRgbRgbRibRibLsbRgLsbRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 25; Drug: Control Apo 0.5 然
bRcLsbsbsbsbsbRsbsbsbsbLsbLsbsbsbLsbsbsbsbsbLsbsbLsbLsbLsRsbLsRsbLsbsb
sbsbLsbsbRsbLsRsbsbRsbLsbLsbRsbLsbLsbLsbLsbRsLsbRsLsbsbLsbLsbLsbRsLsLs
mbRsbLsbRsLsbsbsbsbLsbsbsbsbLsbRsbLsbRsRsmbLsbRsbLsbLsbRsbRsbRsbLsbLsb
sbRsRsmbsbRsbsbLsbLsbLsbRsbRsbLsbRsbsbRsbLsbRsbRsbsbLsbRsbRsRsmbRsbsbR
sRsmbRsbRsRsLsmbRsbRsbRsbLsRsbsbLsRsbLsbLsbLsRsbRsbLsbRsbRsbRsbLsLsmbL
sbLsbRsbRsbLsbsbRsbRsbRsbRsLsbLsbRsRsRsmmbLsbRsbLsbLsbRsbLsbLsbRsbLsbR
sbLsbLsbsbLsbsbsbRsbsbRsbsbLsbsbRsbsbsbRsbsbsbsbLsbRsbLsbsbsbsbsbRsbLs
bsbsbsbsbsbsbLsbLsbsbsbsbsbsbsbLsbsbRsbRsbRsbLsbsbRsbRsLsbRsRsmbsbsbsb
sbsbsbsbsbsbLsbRsbsbsbsbRsbsbsbsbsbsbsbRsbsbLsbsbsbsbsbsbsbRsbLsbsbsbs
bLsbLsbsbLsbRsbsbsbsbsbLsbsbsbsbsbLjbRsbsbLsLsmbsbLsbLsbsbsbsbLsbLsbLs
bLsRsLsbsbsbRsbsbRsLsRsbsbsbsbRsbLsbLsbsbLsbLsRsbLsbLsbRsbLsbRsbsbLsbL
sLsmbLsbsbsbsbRsbRsRsmbRsbRsRsmbRsLsbLsRsbsbLsbsbsbsbLsLsmbRsRsmbRsbLs
bRsbLsbsbLsbRsbRsbLsbsbsbLsbsbsbsbsbsbsbsbsb

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 26; Drug: Control Apo 0.5 然
bRhLsLsmbLjbLjLsmbLcbLgbLjRsbLgbRsbLsbLsbLcbRcbLsbRibLsbRibRsbRsbRsbRs
bRgbRsbLsbRhbRibLhbRsbRibRibRibRsbLgbLgbLcbRob

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 27; Drug: Control Apo 0.5 然
bLsRjbLcbLsbLibLsbLhbRgRsmbRgRsmbLcLsmbRcbRobsb

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 28; Drug: Control Apo 0.5 然
bRobLgbRsbRibRhbLcbLobLcbLibLsbLsbLibLsbLoRsbsbLobLjLsmbRobLibLsbLsbLs
bLhbLsbLsbRsbLcbLoLsmbLoLsmbLcbLobLcLsmbLib

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 29; Drug: Control Apo 0.5 然
bLibLsbLobLsbRgbRiLsbRgbRsbLsbRibRiLsbRsbRsRebRhLhbRebRgbRibRiLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 30; Drug: Control Apo 0.5 然
bRsLsbRsbRcbLcbRgbLjbRgbLjb

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 31; Drug: Haloperidol 1 然 Apo 0.5 然
bLjLsmbRibLgLsLsmbRibRibRcRsmbLcbLibLgbRibLobLiLsbLcbRsbRcbLiRsbRcbLcb
RcbLibRibRiRsmbLsbLjb

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 32; Drug: Haloperidol 1 然 Apo 0.5 然
bLobLsbLgbRcbRobLjLsmbLebLobLgbRsbRsbLsbLibLibLjLsmbLcLsmbRsbLgbLsbLsb
LsbLsbRiLsbLjLsmbLhbRsRsmbsbsbsbRsLsbLhLsbRgbLsbLsbsbLsbLhLsbLgbLsbRsb
RsbLoRsbRibRcbRsbRibLsbLsbLcbLobRsbRsbRgbRiRsmbRgbRsRsmbLgbRcbRsRsmbRs
bRsbRsbRsRsRsmmbRjRsLsmbRgRsmbLcbLgbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 33; Drug: Haloperidol 1 然 Apo 0.5 然
bRibLsbLsbLsbLgbRibLsLsmbLsbLsbRgbLsbRgbLsbLsbRsbRgbRsbRgbLsbRsbRoLsbL
sbRsbLsbLsbRsbRgbLsbLebLibLsbRsbRsbLsbLgbLibRsbLsbLsbLgbLsbLgbRgbRsbRs
bLsLsmbLsbRsbLsbLsbLsbRjbLsbRsbLsbLsLsmbRsbLsbLsLgbLibLsbLgbLgbLsLsmbL
ibRsbsbsbsbLiLsbLgbLsbLgbLgbLgbLjLsmbRsRsmbLibLgbLgbsbLcbLgbLsbLgbLgbL
sbLsbLibLsbLsbLibLibLsbRsbLsbLibLgbLsbLsbLsbLgbLsbLsbLgLsbLsbLsbLsbLgb
LgbLibLibLiLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 34; Drug: Haloperidol 1 然 Apo 0.5 然
bLsbLgbLsbLgbLgbRsbLgLsbLsLsmbLgbLsbLsbLsbLsRsbLsLsmbLsLsmbLsbLgbLsbLs
bLsbLsbLgbLibLgbLgbRsbLsLsmbLgbRgbsbLgbLhLsbLcbLsbRsbLcbRsbLsbRsbLhbRg
bLsLsmbRjbRgbLsbLcbLsbLibLsbLhbLibRsbLsbRsbRibLgbRhbRgbRgRsmbRsbRgbRsb
RgbLsbRgbRgbRsbRgbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 35; Drug: Haloperidol 1 然 Apo 0.5 然
bLibLsbLgbRgbLiRsbLcRsbRoRsmbRiLsbRibRsbRhbLobRgbRobLobLobRgbsbRiLsbLs
bLibRcLsbRhLsbsbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 36; Drug: Haloperidol 1 然 Apo 0.5 然
bLcbRibRgbRjb

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 37; Drug: Haloperidol 3 然 Apo 0.5 然
bLibRgbLibLjLsmbRgbLobLgbLsbLgbLgbLhbLsbRgbLgbLgbLgbRhbLibLibLibLibLsL
smbLgbLgbRjRsmbLhbRsbRsRsmbRibRsRsmbsbsbRibLgbLgbRsbLsbsbLibRoLsbLibRi
bLibLcbRsbLibLsbLibLsbLgbLsbLibRhbLsbRcbLjLsLsmmbLgbRgRsmbLgbLsLsLsmmb
RsRsmbLgbLsbLcbLsbRsbLib

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 38; Drug: Haloperidol 3 然 Apo 0.5 然
bLsbRsbLibsbLibLsbLgbLgbLgbLgbLibLibLiLsbRsbLgbLgLhbLsRsbRsLsLsmbRsbLi
bLsbLgRsbLgbLsbRgbLhbLibLsbRibLibLgLsbLibLgLsbRibRhbRgbRgbLibLibLebLhb
LibLgbRsbLgbLebLiRsbLcLsmbLsbLgbLgbLibsbLhLsbLcbLibLgbLsbLgbLsbLsbLibL
ibRjbRibRibRibLibLgbLibRhbRoLsLsLsmmbRsbLsbRjbRibLgbRobLsbRibRgbRgbLib
RcbLjRsbLsbRgbRgbRibRgbRsbLibRiRsmbRgRsmbRibLjbRcbLgbRgbRibLibRsbRgbRi
bRobRibLsbLsbLibRjbRobRgbRibRsbRgbLjbRiLgbRsRsmbRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 39; Drug: Haloperidol 3 然 Apo 0.5 然
bsbRcbRsLsbRsLjbLobLcbRibRsbLiLsbLsbRjbRiRsmbRsbRgbRgbRgbLgbsbsbsbsbRg
bLgbLsLsmbRibLsbRgbRibRibRibRgbLgbLsbRhbRsbLsLsLsmmbLsbLsbRibRgbLjbRib
LsbRhbRhbRibRgbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 40; Drug: Haloperidol 3 然 Apo 0.5 然
bLsbLsbRsbRsLsbLsbLgbRgLsbLsbRsLsbLgbLsLsmbRibRgbRgbLsbRsbRsbLsbRgbLgb
sbsbsbsbsbRsRsmbRsbsbsbLsRsRsmbLsbRsRsmbsbRibLjbLobRgbLsbLgbRsbLgbLsLi
bLgbLsbLgLsbRsbRgbLsbRsRsmbLibRsbRsbLgbRsbLsRsRsmbLsbLsLsmbLiLsbLhbLhL
sbLsbLsbLiLsbRsbLgLsbRjbLibLibLiLsbLgbLsbLsbLsbRgbRgbRsbLjbLgbLgbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 41; Drug: Haloperidol 3 然 Apo 0.5 然
bLsLgbLsLsmbLgLsbLgbLsbRgbLgbLibsbLibLhbRgbRgRsLsmbLsLsLsRsmmbLgbLgbLi
bLgLsbRsbLsbLgLsLsmbLgLgLsbLsbLgbLgbRjbLcLsLsmmbLgLsbLgRsRsLsmbLibLgbR
sbRsRgbLiLgbLcbLsbLsbLiLsbLgLsbLgbLsbRsbLgbRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 42; Drug: Haloperidol 3 然 Apo 0.5 然
bRgbRgRsmbRgbsbRhbLsbRgbRibLsbRcbRiLsbLcRsRsmbLsbLcbLsbRjbLjLgbLsbLhbR
gRsmbRgbLsLsmbsbLsLsmbRcbLsRsbRiRsmbRibLgLsbRgbRsLsbRgbRsRsmbRjRsmbLsb
LsbRsRsmbRsbRjRgbLsbLsbLgbLhbRoRsmbRibLjbRobRsbRibLsbRebLsbLsbRsRsmbRs
bRcbRgbLsbsbLsbRcbRebRsRsRsmmbRsbRhbRsbLsbRibRsbRobRsbLsbRcbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 43; Drug: Haloperidol 10 然 Apo 0.5 然
bRobLsbLobLhbLobLebLobLobRebRobLobRgbRibRobRcbRgbRobRibLebRobRobLgbLsb
RibRebLobLobLibLgbRobRhbRobLobRobLebRebRcbLebRobRgbRcbLcbRobRobRcbLobL
ebRcbLcbRobRobRobRcbLobLebLibRebRobLcbRsbLobRibRobRobLgbRobLgbLsbLobLo
bRobRobLobRobLobRibRibLobRcbLobLhbRobLobLobLcbLobLobLebRebLhbRhbLcbReb
RebLibRsbLsbLcbRobLcbRgbLobRcbLobRcbLibRibRcbLibLcbLobRobLobLcbRgbLebR
gbLcbLcbLebRsbLobRebRebLsbRebLobRobLgbRobLgbLibRebLobRibLebLgbRsbRgbLo
bLgbRobRcbLebRobRibLobLebLcbRobLgbLobLebLebRebRebLebLobRcbRobLgbLobReb
LsbRobRobLebRobLobRebLcbLsbLgbRgbLsbLibLibRcbRgbRobLcbLobLgbLobLobLgbR
obRibLibRobRobLobRobLibLcbLobLcbLobLobLcbRobRibRebLcbLebRcbRcbLobRobLe
bLobLibRobLobRobRebLhbRobRebLcbLcbLibLobLhbLcbLebLebRobRobRibLibLobRsb
RobRobLobRebRebLjbLobLebLjbRibLebRibLobLsbRhbRebRsbLebLcbLcbRebRobRibR
ebRobRibRobRobRobLobRsbLebLobRibLebLcbLcbRgbLibRobRgbRobRibLsbRobRobRo
bLobRobLobRcbLobRebRcbRobRgbLcbRibRsbLebLibLobRobLobLgbLobLobRobRcbLob
RebLobLebRobRobLebLsbRjbLebLebLgbLobLcbRobRsbRebLobRobLgbLcbLibRobLcbL
ebRebRobLgbRcbRebRcbLobRobRobLobLebRcbRobLobRibLobLobLebRobLibLobRobRo
bLcbLobRsbLobLgbLobRhbLobRobLobRsbRobRobRibRcbLgbRebRcbRgbRgbRgbLobLib
RgbLibLebRgbLebLobRobLebRibLcbLobLobRobRebRsbRobLebRobLcbLcbRobRebLgbR
obLobLibRobRjbLebLobLcbRobRebRsbLsbRobLgbRcbLcbLcbRobRhbRobLobRsbRobRi
bRobLgbLebLcbRibRcbLsbLebRgbLobLcbRebRebLcbLobRebRhbRobRobRibRgbRebRob
RobLebLebLsbRcbRcbRobRobLibRebRobLebRobLcbRobRsbLcbLebRibLobRcbLobLgbR
ebRcbLobRcbRgbRobRcbLibLcbRcbLcbLebRcbLibLobLobLebRebLobRibRobRobLobLo
bLgbLobLhbLebRebRibLobRobRobLebLebLgbLobLebLobRibRobRebLcbRsbLibRcbLcb
LobRebLobRcbLobRgbLsbRobRobRobLebLobLgbLebRobRcbRobLobLobRebRobRcbRgbR
sbRhbLebRebLcbRobLobRgbRobLebLobLebLobLebRobLebRobLebLibLgbLebRsbLebRi
bRcbRcbRcbRcbLebRobRebRebLibLobRsbLebLgbRobLibLobRobRibLcbLgbLgbLibLob
LebLobLobLibLobLebLebLobRibLobRcbLebRobLobLibLebRobLobLebRobLcbLgbRhbR
obRobLibLobLcbLobLibLcbRobLobRebLibLebRgbRibLcbLobLobLobRcbLebLobLobRg
bLhbLcbRgbLgbLebLobRibRhbLcbLebRcbLhbLobLobRebRebRsbLobRgbLobLcbLcbRcb
RobRobRebRsbRebLobRobRcbLobRebRebRobRibLobLgbRgbLebLibLobRobLebRobLobL
ibLcbRobRobRobRobLobRobRobLcbLhbLsbLsbLibLebLsbRobRebRebRebRobRgbRobLo
bLcbRgbRcbLobLibLcbLibRcbRobRibLebLebRibLibLobRebRsbRcbRebRcbLebRebRsb
LebLcbRobRobRobRobLobRhbRobRebLsbRgbLibRobRebLsbRobLibLebLcbRebLibRgbL
ebLobLgbRebLcbRobLobRcbRcbLobLebRsbLcbRobLobRobLsbLsbLebRhbRibRobLobRo
bLobRobLcbLobLobRebLgbLcbRobRcbRcbRhbLhbLebRsbLebLibRcbLobLsbRebRibRgb
RgbRibRobLebRebRgbRobLobLobRobRsbLgbLibLibRobRcbRobRcbLibLsbLobRobLebL
obRgbRcbRibLcbRsbLcbLobLobLobLgbRobLobLebRobRobRebRhbRsbLcbLobRsbRobRe
bRcbLsbRobRibRcbLcbRgbRcbRebRsbRsbRibLobLobRsbLebLebLobLgbRobRsbRobLob
RcbLgbRcbLobRobLibRebRebLobLebLibLobLcbLobLobLibLsbRobLcbLebLsbRobRsbL
cbRobRobLebLebRobRobRobLebRebLebRobRobLobRobRcbRebRobRcbRibRibLobRebLg
bLebLebLobRobRobRhbRebRgbRobRobLobRebLobRebLebLgbRobRhbRobLebRobRibLcb
RsbLobLobLobLebRsbRebLibLsbLobLgbRebLobLobLcbRgbRobRobRebRebLobLobLobR
gbLobLobRcbLebRobLobLjbRobLobLcbRgbLcbLgbLebLibLsbRibRcbLgbRcb

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 44; Drug: Haloperidol 10 然 Apo 0.5 然
bLebRhbsbRiRsRimbRiRsmbRsbRgbRsbRgbRsRsmbRsbRsbRsbRgbRjbLibRsbLibRsLsL
smbLgbLgLsbLsbRjbRibRsbRsRsmbRgbRsbRsRsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 45; Drug: Haloperidol 10 然 Apo 0.5 然
bLsRgRsmbRibRgLsbRsbRsbLsbRgRsmbRsbRsbRgbLsbRsbRsbRsbRsRsmbRgbRgbRgbRg
bRsbLsbRgbRibLgbLgLsbLgLsbLgLsbLgbRsbLgbLgbLsbLsbRsbLsbsbLgbLsLsmbRsbs
bRsbLsbLgbLhLsRgLsbLibLgbLgbLgbRsbRsbRsLsbRsRsRsmmbRgRsmbRgRgbRsRgRsmb
RgLsbRgbsbRsbRsbRsbRsbRsRsmbRgbRgbRgbRsbLsbRoLsbRsbLsLgRgbRgbRsbRsbLjb
LsbLsLsmbRsbLsbLibLibLsbRsbLiLsLsLsRsLsmmbRsLsbLibRgbLsLsmbLsbLsLsLgmb
LiLgRsbLgbLsbLgbLiLgbLsLsLsmmbLsbLgLsLsmbLgbLgbLsbLsLsmbLsbLgbRsbRsbLg
bsbsbRsbLsbLsbLsbLsLsmbRsbLsbLsLsmbLgbRsLgbLgbLgbLsbLsbRsbLsbLsLsmbLsb
RgRsmbLeRsRgbLgbLiLgRsLsbLcb

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 46; Drug: Haloperidol 10 然 Apo 0.5 然
bRobLebLjbLgbRebRjbLcbLjbRebLobRobRobLobRebRsbRobLobLcbRsbRgbLcbRebReb
RsbRebLebLcbLobLobRobRobLobRebRsbLebLcbRobLebRobLobLsbLobLebRebLgbRjbL
obLobLobLobRjbLobRebLgbLobLobLebRibLobLobRobLobRobRobLibRebLgbLobLobLo
bRebLsbRhbRibLobLobLobLcbRobRjbLcbRcbLebLhbLcbLebLcbLebLcbRgbRebLcbLcb
LjbLobLcbLgbLgbRobRjbLobRebLobRcbRcbLgbRgbRebRsbLibRjbRobLobRebRobRobL
obLebRcbLobRjbLsbRobRjbRgbLjbRjbRobLebLobRobRcbRebRebRobRjbRjbLobLobLj
bRcbRobRobLjbRcbLobLebLobLobLebLcbRebRcbLobRjbLebRobLcbLobLibLsbLjbLob
LcbLebLebRebRobLcbRjbLobLobLjbRobLcbRobRobRobRobLobLobLcbLjbLhbRcbLobL
obRobLobLobRsbRobRibRebRebLebRsbLebRobLobLcbRobRebRebLcbLebLsbRibRebLc
bRebRgbRcbLebLebLcbRebLobLebLobRcbRcbLobRjbRobLobRobLjbRobRebRobRobReb
RsbLibRgbLobRobRibLebRcbLebRjbLcbLobRobRibLebRcbRobRcbRobLebRjbLgbRhbR
obRebRibLcbLgbLobRibLebLobRjbLcbRobLebRobRjbRobLobLobRebLobRebRjbRebRo
bRjbLobRobRebLebLjbRebRobLobRebLcbRobLebLjbRebRobRhbRobLcbLobLgbLjbLgb
RobLjbRcbLebLobRebLcbLobLcbLebLobLobLobLcbRibLobLgbLjbLobLobLjbRobLsbR
obRebRobLebRjbRcbLebLebLobRjbLobLibRsbLobLobRobLebRebLebLobLobRobRobLo
bRebLcbRgbRebRobRobLsbLobRobLcbRobRibLgbRobRebLcbLobLobRobRsbRebRebRcb
LobRobLgbLebRobRobLsbRobRcbRibRobLibRibLcbLsbLibRebLcbLebLobLobLcbLcbL
obLobLobLobRgbLobRsbRcbRobRhbRobLobRcbRibRsbLobRjbLcbLobRobRcbLobLobRo
bRobRobRebRobRgbLobLobLebRobLebRobLobLsbRobRcbRebRcbRobLibLobRebRobReb
LobLebRobRjbRebLcbRobLobLobLobRgbLobRobLobLebRcbRebRobLibRebLobRobRcbR
cbRobRgbLebRebLebLgbLobRobRhbLobLcbLebRcbRcbRobRcbRebRhbLebRebLobLcbRc
bRebLobLobLobLcbRebRcbLobRcbRobRebLcbRobRgbRcbRobLcbLobRebRcbRcbLibRcb
LibLobRobRebRcbRgbLobLsbRobRcbRcbLebRebLsbLibRobLcbLsbLcbLcbRebLgbRobL
obRhbRobRebLsbRgbLobLobRibLcbLebRobRebLobLebRgbRobLobRsbLobRsbLebLobRi
bLhbRobRcbRobLibRobLobLcbLebLobLibRebLcbLobRgbLgbRebRcbLobRebLhbRebLcb
LcbRcbLebLobLobRobLebLibLebRebRebRobRcbRobLobLibLebLebRgbRebRibRebLobL
obRobRhbRobLibLobLcbRcbRibLcbLobLcbLebRibRcbRcbLobLcbRobLcbRebRebRebLo
bLobLcbRobRhbRebLebLgbRcbRibRcbLobLebRebLobLcbLobRobRebRcbRcbRobRobLob
RobRhbRobLobLebLebRobRgbLobRcbRebRobLebRobLibRobRcbRibLobRobRobLobRcbR
ebLebLjbRibRcbLebRobRibLsbLobRobLcbLsbLobRobLobLgbRcbRobRobLobRebRgbLo
bRgbLobRibLobLobLobRibRobLobLobRcbLibLobRobRobLobRebLobLobLebRcbLcbReb
LcbLibLebLcbRgbLebLibRcbLcbLgbRebLobRcbRebRgbLcbLcbLobLcbRobLobRcbLebL
obLobLobLcbLcbRobRobLobRebRcbLcbRobRibLcbRobRobLobLobLobLobRobLobLobRi
bRebLgbLgbRobLcbLsbRcbLcbRibRobLobLobLcbRobRgbRebRobLsbLgbLobLibLgbLcb
RhbLgbLcbLobRcbRobRebRobRhbRobLcbRgbRibRobRcbRcbLcbRgbRcbLebLobRcbLcbR
cbLgbRebRgbRobLgbLcbLibLobRobLebRgbRobRcbLobLebRcbRobRcbRsbRhbRibRobLo
bRcbLebLobRobLobRobRobLibLobLobLebRobLgbLjbLcbRebRsbLobLobRgbLobLcbLhb
RcbRobRobLobRobLobRobRobLobLebLsbLcbRobLibRobRebLibLcbLobLcbRgbLcbLobR
ebLobLcbRgbRobLobRcbRcbRsbLibRebRgbRgbLibLebRobLcbRibRebRobRobRcbRebRe
bLobLcbRebRobRebLcbRobRcbRobLebRobLobLobLobLcbLebRebRcbRcbLibLibRebRcb
LobLsbRebLobRobRobLibLcbRsbRebLebLobLobRgbRsbRcbRobLcbRgbLcbRjbRebRibR
cbRobRibRibLibRobRebRobRebRobRebLsbLcbLobLobLebLgbLgbLobLebLsbLcbRobLg
bRobLcbRibRobRebRobLobRobLibRhbRcbLgbLobLobLobLobRobRobLcbRcbLsbLebLgb
RobRibRcbLsbRcbRibLibRobLcbLebLebLcbLcbLcbLob

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 47; Drug: Haloperidol 10 然 Apo 0.5 然
bRsbLgLsbRjRgbRibRiRsmbRsLsRsbLcbLsbLsbLsbLibRsbsbRsbLsbLsLsmbLgbLsLsm
bLsbLsRsbRsRsmbRobRibRsbRsbRiRsLsRsmbLsRsbRgRsmbRsbRgbLcLsmbLibRsLsbLs
bLgbLgbLgbLgLsbLsbLgbLibLibLgLsbRsLsbLsRsbLgbLgbLgbLsLsmbLgLsbLiLsbLsb
LsbLiLsbLgbRsRsmbLsLsmbLgbRsbLobLsLsLsRsmmbLiLeRsbLsRsbLiLibLsbRsRsmbL
gbRsbLsbLgbLsLsRsLsmbLgbRsbRsRsmbLgLsLsmbLgbRsbLsbRsLhLsLsmbLgbRsbLsbL
gRsbLgbRsLsbLsRsbLsLgbLsbLsbLiLsbLibRgbLiLsbLiLsbRsbLsbLgbLsbLsbLsbLiR
sbRsLsLsLgLsmbLsLgbLgLgLsLsmbRebRgbLebLsLsmbLibRjLsbLsbsbsbRsbLibRsbLs
LsmbLsLsmbLsLsmbRsbLgbRgbRsbLsbLibRgbLsbRgbLebRgbLoLsmbLgRsbLibLsbLjbL
iRsbLgbRsRgbLsbLgbLiRsbLgbLgLgbLgbRgbRebLsbLjbLcbLibLgbLgLsbLgbLgLsbRe
RsRgRsmmbRsbsbRsRsmbRobLjbLgbLiLsbRsbLgLsbLsLsmbLgLsbLsLjbLiRgbLhbRjRs
mbRobLhLsLsmbLibRsRsLsLsLsmmmbLiLsbLibRsbLgbLsLsmbLobLsLsmbRsRsmbLsLsR
sRsLsRsmmbRsRsmbRgRsRiRsmmbRsbRsbRsRgLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 155500; End: 160000;
Recording: 6-1; Individual: 48; Drug: Haloperidol 10 然 Apo 0.5 然
bRsbRsbRsLsLsmbRebRcbLsbLsRsLsLgbRsbLsbLsbLgbLebLgbLsbRjbRsbLsbRgRibLs
bRsRgRiRsLsmbLsLsmbRibLsbLsbLsbRsbRsbRibRgbLsbRsbsbLjLgLsLibLsbLgbLiLs
LebRsbRebLebLgbRsbRgLsRsbRcbRibLsLsmbRgRsRgLsRsmbLsRsbRsbRsbRsbRgbRgbR
sRsmbRsbRcbLsRsbLgbLgLgLsRsbRsbRebRibLgRsbRjRsRsmmbLjbLgbLsbLsbLsbLgLs
bLsbLgLsbLsbLsRsLsbLgbLsbLgbLsbLgbLsbLsbLsLsmbLsLgbLsLsmbLsbLoLsmbRjbL
gLgbLsLgLsRcbLsLsRgmbLsLsmbLsLgLsLsmbLibLsbLsbRsbLsbLsLgRsbLsbLsLibLgb
LgLsbLiLsbLgbsbLgbLgbLgLsbRsbLsbRcbRgbRsbLobLcRiRsmbRsbRsbRgRgbRgbRsbR
gRsmbRsbRsRsmbRsbLsbRgRcbRobRibRibRgRgRsmbRsRsmbRsbRsbLsbLcbsbsbsbLsbL
gRsLgRsbLsbLgbLsbLgbLebLgbLsLsmbLgLsbLgLsbLgbLsbLiLsLiLgLsbLebLgLsbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 1; Drug: Control Apo 0.5 然
bLjbLgRsbLiRsbLgbRgbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 2; Drug: Control Apo 0.5 然
bsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 3; Drug: Control Apo 0.5 然
bLsbLsRobLsbRsbLsbLobLjbRhbsbRjbLoLibLjbLcRsbLiRibRsbLhbLhbLsbRsbRsbLs
bRsbRsbLsbRibRgbLibLobRibLjbLsbLsbRsbRsbLsbLjbRsbRsbLsLjbLobsbLibRhbLj
bRsbLsbRhbRsRjLsbLobLsbLsbLebLgbLsLsmbLsbRgLjbRibLsLgbLhbRsbLobRobLebR
obLobRsbRsRgRgbLibLobLebRsbRebRobRobLobRobLcbLobLsbRebLcbLcbLcbRebRcbR
sbLobLebLobRcbLsbLeRsbRsLsLsRsmbLebLebRjbLobRsbsbRebRsbLcRsbRsRsmbRsRs
RsRsmmmbsbsbLebRibsbRiRsmbLobRsbRsRsmbLsRsLsRsRsLembsbRiLsbRjLobLgLsbR
jLjRsLebRebLsbLoRebRjbRebRsRsLsLsmmbRsbsbsbsbRsbsbsbsbsbsbsbsbsbLsbsbs
bRsLsRsRsmbRsLsbRsbLsbRsRsLsmbLsbRsLsRsbLsbLsbLsLsmbRsbRsbsbRjbRgLgRjR
sRsmmbRsbRcbRcbRoRibRibLsbRobsbRgbRib

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 4; Drug: Control Apo 0.5 然
bRsbsbLobRsRsmbLobRjbLsLjbLcb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 5; Drug: Control Apo 0.5 然
bLoRsbRgRsmbRgbLhbRjbRgLsbRsbLibRgbLiLsbRcRsmbLobLoRsbRob

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 6; Drug: Control Apo 0.5 然
bRcbLebLgbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 7; Drug: Haloperidol 1 然 Apo 0.5 然
bLeLsbLibsbsbsbLsbRsbsbsbRsbsbsbsbsbsbsbLsbRsbRsbsbLsLsmbLsLsRsmbRsbsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 8; Drug: Haloperidol 1 然 Apo 0.5 然
bRibRibLcbRsbLsbRsbRhLsbRibRiRsmbRgbLsbLgbLibRsbLobRiLsbRcLsbRibRsLsbR
sbLsbRobRibRgbRsbRgbRibRsbLcb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 9; Drug: Haloperidol 1 然 Apo 0.5 然
bLgbRsbRcbRcbLibRsbLsbLgLsbLgbRibRsbRgbsbLhbRibLsbLibLgbRgbLibRibLcbRs
bRsbLcLsmbLgbLibRcbRgbLgLsbLsbRgRsmbLibRebRibLsbRibLgbLgbRjbLibLibLgbL
sbLcbLcbRsbRgbLebRsbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 10; Drug: Haloperidol 1 然 Apo 0.5 然
bLgbRgbRgbLibRsRgbRgbRhbLcbLcbRhRsmbRobLsbLcbLcLsmbLebLibLiRsbLebLibLc
bRgbLib

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 11; Drug: Haloperidol 1 然 Apo 0.5 然
bRgbLgbLgbLgLsbRebRcbLgbRgbLsbRibRibRsRsmbRiLsbLgRsbLcLsRsmbLcLsmbLgRs
bLibLgLsbRgbLgLsLsmbLgbRgbLgbLobRsbLibRsbLgbRsbsbsbLsbLsbLgbLgbLgbRsbL
jbLsbRoLsbRsbRsbRsbsbsbLsLsLsmmbsbsbsbLsLsRsRsLsRsLsRsLsRsRsmmmbsbLsbL
sbRsRsmbRsbRsbRcbLsbLhbRsbLgbRsRsmbLhLsbLcRsbLcbLsbLsbLsbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 12; Drug: Haloperidol 1 然 Apo 0.5 然
bRsbRsbRsbRjRebLsbRebLoRsbRsLsbLsbLjbRsbLsbLobRebLsbLsbLobLobRsbLsbRob
LcbRobRsbRsbLsbRebRsbLsbLsbRsbRgbRobRebLjbLcbRobLhbRsbRcbLobRobLobRobL
jbLgbLobRobRebLebRobRjbLobRobLobLobRcbLobLobLibLsbRebLcbLobLobLebRebRo
bLebRobLobLcbLobLcbLobLhbLebRebLcbLobLcbLibLobRobRobRobLcbRobRebRobRob
RobRobLobLcbRobRsbRgbRsbRebRobRibRebRobLobRcbRebLebLhbLibLobRcbLobLcbL
ebLhbRgbRobRjbRcbLcbLcbRibLebRobLcbLobRobLsbRcbLebRjbLobLobLobLebRobLe
bLebRebLsbRobRsbLebLobLobRebRcbRcbLobRobLhbLebLobLobLebLobRjbLobLobRcb
LebLhbLobRobRebLebLhbLobRobLsbLobRobLebRibRibRgbRobRjbRebRobRebLcbLobR
obLebLobLibRhbLobLobRobRobLobRobLsbRjbRobLobRobLcbLibRobRibRobLsbLobRo
bLobLjbRgbLebRcbRjbRobRobLibRobLobLobLebLjbLebLobLsbLebRobRcbLhbRjbLeb
LobRibLsbLobLgbRebRibLcbLobLcbRebRhbLcbLobRobRibRjbLgbLebLibRcbLcbLobR
obRebRobLebLobRobRcbLebRobRcbLebRebLebRobRgbLobRobLebRobRobLgbRcbLgbRo
bRebLjbRobRobLebLgbLjbLebRobLebRibRebRebRobLobLobLcbLobLjbLcbRobLobRob
LobRebLsbRobRebLobLobRebLjbRgbRcbRcbLobRcbRobRobRsbLobLibRobRobRhbRobR
obRcbLobRobLobLobLobRebRobRobLobRobRobLebRebLcbLcbRobLsbRjbLobRobLsbLe
bRibRobLgbLebLebRebRgbRebLsbLsbRobLobRjbRobLobLebRobRcbLobLobLsbRobLob
RobRjbRebLcbLcbLobLcbRcbRebRibLebLobLobRebLobRcbRobRcbLsbLcbRjbRsbLcbL
cbLsbRebRobRebRcbLibLobRsbRsbRobRebLobLebRobRobLhbLobLebRjbLgbRobLobLo
bLjbLobRobLgbRobRobLcbRebRsbRsbRjbLobLebLebLobLobRibLcbRcbRebLsbRgbLcb
LobRcbRsbLobRcbLhbLobLobLhbRsbLebLobRobRobRcbRcbRcbRobRobRobRobLobRebL
ebLobLobLjbLsbRobRebRobRjbLobLebLobRebRobLsbLjbLebRobRibLebLebRcbRgbRo
bLobLebLcbLsbLobLgbRebRcbLcbLobLcbLobLibLhbRcbRobRebLebLobRjbLobLsbRob
RebLobRebRibRjbLjbRobRebRobLcbLobRebLcbLebRjbLebLcbLebLgbLobRebLobLobR
obLobRobLobRebRcbRebRcbRhbLobRobRibRibRobLobRobRobLcbLobRobRobRebLcbRi
bLobLebLsbRobLobLjbLobLebLobLobLebLjbRobRjbLibRebLebRebLobRhbLebRjbLob
RgbRebRebLobLobLjbLhbLobLebLhbLibLcbRebLcbLobRobRobRsbRebLobLsbRibRobR
cbRcbLobLobRebRobLcbLobRibLjbLobLobLjbLebRobRobLcbRjbRcbRobRebLcbRebRo
bRebLcbLcbLcbRebLebLebRibLebRebLebRebLgbLebLibRobRobLsbLobRobLgbRcbLsb
RebLobRsbLobRebRebRebLobLebRobRobLsbRjbLcbLobRebRobRsbRobRcbRsbLobLgbL
ebLebLobLcbLcbLhbRcbLebLobLsbRcbRobLebLobRobLebLebRebLebRsbRobRjbRebRe
bRobLcbRsbRibLsbLebRgbRjbRibRebRobRibRobRobLcbLobRobLibLebLobLebLcbReb
RebLobRsbRebLebRobRcbRcbRebRibLcbRobLibRcbLgbRjbRjbRjbRibLjbLobLjbLgbL
ebLgbRobLobRebRcbLobRobLobLobRebLobLobRcbRobRjbRobLhbRcbLebLobRcbRobRo
bRobLebRgbRebRobLobRobRsbLobLjbRobRcbRjbLobRebLobLobRsbRcbLebRsbLebRob
LobRebLebLobLcbRgbLobRjbLebRobRobLjbLjbLebLebLobRebLobLcbLobRebRjbLjbR
obRebLsbRobRebRobLjbLobRcbLebLcbRcbRobRebLjbLebLsbRobRobRobLobRobRebRc
bLobRobRebLobLebLebLcbRhbLcbLobLebLgbLobLcbLebRobLebRobRobRcbLebLobLcb
RobLgbRobLibLobRcbLebLobRebRcbRobLcbRjbRebLcbLobLobRcbLhbRjbRgbRobLobL
gbRebRgbRobLobLjbLebRcbRobLgbRobRobRobRibLcbRcbRcbLobLobLsbLcbLobRobRe
bLobRobRebRobRobRebLobRgbLebRgbRebRcbRobRjbLobRsbLgbLjbLobRcbRebRcbReb
LjbLsbLebLibLobLcbLobRobLjbRcbRgbRobLobLeb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 13; Drug: Haloperidol 3 然 Apo 0.5 然
bRjRsmbRsRsmbRgbRibLgbLibRibLjbLhbLsbLgbRjbRcbRiLsbLsbRibLjbRibLjbRibR
iLsbRibLgbLsbRhbLiLsbRibRsbRjRsRsRsmmmbRgRsRsmmbLsRsbRsbRsbRgbRgRsmbLs
bRibLsbRsbRsbRgRsmbLsbRgbRgbLsLsmbRibLgbRgbsbRibLjbLsbLjbRsbRjRibRsbsb
LsbRjbLjbRhbRsbRiLsbLsRsbRibLsLsmbRsbRcbLjLgbLhbLibLsbRsRsmbLgbLsbLcbR
jRsRsmmbRsbLiLsbLsbLibRsbRibLhbLjLsmbRiRsmbRsbRgbLobLsLsmbLsLsmbLgLsbR
sLsbRcbRjRjRsRsLsmmbLjbRibLjbLiRsRsmbLibLsbLsbRcbRhbsbRsbRgbRcbLsbLgbL
cbRsbRsbRibLcbLsbLibRsbRjRibRibLgbRiRgbRgbRhbRsbRsbRiLsbLsbLsbRcbLibLe
bLibLsbRsbRcbRcbLsbRibLsbLcRsbLibRsLsbLhbLsbRsbLsbRcRibRibRsbLibRcLsbL
sLsmbLgbRhbRibLsbRsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 14; Drug: Haloperidol 3 然 Apo 0.5 然
bRgbLjbRibLsbRsbRsbRibRsbRjbLibRibRibLsLsmbRsbLjbRgbLgbRgRsmbLgbLsbLsb
RsbLsLsmbRgbRsbRsRsmbRgbRsbLsbRebLhbRibLobRebRibRgbRibRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 15; Drug: Haloperidol 3 然 Apo 0.5 然
bRsbRsRsmbLgbsbLibLoLsmbRobLjbLgbLiLsbLsbLsbLsbsbLsLsmbRsbLiLsbRsRsRsm
mbLsLsmbLsLsmbsbRsbRsbLcbLsbRibLcbRjbRhbRhbLsbLgLsbLcLsmbLcbRsbLibRgbR
iRsmbRsbRcb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 16; Drug: Haloperidol 3 然 Apo 0.5 然
bLsbLsbLgLsLsmbLsbLgbRibsbsbsbsbsbLsbsbLibLsbLibLibLibLsbLgbRgbLgbLsLg
LsbRgbLiLsbRoRsmbRgbLsLgbRcbLsbRsbRibRsRsmbRhbRgbLgLsbRibLsbLibRgbLsbL
obRgRsmbLsbReRsmbRibRiRsmbLibLibRibLhbRsLcbLsbRgLsbLiLsbRgbLgbRibLsbRs
bRcbLjbRibRgbLsbRibLsbLoLsmbRsbRgbLcbRsRsmbRsbLeLsbLgLsbLcbLsLsmbLsbLi
bLsbLebLibLebLsbLgLsRsbLibLcbLiLsbLsLsLsmmbLibLib

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 17; Drug: Haloperidol 3 然 Apo 0.5 然
bRsbsbRsbRsbRsbsbRsRsmbLibRsLsbLgbRsbLsbLhbLibLibLiLsbLsLgbLibRjbRibLs
bRibLibLgbLcbRsbLgbRsbLgbLsbsbLgbLgLsbLsLobRsRsmbLcRsbLgLsbRsbRjbRibRj
bLibRgbLcbLgbLgLsbRsbRjbLjbLcbLsbRsRsmbRsbRsLsRsbsbLsbLsbsbsbRsbRsbsbs
bsbsbsbsbsbLgLsbsbsbRsbLsbLsLsmbsbsbRsLsbRsbLsbLsRsbLsbRsbLsbRsbRjbRgb
sbsbRsbsbRsbRgbsbRsbLgbRgbRgbRibLibLib

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 18; Drug: Haloperidol 3 然 Apo 0.5 然
bLoRgLsbLsbLibLsbLibRsbLgbLsbLoRsLsbRsRsmbRibRcLsbLsbRsbRgbRiLsbRgbLsb
LsbRibsbRsbsbLcbLgLsbLibLibLhbLibRsbRsbRsbRoLsbsbLgbRgbRibRgbLsbRgbLsL
smbLsbLsbRibLsbLsbLsLsmbLsbLibLibRsbLsbLibLsbLiLsbRgbLsLsmbLibLgbLibRg
bRgbLcLsmbRsbLibLibLiLsbLiLsbLibRiLsbLibRsbLsbLsbLsbsbsbsbRsbsbLcbLsbL
hbLjbRgbRobsbRsLsbRgbLsbsbLibLsbLibLgbLibLgbRsbRsbsbRsbLsbLsRsbLsRsbRs
bLgbLibLibLsLsLsmmbLsLsmbsbLibLgbRsbRgbsbRsbLibsbLsbLgbLiRsbLgLsbLobRi
bLibLsbRibLjbLcbLhbRsbLibRsLgbLibLibRiLsbRibLsbRsbRebRsbRgRsmbLsbLsbRc
LsLsmbLsLsmbLsbRcLsbRsbRsbRhbLsbLjbLiLsbLibLgbRsbLibLgRsbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 19; Drug: Haloperidol 10 然 Apo 0.5 然
bLsbRsbRsbLsbLsbLgLsLsRsmbLgbRsRsmbLibLgbLsbLebLgLsbRsbLsbRsLsbLgbsbRs
bsbLgRjbRsbRibLgLsbLgbLgLsbLsbLsbLibLsLsmbLsbLsbLsbLsbsbLsbLebRiLsbRsb
LgbLgbsbsbRsbRsbLsbsbLibLsbLsbLsbLsbLgbLsbLsRsbRsbRibRsbLsbLgbLsbLsbLs
bsbLsLsmbLgbLgbLibLgbRsRsmbLhbRsRsmbLsRsRsmbLsbRsLsbRgbRsbRgbRsRsmbRsb
LsbLgLsbLsbsbRgbRsRgRsmbRsbRsbRsbRsbsbsbsbRsRsRsmmbRsRgbRsbRsRsmbLsRsb
RsbsbLsbRsbRsbLsRsbRsbRsLsbRjbRsbRsbRsbRsbLsbLsRsbRsbRsRsLgmbLsbRgLsbL
gbLibLsbLsLsmbLsRsbRsbLsLsmbLsLsmbLsRsbLgbLibRsbLsLsmbLsbRsbRgRsmbRsbR
sbRsbRsbRsbRcbRebRcRsLsRsmbLsRsRgbRsRsmbRgbLsbRsRsmbRsRsmbRsbRsbRsbRsb
LeRsbLibRsbLsbRgRsmbRsbLsbRgbRsRsmbRebRsbRsRgbLsbLhLsbRgbRiRsmbRgbLgbL
gRsLsbLgbRsbLsbRjbRsRsmbLsbRgbRibLgbLibLgbLsbLsbLsbLsbLsbLsLsmbRsbLsLs
mbLsbLjbLjRibRsbRsbLsLsmbRsbLsbRsbRsLsbLsbLebRsbLsbRsbLgLiLsLsRsRsmmbR
sRsmbRibLebRibLgbLsbLsbLsLsLsmmbLsLsmbLsLsLsmmbLiLsbLgbLsLsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 20; Drug: Haloperidol 10 然 Apo 0.5 然
bLsbLsRsLsRgRsmbRsbRsbLsRgRsmbRjbRsbLgbRsbsbLsbRsbLsbRgRsmbRgbRsbsbsbR
sbRsLebLgbRsbRsLjbReLsbLiRgRsmbLiRsbRsbRsRsmbLsbLebLobRsbLgLsbLsbLgLsL
sLsLgmmbRsRsmbLgbRsbLibRgbLgbLobLsLsRsmbLsRsbRjRibRibRsbRsbsbRgbsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 21; Drug: Haloperidol 10 然 Apo 0.5 然
b

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 22; Drug: Haloperidol 10 然 Apo 0.5 然
bsbsbLsRsbLsbRsRsmbRgbLsRsRsRsmmbRsbRgbRgbLsbRgRsmbRsRsRsmmbRsbRsRsmbR
sLsbLsbLsbLobRsbRsLhbLebRebRsbLgbLcbLjbRsbLibLebRobRgRsmbRgbLsbRsbRsbL
ebRsbLgbLgLsbLgbRsbRsbRsRgbRgbRibLibRobLgbRobLhbRsbLobLobLgbLsbRgbRsRs
mbRsbRsLsbRgLsbLsbLsbLsbLsLsmbLgbRsbsbRsbRsLsbRsbRsbLsLsmbsbLsbLsRjbsb
RgbRobLsbRjbRsbRsbRsbRgbRgbRgLsbRgbRgbRiRsmbRsbRgbRsbsbRsbRsbRsRsmbRsb
RsbsbLgbLgbRgbRibRhbRgbRsRsRgLsmbRsbRsRsmbRsbRgbRsbRsbRgbRgbRsbRgbRgbR
sLsbLsRsbLgbLjbRibRgRsmbRgbLsbRsRsmbRsbRgbRiLsbRsRsmbRgbRibRgbRsbsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 23; Drug: Haloperidol 10 然 Apo 0.5 然
bRsLsLgbLibRsbsbsbLsbLsbRsbRsbLsbRsRsmbLobRsbLsbRsbLoLsLsmmbLsbLgbRsbR
sbRsbLsbRsbLgLsbLsbLjLsmbLsbLgbRcbRibLsbRsbLsbRsRsmbRsbRgbRgbRibRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 24; Drug: Haloperidol 10 然 Apo 0.5 然
bLgRsbLgbLgbsbLsbLgbLsLsmbLsbLjRsbRsbRsbLebRiLsbRsbLgRsbLjbLibRsbRibRg
bLsbLsRsbRsbRgbsbLsbRgbRgRsmbLsbLcbLsLsmbLgbLgbLsbLsbLsbLgLsbLgbLsbRsb
LsbRgbRjbsbLsbLgbRsRsmbRsbRebRsLsbLjLsmbLhRsbRcbRibsbRsbLcbLjbLsbLsbLc
bRibRsLsbLsbLgbLgbLgbLgbLgLsbLgbRsLsbLsbRsbsbLsbLsbRsLsbLibLgbLsbLsbLs
LsmbLsRsbLgbLgLsbLsbLjbLsbRibRibRibLgbRsbLsbLsbLgbsbLsbLsbLgLsbLsbRsbs
bLiLsRsRsmbRsbRsbLgbLsLsmbLsbLsbRsbRjbRiRsmbRsRsLsmbRgRsmbRsbLebLgbLsL
smbLgLsbLsLsmbLgbLsbLsbLsbLsbRsbRsbLobLibLiLsbRsLsbRibRgbRibRgbRsbRsRs
mbRsbRibRiLsRsbRsbRgbRgbRsRsLsmbLebLgbLibRjbRhLsbLsbLiLsRsbLgbLsbLsbLg
bLsbLgbRgbRsbRgbRsbRgbLsbLsRsbLsbRjbLjbLibRjbLcbsbLsbLgbLsbsbRsbRsbRgb
LsbRibRsbRsbRibRsbRsbRibLsbLjbLibRsbLgLsbLsbRcLsbRiRsmbLsRsbRsbsbLgbLi
bRgbRsbRgbRgbRsbRobLibLgbLgbLsLsmbLgbLsbRiRsmbRgbLjb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 25; Drug: Control Apo 0.5 然
bRsbRobRoLsbLibLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 26; Drug: Control Apo 0.5 然
bLhbRibRibRsbLsLsmbLobRibRibLiRsbRgbLjLsmbRibRibLibRsbLcRsbRiRsmbRibLs
bLibRibLgLsbRgbLhbRgRsmbLibRsbRcb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 27; Drug: Control Apo 0.5 然
bLcbRoLsbRobLsbRobLgbLjb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 28; Drug: Control Apo 0.5 然
bLjbLcbLcbLhbRsbRsbRsbLhLsbLsLsLsmmbLibRobRsbLsbRsbLsbLsRsbRoLsbLsbRsb
sbLhbLebRsbRsbLcbLiRsbLsbLoRsbRcbLgbRhbLhRsbLiLjbLcbLsLsmbLsbLgbsbsbRs
LibLhLsbRsbRgbRsbRcRsmbLsRsbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 29; Drug: Control Apo 0.5 然
bRibRsbLsbRebRibRibRgbRsbRibLsbRjRsRsmmbRcbRibRgbRgbRsRsmbLgbRsbRibLsb
RgbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 30; Drug: Control Apo 0.5 然
bRibRebLjRgbRsbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 31; Drug: Haloperidol 1 然 Apo 0.5 然
bLibRgbRcLsbLgbLjbsbRcbLobsbRcLsbRsbLibLhbLsbRhbRibLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 32; Drug: Haloperidol 1 然 Apo 0.5 然
bLgbLsbLgbLibLgLsbLhbLgbLgbLhbLibLsbLsLsLsLsmmmbLjLsmbRsLsbLjRsRsmbLgb
LgbLgbLsbRsbLsbLgbLjLsmbLgbLgbLgbRobLibLjbLjbRobLsbRoLsbLjbLsLsmbLgbLj
bLjbRsbRcbLgbRcbRsbLsbRhbRobLsbLsbLsLsmbRcbRgbRibRsRsmbRsRgbRebRhbLsbR
jRsmbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 33; Drug: Haloperidol 1 然 Apo 0.5 然
bLsbLibLsbLibLsbLgbLsbLsbLsLsmbLgbRgbLgbLibLgbLsbLsLsmbLgbLgbLgbLibLsb
LsbRsbRsLsbLgbLgbLsbLsbLibLsbLsbRsbLgbLgbLgbLgbLgbLsbLgbLsbLsbLsLsRsLs
mbLibLgbRsbLiLsbLgbLgbLgbLgbLsbLsbLsbLgbLgbLgbLgLsbLsbLibLibLgbLiLsbLg
bLsbLsbLsbLsbLsbLsbLsbLiLsbLobLjbLsbLsbLsbRsLsbLgbRjbLsbLjLsmbLsLsmbLi
bLibLibLsbLsbLgbLsLsmbLsbLsbRsbLsbLibLgbLsbLsbRsbLgbLsbLgbLsbLsLgbLsbL
sbLgbLsbRobRgbRsbRibLgbLsbRsbRibRgbLsbLsbRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 34; Drug: Haloperidol 1 然 Apo 0.5 然
bRjbLsbLibLibLgbRobRgbRgbRgRsmbRgbLgbLgbLsLsmbLsLsmbRsbLgLsbLgbLgbLsbR
gbLgbRsbLsbLcbLsbLibLsbLgbRiLsbLsbLsbLgbLebLsbLibRgbLsbLcbLgbLcbLsLsmb
RsbLsbRcLsbRsbLjbLhbLsbRjbRibRsbLsbRcbRibLsbLsbRgbRsbLsbLsbRsbLhbLsbLi
LsbLsbLjbRgLsbLibRsRgbLsbLsbLobRgbLsbRsbRibRgbLsbLibLgLsbLibLsbRgbRsbL
iLsbLsbLsbLgbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 35; Drug: Haloperidol 1 然 Apo 0.5 然
bRgbsbsbLjbLjLsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 36; Drug: Haloperidol 1 然 Apo 0.5 然
bRibRgbRiRsRsRsmmmbRgbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 37; Drug: Haloperidol 3 然 Apo 0.5 然
bLgbLsbLsLsmbLsbLgbLgbRsbLsbLiLsbLsbRsbRcLsbRobRgbRibRsLsbLsRsbLsbRibR
ibLsLsLsmmbRibsbLsRsbRibLsbLibLsbLsLsmbLeLsbRsbLibLibLiRsbLibLsbRjbLiL
sbLgLsbLhbLjbRsbRsbRibRgbRgbRsbRgbRsRsmbRibRibRibLsbsbRiRsmbLsRsbLjbLe
bLibLgbRsbLgbsbLiLsbRgRsmbLibRgbLgbLgbLcbLhbRsbRsbLibRebRibLsbRiLsRsbL
sLsmbLgbLcbLhbRsbRcbRhbLsbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 38; Drug: Haloperidol 3 然 Apo 0.5 然
bRgbLgbRibLgRsbLjbLcbRiLsbLgbLcbLibLsbLsbLibLgbLsbLcbLsbLgbRgbLsbRsbLi
bLiRsbRsbLibLgbLgbLgbLsbLgLsbLgbLgbLsbLgbLgRsbLsbRsbRgbLibLibLsbLsbLgb
LgbLsbLgbLiLsbLgbRsbLsbLgbRsbLibRsbLgbLgbLsbLsbLibRsbRjbLobLibLsbLsLsm
bLgbLgLsbLgLgbLsLsmbLibRiRsmbRgLsbLgbRsbLibLgbLgbLhbRibLibRebLcbLgbRjb
LibRobLcRsbLobRjbRcbLibRoRsmbLsbLjbLcbRgbLiLsbLcbRgbLsLsmbLiRsbLsbLgbL
sbLgbLsbLsbLgLsbLsbLgbLgLsbRibLibsbRgbLgbLibLibLiLsbLiLsbLsbLgbLgbLgRs
LibLgbLsbLsLsmbLgbLsbLibLsbLgLsLsmbLsbLsbLgbLgbRgbLobLibLibLibLebLibLh
bLsbLjb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 39; Drug: Haloperidol 3 然 Apo 0.5 然
bLhbLsbRgbLiLsbRsbLsbRjbRibRibRibRgbRgbLsbRibLebLhbLcbRsbLsbRsbLgLsbRs
bRsbLibRsbLibLjLsmbRgbLibLcbLgbLibRibRibLibRobLibLcbLgLsbLgLsbLgbsbLgb
LibRgbLibLcbLibLgbLgbRgbLibRgbLibLhbLgLsbLgLsbLgbLgRsbLhbRsbLgbRgbsbsb
LcbLibRsbRgbRsbLgbRjbRibRibLsbLhLsbLsbLhbRgbLibRsbLhbLgbLsbLiLsbRsbLsb
LibLibLhbRsbLgbLhbLgbRsbRgbLhbLgbLgbLhbLsbLibRjbRgbLsbsbsbLsbLjRsbLeLs
bRsbLibRsbLgbLsbLhLsbLsbLsLsLsmmbRjbLibLgbRsbRsbLiLsbLsbRhbRsbRsRsRsLs
mmbRsbsbRebRgbRsbRgbLsbRibLsLsmbRsbsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 40; Drug: Haloperidol 3 然 Apo 0.5 然
bRsLsLsmbsbLgbRsbLgbLsRsbLgbRsbLsbRsbLgbRsbLsbRsbLsLsmbRsbRsLsbRjbLiLs
bLsLsmbLgbLsbRsbRsbLsLsmbRsRsmbLgbLsbLgbLibLgbLgbLsbLgRsbLibLsbLsbLsbs
bRsbLsbLibLjLsLsmmbRcbRsbRcbLsbRgRsmbLgbRgbLsRsbRibLsbLsbLsbsbRcRsLsmb
RgbRgRsmbRibRsbRsbRgbRsbLsbRsbLsLsmbRibRgbRgLsbLgbLgLsbRibRsLsbRgbLsbR
hbLsRsLsbLsLsmbRjRsRsmmbRhbRsbRsbLsbRsbRsRsmbRgbRgRsmbRgbRgbLgbLibLsbs
bLsbLiLsbLgbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 41; Drug: Haloperidol 3 然 Apo 0.5 然
bLgbRsbRsLsbLgLsbLgLsbLgbLibLgLsbLibLiLsbLiLsbLibLsbLgbLsbLgbLgbRibLib
LhLsLsmbLsbLhLsLsmbLgLsbLgbLibLibLibRsbLibLcbLgbRgLsbLsLsmbLgbLsbLgbRs
bRsbLcLsmbLcbRgbLsbRsbRgbRgbLgbRgbLgbLsbLsbLsbLsLsmbLsbLsLsmbRsLsbLsbL
sbLgbLsbLgLsbRsLsbLsbLgbRsbLgLsbRgbLibRsbLsbLgLsbLsLsmbLgLsbLgbLgLsbLg
bLgbLgLsbLgbLgLsbLsLsmbLgLsbLgbLgbLsbLgbLsbLsbLgbLsbRsbLgRsbRcbRcbsbsb
sbsbRsbsbRgRsmbLgbLgLsbLsbLsbRsLsbLgbLsLsmbLgLsbRgbLiLsLsmbLgLsbLgbRib
LsbRsLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 42; Drug: Haloperidol 3 然 Apo 0.5 然
bRsbRcRsmbRibRsLsbRjRsmbLjLgbRebRsbRgbRgRgRsmbRsbRsbRsbRobLhbRcLsbRsRs
RsRsmmmbLsbRcbLsbLgbLobRsbLcRsbRsbLcbLiRsbLjLsLsLsmmmbRsbRcbRhbLcbLhbL
hRsbLibLobRsRsmbRgbLsbRibsbRsbLhbRobRiRsmbRgRsmbRgbLsbRibLgRsbRjRsRsmm
bLsLsmbLsbRsLsLsLsmmbLsbsbsbLsbRsbLsbsbsbsbsbsbRsbsbLsbsbRsbsbRsRsRsRs
RsmmmmbsbRsLsRsbRsLsbLsbsbsbLsbLsbLsRsLsRsLsbRjRsmbLsLsRsmbsbLsLsRsLsR
smbLsbsbsbRsLsRsbLibLgbLgLsbRib

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 43; Drug: Haloperidol 10 然 Apo 0.5 然
bLgLsLgbLsbRsbLsbLsbLsbLsbLgRjbReRsRgmbRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 44; Drug: Haloperidol 10 然 Apo 0.5 然
bLsbLsRsbLsRsRsRimbLsbLsbLsLcLgbRcbRcbRibRgLsbsbsbLgbLsbLsbLsbRsbLsbLi
bLibLsbLgbRsRsmbLgbLgRsbLgbRsbLsRsbRsbLsbLsLsmbLsbLsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 45; Drug: Haloperidol 10 然 Apo 0.5 然
bsbsbsbRsbsbRsbLgRsbRsbRgLsbRsLsbLsLsmbLgbLgLsbRsbLgbRsbLsbLsLsmbLsbLg
bLgbRsbRsbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 46; Drug: Haloperidol 10 然 Apo 0.5 然
bLsbRibRgRibLsbRebLobRsbLgLsbRsbRibRebRobLgbLcb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 47; Drug: Haloperidol 10 然 Apo 0.5 然
bRgbRgRiRgRsmbRgRsRsLsRgmmbRgbRsRsRsmmbLsRsLgbRcbRebRsRsRsmmbRsRsmbRsR
smbRsbRgbLibLsbLsbLsbLsbLgbLsRsbLsLsLgmbLsbRjbRsRsRgRgmbRsRsRgmbLjbRib
LsLsRsmbRsbLgLsbLsRsbLsLsLsmmbLgbLjbLcbLgbLsbRsbRsLsbLsRsbRsbLsbLsbLsb
RsbRsRsmbLsbLsbLsbLibLgbLgbLibLgLsbLgbLsLsmbLsRsRsRsRsmmmbRsbLsbRgbLsb
RsbRgbRsRsmbRsbLsLsmbLsbLsbLgbLibLiLsbLgLsbLsRsbLsRsbRobLiLsLgLsLsLgLs
LgmbLiLsLgbRsbLsLsmbRsbRsLsbRsbLsbRsLsbRsLsbLsbLsbLsbRsbLsLsmbRsbLsLsL
smmbLsbRsLsbLsbLsbRsRsmbLsbLsRsbLsLsmbLsbLsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160002; End: 160502;
Recording: 7-1; Individual: 48; Drug: Haloperidol 10 然 Apo 0.5 然
bRibRiRgbRgLsRsbLsRsbRcbRiLsbRibRiRsmbRibRiRsmbRgbRsRsmbLsRsbRsbRsbRsb
RsbLjbLsbLsbsbsbsbsbLsbRsbLsbRsbLsbsbLsbsbLibLsbLsbRsLsbLsbLsLsLsmmbLg
bLsbLsbLsbLgbRgbRobLobRgbRgLsbRgbRsbLsbLsbsbRsbRsbRsLsbsbRsRsmbRgbRsbL
sbsbRsbRgRsmbRsbRgbRgbRgbLsLsmbRjbRgbRgbLsbRsRsmbRsRsRsRgmmbRsRsmbRsbR
sLsbRsRsmbRsbRsbRsRsmbRsbRgRsLsmbLebRjbLsbLgbRsbLsbLgLsLsmbLgbLsLgRsbL
gbLgbLgbLgbLsLsmbLgbLsbLsbLsbLsbLsbLsLsLsLsmmmbLsLsmbRsLsbLsbRsbLsbLgb
LgbLsLsmbRsbLgbLsbRsRsmbLcbLcbRobsbsbLsbLgbsbLsbLsRsbLsbLsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 1; Drug: Control Apo 0.5 然
bRjRsmbLibLgbRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 2; Drug: Control Apo 0.5 然
bRgbRsbRgbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 3; Drug: Control Apo 0.5 然
bRhbsbLebRsbLsbRsbLsbRobRjLsbRobLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 4; Drug: Control Apo 0.5 然
bRsbRobLsLsmbLibLibsbRoLsbLob

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 5; Drug: Control Apo 0.5 然
bRgbLjLsmbLsLsmbLjLsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 6; Drug: Control Apo 0.5 然
bRobRsRgbRjRsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 7; Drug: Haloperidol 1 然 Apo 0.5 然
bRsbLsbLsbRsbLsbLsRsbRsbLsbLsbLsbLsLsRsmbsbLsRsbLsbsbRsbLsRsbRsbRsbRsR
smbRsbLsbLsbsbRsbLsRsbLsLsmbLsbLsbLsbRsbRsbLsbRsbRsLsbRsbsbLsLibRsbRgb
RjRsmbLobRhbRobLsbLsbLsbRjLsLobLsbRebRgRsmbRibLsbRjRjbRcbLsLsmbRsbRiRs
mbRsbRibLsbRgbRgbLsbRibRgbRsbRsbLibLsbLsbLcLsmbRgRsmbsbRcbRcRsmbLsLsmb
RsLsbRib

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 8; Drug: Haloperidol 1 然 Apo 0.5 然
bsbsbLibRibRgbRibRibRjbRsbRgbRhLsbRhbRsRsmbRsbRobRibRsbRgbRsbRgbRsbRib
RgbLjbLibRhbLoLsmbRsbRobRibRsRsmbRsbRgbRiLsbLsbLsbRsbRibLsbLsbRsbRgLsb
RsbRcLsLsmbRsbLsbRsbRibRgbRsLsbRsLsbRsbRsRsLsmbRiLsbRsbRgbRjRsmbRibRgb
RsbLsbLcb

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 9; Drug: Haloperidol 1 然 Apo 0.5 然
bLcbLjLgbLhbLsbRsbLgbRebLsLsmbLjbLsLsmbLgLgbRibLsbRgbRsbRhRsmbRcbRibRi
bRibRibRgbRsbRebRjbRcbRgbRcbLsbLebRsbLibLibLsLsmbLcbLsbLsRsbLibLcbRsbR
sRsmbLsbLsbLgbLgbLibLgbLgbLibLgbRibLsRsbRibRgbRibLsbRibRob

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 10; Drug: Haloperidol 1 然 Apo 0.5 然
bLibRhLsbRsbLiRsbLibRgRsmbRgbRgbRgbLibRibLgbLgbLiRgbRibsbRsbLobRib

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 11; Drug: Haloperidol 1 然 Apo 0.5 然
bRsbLsbLsbRsbRsRsmbRsRsmbRgRsmbLgbLobRibRsbLsLsmbRgbLobLcbsbRibLcbRsbL
gbLsbLgbRsRsmbLsLsLsmmbRebRoRsmbLobLsbRcbRobLsbLjLsmbLcbRibLsLsmbLsLsm
b

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 12; Drug: Haloperidol 1 然 Apo 0.5 然
bRsbRibRibLgbRebRcbRibLsbRgbLiLsbRobLibRjRsmbLibLcb

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 13; Drug: Haloperidol 3 然 Apo 0.5 然
bRibLibRibLsbRibLsLsmbRgRsmbLsbLsLsmbRhbLgbRsbRsbLcbLibLcbRsbRgLsbRsRs
mbRsbLcbRgbRcLsRsbLcbLibRsbLiLsbLibLgbLsbLgbRsbLcLsmbLsRsbRgbLsbRgbLgb
LjbRcbLsbRgbRsbsbRibLsLsmbRsbRiLsbRcbRgbLsLsmbRsbRsbRcbRsbLsbLibLcbLgb
LsLsmbLsbLgbLsbRcbRibLibLjLsmbLibRcbRiLsbLiLsbLjbRcbRsbLcbLebLsbLsLsmb
RcbRibsbLjLsmbLiLsbRcRsmbRsRsmbLgbRhLsbLsLsmbRsbRibRibLgbRhbLsbRcLsbLs
bLgRsbRcbRsbRsbRsbRibLjbRiRsmbRsLsbLhbRiRsmbLebLibRsbLiLsbRsLsbRiRsmbL
ebLiLsbLib

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 14; Drug: Haloperidol 3 然 Apo 0.5 然
bRibLgbLgbLsbRgbRgbLibRsbLibLgbLjLsLsmmbRgbRgbRsbLsbLsbRsRsmbRsbRibsbL
sLsmbsbRgbLgbRsbRibRgbRgbRibRcbRibRsRsmbRgbRgbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 15; Drug: Haloperidol 3 然 Apo 0.5 然
bRsRsmbLsbRsbRsbLsbRobRcLgbRibRsbRsbLsbsbRgbRsbRsbRgbLsLsmbRgbsbRsLsRs
bRgbRsbRobRgbLcbRsbRgbLibRhLsbsbRjRsmbLgbsbsbsbsbsbsbLsLgbLsbLsbRsRsmb
RcbRibLiRsbLgLsbRiRsmbLiLsbLoRsbRgRsmbRiRsmbRibRsLsbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 16; Drug: Haloperidol 3 然 Apo 0.5 然
bRjRsRsmmbRsbRgbLsbLcbLcRsRsmbLibLibRsbRsbLsRsLsbLsLsLsmmbLhbsbRsLsbLi
LsbLibLgLsbLibRsbLgbLibRsbLibRsbLsbLgbRgbLsLsmbLobLjbLibLjbLsbRsbsbLsb
RsLibRgRsmbRsbLibLsbLjbLcbLebLgbLiLsbRcRsmbRiRsmbRibRsbRsLiLsbLjLsLiLi
LsmbLcbLibLcbLibLcbLsbLsbLgLsbLjbLcbLcLsmbRebRsbRgbRgbRsbRgLsbRsbRibLs
bLcbLiLsbLsLsmbRgbLcbRsbLsbLeLsbLsbRsbLsbLgbLgbLibLsbLgbRgbLjb

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 17; Drug: Haloperidol 3 然 Apo 0.5 然
bRjbLsbsbsbLsbsbsbLjRsbsbsbsbLsbsbLgbRgbRgbRgbRsRsmbRsbRibRsbRcbRsbLgb
LsbRsbRcbRiLsbRsbRgRgbLsRsbRgbRgbRibRgbRsbRibLebRjRsmbLebLgbLgbRgbsbLg
bLgLsbLsbRsLsLsmbRsbsbRsbsbsbRsbLsbsbRsbRsbRsLiRsbLsbLsbLsbRgLsbLhbLib
LsbLgbLibLsbLgbRcbRsbRgbRgbRsbLcbLiLsbLibLgLsbRsbLsbLhbLhbRgbRibLgbRsb
LibLibRsbLibRsbLgbLsbLcbLibLgbLgLsbRcbLsRsbRgbLsbLiLsbLibLgbRsbLgbLsbL
gbLgbRsbRsbLgbLsLgbLjRsbRsLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 18; Drug: Haloperidol 3 然 Apo 0.5 然
bLhLsbLsbLgbLsLsLsmmbLsbRibLibLsLsmbLibLibLgbLsbLsLsmbLibLgbRsLsRsbLgb
LibRjRsmbLiRsbLgbLsbLsbRsLsbRsbRsLsbRsbsbLgbRsbRsbLibLsbLjbRsbRjbRibLs
bRsbLsLsmbLsbRsLsRsbRsbLcbLcbLjLsmbLgbLsbLgbLsbRsbLibsbsbLgLsbLsLsmbLs
bLibLsbLibLsbLiLsbLibRsLsbLsbsbLsbRsbRsLsbRgbLhbRgbRsbRsbRsLsbLibRsbLs
bRsbLsLiLsbLsbRoRsmbRsbRiRsmbRgbRgbRsRsmbLsbLsLsmbRsRsmbLjbsbsbsbLsbLs
bLgbLgbLsbLhbLcbRsRsmbRgbRgbLgbRgbRsLsRsbRgbRsbRsbRgLsbLsLsmbRsbLcbLib
RsbLgbRsRsmbLsbLsLsmbRgbLibLibRsbRgLsbLiLsbLobLibLgbLibLibLibRsLsbRsbL
sbLcbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 19; Drug: Haloperidol 10 然 Apo 0.5 然
bLcbRgbLsLsmbsbLsLsmbLibLgLsbLgbLsbLsbLsLsmbsbsbLsRsbRsbsbsbLsbLsLsmbR
ebRibLiRsbLsbLiRsRsmbLgbLsbLcRsbRibLsLsmbLgbLgRsbRsRsmbRsLsbLsLsmbLibR
sbRsRsmbRsbRsbLsbRsbLsbLsbLibLsbLsbLgbLsbLsLsmbLsbLsLsLsLsmmmbLsbLsbLs
RsbLibLsbLsbLsbLgbLsLsmbLsbLsLsmbLsbLsbLsbLsbLsLsmbLsbLsRsbLebRibLsRsb
RsRsmbsbRsRsmbsbRsbRsbsbsbRsRsLsmbRsbLjbLhbLsbLgLsbsbLsbLsbLsLsmbLsLsm
bLsbsbLgbLsbLsbLgLsbLsbRibRibLsRsbRobLhbLsbLsbLsbLgbLsbLgbLsbLsLsmbLsb
LgbLsbRsLgRsbLgbLsbLsbLsbLsbLsbLsbLsbLsbLgbLsbLsbLsLsmbRsbLgbLgbLsbLsb
LgbLgbLgbLibLibLgRsLsbLibLibLgLsbLsbRsbRgbRsbLgbLsbRsRsmbRsbRsbLibLibL
sbLsbLsbLgbsbsbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 20; Drug: Haloperidol 10 然 Apo 0.5 然
bLsbRgbLsbLobRgLjLobLiLgbLsLsLsmmbLgRsbLiLgRsbLgLsbLsRjbRsLsbLgRsbRsbR
ebRsLsbLsRgbRgRsRgRsmmbRsbLsRsbLgRsbLobRsRsmbLiLsbRsRgLsbLjbRobLibRebL
gbRsLsLgLgbLibRjbRobLoRsbLibLjbLgbLeRgRsmbLsLsmbLobRsbLibRsbLgLsbRcbRi
LsbRiLsRsbRsbRibLsbLsbRsRsmbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 21; Drug: Haloperidol 10 然 Apo 0.5 然
bRsRebLsbRgbRgbRgbRgbRgbRgbRgbRgbRgbRgbRgbRsbRsbRibRsbRsbRsbLsbLsbRgbR
gbRsbLsbLsbLsbLsbLsbLjLgbLgbLgbLsbLsbLsbRsRsmbLgbLsbLibLgbLsLsmbLsbRsb
RsLsbLsbRsbRjbRgbRgRsRgRgmbRgRsmbRsbRgbRsbRsbRgRgbRgbRgbRgbRsbRsRsmbRg
bRsbRsRgRsRsmmbRgRsmbRsbLsbsbRsbRsbRsRgbRsbRsRsmbRsbRsbRsbRsbRsbRsbRsb
RsbRsbRsbRgRgbRgbRsRsmbRsbRsbRgbLjbRcbLgbLsbLgbLsbLsbLsbLgbLsLsmbLsbLs
bLsbLsbLsbLsbRsLsbLsbLsLsmbLsLsLgLgLsmbLsRsbLsLsLsLsLsLgmmmmbLgRsbLsLs
LgLsmbLgbLgbLgLgbLgRsbLgbLsbLsbLsLsmbRsRsmbRsRsmbLjbLebLsLsmbLsLsmbRsL
sbsbLsLsLsLsRsmmmbRsbsbRsLsLsmbRsbLsbsbRsbLsbLsbRsbLjbRsbLgbLiLiLsbLhL
iLibLcLgbLgbLgLhLiLgLiLiLgbLsbLsbLobLobRebLebLobRgbRjbRjbLebLsbLobLobR
sbLobRsbLobRebRibLobLsbRobRobRobRjb

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 22; Drug: Haloperidol 10 然 Apo 0.5 然
bRgbLgbLebRiLsbRgbRgbRsbLsbRsbRsbLsbLgbLsbRgLsbLsLsmbLgbRobLhRsbLsRsbR
sbRsbRgRsmbRsbsbRsbsbsbRibRsRsmbRsLsbRsRsmbRsRsmbRsbLgbLjbRjbLgbLobRsR
sRsRsmmmbLsbRsRsmbRsbRhbsbLobLgbRsbRgbRgRsRsmmbRgbRgbRsLsbLsbLsbRiLsbR
gbRsLsbLgbRsbRsbRhRsmbRsbRgbRgbRsbRsLsbRsbRsbRsLsRsbRsbRsbRsbRgbRsLsbR
gbRibLibLeRsbLsLsmbRsbRsbRgbRsbLsbRsbRsRsmbRsbLsbRsbRsbRjbRsbLibLsbLsL
smbRsRsmbRgLsbRsbRsbRsbRgbRgbRsbsbsbRgRsmbRsRsRsmmbRsbRgbRgbRsRsmbRgRs
mbRjLgLsbRgRsmbRgbRgRsmbRgbLgbLib

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 23; Drug: Haloperidol 10 然 Apo 0.5 然
bRiRsmbLsbLjRsbRgbRjbRsbLsbRibLsbRiRsmbLsLsmbRgbRgbRgbRibRsRsmbLjbRsbL
ibLsbLsbLgbLsbRsbLsLgbLgbLsbRsbLsLgbLgbLebLhbLsbLcbLjbLsbLjbRiLsbRsLgb
RsbRsbRsbRsbRsRsmbRsRsLsmbLsbRsbRgRsRsmmbRgbLsbRsbRiLsRsbRsLsbRsbRgbLs
bLsRsbRsRsRsmmbRsbRgbRsRsmbsbRsbRibLibRibLgbRsRsmbRgbRjRsRsmmbRsbRsbRg
LsbRgbsbRsbLsRsbRsbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 24; Drug: Haloperidol 10 然 Apo 0.5 然
bLsLsmbLgbLgbRjbLibLgLsbRsLsbLsbLsbLsbLgLsbLsRsbLgbLsLsmbRgbLgbRsbRibR
sbRgbRsRsmbRsbRsbRgRsmbRsbRsbLsbRsbRgbRsbRsbRsRsmbRsbLsRsbRsbRjbRsbRib
LgLsbRgbLhbLibsbLgbLsbLsbRsbRjbsbRsbRsbRgbRibRibRsbRsbLjbLsbLjbLjbLsbR
jbLibRsbRsbRjbRsbRsbRsRsLsmbRgbRsRsRsRsmmmbRsbRgbLsbRgbLsbLjbLsLjLsmbL
sbLsbLgbLsRsLsLsmbLsLsmbLsbLibRsbLibLgRsbLsLsmbRsbLibRsRsmbLsbLsbRsbsb
RsbLsbLgbLsRsbLsLsmbRsbRjbLiRsbLsRsbRsLsbLiRsbRgbRhRsmbRgbLibLibLsbRcR
smbRsLibLibLsbLgbLgbsbsbRgbLsbLgbLgbRsbRjbRjbLsbLjbLsbLgbRsLsLsmbLsbLs
LsmbLgbLgbLsRsbLsbLgbLsbRsbLsRsbRsbRjbLgbLsbRibLgbRsbRgbLibLsbRsbLibLs
bsbLsLsmbLibLgbLgLsbRgbsbLsbLsLsmbLgbLsLsmbLiLsbRgbLibLgbLgbRsLsLsRsRs
mmbRibLsbLgbLgLsRsbLsbRobRgbLsbRgbRobRjbsbLcbsbLsbLibLibLsbLsLsmbLsbLg
bsbRsbLiRsbLsbLsbLgLsbLgLsbLsLsmbLgbsbLsbLsbLgbRiRsmbLgbRsbRsRsmbLsbRj
bRibRibLsbLsbLibLgbLgbLgLsbLgbLsLsmbLgbLsLsmbLsbLgbLsbLsLsmbLgLsbLsLsm
bLsbsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 25; Drug: Control Apo 0.5 然
bRibsbsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 26; Drug: Control Apo 0.5 然
bRibRobRibLjRsbRibLcRsbRsbRibsbRiRsmbRsbRjbLibRjbRcbRgbRsbRgbRgbRsbRgb
RgbRgRsmbRibLgbRsbRgbLsLsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 27; Drug: Control Apo 0.5 然
bRjbLgbLgLhbRgbLgLsLsmbLgbLsbLhbLsbLgbLgbLgbLgbLsbLgbLgbLsLgbRobRiRsmb
LsbLobRoLsbRhbsbRsbRobRcbLsbLobLgRsbLobRgbRhbRjbRibLgLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 28; Drug: Control Apo 0.5 然
bRsbLibLsbLsbLsLsmbLsLsmbLsbLsbLsLsmbLibLjRsbLcbLsbRsbLcbRjbRobLsbRsRs
mbRsbLobRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 29; Drug: Control Apo 0.5 然
bRgbLibRgbLgbLgbRcbRibRsRibLsbRibRhbLsbRiRsmbLsbLsbRhbLsbsbLcbLibRcbRi
bLgbRsbRgbLsbLsbRibLjbLcbLibLcbRobRibRsbRibLsLsLembLjbLsbLsLsmbLsbRcbR
cbRcbLgbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 30; Drug: Control Apo 0.5 然
bLhbRsbLgLsLsmbLhbRgbLjbLebLibLjbLsbLebRiRsmbRcbRibLjbLibRibRibRib

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 31; Drug: Haloperidol 1 然 Apo 0.5 然
bLhbLibRgRsmbRsbLcLsmbLjbLcLsmbLibLiLsbRobLcbRgbRsbLjLsmbRsbRsbLsbRibR
sLsbLebLgLsbLibLiLsbLgbLjbLjLsmbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 32; Drug: Haloperidol 1 然 Apo 0.5 然
bLsLsmbRsRsmbRcbRsbLgbRibRsRsRsmmbRgLsbRsbLsbRsRsmbRibsbRsbLgbLibLibRs
bRsbLsbLjLsmbLgbLsbLsLsLsmmbLsbLgbLibLgbLhbsbRsbLgbLgbLsbRsbLgbRjbRsbs
bsbLsbRgRsmbRjRsRsmmbRobRsbRsbRgbLsLsmbRsbRsbRgbRsRsRsmmb

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 33; Drug: Haloperidol 1 然 Apo 0.5 然
bLsbRsbLsbLsbRgbRibLsbLsbLsLsLsmmbLibRsbLsLsmbRcbRibLjbsbLsbsbsbRsLsbs
bLjbRsbRsbRsbLgbRsbLgLsbRibLsbLibLsbLgbLibLgbRibLhbLibLsLsmbLsbLibLcbR
sbLsbLgbLsbLibLsbLsbLsbLsbLgbLgbLsbRsbRgLsRsbRsbsbsbsbLibLsbLsbLgLsbLs
bLgbLgLsbLsbRsbLgbLibLibRsbLsbLgbLgbLsbRsbLsbLsbLgLsbLsbLibLgbLsbRsbLi
bLibLibLsbRsbLgbLgbLgbLsbLsRsbLgbRsbLsbLsbLgbLsbLiLsbLsbLsbLibRsbRgbLh
LsbRgbLgbLgLsbLcbLsbRsbLgbLgbLibLsbRsbRsbLgLsbLibLibLgbLibLsbLsbRsbLsb
LibLgbLgbLsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 34; Drug: Haloperidol 1 然 Apo 0.5 然
bLjbRobLsbLgLsbLgbLgRsbLsbLsbLgbLsbLgbLsbLgbRsRcbRibRsbRgbRsbRsbRsRsmb
RsbRgbRsbRsbRsbRsbRsbRebLjbLcbLgbRgbLobRgbLibLsbLgbLgbLsbLsbLsbRjRsmbL
gbLebRibRiLsbLsbRibRsbRgbRsbLobRjbLsbLiLsbLsbRsbRsbLsLsRsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 35; Drug: Haloperidol 1 然 Apo 0.5 然
bRsbsbsbLsbsbRsbRoLsbLsbRgLsbRsRsmbsbRgbRsbRsbRiLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 36; Drug: Haloperidol 1 然 Apo 0.5 然
bRjbRoLsbLoLsmbRcLsbRhRsmbRiRsmbRgLsbRsbRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 37; Drug: Haloperidol 3 然 Apo 0.5 然
bRsbLibLibLgLsbRsbLsLsmbLibRsbRgbLibLsbRgbLsbLibsbLsbLgbLsbLibLgbLgbLi
bRhRsmbLjbLhbLibLsbLibLsbLibRsbRgbLibRsbRiLsbRgbLsbLsbRibLsbLsRsbLcbLg
LsbLgbLibLgbLibsbLibLibLsbRgbLgLsbRsbLgbLsbLibRoRsmbRibLjbLiLsbRsbLsLg
bLgbsbRgbRcbRhbRibLsbRgbRibRsbRgbLsLsmbRibRsbRgbLsLsmbLsbRhbLgbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 38; Drug: Haloperidol 3 然 Apo 0.5 然
bRgbLsRsbLgLsbLibLibLgbRgbLhbLiLsbLgbLiLsRsbLgbRsbLiLsbRibRcbRobRibLib
RibRcbLsbLcbLcbLibLsbLibRibRsbRgbRiRsmbLebLhbRhbRjbLcbLibLsbLsbLsbLhbR
cRsmbLjbLcbLcbRgLsbLsbLsbLsbRibLibLsLsLsmmbRsLsbLcbLgbLsbLsbLibLsbRsbL
ibLibLibLibLsbLibLibLibLobLgbLibLgLsbRibLsbLjbLibRsbLoRsbLibLgLsbLsbRg
bLgRsbLsbRibLjbLcbLjbRgbRobRgbRgRsmbLcbLgbLhRsbLcbLibLsbLsbLibLiRsbLsL
smbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 39; Drug: Haloperidol 3 然 Apo 0.5 然
bRgbLsbLsbRsbRgLsbRsbRgbRibLibRcbRgLsbRgbLsbRhbRgbRgLsbRsbRgbRgbRsbRsb
RgbRgbRgbRcbRsbRgbRgbLgbsbRsbRjbRgbRsbLgRsbRcbRibRsRsmbRibRgRsmbRgRsmb
RcbLjLgLsbRgbRgbRibLsbLsbRibRsbRibRgbLhbRgbRgbLsbLcbLibLibLgbLsbRibLgb
LibLibLgbLsbLsbLibLgbRibRebRsbRcRsRsmmbRiLsbRibRsRsmbRsbLhbLsbLibLgbLj
RsbLgbLsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 40; Drug: Haloperidol 3 然 Apo 0.5 然
bRsbLsbRsbLhbLsbLsLsmbLgbRsbRsRsmbRsbLgbRsLsbLibLgbRsbLsbLsbLsbLsbRsbL
sbRsRsmbLsbLsbLgbRsbRsbLgbLgbRsbRsbRsbRsLsbLhbRsbLsLsmbLgbLsbLsRsbLsbL
sbLsRsbRsLgbRsbLgLsbRsbLgbRsbLsbLsRsbRibRsbRsbLsbRgbLsbRgbRibRsLsbLsbR
hbLgbLsbRib

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 41; Drug: Haloperidol 3 然 Apo 0.5 然
bLsbLgbLgbLsbLsbLgLsbLgbRsbRcbRiRsmbRsRsmbRsbRsbsbRgLsLsmbRgLsbRsbLsbR
gbRgbLsbRgbRgLsbsbLjbLobRgbLsbLsRsbRgbRibRgbRsbLsbRsbRibRsbRgLsbLsLsmb
RcbRsbRgLsbLsbRgbRiRsmbRsbLsbRsbLgbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 42; Drug: Haloperidol 3 然 Apo 0.5 然
bLobRobLgbRebRsRsmbLjbRgRsmbRhbLgbRgbLsbRsbLgLsbLsbsbRgbLgbRebRibRsbRs
RsRsRsmmmbLcbRjbRsbRhbRibRsbRjRsmbRsbRibRibRsRsmbRcRsRsmmbLsLsmbLgLsbR
ibRibLobLibRibRcbRgbRibRsbRgbLgbRoLsRsbRibRgbRcbLsbRhRsmbRgbLgLsbRsbLi
bLibLhbRibRcbLebLcbRjRsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 43; Drug: Haloperidol 10 然 Apo 0.5 然
bRsRsmbRsbRsbRsbLebLsbLgbRsbLgbRsbLsbRjbRibRgbRgbLsLsLsmmbLsbRsbRsbRsb
RsbRsbRsRsmbRgbRsbLsLcbLgbLgbLsbLgbLsbLsbLsbLsLsLsmmbLsLgbLsbLgbLsLsmb
LsLsmbLgbLsbLgbLsbLsbRsbRjbRibRgbRsbRgbLsbRgbRsbRgbRsbRsbRgbRgbRsbRsbR
sRsmbRsbRsbRsbsbsbRsbRsbRsRsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 44; Drug: Haloperidol 10 然 Apo 0.5 然
b

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 45; Drug: Haloperidol 10 然 Apo 0.5 然
bLsLsLsmmbRsbRcbLsLsmbLiLsbLgbLiLsbLgbLgbLsLsmbRsbReRjbLgLsRjbLiLsbLgR
sbLgbLsbLsLsRsRsmmbLsbLsbLsbLsbLsbRibRgbRsbRsbRsRsmbRsbRgbRsbRsbRsbRgb
RgRsmbRsbRsbsbRgRibRsLsbLgbRgbRgbRgbRsbRgbRsbRsbRsbRgbLgbLsbLsbLsbLsRs
bRsbRjbRgbLgLsbLgbLgbRgbRsRsmbRsbRsbRsbRgbRsbLhbLgLsbRsbLgbLgbLgbLgbLg
bLsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 46; Drug: Haloperidol 10 然 Apo 0.5 然
bLeLsbRsLsbRsbRiRsmbLhbLiLsbLsbLsbLsRsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 47; Drug: Haloperidol 10 然 Apo 0.5 然
bLsbReLsLsLsLgRsLsLeLsLsLsLemmmmbLibLibLobLcbLebRgbLsRsRgbReRgLsbLsLgb
LgLsbLiLsLsLiLsmbLsLsLgmbLibRgbLsbRsbLsRsbRsbLsbRsLsLibLgbLjbRsbLsbLib
RgRsmbRgbLoLgLsLgbLebLiRgRiRsmbRsRsmbRgbRsbRgRsmbRsRsRgmbLsRsbLsRibLhb
LcbLsbRsbLsbRjbRsbLgbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 160503; End: 161003;
Recording: 8-1; Individual: 48; Drug: Haloperidol 10 然 Apo 0.5 然
bRsbLsRsbLsbLsbsbRsbsbLgbLsRsbLsbLsbLsbLgbLsbLgbRsbLsbLsbLsLsmbRsbLsbL
sbLsbLsbsbLsLsRsmbRgbLsbRsbLiLsRsLsLgbLsLgRsRsLsmbLsbRsbLsbRhbLobLgRsR
smbRsbLgbLob

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 1; Drug: Control Apo 0.5 然
bRobRcLsbRhbRgbRsbRsLsbRobLhb

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 2; Drug: Control Apo 0.5 然
bLjbLjbRebLebLjbLobRsbLsbsbRsRsmbLjLsmbLsbRobLobLobLsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 3; Drug: Control Apo 0.5 然
bLebLgRsbLcbLgLcLsLsmmbLgbLsbLgbRcRsRsmmbLjbLhbLjbLibRsRsmbRobLcRsbLgb
RobRhbLib

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 4; Drug: Control Apo 0.5 然
bRibLibLibLibRibLcbLsbRgbLcbsbLibLsbRcbLsRsLsbLjLsmbLibRobLcbRibLsLsmb
sbLiLsLsmbLgbLgbRsbLsRsbLgbLgLsbLgbRsbLsbLsbLsRsbsbLsLsmbLgbLsLsmbLsLs
mbLgbLgbLsbLsbLgbLiRsbLhb

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 5; Drug: Control Apo 0.5 然
bRgbRhbsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 6; Drug: Control Apo 0.5 然
bLiLsbRcbLibLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 7; Drug: Haloperidol 1 然 Apo 0.5 然
bLibLsbRsRsmbRsbLcbRobLibLcbRsLsbLgbLgLsbLobLcbLjbLcLsmbLcbLgbLcbLibLh
bLebsbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 8; Drug: Haloperidol 1 然 Apo 0.5 然
bLgbRsbLsbLsbLsbLgLsbLsbRcbRhbRgRsmbRibRgbRsRsmbRibRsbRsbRgbRsbRsbRibR
cbRgLsbRsbRcbRebRibRsRsmbRibRibRsLsbLcLcbRsLsbRsbLhbRib

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 9; Drug: Haloperidol 1 然 Apo 0.5 然
bRcbRsRgbRsbRsbRsbRsbLiLsbRsbLsbLcbLsbLhbLsbLgbLjLsmbRibRcLsbLcbLgRsbR
iLsbRsRsmbRsbRhbRiRsmbRhbRcbRgRsmbRibRsbRsbRgbRsbLsbRgbLsbLsbLcbLcbLgb
LcbLhbLcbLiRsbLibLgbLgbRgbLibRebRsbLjLsmbLsbRsbRgbRibRib

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 10; Drug: Haloperidol 1 然 Apo 0.5 然
bLibRgbLibRsbLibLgbLcbRcLsbLibLibLgLsbRobLsbLibLjbRhbLgbLcbLcbLgbRibRs
bLhbLibRsbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 11; Drug: Haloperidol 1 然 Apo 0.5 然
bLiLsbRjbRibRibRoLsbRibRgbRsbRoLsbRobRiLsbRgbRsbLsbRsbLgLsbRsRsmbRsbRi
bRsRsRsmmbRgbsbRgbLsbLgLsbLgbLsbRsRsmbRobLgLsLsmbLoLsmbRibRgbLcLgbRjbL
obRgbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 12; Drug: Haloperidol 1 然 Apo 0.5 然
bRoRsmbRsbLsbLcbLgbLsbLsbLsbLiRsbLhbLibRibRibLibRsbRgbRgbRgbRgbRsbLsbR
iLsRsbLsbLsbLhbRsbRibRhLsbRibLgbLgbLsbRobRib

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 13; Drug: Haloperidol 3 然 Apo 0.5 然
bLgLsbLsbsbLiLsbLcbRgbLgLsbLsbRcbRiRsmbLsbLsRsbRibLsbRsbRgbRsbRgRsmbRg
RsmbRgbLsRsRsLsmbRsRibLcbLcbLhbRgLsbRsbLgbLcbLibLcRsbLibLgRsbRsbLibLib
RgLsbRcLsbRibLjbLibRjRsmbRhRsmbRsLsbRsbRiLsbLsbRcbLsbLsLgbLgLsbRsbRcRs
mbLebRgRsmbLhbRcbRiLsbRsRsmbRgbLsLsmbLsbRibLjbLjLsmbLsLiLsbLsRsbLibLgb
LgLsbLsLsmbLgbRgRsmbLgbLsRsbLsbRjbRhbRgRsmbLebRcbRsLcbLcbLcbLjLgbLsbLs
RsbLsbLsLsLsmmbLsbRsbRsbRsRsmbLibLcLsmbLjLsLsmmbLsbLibLsbLebLibRsbRibR
gbRiLsbLsLsRsmbRsbLsbRhbLgbLjbRiLsbRibRsLsbsbLcbLcRsbLjLsmbLgbLsLsmbLs
LsmbLibRhbLibRcbsbLsbLjLsmbLebRsbLibLgRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 14; Drug: Haloperidol 3 然 Apo 0.5 然
bLsLsmbRsLsbRsbLsbRsRsRsmmbRibRsbLjbLcbLibLgLsbLibLgbRgbRcbRgbRgRsmbsb
LgbLsbLsbRgRsmbRsbLsbRgLsbLsLsmbRibLgbRgbRsbRgbRsRsmbLgbLsLsmbLjbLcbLi
bLgRsbLsLsmbRcRsmbRgbLjRsbRsbRsbLjbLibLgbRibLsLsmbLsbRibLsbLsRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 15; Drug: Haloperidol 3 然 Apo 0.5 然
bRsbsbLsRsbLsbRsbRhbLiLsbRiRsmbLibRcRsmbLibRgbRibRobRjRsmbLgbLsbLibRcb
LsbLsbsbsbLsbsbRgbLsbRobLebLsbRgLsbLhbLsLsmbRibLsbLibLgbRoLsbLjbLjbLcL
smbLibLgLsbsbRgbLjbLcRsbRiRsmbLsbLgLeRsbLoLsmbRsbLgbRsbRibRhbLsbRib

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 16; Drug: Haloperidol 3 然 Apo 0.5 然
bLsbRsbRsRsmbLiLsbLgbLgbLibLhbLsbLibRiRsLsmbLsbLsLsmbRiRsmbLsLsmbLcbLi
LsLsmbLiLsbRsbLhbLsbRgbRhbRsbRsLsbLgbRgbReRsmbLsbLgLsbRcRsRsmmbLsbLsRs
bRiRsmbRsbLgbLibLjbRcbRobRhbLgbLjbRcbLsbRibRsbLiLsRsbRibRibRiLsbRsbRgb
LsbLsRsbRsbRgbLsbRebRibLebReRsmbRgbRsRsmbRibRibLsbRibLsbLsbRobRgbRsbRh
RsmbRebLjbRcRsmbLsbRsbLsbRibRibLsbRgRsmbRiRsRsmmbLhb

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 17; Drug: Haloperidol 3 然 Apo 0.5 然
bRsLsbLjbLjbLiLsbRjbLibLgbLsbLsRsbsbLsbsbsbLsLsmbsbsbLsLsmbRsRsmbsbLsb
RgRsmbLhbLsbRgbRsbLcbRgRsmbLibRsLsbLsbLgbLsbLiLsbRsbLhbLibLsbLgbRibLgb
RgbRiRsmbLibRibRibRsbLjbLcbRsbLhbRsbLgbLgbRsbRsbsbsbLibRsbsbLsbLsbsbLs
bsbsbsbRsbRsbLjbLsbLgbsbLsbLibRsLsbLgbLsbLiLsLsmbLsLsmbLgbLsbLobLibRjb
RgRsRsmmbRobRsbLgbLobLgbLsbLsbLibRjbLibLcbsbRgbLgbRsbRibRsbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 18; Drug: Haloperidol 3 然 Apo 0.5 然
bRsbRgbLibLsbLgbRsbLsbLsbLgbRsLsbLjLsmbLibRsbLcbLsbLgbRhbRcbRgbLgbRcLs
bLsbRcbRgRsmbLgbLsbRcbLgbRiLsbLcbLibLiLsLsmbLibLgLsbLgbLgbRsbLsbRsbLsb
LsRsbRsRsLsmbRsbLgLsbLgbRsLsbRgbRsbRgbRibLgRsbRibLjLsmbRibReLsbLsbRgbR
gRsmbRgbRebRhbLibRibRcbRcbLibRsLcbLhbLibLgbLgbLgbLhLsLsmbLsbLsbRcbRhLs
bLgbLcLsmbLsbLcbLibRsbLcbLiLsbLibLsbLibLsbLsbLsbRsbLhbLgbLsbsbLgbLgLsb
RgbLgLsbLsbLibLgbLsLsmbLsbRsLsbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 19; Drug: Haloperidol 10 然 Apo 0.5 然
bLsbRsbRsLsbRsbLgLsbLgbLsLsRsmbLsLsmbLsLsmbRgbRsbLgbLgLsbLgbLgbLgbLebR
gbLgbRsRsmbRsRsmbRsbRibLsbLsbRsbRsLsbLsbsbRsbRsbRgRsmbRsRsmbRsRsmbLsbR
sbLsbsbsbsbsbsbRsbRsbRsbRgbRsbLsbRebRsRsRsmmbRgbLjbRibRsbLsRsbLgbLsbLs
LsmbLsbLsLsmbsbLsbLsLsmbLsLsRsmbLibLcbRobRsbLsbLsLsmbRcbRsbsbLgbLebLsb
LibLgbLgbRsbLibLjbLibLgbLsbLgbLgbLgbLsbLsbLsLsmbRsRsLsmbLsbLgLsbRsLsLs
RsmbLsbLsLsmbLgbLgbsbLsbLhLgLsbLibLiLeLsbLiLsbLibLibLgbLsbLgRsbLgbLgRs
bLgbLsbLsbLgbLgLsbLgLsbLgLsbLgLsbRgbRgbRsbRsbLsLgbLgbLgbLgLsbLsLsmbLsb
RsbsbRsbLsbLgbLgbLibLgLsLsmbLgbLibLiLsbLgLsLibLibLibLgbLgbLsbLgLsLsmbR
sbLsRsbLsbLsbLsbLsbLsbLgbLsbLsLsmbLgbLsLsmbLsbLsbLgbLsbLsbLsRsbLgbLjbR
sbRsbLsbLsbLsbRsLsbLgbLsbLsbLsRsbLjbLsbLsLsmbLsLsmbsbLsbLgbLsRsbLsbLsb
LgbLsbLsLsmbLsbLgbLebRobLsbLsbLobsbLsbLeRgLsbLsbLsLsLsmmbRsRsmbRsRsmbR
sbLiLsbLsbLsbLsLsmbLiRsRsmbLgbLgbRibRgbRsbRsbRgbLibLgbLsbLsRsbLsbRobLs
Lsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 20; Drug: Haloperidol 10 然 Apo 0.5 然
bLsRsbLgbLsLgLsLsLsLgRsmmbLgLsbRobLsRiLsbLsRsbRgRsLsmbRgRsmbRibLsbLsRi
LsbLsbLsbLobRgLsRsRsmbRsRsmbLjbRsbsbLgbLsbLgLiLsbRsRsmbLgLiRsbLgbLsLsm
bsbLsRibLgbRgbLsRgbRgLsbRgLsbRgLgbLoRsbRgLsbRsLsbRsRsmbRsbLsbsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 21; Drug: Haloperidol 10 然 Apo 0.5 然
bLsbRjbRobLsbLjbRebLsbLsbLebRsbLebLsbRsbLjbLjbLjbRjbRebLsbLjbLsbLjbRjb
RsbLjbRjbLsbLjbLobLjbLsbLsbRebRobLsbLebRjbRjbLsbLebRsbRobLjbLjbLobRebR
jbRjbRjbRebRsbRsbLsbLcbLsbRsbRjbLjbRcbRjbRjbLsbRobLsbRobRsbRsbLsbRsbRo
bLsbLsbRebRobRjbLsbRebLjbLsbLobLebLobRsbRebLjbRjbLebRjbRcbRjbLsbLebReb
RjbLjbLjbLjbLsbRjbRjbRjbRjbLjbLjbRebLsbLobRjbLjbLsbRobLsbLebLebLjbRobR
jbLjbRebLobRobLjbRjbRsbRebLebRebRebRobLsbLsbLjbLjbLobRebRsbLebLebLsbLe
bLobRjbLjbLjbRjbLjbLebLobLsbRjbRebLsbRjbRjbRsbRobLobRjbLjbLjbRjbRebRjb
RebRsbRsbRobRjbLjbRjbLsbLjbLjbLjbLobRebRjbRsbLobRebRjbLobRsbLjbRcbRsbL
jbLsbRobRjbLjbLsbRobRjbRebLsbLjbLjbRjbLjbLjbLjbLobLobRobLjbRjbRebRjbLj
bLsbRsbLebLsbLjbLsbLobRobLebLsbRebRjbLjbRsbRjbRjbRobLsbRjbRebLebLcbLeb
RsbRobRebRebRsbRsbRobRobRebRebRebRjbRebRjbLsbRjbRjbLsbRjbRjbRjbRjbRjbL
jbRjbLjbLjbLjbLjbRebLjbRjbRsbLjbRsbRcbRebLjbLebLjbLebRjbRsbRjbLjbLobLe
bRjbRjbLjbRebRebLsbRobRjbRobLjbRjbRobLjbRobLsbRjbRobLobRjbLobRjbLebRjb
LebRjbLsbRebRjbLcbRebLobRsbRsbLsbRobLjbRjbLsbLjbRcbLjbRobRjbRobLobRebL
jbRsbRebRebLcbRobLebLobRebRsbLebRobRjbLjbLjbRebRsbRobLebRobRjbLobLjbLo
bLjbLobLsbRobLebRsbLjbRebLjbLobLobLebLjbLebLobLobRobLebLjbLcbRebRsbLob
RsbRsbLjbRebRobLjbLjbRebLebLjbRobLebRjbRebLjbLobRobRebRebLjbRobRobLebR
jbLebLsbRjbLobRjbRebLjbLebLsbLsbLebLebLjbRebLebRsbLjbRsbRsbRsbLebRjbRo
bRebRsbLobLsbRobLebRsbLjbRjbRcbLebLjbRebLsbLjbLobRsbRebLebLobRebLsbRjb
LsbRjbRebRsbRjbLjbRjbLsbRjbLobRjbLebRjbRjbLsbRobLjbRsbLsbLjbRebRobRebR
jbLebRebLjbLjbRjbRebLjbLebLebLjbRsbLebRebRjbRebRobRobRebRsbLjbLebLjbLs
bRobLebRsbLjbRsbRsbRobLjbLebRsbLobRsbRobRobLobLebRjbLebLebLsbLebLobRob
RjbLsbRjbRsbLobLebRobRsbRcbLjbRsbRjbRsbLsbRjbLobLobLjbRobLsbRsbRobRobL
ebRobRobLobLebLjbRcbRjbLsbLobRsbRebRebLobLobLjbRjbRjbRsbLobLsbRjbRsbLe
bLebLebLcbLjbLjbRebLsbRjbLjbLcbLjbLebRsbRsbLjbRobLobLsbRjbRebLobLobLsb
RebLsbRjbLebLobRjbRjbRjbRsbRsbLsbRibRgbRsRsRgRsRsLsRsmmmbLsRsLsbRobLib
RsbRgbRsbRgbRibLsRsRsRsmmbRgLsbRsLsRsRsRsRsRgRsmmmmbRsbRsbRsbRsbRsbLsL
smbRgbRsbLsRsbsbRsRsLsRsRsmmbRsbRsbRsbRsRsmbRsRsmbRsbsbRsbRsRsmbRgRgRg
bRsbRsbRgbRgbRsRgbRgbRsRsmbRgbRsbRsbRsbRgbRsbRsbRsbRsbRsbRsbRsbRsRsmbR
gbRsbRsbRsRsmbRsLsbRgbRsRsRsmmbRsbRsbRsbsbRsbRsRsmbRgbRsbRgbRsbRgbRgbR
gbRgbRgbRgbRgbRgbRgbRgbRgbRgRgbRgbRgbRibRgbRgbRgRiRiRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 22; Drug: Haloperidol 10 然 Apo 0.5 然
bLgbLgbRsbRgbRsbRsbRibRsbLsbRsbRsbRsbRgbLsbLsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 23; Drug: Haloperidol 10 然 Apo 0.5 然
bRsbRsbRsbRgLsLsmbRsRsLsmbLsbRsLsbRsbsbRsbLsbRsRsmbRsRsLsmbLsbRsbRsbRg
bRsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 24; Drug: Haloperidol 10 然 Apo 0.5 然
bRjbRibRibsbRsbLsbLjbLibLsRsbRjbRsRibRgbLgbsbLjbLsbsbLsbLsbLsbLsLsmbRs
LsLsmbLsbLsbLgbLsbLsbLsLsLsmmbLgRsbLgbLgLsbLgbRsbRsRgbLsbRsbLsbLsbLsbL
gbLsLsmbLsbLsbLsLsRsmbLsbLsbLgLsbLgLgbLsbsbRiRsmbLgbLsbLsbLsbLsLsmbLgb
LgLsbRibLgbLgLsbLsbLsbLsLsmbLgLsbLsLsmbLgbLgbRsbLgbLsbLhbLiRsRsmbLsbLs
bLiLsbLgRsbLgLsbLgbLgbRebRgbRsbLsRsRsmbLjbLibLibRjbRgbRgLsbRsbRgbRgbRs
LsbRgbRgbLsRsbRsLsbRibLsbLcbLibRsLsbRjbRjbsbRjbRgbLgRsbLibLsbLsLsmbLsb
LsbRsbLgbLsbLsbRsbRgbLsRsbRsbRgbRsbLcbLgRsbLiLsbLsbLsbLsbLsbRsLjbRibRs
RsmbLgLsbLgbLgbLsbsbLgbLsbLsbLgbLsRsbLgbLsbLsbsbLsbLgbLsbLjbRsbLsbRsbR
ibRgbRjbRsbLcRsbLsRsbsbLgbLsLsLsmmbLgbLgLsbLgbLsbLgLsbsbLsRsbLgRsbLsbL
gbRsbRjbRibRsLsbRhLgLsbLibLgbLgbLgbLsbLsLgbRsLsbLgLsLgLsbLibLsRsRsmbLg
RsbLsbRsbRibLobLcbRsbLjbLjbLgLgbLgLgLgbLgbRsbLiRsRsmbLsLsmbLsLsmbLsbLs
bLsbLsbLsbLsLsmbLsbLsbLsbLsbLsbRsLsLsmbRsLsbRsbLgbLsbLsRsbRjbRsbRgbLsb
RgRsmbRgbRjbRibLsbLsbsbLjbLjbLgbLsbRsLsbLsbLgRsbLgLsLsmbLsbLgbLsbRsbLg
bLsbRjb

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 25; Drug: Control Apo 0.5 然
bLsLjRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 26; Drug: Control Apo 0.5 然
bRcbLcbLcLsmbRibRgbRibRgbRibRgbLsbRgRsmbRgbRgLsbRsbRgbRsbRgbRsbRsbRsRs
mbRsbRsRsmbRgbRgbRgbRsbLgbRcb

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 27; Drug: Control Apo 0.5 然
bLcbRgbRcLsbRob

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 28; Drug: Control Apo 0.5 然
bRgbRsbRcRsmbRsbRsbRsbRhRsmbLoLibLgbLsbLgLgbRoRsmbRgbRoRsmbRsbReb

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 29; Drug: Control Apo 0.5 然
bRibRoLsLsmbRgbRibLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 30; Drug: Control Apo 0.5 然
bLobRjbRcLsbRoLsbRgbRgbRib

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 31; Drug: Haloperidol 1 然 Apo 0.5 然
bRcbRobRjbLibLobRgLsbRobLhbLsbLsbsbRibLsLsLsmmbRsbRcbLsbLsbLsLsLsmmbLi
bLcbRjbRcbRibLcRsbLhLsbLjbLobRibLibRibLsbLcbLjLsmbRsbRiLsbLcbRsbRsRsmb
LobRgbLiLsbLcbRibLibRgbLsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 32; Drug: Haloperidol 1 然 Apo 0.5 然
bLsLsmbRcbsbRsbRibLsbRsRsmbsbRsbRoLsbLgRsbRsbRgbLsbRsbRsRsmbRgbLsbRobR
sbRobLsbLsbRibRibLsbRsbRobRsbRgbsbRsbLsbRsRsmbRgbLjbRgbRsbLjbRsbRsbRsb
RgbLjbLjbLibLhbLsLsmbLsbLibRobRibLsbLgRsbRgbLibRcbRhLsbRsLsLsmbLiRsbLg
bRsRsRsmmbLcbLgbLgbLibLgbRsbRsbLiLsbRoLsLsmbsbsbLsbRhbRcbLsbLjLsmbLgbR
ibRsbLsbRgbRjbLoRsbRjRsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 33; Drug: Haloperidol 1 然 Apo 0.5 然
bLsbLsbLgbLsbLsbLsbLgbLsbLibLgbLsbLjbRsbLgbRobLibLibLgLsbLsLgLsbLsbLsb
LgbLsLsmbLsbLgLsbLgbLibLibLjbLgbLibLsbRsbRsbRsbRsbLsbLsbLobLibRsbRsbLh
LsbLibLsbRsbRsbLibLgbLsbRgbLsbLgbLsbLsbRsbLgbLibRhbRsbRsbLsbRsbRsbLiLs
bRsbLjbRsLsbLsbRsRsmbLcLsmbLsbLsbLgbRsbLibLsbLgbLsbLsbLsbLsbLgbLsbRgbL
jLsmbLgbLjbRsbRsRsmbLsbLgLsbLgbLibLibLsbRsbLsbRsbLgbRcbLibLibLibLsbRsb
RsbLgbLsbRsbLibLsbLsbLsbLsbRsLibRgbLgbLsbRsRsRgRsmmbLoRsbLsLsmbRsbRsbL
sLsmbLsbsbRsLsRsbsbsbsbsbsbsbLsbLgbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 34; Drug: Haloperidol 1 然 Apo 0.5 然
bLgbLsbRsbLsLsmbLhbLsbRobRibRgbRsbLsbRgbLebRobRgbLsbLgbLsbLibLsbRsbRsb
LsbLgbLobLsbRsbsbLsLsmbLsbLsRsbLsRsLsRsbRsLsLsRsmbLjbLiLsbLibLsbLgbLsb
LsbRsbLhbLgbLsbLjLsRsmbRgbLcbLibLsbRsbLsbRcbLsbLgbRgbLsbRibRgbLsbLgbLs
bLibLgbLsbLsbLgbRsbLobRsbRsbLibLsbLsbRgbRibRgbRsbRsbRsbRsRsmbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 35; Drug: Haloperidol 1 然 Apo 0.5 然
bRsbRibLgbLoRsRsmbRsLsbLobLhbRcbRcbRiRsLsRsmbsbRibRgbLsbRgbLsbsbLobRgb
LsLsmbRgbRsRsmbRsbRobRgRsRsmmbRsLsRsRhbLsbRsbLobLibLibRsbRiLsbLiRsbRoL
sbRcLsbRsRsmbRibLebLibLsRsbLgbLibLgbLsLsmbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 36; Drug: Haloperidol 1 然 Apo 0.5 然
bLjbRiRsmbLhbRibRibRobsbRiLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 37; Drug: Haloperidol 3 然 Apo 0.5 然
bRsLsbRiRsmbRcbLsbRsRsRsmmbLhbLgbRcRsmbLebLibLjbLibRsbRgbLibLgbLibRibL
ibRcbRibRiRsmbLibLsbLgLsbLibLgbLcbRiRsmbLiRsbLsLsmbLgbLgbLibRsRsmbLsbR
sbLgbLgbRjRsmbLhbLsbLgbLgbRjbLibLibRebRcbLjbRibLjbRiRsmbsbsbLib

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 38; Drug: Haloperidol 3 然 Apo 0.5 然
bLsbLgbRcRsmbRcRsmbRhbRsbLsbLgbRjbRiLsbLgbRibLobRebRgbLsbRsbLjbLobRgbL
gLsbLibLsbLsbRcbRgbRibLjbLcbLibLgbLgbsbLibRgbLibLobRsbLibLgbLcbLjbLcbR
sbLibLhbLiLsbLiLsbLcbLibLsbLhbLsbLibLebLibLsbLgLsbLgLsbLsbLgbLibRcRsmb
RsbsbRgbLjbLibLibLgbLiLsbsbLgLsbLibLhbLgbRib

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 39; Drug: Haloperidol 3 然 Apo 0.5 然
bLgbsbReLsbRibRhbRgbRibRcbRgbRhbRsbRibRibLjbRibLjbRhbLsbRsRsRsmmbRsRsm
bRgbRgRsRsmmbRsbRgbLibLjbLibLibLgbRsbRibRgbRhbLjbRgRsmbRhRsmbRiRsmbRib
RhbRibRibRiRsmbRibRgLsbRgbRibRgLsbRgbLsbRibRgbRgbRibRgbRiLsbRgbRgLsRgb
RgbRgRsmbRibLsbLgRgbRgLsbRsbRgRsmbRgbRsbRgbRgbRgbRsbRibLjbLjbLsbLgLsbL
gLsbLsbLgbLsbRsLsbLgbLsbRhbRgbLsbRibLobLiLsbLobRgbLcRsbRsbLobRjbLhbLib
LibLhbLiLsbRsbRgbRibRgbLjbLoLhbRsbLibLcbLgbLibLsbRgbRibRgbRgbRsbRgbRsb
RsRgRsRsmmbRgbRgbRgbRgRgbRibRgbRsbRibLjbRibRgbRgbRibLibLibLibRjbLibLob
LiLsbRgbLgRsbRgbRgRibRgRgbRgRgbRgbRibRgbRgbRgbRgbRgbRgRsmbRgbRgRgLsbRi
bRgbLibRebLgbRsbLgRsbRcbRib

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 40; Drug: Haloperidol 3 然 Apo 0.5 然
bRsRsmbRsbLsbRgbLgbLjbLobRgbLobLsbLgbLsLsmbLsbRsLsbRsLsbLibLibLsbRsbLs
LsmbLgLsbRgbLibRsbLsbLsbLibLsbLgbRsbRsbLgbLgbLsLsmbLsbLsbRsbRsbLsbLsLs
mbLsbLgbLgbLsLsmbLgbLgLsbRjRsmbLgLsbRjbRibRcbRebRsLsbRiRsmbRsbRgbRgbLs
bLcLsmbLsbLsbRsbLsbLgbLgbLgbLgbRsbRsbRsLsbLgbRhbRsbLhb

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 41; Drug: Haloperidol 3 然 Apo 0.5 然
bRsLsbLgRsbLsbLiLsbLsbLsbRsbRhLsbRgRsmbLsLgbRcLsbLsbLsLsmbLgLsbRgbRgbR
sLsbRgbRgRsmbRcLsbRiLsbLsLsmbLiLsbRsLsbLsLsmbLgbLiLsbRsLsbLgbRsbLiLsbL
gbLibRibRcbLsLsmbLibLibRcbRgbRgRsmbRsLsbLgbRgbLsLsmbLsbLsLsmbRsLsbLsbs
bRobLsbRiLsLsmbRsbRobRsRsmbRgLsbLsbRibLiLsbLcbLsbLibLsbRgbRiLsbLsbLgbR
cbRgbRgbRsbRgbRgbLsbRgbRsRsmbRgbRgbLsRsbRibLibRsbRibRsRsmbRsbRgbLibLgb
LgbLsLsmbLsLsmbRsbRoLsLsmbLsRsbRibRhbLibLiLsbLibLgbLsbLgLsbLsLsmbLgbRs
bLjLsmbLgbRsbLgbLgbLsLsmbLsLsmbLsbLsbLgLsbLsLsmbLsLsmbLsLsmbLgbLgLsLsm
bLgLsbLgbLsLsmbLsLsmbLsLsmbLsbLsbLgLsbLgbLsbLsLsmbLsbRsLsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 42; Drug: Haloperidol 3 然 Apo 0.5 然
bRgbRsbRcbLsLsmbLibRhLsbLgRsbLibLsbRhbRcbLjLcLsmbLjLsmbLsbLobRibLoLsmb
RsbRcbRgRsRsmmbLebLhRsbRobRobRcbRiRsmbLcbLoRsbRcbRibRgbRiLsLsRsmbLsbRg
bRibRcbRibLcLsmbLibLibRgbLsbRcbLcbRjRsRsmmbLcbRsRsmbLjLgbLsbRebRobLcbL
cbsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 43; Drug: Haloperidol 10 然 Apo 0.5 然
bRgLsbRsRsmbRsbRsRsRsmmbRsbRsRgbRsRsmbRsbRsRsRgLsmbRsRgbRsRsmbLsRgbRsb
RsRsmbLsbRsLsRgRsmbLsbRsRsRsmmbRsbRsRgRsRsmmbLsRgRsRgRsmmbRsLsbRgbRsLs
bsbLsbLsRsRsmbsbRsRsLsmbRsRsmbLsbRsRsRsmmbRsbRsRsRsmmbRsLsbRsbRgbRsRsR
sRsmmmbRgbRsbRsbRsbRsRsRsLsRsmmbRsbRgLsLsmbRsbRgbRsbRsbRsLsbRsbRgbRsLs
bRgRsRsLsmmbRsbLsLsmbRgLsbRgbRgLsbRgbRsbRsLsbsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 44; Drug: Haloperidol 10 然 Apo 0.5 然
bRgbLebLsbLsbLsLsmbRsLibLsbLsbLgLsbLgbLgbLgbRsRsmbLjbLgbLsbLsRsbLgLsbL
sbLsbRsRsmbLsbLsbRiRsmbLebRibLsbRgbLgbLgLsbLsbRsbRsLsbLsbRsbRsbRsbLsLs
LsmmbRsbRsRsmbLsbLsbLsbLsLsmbRjbLsLsmbLsLsLsmmbLsbLsbLgbRsbLsbLsbLsbLs
bLsbLsbLgbLgbLibLsLsmbLsbLgbLgbLsbLgLiRgbRsbLhLsRsbRsbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 45; Drug: Haloperidol 10 然 Apo 0.5 然
bRgLhbLiRiRiRsmbRjbRcbRgRsmbRsbLsbRgbRsbRsRsmbRsbRsbRobRsRsmbRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 46; Drug: Haloperidol 10 然 Apo 0.5 然
bLgbRsbLsbRgbLsbRjbRcbRcLsRsRsmbLsRsbRgbRsRsmbRgbRsbLjRgbLsbRsbRebRcRs
LsmbLcbRsbLiLsbLgbLsLsmbLsbLgbLgbLgbLgLsLsmbLsbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 47; Drug: Haloperidol 10 然 Apo 0.5 然
bLsbLsbLsbLsbLsbLsbRibLsbLgbLsLsmbLgRsbRsRgbRgbRsRsmbRsbRsLsbRgbRgbRgR
hLsRgLsbRgRgbsbLsbLcbLgbLsbRsRsmbLsbLgbRsbLgLsbLsLgLsbRcbRibRsbLsbRsbR
gbRsbLsbLgbRsLsbRsbLgLsbLsLsLsLsmmmbRgbRobRcbLgbLibsbsbLsRsbLgbLgbLgLs
bLiLsRsLgLsLsmbLgbLibRhRsLgmbLgbLiRsbLibLiRsbLsbsbLibLsbRgbRsbsbRsLsbR
sLsbLgbRsRsmbsbRsbLsRsLsbRsLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 161005; End: 161505;
Recording: 9-1; Individual: 48; Drug: Haloperidol 10 然 Apo 0.5 然
bLsbRsRsRgmbLsRsbLsLgbLsbRsRsmbLsbRgRebRgRsLsmbRebRibLsbLcLsmbLsbLgLgb
LiLgbLgLsLsmbLsLsLsLsmmmbRsRsmbLsbLsRsbRobRsRsRsRgRsLsmmmbRgRsRsmmbRiR
smbRjRsmbLjbLjLsmbRjbLgbRjbRgbRgbReRsLsRsmbLibLsLgbLjbLibRsbLsbLgbRgbR
cbLibRgbRgbRjbRsRsLsLgmbRsRsmbRsbRsbRgbRgRsmbRsbRjbRgbRsbLsbRsLsbRsbRs
bRgbLcbLgbLsbRjbLjbLjLgbLsbLebLgbLibRibLgbLsbLsbLsLsRsmbsbRsbLsbLsbLsb
LsbLsLsRsmbLjbRiLsbRgbRhbRsRsmbRgbRgbLsbLsLgbLebLeLsbLsRsbLgLsLgbRjbRs
bLjbsbLsLsLgmbLsbRgRsmbRsbLsbLsLsRsmbLgLsbRsLsbLsLsmbLsbLgLsLsmbLsLsLs
mmbLsLsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 1; Drug: Control Apo 0.5 然
bRibLobRibLsRsbRibLhbRhbLsbLibLsLsmbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 2; Drug: Control Apo 0.5 然
bRhbRsbRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 3; Drug: Control Apo 0.5 然
bLcbRiRsmbRibLsbLibLcbRsbRgLsbLsbRoLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 4; Drug: Control Apo 0.5 然
bLsbLsLsmbLgbRjb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 5; Drug: Control Apo 0.5 然
bRgbRibRgbLjbLcbRgbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 6; Drug: Control Apo 0.5 然
bRcLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 7; Drug: Haloperidol 1 然 Apo 0.5 然
bLeLsLsmbLsLsmbLsLsmbRsbLcbRsbLibLsbRibLiLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 8; Drug: Haloperidol 1 然 Apo 0.5 然
bRgbRibRsbLsbRcRsmbRsbRsbRjbRibRsLsbRiRsLsmbRsbRibRsbRsbRibRsbRsbRsRsm
bRgbRcLsbLibRhbLgbLhbRgbRsbRibRgLsbRsLsbRsbRgLsRsbRsbLsLjbLcbRsbRjRjbR
cbRjRsmbRgbRibRsbRsbRsbRibRgbRiLsbLsbRgbRgbRsbLobRebRhb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 9; Drug: Haloperidol 1 然 Apo 0.5 然
bRibReRsmbRgbRcbRibRibRhbRcRsmbRibRcbRjRsRsmmbRjbLgLsbRoRsmbRgbRcbRibL
gbLgbRibRibRibRibRibRjbRibRibRsbLgbRgbRjbLsbLjbLgLsbLgbRobRebRsbLsbRsb
RcbRjbLsbLibLebRebRhbRsbRiLsbRsbRibLjLsmbRcbRjbRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 10; Drug: Haloperidol 1 然 Apo 0.5 然
bLsLsmbLibLibLgbsbsbLgbRsRgbLibLjLsmbRhRsmbLoRsbLcbLsbLibRibRsbRsbRgbR
gbLsbRgbRsbLsbLeLsbRhbRsbRhb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 11; Drug: Haloperidol 1 然 Apo 0.5 然
bRhbRsbRsRsLsmbRsbRcRsRsLsmmbLsbRgbLcbLgbLhRsbLsbsbsbLsLsLsmmbLsbLgbsb
sbLsbLsLsmbRsRgbRsbLgbLeLsLsmbLsbLeLsLsmbLsbLsbLsbLsbLsbReRgbRgLsbRjbR
sRsmbRcbRibRgLsbRoRsmbRgRsmbRsRsmbRgRsmbsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 12; Drug: Haloperidol 1 然 Apo 0.5 然
bsbLobRobLgbRhbLgbLobLsbLgbLoRsbRibLibRgbLib

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 13; Drug: Haloperidol 3 然 Apo 0.5 然
bLcbRsbRgbRgbRjbRcLsbRjLsbRsRsRsmmbLgbLsbRcbLsLsmbRiRsmbLsbRcLsbLsbRjb
LibRgbsbLsbRsbRgbRsbRsbRsbRsbRibLgLsRsbRsbRsLsbRsRsmbRsRsmbRsbLjLsLsmm
bRibLsbRibRsRsRsmmbLsLsLsmmbRcbLsLsmbLsbRsbRcbLsLsmbRjRsmbRsbLsLsmbRhb
RsbRcbLsbRcbsbRsbLcbRgbLiLsbLsbLiLsbRgbLibLsbRgLsbLhbLgbLcbLibRsbLcbRg
bLibLibRsbLsbLhbLsbLgLsbLibRsbLgbRgbLgbLgbRgbLgbLsbLgbRsbLgbRgbLgbLgLs
bLgbLibRibLgbsbLsbsbLsbLsLsLsmmbLibRsbRsbRebRiRsmbRgLsRsbLjbRibLsbRgbR
gbRgbRsLsbLgbRsbRsbRsbLcbsbsbsbLgRsbRsbLsRjbRibRibLsbRgbRsLsbLsLsmbRsb
LcbLgbLsbRsLsbRcbRibLsbRibRiRsmbRgbLsbLiLsbLcbLcbLibRgbRcbRsRsmbRibLsb
RcRsmbLgbLsbLsLsmbRcbRiLsbLibRcbLgRsbRibRsbRgbLsbRgLsbRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 14; Drug: Haloperidol 3 然 Apo 0.5 然
bRibLsbRibLsbRgLsbRsbRsbRsbRgRsmbRgLsbRgbLobLiLsbLgbLsbRsbLcbLibLibLsb
LsLsmbLsbLgbLsbLgbLcbRjbLebRgbLhLsbRjbLcRsbLgbRsbLsbRsbLsbLgbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 15; Drug: Haloperidol 3 然 Apo 0.5 然
bRobLsbsbLcbRgbRibLibLcbRgbRobsbRsbsbsbsbRhLsbLsbLsbsbRibLsbRsbsbsbLgR
sbRibLibsbsbLgbLgLsbLsbLsbsbsbsbLsbsbsbRsbRsLsbLsbsbLjbLjLsLsmmbsbsbRs
RsmbLibLsbRcbLsRsbsbRobsbRsLsbLsbRgbRibLsbRgbLgbRgRsmbRobsbRibRsbLsLsm
bLsbRsbLsbRsbRsRsmbLsbRsRsmbLgbRsbLibLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 16; Drug: Haloperidol 3 然 Apo 0.5 然
bRsRsmbRiRsmbRsLsRsbLsbLsLsmbLsbsbsbRobLebLibLcbRgbLgbLgLgbRsbLsLsmbLg
bRibLibLsbRsbLibRsbLsbLgLsbLsLsLsmmbLgbRibLsbLsbLibLsbLsbLebLibLoLsmbL
sbLsbLsbLgbLgbLsRsbRebRobLobLsbLcLsmbRhbLsbRibRibRsRsmbRsRsmbLcbLobLgL
sRsbLsbRsRgRsmbRsbLgLsbLcbRsRsmbLsbLsLsmbLsLsmbLsbRsRsmbRsbLsbRsbLsbLs
bRsLsbRebRibLsbLsbRebLsbRsbRsRsmbRibRsLsbRgbRibRibRsRsmbLsRsbLcbLhbLsb
LsLsmbLobRsbRibRsbRsbRgbRgRsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 17; Drug: Haloperidol 3 然 Apo 0.5 然
bRsRgbRsbsbsbRgbRgbRibLsbLgbRhbLjbRibRgbRsLsbRgRsmbRgbRsbRgbLgbRgRsmbR
sbRgbRiRsRsmmbLgbRgbRibLobLhRsbRgbLcLsmbLgbLsLsmbLgRsLsbRsbLibLhbRgbRs
bLibLsbLgLsbLsbLgLsbLsbLibRsbRibRsbRibRsbLibLgbRsbLhbRsLsbRcbRjRsmbsbR
sbsbLsbsbRsbLsRsRsRsmmbsbsbRjbsbRsLsbsbLsRsbLsbsbLsbsbLsbRcLsbRsbRgbRg
bLgbLobLgbRsbRsbsbRhbLebRobLsLsmbLgbRsRsmbRsRsmbsbsbsbsbLjbLsbLgbsbLsb
sbsbsbsbsbsbsbsbRjbsbLsRsRsLsRsRsmmbsbRsbsbsbRsbLsbsbRjbsbRsRsmbLsbRsb
RiRsmbLsbRjbsbsbsbsbsbsbsbsbsbLsbRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 18; Drug: Haloperidol 3 然 Apo 0.5 然
bLgbLgbLgbLsRsbLgbLgbLsbLsLsmbLsbLsbLgbLgbRsbRsbLibLgLsbLcRsbLcbLgbRcb
LsbLcbLgbLibRsRsmbLibRsbRgLsbLsbRsbLgbLiLsbsbRhRsmbRibRiRsmbRibRgRsmbL
gbLgLsbRcbRibRgLsbLsLsmbLsbRiRsmbRgLsbLsbRgRsmbRgbLgbRcbLgbRcRsmbRgbLi
bLjbLcbLhbLgbRsbLsbLsbLgbLgbLsbRsbLibLibLsbLsbRsbLhbLgbLibRsbLsbRibLib
LibLibLsbLjbRsbLsbRsbLsRsbLibLibRsbLibLsbReRsmbRhbRgbRsbRibRsbRibRsbRi
bLgbLiLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 19; Drug: Haloperidol 10 然 Apo 0.5 然
bRcbRhLsbLgbLgbLsbLsRsbLgbLgRsLsbLsbLgbsbLsLsmbLsbLgRsbLsbLsbLgbLsRsbL
gLsbLsbLsbRsbRsRsmbLsLhRsbRgbRgRsmbLsLsLgLsLsRsLsmmbRsbLgbsbLgLsbLsbRg
bLsbRsbRsbLgLgLsbLgbLsRsbLsbLsbLsbLsbLsbLgbLgbLgbRsLsbLsbRsbLibLsbRsbR
sbRsbRsbLsbLgbLsbLsbRsbRsbLiLsbRsbLgbLsbRibRebReb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 20; Drug: Haloperidol 10 然 Apo 0.5 然
bLsbRsLebRsbLgLsRsLsbRibLebRsLgLsbRsRsmbLgbRsLsbLebLsbRgLsbRsbRsbRgbLs
bRibRhbLiRsRsmbRgRsmbRsbLobLsbLobRcbRjbRsRsmbRjbLcbLsRcbRebLjbRsbLsRsb
sbRsLsbRsLsbLjbRibLjbRebRjbLgbRsbLsbRsbLsbLsLsLsmmbsbRsbLsbLsbsbsbLsbs
bLsbLsLsLsRsLsLsLsLsmmmmmbsbRsbLsbLsbRsLsbsbLsLsmbsbsbsbsbsbsbLsbLsbsb
RsbLsbsbsbLcbLcbLsbLsbLgbsbLsbLgbRsbLjbRsLob

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 21; Drug: Haloperidol 10 然 Apo 0.5 然
bLiRsbLgbLgbRebRiLsbRibRiLsbRsLsRsRsRgRgmbRsbRsbLgRsbLsbRsRsmbRsbRsbRs
bRsbRsbRsRsmbRjbLsbRgRsmbRgRsmbRgRgRgRsRgRsRgmmbRgRgbRgbRgbRgRsRgmbRgR
gbRgbRsRsRsLsmmbLsbLsLsmbLgbLgLsbLgbLgLgLsbLgbLgLgbLgLsbLgbLgLgLsLgLib
LsLibLsbRebRsbRsbLsRsbRsbLsLgbLsbRsbRsLjbRsbRjRsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 22; Drug: Haloperidol 10 然 Apo 0.5 然
bRebRjbRsLgLsbRsRsmbRgRsmbRsbsbRgbRsRsRsmmbsbRgbRgLsbRsLsbRiLsbRgbRsbR
gbLsbRgRsLsmbRsbRebLebLgbRgbLgbRjbRobLobRsbRsRsmbRsRsRsmmbRsbRgbRgbRgb
RjbRsbLibLibLgbLsbRiLsbRsbRsbRsRsRjmbRgbRsbRhbLeLgbLibLjbLcbLgbLjbLebR
ibRgbRgbLsbRsRsmbRsbRsRsmbLsbRsRsmbsbLsbRsbLsbLgLsbLgbLsLsmbLsbLgbLgbR
jLsbLsbLsbLsLsmbLsLsmbLsLsmbRsbLjbRsLsbLsLsmbLibLibsbLgLsLsmbLgLsbLgbL
gbLsLgLsbLgLsbLsbLgbLsRsbLsLsLsLsLsmmmmbLgRsbRsLsRsbLsLsmbLsbLsLsLsmmb
LsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 23; Drug: Haloperidol 10 然 Apo 0.5 然
bLcbRcLsRsbLjbLsbLsRsbRcbLsbRjRsmbRsbRsbRgLsbLsbReRsRsmmbLsbLgLgbLiRsb
LgRsLsbLsbLgLgLsLsmbLgbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 24; Drug: Haloperidol 10 然 Apo 0.5 然
bRjbRsbRsbLsbRgLsRsbRsbRsbLjLsmbRgbRgbRibsbLsLsmbLgbRsLsbsbLsbLsbRjbRi
bRgbRgbLsbRgbRgbRibRsbRsbsbLgbRibRsbRgbLsLsmbRibRgbRsbLsRsbRsbRsbRsbRs
bRgLsbRsbRobLibLgbLgLsbLsRsLsbLsLsLsmmbLsLsLsmmbLiLgbLgbLgbLsbLgbLgbLg
bsbLgbRgbRjbRsbRsbRsbRsbRsRsmbRsLsbLsbRgRsmbRsbRsbRsbLsLsmbRgbRsbRiLgR
gRsRembRsRsRsRsmmmbRgRsmbLhLgbsbRsRsmbLsbLgLsbLibLgLgbRsbRsbLsbLsbRjbR
sbRsLsbLgbRsbRsbLsRsRgLsbRsbRsbsbLsbLebRgLsbRgRsLsmbRgbsbRsRsmbsbRebRs
bRsbLsbLgbRjbRgbRjbRsLsbLsLsmbLsbRsbRsbRsbRgbRsbRsbRgRsmbRibLsbRsbRsRs
RsmmbRsbLsbLjbRgbRibRsRsRsmmbsbRgLsbsbRsRgRsRsmmbRsbLsLsmbRibLjRsbLjbL
gbRgbRgbsbLjbLibLsbRibRgLsbRsbRsLsbRsbRsbRsbRsRsmbsbRsbsbRsRsRsmmbRsRs
mbLsbsbRsbLsbRsbRgbRgLsLsLgmbRsbRgRsmbRgRsmbRsbRsbLsbRgbRgbRgRsmbRsbRg
bRgRsmbRsbRsRsmbRjRsmbRgRsRgRgmbRgbRgRsmbRgbLgRsbLjbLiRsbLibLsLsRsmbLg
bLibRsbLsLsmbLsbLgLsbLsbLsbsbsbLsbsbLsLsmbLsLsLsmmbLgbLgbLsbRjbRgbRgLs
RsbRsbLebRsbLiLsbLgbLsbRsRobRiRsmbLsRsbRsbRsLsbRsLsbRgbsbLgbLhbLsbRibR
jRsmbRhbRgbRsRsmbLsbRsRsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 25; Drug: Control Apo 0.5 然
bLsbLobRsbsbRobRobRoRsmbRjRsmbRibRjRsmbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 26; Drug: Control Apo 0.5 然
bLcRsbRibRgbLsbLcbRebRjRsRgmbRgLsbRsbLsLsmbRgbRsbLsbRsbLibLcbRhbRsbLsb
RsbsbLibRiRsRsmmbRsbRobRjRsmbRsRgbRgRsmbLsLsLsLsmmmbRgRsRsmmbLsbLsRsbL
sLsmbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 27; Drug: Control Apo 0.5 然
bLsbRjRsmbLsbLsbRobLhbLiLsbLsbLgbRhbRibRhbLobRobRibRcbLsLsmbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 28; Drug: Control Apo 0.5 然
bRgbRsbRsRsmbLcbLibRsLsbRgbRsbLsbRcbLsbRsbLcbLcbLgbRoRsmbLcbRobLiRsbLs
bLsbLgRsbLsbLsRsbLcRsbRebRsbRsbRsRsmbLcbRsbRibLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 29; Drug: Control Apo 0.5 然
bRgLsbRibRgLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 30; Drug: Control Apo 0.5 然
bLhbRobLhRsbLsbLsbRjbRobLsRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 31; Drug: Haloperidol 1 然 Apo 0.5 然
bLhbLcbRsRsmbLjLsmbRsbLhbRsbRgbLcLsmbLjbRibLhbRgbLsbLgbRsbRibLsRsbRibL
sbRgLsLsmbLoLsmbLsbRibLcLsmbRhRsmbLjbLcbLsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 32; Drug: Haloperidol 1 然 Apo 0.5 然
bLgbRgRsmbRgRsmbLsRsbLsbRsbRhbsbsbRsbRsbRgbLgbRjbRgbLsbLibRsbLsbRjRsmb
RjRgbLhLsbLsLsmbLsLsLsmmbLsLsmbLsLsmbRcbRgbLgbRsbRsbsbRgLsbRjRsmbsbLsb
RibLjbRjRsmbLsbRjRsRsRsmmmbsbsbLsLsmbRsRsmbLjbRsbLjbRsRgbRsbRjbRsRsmbR
iLsbRsbRsbRsRsmbLsbLgbRobLsLsmbRobLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 33; Drug: Haloperidol 1 然 Apo 0.5 然
bLgbLsbLgbLsbLsbLgbLsLsmbLgbLsbLsbLsbRsbLsbLsbLibLgLsbLsbLgbLsbLsbRsbL
sLgbLsbLsbRsbLsbLgbLgLsbLsbsbLsbLgbLsbLibLgbLgLsbLibLsbLsbRcbLsbLibRcb
LsbLgbsbsbsbRsRsmbLgbLsbLsbLcbRjRsLsmbLcbLibLsbLsbRgbLjLsmbRgbRjRsmbLs
LsRsmbsbsbRobLgbLsLgbRsbRsbRgbRsbLjbLibLgbRsbLgbRsbLgbLibLgbRsbRgbLibL
gbRsbLibRsbLgbLibRsbRgLsbRgbRgbsbLsLsmbRhbLsbLsbLsbsbRgbRibLsbLsbRgLsb
RgRsmbRgbRibLibLsbRhbRsbRsbLsbRsbRibRgRsmbRsbLsbRsbLsbRsbRsbRgbLgbRgbR
gRsmbRgbLsbLsbRsbRsbRgbRgbRsLsbLsbRgbRsbRsbLhbLgLsbLsbLsbLsbLsbRsbRib

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 34; Drug: Haloperidol 1 然 Apo 0.5 然
bRsRsmbLsbLsbLcbLsbRgbLgbLsbLsbLibRsbRsbLgbLgbLsbLsRsbLsbRsLsbLibLsbLg
bLsbLibRsbLsbLgbLsbRsLsbLsbLibRgbLgbRsLsbLgbLsbLgLsbRsbLgbLgbLsbLgbRsb
RsbLjbRibLsbRsbLjbLsbRsbLsbsbRibLsbRgbLibRjbLsbLsbRgbRsbLgbRsbsbLsbRsb
RsbLsbRgbRsbRgbRjRsmbLiLsbLsbLhbRsbLhRsbRgbLsbLiLsbLsbLgbLsLsmbLsbLibL
gbLjbRibLsbRibRjRsmbLebRsbLibLsbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 35; Drug: Haloperidol 1 然 Apo 0.5 然
bLsLibLobLibLgbLsbRsbLoRsbRibRibLsbLsbLhbRcbRsbLoRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 36; Drug: Haloperidol 1 然 Apo 0.5 然
bRibLgbRgbRgLsRsbRibLsbLsLsmbLsLsmbLsRsbRgbRsbRsLsbLibLsbLhbRsbLsbLibL
sLsmbLsRsbRib

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 37; Drug: Haloperidol 3 然 Apo 0.5 然
bLhbRcbLcbLiLsbLibLjbsbLiLsbRgbLobLsbLgbLsRsbLibRibLibLsLjLsmbLibLebLj
RsbLgbLgbLcbRsbsbLgLsbLsbsbLgbRgbRjbLgbLgbLgbLibsbLgbLhbLsbLibLsbsbRib
LhbRjbLibLsbRsbRcbRiRsmbRobLgbLsbLsLsmbLcRsbLibRjbLibRsbLsbRsLsbLibLcb
LsLsmbLcRsbLsRsbRgbLibLiLsbLibRsbRsbLobLjbRsLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 38; Drug: Haloperidol 3 然 Apo 0.5 然
bLsbRgbRsbLsbLsbRgRsmbRgbRgbRibRibLgbLibRsLsbLsRibRsbRibRsbRgbRcbLjbLg
bRgbRsbRoRsLsmbRibRgbRgbRgbLiLsbLsbRibRsbLgLsbRsbLcbLsbLibLsbLsbLibRsb
RiRsmbLhbLsbRgbLibLibLsbRibLgbLjbLhbLgbLsbLsbLgbRgbLibLibLibLsbLsLsmbL
iLsbLgLsbLsbLibLgbRgbLhbLibLgbLsbRsbLibLhbLsLgLsLsLsmmbLsLgLsLsLsLsmmm
bRobRoRsmbRibLhbLibLgbLibLobLgbLibLsbLgLsbLibLsbLibLiLsbLcbLhbLjRsbLsb
LibLsbLgbLgbLibLgbLsbRibRsbLsbRobRibLibLsbLibLhbLibRsbLjLjbLsbRgbLhbLs
bRebRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 39; Drug: Haloperidol 3 然 Apo 0.5 然
bRoRsmbRsbLibLibLgbLibRgbLibLhbRsbRibRiRsmbLibRebRcbRsbRsbLsbRgbLjbRcb
RhbRhbRgbLcbLgbLhbRsbLsbLibLibRsbLsbLibRgbLibRiLsbLiRsbLibLsLsmbLgbRgR
smbRgbLhbLgRsbLsbLibRsbLobLcbLibLibLobLsbLcbLsRsbLibLsbLibRsRsmbRjbRib
RgbRcbLibLsbLjbLibLibLhbRsbLibLsbLsbLibRgbLibRsbLiLsbRsbLibLsbLsLibLgb
LjbLibRsbRgbRibRibLsbRibLgbLsRsbsbsbLib

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 40; Drug: Haloperidol 3 然 Apo 0.5 然
bRsbLibRsbsbLgbRsbLibRgbLgbLsLsmbLgbLsbRsbLibRgbRsbLcbLgbRobLjbLgbLjbL
sbRsbRsbRiRsmbRcbRsbRsRsmbRsbRgbLibLibLgbLgLsbLsbRsbLsbLsbLgbRsbLsRsbR
sLsLsmbRsbsbsbRsbLiLsbLsbRsbRsbLgLsbRsbRsbLsbLsbLgbLsbLsLsmbRsLsbRsbLs
bLsbsbLgbLsbRsbLsbLgbRcbRibRcbLsbRgbLsbLgbRibRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 41; Drug: Haloperidol 3 然 Apo 0.5 然
bLgLsbRgbLgLsbLsLsmbRibRjbRibRibLcbLiLsRsbLgbLsbLgbRibRiLsbLibLiLsbLsb
LsbRjbRobRgbRibRgbRgbLsRsbRgbLsbLsbLsbRgbRibLiLsbLsbRgbRcbRibRgbRgbRgb
RsbRgbRsRsmbRsRsmbRgbRsbLsbRibLgbRsbLhbRcbRcbRsbRgLsbRsbRibRsbRiLsLsmb
LgbLsbRhbRsLcbLsbRsLjb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 42; Drug: Haloperidol 3 然 Apo 0.5 然
bRjRsmbLibLibRsbRobRibLsbRibLsLsmbLsbRgbRsbLebLibLgLsLsLsmmbLjRsbLcbLg
LsbRhbLibLjLgbRoLsRsbRsbLoLsmbLgbLcbLebRgbRhbRcbLibLobLibLibLgbRoRsmbR
ibRjRsmbLibRibLsLsmbRjRsmbLibLcbLiLsRsbRgbLcbLsbRcbRcLsbRcRsmbLsbRgbLc
bRcbRobRsbRjRsRsmmbLibLgbLsLsmbLsbLsbLsbRcRsmbRibRibsbReb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 43; Drug: Haloperidol 10 然 Apo 0.5 然
bRobRobLebLobRobLobRcbRobRebLsbLebLcbLebLgbRobRebRibLcbRobLobRobLcbRob
RgbLibRibRebRobRebLcbLibLsbLebLobRobRebLgbLebRobRobLibLobLobRcbRibRebL
cbRobLibRebLobLobLobLebRcbLibRobLgbLibLobRobLebLibLcbRibRobRebLobLobLe
bRsbLobRebLibLobLibRobLobLcbRobRgbRebLebRebLcbRebRobRibLcbRhbRibLebRob
LcbRobRsbRibRobLobLebRgbRcbRcbRebRcbRcbLsbRobLcbRobLjbLhbRobRebLibLgbL
ebRebRobLobLibLobRobLobLebRebRcbLebRsbRcbRcbLobLsbRebRebRobRsbRobLobLe
bLebRobRgbLibRobLobRobRobLgbLobLcbRsbRobRibRcbLcbRebLcbLobRobRobRobRob
LobLibRsbRsbRobRgbRibLebLobRebLebRebRsbRsbRhbRebLebRcbRgbRcbRgbLobLobL
obRcbRebRobRebLgbLcbLobLebLobLebRobLcbRobLobRobLobRhbRsbLgbLibRobLobRo
bRcbRobRebRebLobRcbRobRobRobLobLebRebLgbRebLobRgbRebRebLobLgbLobRebRob
RobLcbRcbLobLebRobRebRobRobLcbRcbRobLebLebRobRebRobRobLcbLebRobRobRobL
cbRsbLobRhbLhbLgbRobLobLcbLsbRgbLebRobRebRobLobLobLebRgbRebRgbRobLobLc
bLebRobRebRebRobLobLibLebRgbRobRobRibRcbLibRobLebLobRgbLcbRobLobLobLcb
RebLebRobRobRcbLcbRebRobLobLgbLebRgbRibRgbLobLebLobRcbLcbLobLebLobLobR
ebLcbLobRobLobLobLsbRobRebLgbLobRebLebLebLsbRobLobRsbLobRebLebLcbRobLe
bLobLobLobRebRobRibLcbLobRobRobRobLobRebRobRcbRgbRobLobLobLcbRobRgbRob
RobLobLebRebRobRebRsbRobLcbRobLhbRobLebLcbLebLobRobLobLibRibRobLebLgbR
obRibRebLobLobRcbRobRebRobRobLobRobRobLhbRobRobLcbLobLibLebLibRebRibLc
bLcbLobLcbRebLobLobLgbRobLjbLobRobRobLibLobLgbLsbLobRgbRobLebRebRebRob
LjbLobRjbRcbLgbLebRebLobLsbRgbLebRobLebLcbRebLebRobRsbLobRibRgbLobRebL
obLobRebRebLobLebRebRibLebRobRebRobRobRebLibRobLebRobRebLobLebRebLibLo
bLibRebRgbRobRobRobLebRobLcbRibRgbRobRcbLobLibLobRibRcbRcbRobRobLobReb
RcbLebLgbLebLhbLcbLobRebRcbLobRobLjbRcbRobRobLebLcbLebLobRobRobRibRebL
ebRobRobRobRibRcbLobRebLobRgbLebLobLobRobLibRebLobRebLebRsbLibLobRobRo
bLobLobLebLobLobRebLobRobLobRebRobLobLobRebLobRebLcbLcbLobRobLobLobLcb
LobRcbLsbRcbRsbRobLobLebRebRobRobRgbRebRobLobRobLhbLebRobLobLebLhbRcbL
ibRebLibLobRobLebRibRgbRcbRibRobRobRobLobRobRobRebRcbRobLobLgbRgbRebLi
bRebRgbRcbRebLebLgbRobLibRobLebRobLgbLebLobRobRsbRebLobRhbLsbLebRebRhb
LobRobLebRcbRcbRebLcbRobLobLcbLobLebRobLibLobLobRcbRobRebRcbLcbRcbRibR
ibRgbLebLobRcbRsbLobRobRobLobRibRobRcbRcbRgbLebLobRebRgbRibLibLebLsbLo
bLcbRebLebRobLobRsbLobLsbRsbLebRibRobRebRobRibLobRobLobLgbLobLobRgbRhb
RobRebLcbRcbRsbRebLcbRobRobRcbRobLcbRobLobRobRobLobLobLibLobRebRebLobR
ebLobLebRgbLobRibRgbRobLobRsbLobLobLobRobLebRgbRobLebLibRebRobLobRobLc
bLcbRebRebRobRobRobLsbRobRibLebRgbLcbLebRobRgbRobLobRobRebRobRebRebRob
RobLobRobLebLcbRibRebLobLibRibLebRobRebRobLsbRgbLhbRebLobLobRebLibRgbR
ebLgbLobLobRobLobLgbRebLcbLebLcbRcbRcbLcbRibRibLcbLebRobLobRgbLobLebLo
bLebRsbRhbRcbLgbLobRcbLcbRobRebRobRcbLobRebRobRobLcbLebRebRobLobLibReb
RhbLebRibRobRobRcbRibLibRobRgbRcbLibLobLebLsbLcbLobLobRobLobLobLebLobR
sbLebLebLobRebRebRebLebLebRebRobRobLobRobLobLobLsbLobRibRobRcbRebLibLc
bRobRibRobRcbRebRobLibLsbLibLcbRobRibRobRobRgbRibRebLobLobLcbLgbRobReb
RebLib

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 44; Drug: Haloperidol 10 然 Apo 0.5 然
bLgbLsbRgbRjbRibRgbRsbRsbRsbRsbRgbRsbLsbRgbRgbRsbRgbRgbRsbRsbRgbRsbRgR
smbRsRsmbRsRsmbLsbRsbRibsbRsbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 45; Drug: Haloperidol 10 然 Apo 0.5 然
bLsbRsLsbLgbRebLgLsLsLsmmbLhbLgbLsbLsLsmbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 46; Drug: Haloperidol 10 然 Apo 0.5 然
bRsbRsbLsLsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 47; Drug: Haloperidol 10 然 Apo 0.5 然
bRsbLsbRgbLsbLgLsbLsbLgLsbLebLibLsbLibLsbLsRsbRsRsmbRsRsmbRsbLibRsbsbL
gLgbLgLgLsbLgbLgbLsbLgLsLgLiLgLiLiLsbLobLgbLsbLjbRgbLgbLibLgbRsRsmbLjR
gLjbLcbLibLgbLsLsLgmbLgLgLsbLgLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 161507; End: 162007;
Recording: 10-1; Individual: 48; Drug: Haloperidol 10 然 Apo 0.5 然
bRsbLgLsbLsLsmbLsbLgLsbLgbRobRsRsLsmbLsLsmbLgbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 1; Drug: Control Apo 0.5 然
bLobLibLjbLebRoRsmbLsbRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 2; Drug: Control Apo 0.5 然
bRsbRobRsbLebRcbLobLebLjbRebLjbRjbLjbRebRobRobLebRobRobRobRjbRjbRobReb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 3; Drug: Control Apo 0.5 然
bLiRsbLobRgbLebLobLebLobLjbRobRebRoLjbRcLjbsbsbLobLobLcbRsbLcbLcbsbsbs
bsbRsbRsbLebRobLebRobLobRcbRobRobRobRcbRcbRcbRcbRsbLcbLobLsbLcbRobRjbL
oLobLobRsbRobLebRsbLobLhbRobLobRobLobLcbRobLhbRebLsbRobRobLjbRcbLsbRjb
LobLibLsbRobLhbLobLobRebLjbRsbRobRsRsmbRobLobRsbLsbLsbLebLebLobLsbRebL
ebLsbRobLsbRobRsbRobLobRobLobRsbLibLsLsmbLsbsbRsbRoRibLibLebLibLcbRgbL
cbReLebRsbLsbLsbLsRsbLsbRsRsmbRsRebLobRsbLsbRsLsLebReb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 4; Drug: Control Apo 0.5 然
bLobRcbRsRsmbRgbRgbLibLsbRjbRibRgbRobRibRcRsmbLsbRiLsbRhbRibLcbLobLobR
ibLjbLjLsLsmmbLjbRjRsRsmmb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 5; Drug: Control Apo 0.5 然
bRsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 6; Drug: Control Apo 0.5 然
bRsLsbRsbRsLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 7; Drug: Haloperidol 1 然 Apo 0.5 然
bRhbRgbRobRoLsbLsbLsbLgLsbRsbRsbLjRsbLgbLsLsmbLgLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 8; Drug: Haloperidol 1 然 Apo 0.5 然
bLgbLsbLsbLcbRobRibLobRcbRsbRsRsmbRjbRsLsbRgLsbRsLsbRgbRsbLsbsbsbRgbRi
bRgbRibRgbRiLsbRgbRiRsmbRgbRgbRsRsLsmbRgbRgbRsbRgbRsbRsbRsRsmbRgbRgbRs
bRgbRsbRgRsmbRsRsmbRgbRgbRsRsmbRsbRsbRgbRgbRsbRsLsbRsbRgbRgbRsLsRsbRgb
RgRsmbRsbRgbRibLsRsbLgbRhbRsbLsLsmbRib

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 9; Drug: Haloperidol 1 然 Apo 0.5 然
bRobRsbRsbRgbRsbRibLgbRibRsbLsbRjbRgbRsRsmbRgbRhLsLgbRsbRibRibRsRsmbRi
bRsbRgbRsbRgbRsbRsbRsbLgbRibLgbRsbRiRsmbRsRsmbRsbRsbRgbLsbLsbRibLsbRcR
smbLibRsbRsbRibRsbRgbLsbRibRibRibLgLsbRsbRibRsbRsbRgbRsbLgbRsRsmbRsbRg
bLsbRibRsbRsbRsbRsbRgbLsbRgbRsbRsbRsbRsbRgbRgbRsbRgbRsRsmbRsbRibLgbRsb
RgbRibRiRsmbLjbRjbRhbLcbLcbRsbLibLibLibLgbReRsmbRgbLgLsbRibReRsmbLsbRc
bRgRsmbRibRibRsbLgbRibLgbRibRhbRsbRgbRhbRibRjRsmbLibRcbRcbRsbRgbRgRsmb
Lib

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 10; Drug: Haloperidol 1 然 Apo 0.5 然
bLjLgbLhbLhbLgbLobLibLsbRobLibLgLsbRgbLsLsLsmmbRcbLibLsbLsbLgbLsbLgbLg
LsbRgbLgLsbLiRsbLsbRsbLsbLsbLgbLsLsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 11; Drug: Haloperidol 1 然 Apo 0.5 然
bRjLsbLsLsmbLsLsmbsbRsRsRsmmbRgRsmbRsbLsbRsbRsbRsRsmbRsRsmbRgLsbRgbsbs
bsbLsbRsbLsRsbLsbRsbRcbRsbRebRsbRsbRsbRsbRibLsbRgbRibLsbLsbLoLsmbLsbRc
bRsRsmbLhLsbRjRsmbLsLsmbLsbsbLcbLsLsmbRsLsbRgbRjRsmbLsRsbRgbLsbLsLsmbs
bRjRsRsRsmmmb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 12; Drug: Haloperidol 1 然 Apo 0.5 然
bLjbLeLsbLsbLibRgbRibLobLsbLiLsbLsbLhLsbLsbLsbLiLsbLhbRib

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 13; Drug: Haloperidol 3 然 Apo 0.5 然
bRgbRsbRibLgbRgbLsbRgbRsRsRsmmbRhRsmbLjbRsLsbRibRsbRgbRgRsmbRsRsmbRsbL
sbRgbLebLibRgbLeRsbLsLsmbLcbLhRsbLsbRgbRsRsmbRgbRhbRiRsmbRgbLcbLgLsbsb
LsLsLsmmbLjbLjbRibLsbLgbLibRhbRcLsbLsbRhRsmbLgRsbRibRgbRsbLsbRjRsmbRcb
LibLgLsbRibRjbsbRgbRsRsmbLsLsmbsbRibRsbLhbLjLsmbLsbLibLsbLjLsmbLcbRsRs
mbLsbLibRsbLcbRgRsmbLcbRsbLsLsmbLcbRsbRsbLgLsLsLsmmbLsLsmbLibLsbsbLcLs
mbLsLsLsmmbRsbRjbLsbLsRsbRsRsmbLcLsRsmbLsLsmbLibLsbLsLsLsmmbLsbLsbLsbL
cbLsbRgLsbLcbRsbRsLsbLibLiRsLsbRsLsbRgbRsbLcLsmbLsRsbRsbLsbRsbLsbRgLsb
RjbRibLsRsbLcbLsbLibLgbRsbRsbLhLsbRsbRsLsbLibRsbRebRcbRgbsbRsbLsbLcbLh
bRsbLsbLgbRsbRsRsLsmbRhbRhbRsbRsLsbRsbRibLsbRib

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 14; Drug: Haloperidol 3 然 Apo 0.5 然
bLgLsbRsbRsbLiRsbRsbLobLsbLsLsLsmmbLsbRgbLgbRsbRibLsRsbLgbLoLsmbLsbLib
RjbRcbLibLsbLgbLsbRsRsmbLgbsbRgbRcbRjbRiLsbLhb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 15; Drug: Haloperidol 3 然 Apo 0.5 然
bLibRsbRjbRibLsbLibRsbLibLibLibRsbLsbLsRcbsbsbsbRsRsLsmbsb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 16; Drug: Haloperidol 3 然 Apo 0.5 然
bLgRsbLsbLgbLibLsbRsbLgbLgLsbRsbRgbLcbRsbRsLsbLsLsmbLibLsbLsbLhbRsbLgb
RsbRibLsLsmbLgbRjRgRsmbRcRsmbLsbLibLsLsmbLsLgbRcbLjLjbLsbLcbLibLeLsbLi
bRsLsbRsLsLsmbLgbRsLsbLgbLsbLgbLgbRsbLsbRibRibRibRsbRgRsmbRsRsRsRsmmmb
RibLgbRsbRsbRsbLsbLsbsbLcbLcbLcbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 17; Drug: Haloperidol 3 然 Apo 0.5 然
bsbsbLsLsmbRsbRsbsbLsRsbRsRgRsmbRsbRsRgbLjbLsbLcLsmbLsRsLsbLibLsRsbRsb
LsbRsbLsLsmbLsLsRsmbRsRsmbRsLsLsmbRsRsLsLsmmbRsbsbLsbLsLsLsmmbRsbLjbRg
bRibRgbRgbLsRsbRsRsRsmmbLsbRibRgbRsRibRsRsmbLgbRhbLibRcbLsbRiLsbsbsbsb
LsRsRsmbsbRsLibRsRsmbRcRsmbRgRsmbRgbLjbLcbLibRjLsbsbsbsbsbsbRjbLsbRsbL
sbRgbLjbRhbRsbRibLsbLjbRhbRsbRgbRibLgbRibRibLibLibLibLgbRibLcbLsbLsbRs
bRgbLibRcbRiRsmbLjbLcbLsLsmbLibRsLsbsbsbRsRsmbLjbsbRsbLgbLsRsbLibRsbRc
bRibLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 18; Drug: Haloperidol 3 然 Apo 0.5 然
bsbsbLsbLsLsmbsbRsbsbsbsbLsbRsRsmbLsbRsbRjbRcbRgbRgRsmbRibLsbLgbLsbLcb
LgbLsbLsLsLsmmbRsbsbLsRsbLsbRsbsbLsbRsbRsbLhbLsbRsbLibLcbLiLsbLibsbsbL
hLsbRgbRobLgbLsLsmbsbLgbLsbLsLsmbLsbRsLsbRsbRgbLsbRsbRsbLgbLsbsbLsbLsb
LsbLsbLsbLsbLsbRsbLgbLgRsbRgbLsbLgbLsbRsbRsLsbLsRsbRsLsLsLsmmbRsbRsbLc
bLhbLibLibLibLsLsmbRjbLgLsbReb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 19; Drug: Haloperidol 10 然 Apo 0.5 然
bLsLsmbLgLsLsmbLsbLsbRibRgbRsbLsbRsbRsbLgbLobRsRsmbRsRsmbRsRsmbRsRsRsm
mbRgLsbRgRsmbRgbRsbRsbRsRsRsmmbRgbRsbRsbRsbRgbRsbRgbRsbRsbRsbRsbLgbRib
RsbRsbRsbRsLsbRsbRsbRsbRsbRsbRsLsRsbLibLsLgLgbLgbLsbsbLsbLsbLsbLcbReRs
mbLsbLjbRsLsbRsbRjbLcbLobRibRebRsLsbRgRsmbRgbRsbRsbRsbRgbLsLsmbsbLgbRs
bRsbLsRsbRsbRsbRsRsRsmmbRsLsbsbLsbRsbRsLsbLsbLsbRsLsbLjbLcbLgbLsbLibRs
RsmbRsbLsLgRsbLsLsmbLgbLsLsmbLsbLsbRsbRsbRgbRgLgLsRsbLsbLibLsbLiLsbRsL
sbLsLsmbLsbLsbLsbRsbLsbLgRgbLsbLsbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 20; Drug: Haloperidol 10 然 Apo 0.5 然
bRsLsbRsbLiRsbLhbRibLibLibLiLsRsbLgLsLsmbLebLgLsbLsbLgbLsLsmbLebRgRsLs
mbRgbLsRsbLjbLeRsbLsbLgRsbLgLsLsmbRsbLsbLsbLsRsbLgbRobLsbLebRgbRsRsRsm
mbLebRsbsbRibLsRsbRsbLsbLebRjbLibLgRsLsbLgbLsbRsbLgbLgbLobRebRibRgRsRs
mmbRsRiRsRsmmbLgRgbRgRsRgmbRsbRgbRebLibRgbRsbRsbLebRsRsmbRibLsbRsRsLsm
bLgbRsLsRsbLgbsbsbRsbsbRsRsmbsbRsRsRsmmbsbsbRsRsLsRsRsRsRsmmmmbRsRsLsR
sRsmmbLsbRsbsbsbsbsb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 21; Drug: Haloperidol 10 然 Apo 0.5 然
bRsLjbLsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 22; Drug: Haloperidol 10 然 Apo 0.5 然
bLsbLsLsmbLgbLgbLibLgLsbLibLibLibLibLibLibLibLgbLgbLgbLgbLibLiLsbLgLsb
RgbRibRgbRgbRgbRgbRsRgbRgbRsRsmbRgRsmbRsbRsbRsbRsbRsbLsLsmbLsbRsbLsRsb
LsbsbRsbLobLebRsbLcbLcbRobRjbLgbLobRibRibRebRsbLsbRhLsbLsLsmbRgbRibRsL
sbRibRgbLsbRcbRebRjbRsbRsbRsLsLsLsmmbLsLsmbLsbLsLsmbLibRgRsmbRsbLgbLsb
LsbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 23; Drug: Haloperidol 10 然 Apo 0.5 然
bLsLgLsbLgbLgbLgbLibLgLsbLgbLibLibLgbLgLsbLsbLgRsbLgLsbLgbLgbLiRsLgRsb
LsbLobRhbRsbRgRsmbRsRsmbRgRsRsRsmmmbLsRgbRgbRgRsmbRsRsmbRsbRsbRsRsmbRg
bRgRsmbRgbRgRsmbRgbRgbRsbRgbRgRsmbLsLibRibLobRsRsRsRsmmmbRobLsbLcbLobL
sbLgbLgbLsbRebRsbRsRsRsmmbRsbLobRsbRgbRsbRsbRgRsmbRsbRgRsLsmbLgbRgbRgb
RsRsmbRsbLsRsbsbLjbLiLsbLgRsbLgbLgbLgbLgRsbLsbLebLgbLsbLsbRsLsbsbsbLob
LibLsbRgbLsbsbRgbLgbLgbLgbLgbLsbLsbLsbRgRsmbLsbsbRgRsmbRgbRsbRibRibRgR
smbRiRsLsmbRsbRgbLsbRsbLjbRsRsLsmbRjbRsbRsRsmbRobLsLgRsbLsLsLsmmbRobRs
bLebLcbLobRsbLsbLsLsmbRsbLsbRsLsRsLsbLsLsRsLsmbLjLsmbLgbLsbLgbLsbRsbRs
bsb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 24; Drug: Haloperidol 10 然 Apo 0.5 然
bLgbLsbLsbLsLsmbLgRsbLgbLsbLgbLsLsmbLgbLsbLgbLsbLgbLsbLsRsbLsRsLsbRsbL
jLsLsmmbLsbLgbsbRjbRgbRibRgRsmbRsbsbLsbRgbRibRgRsmbRsbRsbLsRsbRsbRsRsm
bRsbLsbRgbRsbRsbLsbRsbRsRsmbLsbRsLsbLjbRiRsRsmmbRsbRgRsRsmmbRsRsmbRgRs
mbRsRsmbRgRsmbLsbRsbRjbLsLsmbLjbLibRjbRibRsbRsbRsbRgbLsRsbLcbLgbLibLgb
LsbLsbLgbRgbsbRsbRsLsbsbLjbLhbLgbLsbLsbLsbLsbLsLsmbLgLsLsmbLibsbLsbLsb
LsLsRsmbLsRsbLsLsmbsbLsRsbLsLsmbRsbsbRsbRsbRsRsmbRibLgbLjbLsbLsbRsbRsb
RjbLiLsLsmbLsbLsbsbLsbsbLiRsbLgbLgbsbRibRsRsRimbRgbRsRsRsmmbRsbRgRsmbR
gLsRsbRsbLsLsmbRsbRiLsbRsbRsbLsRsbRgbLsbRgbRgRsmbRsRsmbLsbsbLsbLsbRjbR
ibRgRsmbRjbRgbRsLsbsbLsbRsLobRsbRgbRjbLjbRjbLsLsmbRsLsbRsbLgbLsbRsbLsb
RjbLgLsbLgbLgbLgbLsbLgbLgbLsbLgLsbLsLsmbRibRgbRsbRsbRsbRgbRsbRsLsbRgbR
gLsbRsLsbRgbRgRjbRsbRsRgbRgRsRsLsmmbRgbRgRsmbRsLsbRgbRsbRsRsmbRsbRgbRs
bRsbLsbLjbLgbLgbRsbLsbRsLsbLgbLgbLsLsmbLsbLsbLgbLsbLsLsmbLsbLsbLsbRgRg
RsmbRsRgRsRsmmbLsbsbRsRsmbRsbRgLobRsRsmbRsRsmbRgbRsbRsbLgbLgRsbLsLsmbL
sbLsbsbLsbsbsbsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 25; Drug: Control Apo 0.5 然
bRcLsLsmbLobRsbsbsb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 26; Drug: Control Apo 0.5 然
bLoLsmbsbRibRiRsmbRibLibLcbRibRgbRsRsmbRsRsmbRgbLcRsbRgbRibRsRcLsbLsLs
mbLsRsbRoRsmbRiRsmbRjRsmbLcbRgbRgbRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 27; Drug: Control Apo 0.5 然
bLibRsbLcbLibRcbLibLgLsbLsbLgbLob

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 28; Drug: Control Apo 0.5 然
bsbRgbRgbRsRsmbRsbLsLsmbLcRsLsbLsbLobRhRsmbLsRsbRsbRoRsmbLibLgbLsbRsbL
sbLsbLsbRcbLgbRibRsbLsbLibRsbRcbLhbRsLgbsbLcb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 29; Drug: Control Apo 0.5 然
bRgbRgbLhbRcbRgbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 30; Drug: Control Apo 0.5 然
bRobLobLsbRobRobRobLsbRebLjbRebLjbRsbLsbsbLsbLsbLibRjb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 31; Drug: Haloperidol 1 然 Apo 0.5 然
bRoLsbLsbLcbRsbLhbRgbLibRsRsmbLiRsbLsLsmbsbLibRsRsmbLibLcbRsRjbRobRcbL
cLsmbLibLhbRsbLibRsbRsbLiLsbRgbLgbLibLgbRibLsbLsLsmbLcbRsRsmbRgbLibLgb
LibLcbLibLibLgbRjbRobLebLcbRsbRibLcbLsLsmbLibLsLsLsmmbLgbLsbLsbLgbLsLs
mbLib

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 32; Drug: Haloperidol 1 然 Apo 0.5 然
bLgbRsbRcbRsbRsRsmbRsbRjRgRsmbRsRsRsmmbRsbLibLsbRebLjbRsbRobsbLsbLjbLi
bLhbLsbRsbLsbLsRsbLsbLcbLgLsbLobRsRsmbLgbRcbsbRgbLsLsmbLcbLgbLgbLjLsmb
LcbRgbRjbLgLsbLsbLiLsbLgbLhbLgbLgbLhbRjbRcbLgbRoLsLsmbLsbLibLebRsbLgbL
sbLsbRcbRsbLsLsmbLsbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 33; Drug: Haloperidol 1 然 Apo 0.5 然
bLibLgbLsbLsLsmbLsbRsbLsbLsbLsbLgbLsbLibLsbLgbLibLibLgbLgbLsbLsbLgbLsb
LsbLsRsbLgLsbLsbLsbLgbLsbRsLsbRgbLsbLsbRibLsbLcbLsLsmbLgbLsbLgbLgbRgbL
sbLsbLsbRsbLjbLibLsbLsbLsbLgbLgbLgbLgbLibRsbRgbRsbRsbLgbRsbLgbLebLsbLs
bRsbLsbRibLjbLcbRsRsRsRsRsmmmmbLcbLibLgbLsbRgbLjbLgbLsbRsbLsbLcbLsbLsb
LsbLgRsbLhbRsbRsbRgbRgbLjLsLsmmbLiLsbLibLsbLsbLsbRgbRgbRcbLcLsmbRsbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 34; Drug: Haloperidol 1 然 Apo 0.5 然
bRjbLjLsmbRsbRjbLgbRsbLsRsbsbsbLsbsbLsbLsbLsbRsLsLsmbRsLsbRsLsLsmbLsbs
bRsbLsbsbRsbsbLgbRibLsbLsbsbsbLsbsbsbLsLibRsbRobRsbRjRsmbRgbLsbRgbRsbL
jbLhbLsbLgbRsbLsbLsbLgbLgbRebRjbLjbRibRibRgbLsbRsLsbLjLsmbRjbRobLsbRgb
RsbRsbRsbRsRsmbRibRgbLsbLsbLcbRsbLsbLgbLsbLgLsbRsbLsLjbRibLsbLsbRgbsbR
gbLeb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 35; Drug: Haloperidol 1 然 Apo 0.5 然
bsbRcbLsbLjLsLsmmbLobRsbLcbRsbLhbsbRgbLcbLobLhRsbLsbLgRsbLjb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 36; Drug: Haloperidol 1 然 Apo 0.5 然
bRsbLobLiLsbRcbRgbLsbLobLsLsmbRebRhbLcbLjbLibLhbLsbRiLsbRsLsbLcb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 37; Drug: Haloperidol 3 然 Apo 0.5 然
bRsbRsbLgbLgLsbRhRsmbRsRgbRibRsbRsbRsRsmbLgbLsLsmbRgbsbLgbRsRsRsmmbLgb
LjbLibLgbLgLsbRjbLibRcbRiRsmbLjbRiRsmbRsbRsRsmbRobRgbLiLsbRibLibLgbLsR
sbRsbLsbLsLsmbLsbLsbLhbLsbRgbRsbRoRsLsmbRgbLsbsbRsbRgbRsRsmbLgbLsbRsbL
gbLjRsRsmbRsLsbLsbLgbReRsmbLsbRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 38; Drug: Haloperidol 3 然 Apo 0.5 然
bRgbRibRibLibLsbLsbRibLgbRiLsbRibRsbRiLsbLsbRgRsmbRobLgbRsbRoLsLgLsbLs
bRibRgbRgbRgbLgbLobLibLgbLobLsbLgLsbLgbLgLsbLiLsRsbRsbRcbRjbLhbLhbLibL
ibRiRsmbLibLibLgbLsbLcLsmbLhbRgbLibRibRcbRgbRgbRgbLibRibRhRsmbLsbRcbRs
bLgbRibRibLibRibRgbRsbLsRsbRgbRsbLsLsmbRjLsLsLsmmbRiLsbLibLoRsbLgbRjbR
cRsmbRsbRobLibLgbLoLsRsmbLgbRebRibRsLsbRhbLsbRibRhLsbLgbRjbRibLsbLcLsm
bLsbLgbLgbLibLibLsbRsbLsbRcbRcRsLsmbRsRsmbRgRsmbRsbRibLjbLcLsmbLibLgbR
gbLcLsmbRsRsmbRgbLsbLcRsbLibLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 39; Drug: Haloperidol 3 然 Apo 0.5 然
bLgRsbRsbRjbLgbRibRgbRgbRgbRebRgbRsbLibRsbLhbLgbLhbLsbLibLsbLibLibLibR
jbLibsbRsbsbLsbRsbRsbRjbLjbLsbRsbLsbRsbLgbRsbLjbRsbLjbRsbRsbRjbRsbLsbL
jbRsbLsbRsbsbLhbLsbLgLsbRsbLjLsmbLgbLsbRsbLibRgbLibLsbLibLsRsbLhbRsbLi
LsbLibLibLgbRsbLsbLibLhbRsbRsRgRsmbsbRsbsbRsbRsbRsbRgbLsbRsbLsRgRsmbLs
bsbRsbRsLsbsbRsbRsRsLsmbsbLsbsbsbsbsbLsRsRsmbLsbLjbLhLsbLsbLjLsmbRsRjb
RgbLibLcbLibLsbLibLsbsbsbLibLibLgbLibLcRsRsmbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 40; Drug: Haloperidol 3 然 Apo 0.5 然
bsbsbRibRobRoRsmbLjbLobLsRsbRsLsbRsbRibLcbRsbLibLgbLibLgbRgbRgRsmbRsRi
bLsbRsbRsbLsbLsRsbLhbLibLgbRsbRsbRsbRsbsbRsbLibLjRsbLsbLsbRsbLgbLebLsb
RsbRsbLibLgbRsRsmbRsbRsbRsbLgbLebRsLsbRsLsbLgbLsbLsbRsbLiLsbRsLsbLsbLs
bRsRsmbLgbRsbLsRsLsbLgLsbLsbLsbLjLgLsbLgbLsRsbLsbRsbLsbRjRsmbLgbRgbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 41; Drug: Haloperidol 3 然 Apo 0.5 然
bRgbRgbLsbLiLsbLsbLibLgbLsbsbLsbRgbLsbLgbRsbLgLsbLsbLgLsbLsbLsbLsbLsLs
mbLsLsmbLgbLibLsbLsLsmbLgLsLsmbLgbLsLsmbLsLsmbLsbLsbLgLsLsmbLibLsLsmbL
sLsmbLsLsmbLsLsLsmmbRsLsLsmbRsbLgLsbLgbLsLsmbLsbLsbRsLsbRgLsbLgLsbLgLs
bLsLsmbLgLsbLsLsmbRsLsbRgbRhbRibRgbLsbRibRgbLsbLsLsmbLibLgbLibLsbRsbRs
bRsbLgLsbLsbLsLsmbLsbLgbLsLsmbLgbLsbLsbRgbRgbRibRgbLsRsbRgLsbLsbLeLsbR
cbLsbRsLsbLsLsmbRsbRsbRhLsbRibLsbRgbLsbLsbRibLsRgbRsbRgbRgbLsbLsLsmbRi
LsbLsLsmbLgbLhLsbLsbRgbLsLsmbRibRibRgbLsLsmbLsbRiRsmbRgbRgbRgbRgbLsbRi
bRibLibRsbLgbLibLsbRsbRsbLibRgbLsLsmbLgbLsbLsbLsbRgbReLsRsbsbRgbRgbRgb
LgbLebLsbLsLsmbRgLsbLsbLgLsbRibRiLsbRgRsLsmbRgbRgbLsbRsbRgbRsRsmbRgbRg
bRgLsbRiLsbRgLsbRgbLgLsbLsbLibLgbLsbLsLsmbLsbLsbRsLsbLsbLgbLiLsbLgbRsb
RsbsbLsbLgbLgLsbRsbLsbLgLsbLgLsbLsbLsbsbLsbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 42; Drug: Haloperidol 3 然 Apo 0.5 然
bRgbRsRsmbRcbRsbLsLgbRsbLjLsmbRsbLebRcbLhRgbRsbLibLibLsLsmbLcRsRsmbRhb
LsRsbRibRsbRsbRjbRibLsbLsRsLsbLgbLcLsmbRgbLhLsbLjLsmbLcLsmbRsbRsbRsbRi
RsRsmmbLjLsmbRibRsRsRsRsmmmbLsbLebsbLcbRsbLsbLhbLobRsbRiRsmbLsbLcRsbLo
bRiRsmbLcLsmbRsRsRsmmbReRsmbLjLgbLcRsbRsLsRsbRgbLebLsbLsbLgbRjRsmbRjbL
sLsmbLhbRsbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 43; Drug: Haloperidol 10 然 Apo 0.5 然
bRobLgbLebLobLobLobLobRobLcbRobRebRebRcbRebRibRobRobLgbLcbRcbRobLhbRob
RebLobLebRebRobLebRgbRobRobRobLibRcbLebRcbRobLibLobLobLibLebLebRobRobL
hbRsbRobRcbLibLgbRobRebRebRebRebRcbLibLebRobLcbLobRobRibLcbRobLsbLebLo
bLebRebRobLobLobLgbLebRebLobRobRobLobLobRebLcbLobRibLobRebRobLebLobLob
RobLgbRcbRobRobLebRgbRobRgbRobLebLibRobRebRebRibLobLgbRobLebRsbLobLebL
ebLebLobLobLebLobRobLgbLcbLobRibLobRcbRibRobLobLobLcbRibLobRobLobRcbRc
bLobLibLobLcbRcbRobRebLebLibRgbRgbRobRobRgbLhbRgbRebLobLebRobLobRobReb
LebLebRebRobRcbLobRcbRobRsbRebRobRibLsbRcbLebLobLsbLcbRebLebRebRebRhbL
hbRsbLobRebRobLhbLobLcbLgbLgbLobLibLebLhbLobRobLebRcbRobRebRebRcbLcbRe
bRobRobLibLgbRobRgbLsbRobLcbLebRebLebLibRgbLibRgbRsbRcbRhbRobLobLebRgb
RobRobLobLobRobLcbLobLibRsbRobLebLsbLhbLcbLebLhbRobLibRobLsbLibLobRgbR
ebLebRebRcbRibLcbLhbLobLebLobLcbRebLcbRcbRcbLobLobRobLobRobLobLobLobLe
bRsbRobLobLgbRsbRcbRebLobRobLsbRsbRobRebLebLobRobRobLobRobRebRobRibLob
LebRebLobLcbRhbRebRcbLhbRobLcbRsbRobRobLebLsbLgbRcbLobRibLobRebLgbRcbL
obRobRhbLobLobLobRibRobRobLcbLcbLebRibLobRobRebRobRobRcbLobRcbLebRebLo
bLobRcbLobRcbLcbLjbLibLhbRobLgbRebLobRobLobRgbRebLgbLobRgbRebLobLobLeb
RobRgbLebRgbRobRobLgbLcbLobLebLebRebRobLibLcbLsbRcbLobLsbRebLcbRibLobL
obRgbRobLhbRgbLcbLobLebRcbLobLgbLcbRcbLobLcbRebLebRsbLobRobLebRebRobRo
bLobRobLobRcbLcbRobRcbLobRebRobLgbLebRebRebLhbRebRebLebLebLibLebLsbRib
LobLcbRobLebLhbRcbRobLcbRebRobRobLcbRobRebLobLsbRgbRebLobLobRobRibLobL
obLobLobLobLobLebRebLcbRobRgbRobRebLobRgbLcbRobRebRcbLobLebLhbLcbLcbRe
bRcbRebLcbRobRobLobRobLebLobLobRgbRgbLobLebLobLobLibRjbRibRebLebRobRcb
LcbLsbLebRobLsbLebLcbRcbRobRgbRcbLcbLhbLebLobRibLcbLibLobLsbLhbLcbLobR
gbLobLebLibRobLobLobLgbRebRebLobLobRcbLebRsbRibRebRcbLobLgbRobLobLebLo
bRgbRsbRsbRobRobLebRgbRobRobRibRgbRobLobLebLcbLobLebLebLebLebRebLobLib
LobLobRebLobRcbRobRcbLcbLgbRobRcbLcbLobLobLcbRobLcbRsbRobLobLebLebRobL
obLobRebRobLobRebLobLobLhbRibLebLsbLcbLebLebRcbLcbLobLobRcbLobRobRibLo
bLgbLgbLibRcbLcbRobRebLcbRobLobLobLobLebLebLebLobRobRobRebLjbRobLgbLeb
RobLcbLebLibRibLobLobRgbLebRobLcbLebRobLcbLhbLobRobRsbLcbLebRibRobLhbL
obLobRobLobRebLcbRebLobLebRobLebLebLcbLobRobRobLobLebLobLobRcbRobRibRo
bRebRibLobRcbRcbLobLobRebRcbRgbLobRgbLobRcbLobRebLobRcbRobLsbRobRobLob
LcbLsbLobRebLobRcbLobRebLobRcbLebLcbLobRgbRobRobRobLobRcbRobRcbLebLebL
gbLebRebLebLebLobLebRibLobLebRibRgbLobRobRhbRobRcbLibRobLibRcbLebRobRc
bRjbRibLgbRcbLgbRcbRcbLgbRcbLsbRgbRebLgbRgbLobLcbRobRibLsbLobRibLcbLob
LebRcbLobRobRebLgbRibRhbRobRobRibLobRobLobRcbRibRhbLibLebLgbRobLobRebR
cbLobLgbLcbLebLobRebRobLobRebRhbLgbLebLhbLobRcbLobLobRcbLgbRebRcbRobRo
bRgbLobLebRebLobRsbLebLobRcbRebLcbRcbLebLobLebLobLobRjbRcbLibRobLobLeb
RebRibRobRebRobLobRebRobLobRcbLobLgbRhbLobRebRcbRsbRobRobRobRobLibLibR
obLcbRhbLcbLibLibRobLcbLobLebLobRobLobLobLebLobLebLobLcbLobRobLcbRcbLi
bLebRebRobLsbLobLsbRobRobRobLobRgbLobRobLcbLsbLobLobLcbRcbLcbRobRobLob
LibLcbLobRebLebRobLobLcbRebLcbLcbRobRcbLcbLobRebRibRobRgbRobLsbLobRobR
obRibLobRobRsbRebLobLcbLsbLibRobLebRebRobLobRcbRobLibRebLeb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 44; Drug: Haloperidol 10 然 Apo 0.5 然
b

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 45; Drug: Haloperidol 10 然 Apo 0.5 然
bLgbLsLsRsLsmbLibLgbRibRgbRsLsRsbRibRgbRgbRgbRgbRgbRgbRgLsbRsLsLsmbRgb
RsLsbLsbRgRsRsRsmmmbLsbRibRiRgbLgbRibRibRsbRsbRsbRsbRsbRsRsmbRsRsRsmmb
RsbRsRsmbRsbRgbRsbRibRsbRsRsLsRsRsLsmmbRibRiLsbRsRsRsRsmmmbLsbRiRsmbRs
bRebRgbRgbRgbRgbLsbRgLsbRgRsmbRgbRgbRgbRgbRsbLsRsbsbRsbLsLsmbLgbRsbRsb
RsbRsbRsRsmbLsbRsbRsbRsbLsbRsbRsRsmbRsbRsbRsbRibRgRsRsmmbRgRsRsmmbRsbR
sbRsbRgbRsRgRsRsmmbRsbRibRhRibRgRsRsmmbRsbRsRsmbRgbRsbRgRsmbRgRsRsRimm
bRgRsmbRibRgbRgRsmbRhbRsRsmbRsbLcRgbRjbRgbRgbRsbRjbLsbRsbRsLsbRsbRsbRs
bRsbRsRsmbLgbLgbLgbLsbLjbLgRsbLsLgLsLsmbLsbLsbLgbLgbLgRsbLgRsbLgbLibLi
bLibLibLibLgLsbLgbLgLsbLgbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 46; Drug: Haloperidol 10 然 Apo 0.5 然
bLebRobLebLcbRcbLgbLebRobLibRcbLobLebRgbRibRobLcbLebRgbLobRsbRobLcbLeb
RobLobLobLcbRebLcbRobLcbRgbRcbLobLhbLebLhbRebRsbRebLsbLebRcbLibLobLibR
ebLobRobLebRcbRsbRobRcbLobLgbLcbLobRebLsbRebRobLcbLcbRobLcbRobLobRobLo
bLibRobRcbRebRebRebRibRsbLcbRebLcbLobRobRobLobRobRcbRhbRgbLebRebRgbRob
LcbLebLibRobLebRhbRcbRobLhbRobLobLibRibLebRobRcbRobLcbRcbRebRsbRibLcbL
ebLobRebLcbLobLsbRibLgbRebLobRobRcbRhbLgbRibLobRobRibRobRsbLibRgbRcbLs
bLgbLebLebLobRcbLobLgbLobLebLobRibRibRjbRibRcbLebLsbLebLibRebLobRobLib
LobRhbRebLsbLobRebRibRibLibLobRobRobRsbRgbRcbRebLobRobRibRsbLcbRobRcbL
obLobLobRebLcbLobLebLebRobLgbLobLobRibLobRobRobLebRcbRebRibRobRobRsbRo
bLhbLebLobLsbRcbLobLsbLobLebLsbLobRebLobRebRobRibLobRsbRobLebLobLobLob
RebRobRebLebLobLobLebRhbRebRcbRobLgbLobLebLebRobRobLobRhbLobLebRibLobR
obRebRebRobLgbLebLebRcbRobLobRobRobLgbLgbLobRobRibRobLobLobRebRcbRcbRh
bLebLhbRobRobLobLobRobRcbLobRgbRcbRobLobRobLibRobRcbLcbLobRobLebLcbRob
RsbRibRobLobLobLobLsbLebRobRobLibRibRcbLebRobRsbLibLibLebRibRcbLebRobR
obLgbLobRsbLebRcbLobRobLsbLobLebRobRcbLcbRobRcbLobLebRebLebRobLobRobLe
bRebRobLobLobRobLobRobRobLobRobRobLobLebLsbRebRobLobRibLobLobLebLebLob
RebLibRebLebRobLcbLobRebLibRobLgbLobRobLgbLebRobLobLebLgbRcbLebLsbLobR
obRsbLobLobLobLebLibRebRebRebRhbRobLibLgbLcbRibLobRgbRcbRcbRibLsbLobLi
bRobLobLobRebLobLobRobRebLobLebRobLebLcbLhbRcbRobLgbLobRobLsbLobRobLcb
LibRcbLebRobRobLebLobLebLobRobLebRcbRsbLobRobLebLobLobRebRobLcbRcbRobR
obRobLcbLobLobRebLobLebRobLobLobLobLobLobLobLcbLobLsbLhbRobRhbLobLebLj
bRgbLcbRcbLobLobRebRobRhbRcbLobLebLobRgbRhbLobLibRobRobLobRobLhbLsbLob
LcbLjbRobRibLobLebLebRobRobRsbRobRcbRebLobLgbRcbRibLcbLsbRsbLobRibLobR
ebRibRibLobLobRebRobRobLibLobLebLebRcbLebLjbRobLsbRebRcbLgbRsbRobLcbLo
bLgbRsbLobLcbLebLobRebLcbLgbRebLobRebLebLcbRcbRobLobRobRobRgbLibLcbRob
LebLibRobRhbLobRebRcbLobLebRcbRibLobRobRebRhbRhbLobLobRgbLcbRebLibRobL
ibLobLgbLobLobRobRcbRcbLobLobRobLcbRobLobLebRobLebRgbLcbLebRebRobRobLc
bLobRcbLebRcbRobRebLhbRhbRcbLebLcbLobRhbLobLebRebLcbLsbLebRobRobRgbReb
RobRobLebLcbRobRsbRebRobRcbLobLobLobRobLcbRibRobRobRebRobLobLcbRebRobL
ebRobLibRobLebRibLobLgbRcbLebRebRsbRobRobLebRjbLobRobLobLobRebRobRobRo
bRibRobRebLcbRobLcbLobRcbLobLcbRebLcbRobLsbLobLobRebLobLobLcbRhbRcbLcb
RebLcbLobRebRibLobLibRebRebLobLobRcbRcbLobLobRobLobRobLcbRibRgbLebRhbR
obLcbRebLobLobLibRebLhbLobRcbLobRobRcbRebLobLebRcbLibRgbRebLcbRebLebRh
bRgbLobRobRobRobLgbLobRibRcbRobLsbLobLebRobRebRobLobLibRgbLobLhbLcbRob
LobRobRebLgbLcbLgbRcbLcbLebRebRobLgbRobLobRobLebRobRhbLobLobLhbRobLobL
obLobRebRobRobLobRebRobLobLobLhbRcbLobLobRebRcbLobRebLcbLebLobLebLjbRe
bLobLibLsbLobRobRebLobLcbRhbRobLsbRcbLebLcbRebLcbLcbRebLobLebLobRgbLsb
LobRjbLobRobLgbLebRobLibRobLcbLebRsbLobRobLhbLebLobRgbRebLcbRobRebLjbR
ebRcbLobRebRobRhbRobLobLcbLobRgbLgbRobLcbRcbLobLibRcbLobRobRebRobLobLe
bRcbLcbLobRibRcbRobRhbRcbLebRebRebRobRcbRibRsbLcbLibLebLobLcbRcbLobRgb
LobLebRebLobLebRobRobLebRobLcbRebLobLobRgbLobRebLhbLobRsbLgbRebRebRobL
obLgbRobRcbLebLhbRibRcbLobLobLcbRob

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 47; Drug: Haloperidol 10 然 Apo 0.5 然
bLsbRgbLcbRsLsLgLsRebLiLsbLcRsbLcbLsLsmbRgbRcbRsbLoLsmbLhbsbLgbLgbLiRs
LgLsbLgbLgLsLsRembLsRiRibRsRgRsmbRiLsbRgRsLsmbRcbRsLcbLsLsmbLibRsRsmbR
sbsbLsbLibLgbLiRgbLibLsbLiRsbLibRsRjbsbLsLsmbLsbsbLsbRsRsRsmmbRsbLiLsb
LsRsbRsbLibLiLsbLgbRsbLibRsbLsbLgLsbRobRgbRsRiRsRgmbRsbRsRsLsmbLeLsbLg
LsbLgbLgbLiRsbRgbLsbLibLcbLsbLsbLgbLgbRsbRsbsbRsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 162009; End: 162509;
Recording: 11-1; Individual: 48; Drug: Haloperidol 10 然 Apo 0.5 然
bLsbsbsbLsbLsbLsbRsbLeRsbLsRsRsmbLsLsmbRsbLsbLgbLsbLsbLsbLsbLsbLsRsbLg
RsbLgbLsbLsLsmbLsLsmbLsbLsbLgbLsbLsbLsbLsRsbLsLsmbLgbLgLsbLsbLsbLsLsLs
mmbLsbLsbLgLsbLsbLsbsbsbLsRsbRsbLsbLgbLsbLsRsbLsbLsbLgLsbLsLsmbLsLsmbL
gLsRsbLsLsmbLsLsmbLgLsbLgbLgbRsLsbLsbLgLsbLgLsLsLsmmbLgbLgbLsLsmbLgbRs
bLsLsmbLsbLsbLgbLsLsmbLgbLsbLgRobLibLgbLsbLsbLsbLsLgLgLsLsmbLsLgLsbsbL
sbRsbLgRsbLsRsbLhbLobReLsbLsbLsRsbRsRsmbRgRsmbRsbLgbLgLsLgbLgRsbRjbReb
LcbLgbLsLsmbLsbLgLsbRobLgbRiRsLsRsmbRsRsmbRsbLsRsbRsbRgbLsbRobLsbLiLsR
sRsRsmmbLsRsLsbLsRsbLsbRgbLgbLgbRibLgbLsLsmbRsLibLgLsRsbLgbLsbLgbRgLgb
LgbLsLsmbLgLsbLgLsbLgbLgbLgbLgLgLgbLgLsbLsbLsbLgbLsLsmbLsbLsbLsLsLsLsm
mmbLgbRibsbRsbRibRgRgbLsLsmbsb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 1; Drug: Control Apo 0.5 然
bLcbRjbLhbLcLsmbLhbLibLsbLsLsmbLibLsbLgbLcRoRsmbLcbLhbLcbRsbLsbRsbRsbR
gbRsbRsbLhLsbLcRsRsmbRsbRsbRsbLjLsmbLiLsbLcbLsLsmbLib

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 2; Drug: Control Apo 0.5 然
bRjbRjbLobLcbLebRsbRobRobLcbLsbLcbRcbRebLebLjbLcbRcbLobRobLcbRjbLobLob
RjbRcbLobRebRjbRgbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 3; Drug: Control Apo 0.5 然
bLebRjbLsbRsLsbsbLsbRsbRobRoRsmbReLsLsmbLgLsbRcbLsLsRombRsbRsbsbsbsbsb
sbsbsbsbsbLsbsbsbsbsbsbLsRsbLsbsbLsLsLsmmbsbLsRsLsbLsbRsbsbsbLsbsbsbsb
sbLsbRsbRobLebRjbLjbLsbRobLebRsbRsbLjRsRsmbRsbLjbLsLjbRsbRsbRsbLsRsbRs
bRsLsbsbLsbsbsbRsbLsbLsbLgbLcbRjLsbRgbLsbLsbLsbRsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 4; Drug: Control Apo 0.5 然
bsbRiRsmbRibLcbLoRsbLibRcbRibRib

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 5; Drug: Control Apo 0.5 然
bRgbRgbLgbRoLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 6; Drug: Control Apo 0.5 然
bLjbRhbLjb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 7; Drug: Haloperidol 1 然 Apo 0.5 然
bLibRcbLcLsmbLcLsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 8; Drug: Haloperidol 1 然 Apo 0.5 然
bRgbRsbRsbRsRsmbRgbRsbRgbRsbRsbLsbRsbRsbRsRsRsmmbRjLsLsLsmmbRgbRgbRibR
sbLsRsbLcbRgbLgbRibLjLsmbLibRcRsRsmmbRibRsbRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 9; Drug: Haloperidol 1 然 Apo 0.5 然
bRcbRsbLibLsbLsRsbRsbLgbRjbLgbRcbRhbRcbRhbRhLsbLcbRibRgbRibRcbRcbRgbRi
RsmbRgbRjbRcbRibRibLjbRibRgbLiLsbRsbRcbLhbLsbLcbRibRsbLgbLsbLsbLgLsbRg
bRsbLjbLgbLjLsmbRibLjLsLsmmb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 10; Drug: Haloperidol 1 然 Apo 0.5 然
bLgbLgbLhbRsbRhbLsbLiLsbLsbLgRsbLibRcbRsbLibLgLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 11; Drug: Haloperidol 1 然 Apo 0.5 然
bLsbsbRgRsmbLsLsmbRsbRibRcbLsbRsbRgbRjRsRsmmbRsRgbRsbRibRsbLcRsbLibLob
RibRsbRgRsmbRsbsbRsbRsbRsRsmbLsLsLsLsmmmbLsbRjRsmbRsbLsLsLsmmbRgRsmbRs
bsbLsbRibRgRsmbRsbRsLsbRibRgbLsbRsbRiLsbLsLsmbRhbLgbLsbsbLsLsmbRgbLsbR
gb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 12; Drug: Haloperidol 1 然 Apo 0.5 然
bLibRibLsbRobLsbLcbLgbLsbLgbLsLsmbLsbLgbLgLsbLgbLsLsmbRsbLsbLibRiLsbRg
bRgLsbRsLsbsbRsLsRsbRsbRgbRsLsbRgbRobRibLcbRhbLibLhLsbLobLcbLsRsbRibLc
bLob

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 13; Drug: Haloperidol 3 然 Apo 0.5 然
bLibLjbRebsbRiRsmbLjLsLsmmbLsRsbLcbLsbRsbsbLcbLeLsbLhbRsbLcbRsbLsLsmbL
sbLebLsbLsRsbLcbLsbLcLsmbLsbLibRsRsmbLibLgbLsbRsbLibLcbRsbRsbRgbRsbLgL
sLsmbLsRsbLiLsbLibRsbLgbRsbLsLsmbLgRsbLsLsmbLgbLsbRsbLgLsbLibLsbRsbLsL
smbLgLsbLsLsmbLgbLsLsRsmbLsbRcbRhbRsbLsbLgLsbLebLsbLhbLsbRsbLiLsbRsRsm
bLgLsRsbLgLsbRsRsmbsbLibLgLsbLsbLsbLgLsbLcLsmbRcbRsbRhbRibLsbRcbLgbRib
RsbLjLsmbRjLsLsmbRiRsmbRibRsbRibLsbRsRsmbLsbRcbRsbsbRhRsmbRsbLsbLcbLsL
sLsmmbLsbLjbLsLsmbLsbLsLsmbLsbRcbRibLsRsbRsRibLgbRhbLgbLsLsmbRcLsbRhRs
RsmmbLjbRibRsbRcLsLsmbRsbLgLsbLsLsmbRhRsmbRsRsmbsbLsbLsbRsbRibRsbRgRsm
bRsbRsbRsRsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 14; Drug: Haloperidol 3 然 Apo 0.5 然
bRcLsbLgLsbRgbRgbsbRgRsmbLsbLsbRibRobRgbLibLcbLgLsbLsLsmbRhbLeRsbRibRg
bLsbRgbRhbLhbLcbLjbLgLsbLibLgbLsbRgbLjb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 15; Drug: Haloperidol 3 然 Apo 0.5 然
bRsbsbLsbsbRsbRsbRsbRibRiRsmbLsRsbLibLgLsbLhbLcbRsbRsbRsbLsbRhRsmbLsbR
cbRgbRibLsbLsbLibLibLibRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 16; Drug: Haloperidol 3 然 Apo 0.5 然
bLhLsbLhbLsbRsbRsbLebLsLsmbLgbLsbLcbRgbLebLsbLiLsLsmbRsLsbLsbLibLoRsbL
jLhbLgbRsbsbsbsbLsbRsRsRsLgLsmmbLsLsmbLgRsbRsbLsRsLsbRsbRsLsbsbRsbRsLs
bsbsbRsbLsbLsRsbRsLsbsbLsRsbsbRsbRsbRjRsmbRcbRsbLsRsbLhbRsbLebLsbLsbRo
bRcRsmbRsbRsbRoLsbRsbLsbRsbLhbRsLsbLjLsmbLiLsbLhbRsbLsbLibLgbLgbLibRsb
RsbRsbLcbLsLsmbRsbLcbLgLsbLibRebRcLsbLjbLcbLjLgbLsbRsLsLsmbLsbLsRsbLsb
LibLibLsbLibLsbLibLsLsmbLgbRcRsmbRibRgbRibRhbLsbLsLgbLsbLgbRibRcbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 17; Drug: Haloperidol 3 然 Apo 0.5 然
bLgbLibRsbRjbLibLibRsbLsbRsbLhbRsbLibRsbLhbLibLcbLibLjbLiLsbRsbRsRsmbL
gLsRsbRsLsLsmbsbsbRsbRsbsbsbsbRsbsbsbRsbsbsbsbLsbsbLsbsbLsbLsbsbsbsbsb
sbLsLsLsLsmmmbsbsbsbRsbsbsbLsbRsbsbRgbsbsbsbRsbLsRsRsRsmmbLsRsRsLsmbLs
bRsbLsbRsbRsLsbsbsbRsbLsbRsLsLsmbLgLsbsbsbRsbRsbRsbsbLsLsmbsbRsbRsbLgL
sbLgbLcbLsbLgbLgbRsbLibRgbLiRsbLibRgbLjbLgbLsbRobRiRsmbsbsbsbsbRgbRsbR
sRsmbRsLsLsLsmmbRsLsLsLsmmbRsbLcbLsbLsLgLsRsbsbsbsbsbLsbLsbLhRsbLgbRsb
LcbLsRsbLsLsmbRjbLibLibRsLsbRobLgbLcbLibRsbLsLsmbRsLsbLgbLhbLsLsmbRsbR
obLsLsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 18; Drug: Haloperidol 3 然 Apo 0.5 然
bRgLsbRcbRsbLhbLibsbsbLcLsmbLgbLsbLgbRhbRgbRibRgbLgbLcLsmbLgbRsbLgbLib
LibRjbRibLsbLjbLibLsbsbsbsbsbsbsbRsbRsbsbLsLibRsbLsbLsbLgbRsbRsbLgLsbL
gbLibLoLgbLgLsbLgbLgbLsbLgbLgLsbLgbLgbLgbLsLsmbLsbLgbLgbLsbLgLsbLiRgRs
mbRgbLibRsbRsbLgbRsLsbLgbLgbLibLibLsbLsLsmbsbsbsbLiLsbLsbLsLsmbRgLsbLs
bRsLsbLgbLsbLsbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 19; Drug: Haloperidol 10 然 Apo 0.5 然
bLgRsbLsLsLsmmbRsLsbLsbRsbLsbLsbsbRsbsbsbLsbRsRsmbsbLsbRsLsbsbLsbsbRsb
RsbLsbRsLebLsbLobLobLgbLgbLgbLgbLsbLsbLsRsbLsbLsRsbLsRsbLsLsmbLsbLsbRs
RsmbLsLsmbLsbLsbRsLgLgLsRsbLsLsLsLsmmmbLgbLgbLsLsLsmmbLsLsmbLsLsmbRsbs
bLgLgbLgLsbLsbRsbLsbLsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 20; Drug: Haloperidol 10 然 Apo 0.5 然
bReRsRiLsLsmmbLsLgbLsbLsbRjRsRsmmbRsbRsbLsLsmbsbRsbRsLsbsbRgbRobRgbLcb
LsLgbLsbRebsbRsRsmbsbLsbRsRsLsRsmbRsbLsbRsLsbRsbRsbRsbsbsbLiLsLsmbRsbL
gLsbLgbLgbLgLsbLgbRsbRebLsbRsbLiLsLsmbLgRsLsLsmbLgRsbLjbLiRsbLibsbRsLs
bsbsbsbsbLsRgbLhbRsbLsbLsRsbLgRsbLiRsRsLsLsmmbLibRsLsbRsbLgbLibLgLsbLs
LgbLgbLsbRjbRhLsRsbRsbRgbRsRsmbRsRsLsLsmmb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 21; Drug: Haloperidol 10 然 Apo 0.5 然
bRebRgbLsbLjbRgbLhbsbRsRsRgmbRebReRsmbRgbRsRsRsRsmmmbRgbRsbRsbRgbRgbRg
bRgbRsbRgbRgbRgRsmbRgbRgRgbRgbRgbRgbRgbsbLsRsbRsRsRsLsRsmmbRsbRgRsmbLg
bRiLsLsRsmbLjbRibLsRsbRiRsRsmmbRgRsmbRsbRgbsbRsRsmbRsbRsbRsRgRsmbLsbLj
bLibLgbLgbLgLsbLsLsmbRsbLsbRsbRjbRgbRgRgRsRsRsmmmbRsbRsbRgRgRgRgbRsLsb
RsLsbRsbRgbRsRsLsRgRgRsmmbRsRsRsmmbRgbRsRsmbRgRsLsmbLibLgbLgbRoLgRsbRs
RsRgmbRgRgbRgRgbRgRgRgRsmbRgRgRgRgbLibLibLibLiLeLiLsbLgLgRsbLib

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 22; Drug: Haloperidol 10 然 Apo 0.5 然
bLgbLgLsRsLsLsmbLgLebLsRgbRsLsbRjbRsLsLsmbRgbRsbRsbLcbLobLsbLibRsbRgbR
sbLsRibRsbRsRsmbRgbRsRsmbLsbRsRsmbRgbRibRgbRjbRibRiRsmbRgbRjbLsLsmbLgb
LgbRibRgbRgbRgbRiRsmbRgbRgbRgbRgRsmbRibRjbRgbRgbRgRsmbRgbRgbRibLsbLiLs
bLibLibLibLjbLgbLibLhbLibLgbLgbLibsb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 23; Drug: Haloperidol 10 然 Apo 0.5 然
bRsRsmbLsbLsLsmbRobLgbLobLebLgbLgRsbsbLsbRsbsbLsbLsbRsbLsbLgbLibLsbLsb
LebRsbLjbLsRjbLobLsbLsbRsbLsRsbLsbLgbLgbLgbLgbLgbLgbLibLgbLgRsbLgbLsbL
gLgbLgRsbRjbRsRsmbRsbRebRoLsbLsbLsLsLsmmbsbsbsbRsRsmbLobRsbRgbRgbLsbLg
bLibLgRsbLsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 24; Drug: Haloperidol 10 然 Apo 0.5 然
bRsbLsbLsbLjbRiRsmbLsbLjbLcbRjbRgbLgbLgbLsbLsbLibLsRsbLgbLsbRsbLsbLsbR
iRsRsRjmmbRcbLsbLgbRsLsRsLsLsmbLiRsLsbLobRibRgbLjLsLsLsmmmbRgbLsLsmbRg
bLibRiLsbRgbRsLsbRsbLsRsbRgbLsbLebLsbRsbRsRsmbRgbRsbRsbRgRsmbRjbLgbRsb
RebRsbRsbRgLsbRsbRsbRsbRsRsmbRsbRsbRsbRsbRsbRgbRsbRgRsmbRsLsbRsbRsLsbL
oLsmbRsbLgbLsLsLsmmbLsbLsbLsLsmbRjbLsbRgbRebRibRsbRsbLgbRsLibLgbRsbRgb
LsbsbLgbLsbLgbLsbRcbLgbLcbLobRgRsmbRsbRsLsbLsRsbRsbRiLsbLsbRgbLobRiRsm
bLsbLjbLjbLjRsbRsRobRsRsRimbRhbRsRsmbRgbRgbRsbRsRsmbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 25; Drug: Control Apo 0.5 然
bLsbLobLgbsbLibRsbRsbRoLsbRhbRibLsRsbLsbLgbLgbRsbLibRjbRcbRsLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 26; Drug: Control Apo 0.5 然
bLcbRgRsmbLgbRgbLgbLsbRsbRsRsmbLgbRsbLsbLgbLgLsbLsLsmbLsLsmbLhRsbRhbLg
bRobRibLibLsbRgbRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 27; Drug: Control Apo 0.5 然
bRcRsmbRcLsbLsbRsbRcbRgbLsbLsbRsbRjbLgRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 28; Drug: Control Apo 0.5 然
bRoRsmbLsbLibRoRgbLgbRsbLsbLsbLsbRjbLjRsbsbsbsbLsbLgRsRsRsmmbsbRsRsRsm
mbLgbsbsbsbsbsbsbsb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 29; Drug: Control Apo 0.5 然
bRibRibLhLsbLgRsbRibRgbLsLsLsmmbRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 30; Drug: Control Apo 0.5 然
bRsbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 31; Drug: Haloperidol 1 然 Apo 0.5 然
bLibLsbRgbRsbLgbRcbRsbRsRsRsmmbRhbRsbLiLsbRsbLcbRobLsRibLoLsmbLiRsRsmb
RibLsRcbLibLgbRsbRgbLibLsbLgbLibRsbLibLibLebRibLcRsbRsbRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 32; Drug: Haloperidol 1 然 Apo 0.5 然
bLcbLibRobLgbLsLsmbLcbLsbLgbLgbLgRsbLsLsmbLibLoRsbRsbsbLsbRcLsbLsbRibL
sbLsbsbsbRobLgbRcbLgLsbLgbLsbRsbLibLsbLgLsbLgbLibLibsbsbLgLsbLjLsLsmmb
LjRsbLsLsmbLhbRsRsmbLoLsmbRobRobLsbLgbLsLsmbLcbRsbsbRsbRcRsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 33; Drug: Haloperidol 1 然 Apo 0.5 然
bLgRsbRsbLgbLsbLsbLsbRsbRsbRsbRsbLhbLibLsbLsbRsbLgbLibLibLsbLsbRsbRsRs
mbRsbLsbLsbLibLsbLgbLsbLsbRsbLgbLiLsbLgbsbRibRobLsbLgbLsLsmbLsbLsbLibL
sbRsbLibLsbRsbRsbLsLsmbLgbLsbLgLsbLiLsLsmbLgbLsbLsLsmbLsbLgbRebLibsbLh
bLibLgbLgbLsbLgbRsbLgbLgbRsbLsbLsbLsbLsbLgbLhbLgbLsbLgbLibLsLsmbLsbLsb
LsbLgbRsbLgbLsbLsbLsbLsbRsbLjbLsbLibRiRsmbLsbLsbRsbLibLsbLsbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 34; Drug: Haloperidol 1 然 Apo 0.5 然
bLsbLsbRgbRsbRgRsmbRsbRsbRjLsbRsbRsbRgbRsbRgRsmbRsbLsbRgbRsbLsbRsbLiLs
bLibLsbLsbLsRsbLgbLsbRsbLsRsbLsbLibLgbRsbRsbLsbLiLsbRsbLsbLgbLsbLsbLsb
LgbLsbRibRibRiRsmbRsbRsRsmbLobLgbRsbLsbLsbLsbLsbLhbRcbRhbRgbRhbLsbLsbL
iLsbLsbsbRsbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 35; Drug: Haloperidol 1 然 Apo 0.5 然
bLsbLgbLsbLobsbLhbRgbLhRsbsbRcbRob

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 36; Drug: Haloperidol 1 然 Apo 0.5 然
bRcLsbRgbLcLsmbRgbRgLsbLsbRoLsbRsbLiLsbRcbLjLsLsLsmmmbLsbLsLsmbRjRsmbL
sbRcbRgbsbRibRsRsmbRcbRibLsbRsbLibLsbLsbLibRsbsbRsbRcbLsbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 37; Drug: Haloperidol 3 然 Apo 0.5 然
bRsbLhbLjbLhbLjLsmbLsRsLsbLgLsbLibLgbsbLgbLsbsbRsbRsbLsbLsbLsbLgbLibLg
bRsbLibLsbRsbRsbLgbsbLgbLsbsbLibRsbRoRsmbRgRsmbRgbRgbRsbRgbRgbLsRsRsmb
RgbRsbLsbRsRsmbsbRsRsmbRsbRsRsmbRsbRiRsmbRsbRibLsLsLsRsmmbLsbRjbLgbRib
LobLsbLsbRsbRibLgLsbRsRsRsRsmmmb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 38; Drug: Haloperidol 3 然 Apo 0.5 然
bRibLgbLibLebLibLibRcbLsbLibLcbRsbLsLsmbLibRsbRgRsmbLcbLibRibLgbLgbRsb
LibLibLibLgbLgbLgbLcbLsbLgbRgRsmbRgbLgLsbRiLsbLsbRibLhbLcRsLsbRjbLcRsb
RsLsbLibLibLibLibRibLibLhbLibRgbLiLsbRsbLgbLibLibLgbLsbRgbRibRibRgRsmb
RoLsLsmbRgbLgbLgbLibLsbLgbRgbLgbLsbLibLsbLibLibLgbRsbLibLobLibLibLsbRg
bLibLibRsRsmbLsbLcbRsbLibRsLsbLsbLgbLgLsLsmbLsbLgbRsRsmbRcbLcbLibRsbLg
LsbLibRsbRsbLgbLsLsmbLsbLgbLobRsLsbLiLsbLgbLgbLibRsbLgbLsbLcLsmbLgbLhb
LibLibLibLjbLsbLobRsbRibLgbLgbLsbLsbLgbLgbLsbLsLsmbLgbLgLsbLsbLsbLgbRs
bLgbLgbLgbRsRsmbRcbRjbLibRibRibLibRjLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 39; Drug: Haloperidol 3 然 Apo 0.5 然
bRibRsbRgLsbRsRsmbRgbRgLsbLsbRibRibRgbLsbRsLsbLsbLgbLoLsmbLibLsbLibLib
RsRgbLeRsRsmbLcRsbRgbRgbLibLibRsbLibLsbLebLsLjRsbLgLsbLgbRibRhbRibRiRs
mbRgbRiRsmbLsbLgLsbRgbRibRibRjLsbRcRsmbLsbRsRsmbRgLsbRsbRgbRgbRgbLsbRs
bRsbRsbRsLsbRsRsmbRsRsmbRgRsmbRgbRibRcbRgbRiRsmbLhbLiLsbLgbLhLsbRsbLgb
LgbRgbLgbLcRsbRsbRgbLibLibRgbLibLsbLgbRgbLibLsbLgbRsbLibRsRsmbRgbRjRib
RibRiRsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 40; Drug: Haloperidol 3 然 Apo 0.5 然
bRsbRsbLgbLgbRsbRgbLsbLsbLsLsmbLibLgbRsbRsbRsRsmbRgbLsbLibLiLsbRsbRibR
cbLgbRcRsmbRgbLsbRsbRsbRsbRsRsmbRibLsLsmbRgRsmbLgbRgbRsbRsbRsbRgRsmbRg
bRgbLgbLsLsmbRibRgbLsbRgbRgbLsRsbLsbRsRsmbRsbLsbRgbLgbLsbRibRgbRgLsRsb
RsRsmbRsbRgbRgbRgRsmbRsbRgLsbLsRsRsmbRgbLsbRgbRsRsmbRgRsmbLsRsbRgbLsbR
sbRsRsmbLsLsRsRsmmbRgbRsbRgLsbRsbLsbLsbRgbLsbRsbRsbLsbRsRsmbLsbRsRsmbR
sbRsbRsbRgRsLgmbRebRcbLsbLcbRsbRebRibLsbLsbLsbLgbRsRjbLsbLgRsbsbsbLjbL
ibRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 41; Drug: Haloperidol 3 然 Apo 0.5 然
bLgbLgbLsbLsbLgLsLsmbLgbLgLsLsmbRsLsbLsbLsbLgLsbLsbLsLsmbLsbLsbLsbLsbL
gbLsbLsLsRsLgLsmbLsbRibRcbRgbRsbRgbRsRsmbRgRsmbRgbRsLsbsbRgbRsRsmbRsRs
RsRsmmmbRgbLsbRgbRsbRsRsmbRgbRgbRsRsmbRsLsRsbRsRsmbRgbLsbRiLsbLiRsRsmb
RsLsbLibLgbLgbLsbLibLgbRjbLhLsbLsbRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 42; Drug: Haloperidol 3 然 Apo 0.5 然
bRgbRjRsmbLcbRsbsbLjbLjbLsRsRsmbRebLcbLsLsmbRsbLsLsmbRgRsLsmbLgbLsbLcL
smbLgLsbRebLsbLgbRsbRsbLsLsLsLsmmmbLgRsbLsbRobRibRsRsmbRsRsmbLsbRcbLsb
LsbRcbRsbLsbRobRcbRsRsRsmmbRsRsRsmmbRcLsbsbsbLsbsbsbLsLgbRsRsmbRobsbRs
RsmbRgbRsbLsbRcb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 43; Drug: Haloperidol 10 然 Apo 0.5 然
bLebRcbRobRcbLebRobRobRgbRgbRobLobLgbLgbRobLebLebLcbLgbLobRgbLobRobLob
RobRebRcbLebRgbRobLhbLcbLobLcbLobRebLobLobRobRibLcbRobLgbLgbLcbLhbRobL
sbRobLobLobRobRobRcbLobLobRobLgbRibLgbRobRobLgbRobLobRibLebLcbRobRobRe
bRsbRcbLgbRobRobRebRobLobLobRobLobRebLobRobLobRobLebLgbLgbRebRebRebLib
LibRobLebLhbLibLcbLcbRcbLibLgbLobLobRobLhbLobRibRcbLebLibRobLobLobLcbR
ebRobLebLgbLobRcbLobLobRcbLobLgbLgbLebRobRobLsbLcbLobRobRobLobRobRebLo
bRebRgbRebLcbLebLcbRsbLcbRebRebLebLobRobRcbRobRobLebLcbLebRgbLcbRobReb
LobRobLobLobLobLobRgbLcbLcbRcbRobLibRobRsbLgbLebLsbRcbLobRebLobLobRobR
ebLebLobRobRebLebLobLibLobRcbRebRebRibRobRebRebLgbRobRsbLobRobRobLibLc
bRobLsbLebRsbRcbRcbLobLobRebLsbRhbRobRobLebRebLobLobLebLobLibLgbRibRob
LcbLobRobLebLgbRobLobLibLibLobLebRobRobLebLcbRcbRebLobLcbLobLebRcbLobL
sbRcbLobRobRobLobRebRobLobLebLobLcbLobLebRebLcbLobRibRebLibRobRobLebRe
bLebRebRobLobLobRobLcbLobRobLebLobRebRobLcbLsbRobRobRobLibRgbRcbRobReb
RebRebLobLhbRebLebRsbRebLcbRebRebLobLobLobLebLibLobLobRobRcbRibLobLobL
obRobLobRobLibLebLobLebRobRcbRcbLibRebRobRibLobLcbLgbLobRobLobRobLobRo
bLgbLobRobLobLobLcbLebRgbRcbRobLobLobRibLebLobRcbLobRibLebRobLcbRibLeb
RebLebRgbLebRebRobRobLcbRobLobRebRcbRobLibLcbRebRobRgbRcbLcbRebRgbLebR
obRibRcbLebRhbLobLebRobRebRibLobRobRebRobLobLobLcbLebRebLebRobLcbRebLo
bRebLibRobRobRcbRibLgbLobLibRibLobRjbRebRhbLebRobRhbRibRobRcbRobRibLcb
LobLgbLobRobLibRibLobLobRjbLhbRgbRcbRobLobLibLibLobRsbLebRobLebLobLhbR
ebRgbRcbLobRebRobRcbLobLcbRobLgbLobLsbRcbRcbRcbLobLobLgbRsbLcbLobRebRo
bRgbRebLobRcbRibRhbLobRcbLsbLobRobLibRebRebRibLcbRobLcbRobLhbRobRcbRcb
LebLhbRebLcbLcbRobRobRobRcbRebRebLhbRobLobLibLobLobRebLsbRebRsbLebRibL
obRobRobLgbLobRebRobLibRgbRsbRcbLobRobLobRobRibLgbRcbRgbLebRobRobRobLg
bRobRgbLobLcbLobRebLsbRebRebLobRobLcbLobLebRhbRhbRobRobRcbRsbRebLgbLsb
LobRebLgbLebRcbLibRebLgbLebLibRobRcbLebRsbLgbRobLhbLgbLsbRebRobRobLsbL
cbRcbRibRgbRcbRobLobRcbRobRobLcbRebLebRobLibLgbLebRobLebLobRobLgbRibLo
bRobRgbLgbLcbRcbRobLebRebLobLobLgbLcbRcbLcbLobLcbRobRgbRcbRebLebLobRob
RobRebLobRebRebRsbRebLcbLobRebLcbRobRibRobLcbRgbLobRobRcbLobRobRobLobR
cbLcbLsbRibRibLebLobLcbLobRobLcbLobRcbRobRgbLebRibLobLgbRebRobRebLgbLg
bLobRibRcbRibLgbRcbLobLobRebRobRebRobRobLhbLobRcbRcbRibRobLobRebRobLeb
RebLobLobLobRebLobRobRebRobLebLgbRcbLobRgbRebLobRcbLebRobRebRgbLebRobL
obRgbLcbRibLebRobRebRobRsbLebRebLgbRobLibLibLobLibRobLobRobRobLobRobRo
bRjbRcbLebLgbLebLgbRebRgbRobLobLobRebRobRobLobRibLobLcbRobRcbLebLsbRob
LgbLobRgbLebLobRobRcbLibRgbRibRibRcbLibLobRobLebRcbLsbRobRgbRcbLobRebL
ebLobLobLebLsbRhbLobLhbLgbLobRebRcbLebLobLibRobRibRobLibLcbRhbRebRobRo
bRebRibLebLobRibRsbLcbRsbRcbLebLobLobLsbLgbRobLobRobRobRgbRcbLebRgbReb
LebRhbLgbRebRcbRobLobLibRebLobLobRebLobRebLobLcbRebRobLibRebLobLobRobR
obRgbRebLobRcbRcbRibRgbRobLobRcbRobRobRobLebLebRobLobLebRobRsbRobLobRc
bLcbRcbRsbLcbRebRobLobLcbLcbRgbRebRgbLcbLobLobLsbRobLcbRcbRobRobRobRob
LibRebRcbLobLobRobRob

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 44; Drug: Haloperidol 10 然 Apo 0.5 然
bRgRibRibLibLoLsLeLsmbLsbLeRsRiRgbLgbLgbRsbLgbLsbLsbLgbLsbLgbLgbLgbLsL
smbLsbLcbLsLsRsmbRgbLibLsbRsbRsbLsLsmbLsbLsLsmbLgbLsbLsbLgbLgbLsbLsbLs
LsRsmbRsbLgbLhRibLcbRibLhLsbRgLsbRgbRsbRsbRsbRsbRsbRgbLsRsbRgbRgbRgbLs
bRsbRsLsbRsbRsbRsbRsbLsbRgbRsbRsbRgbRsbRgRsmbRsbRgLsRsbRibRsbLsbRibRsb
RsbRgbLsLsmbRgbRgbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 45; Drug: Haloperidol 10 然 Apo 0.5 然
bLiLsbLhbLiRsbLsbRgbLib

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 46; Drug: Haloperidol 10 然 Apo 0.5 然
bLgbRobRcbLcbRobLobLobRobRibLobRcbLebLsbRobRebRcbRobRhbLobRcbLebLobReb
RibLibLebRebLobRibRebRcbLobLibLebLsbLcbRebRcbLebRobLcbLebLcbRobLobLebR
cbLcbRhbRobLobLobLebLebRebRobLsbLebRsbLobLobLibRibRobRibLobLibRobRebRc
bRobLsbLobRebLobLobLebLebLibLobLsbRobLgbRcbLebRebRobLobRcbLobRobRcbRob
LobLobLobRebLebLhbLcbLobLgbRcbRobLobRebRebRobLibLebRobLobLobRibLsbRibL
ibLcbLcbLobLobLebRobRebRibRobRcbLibRibLgbLcbLebLcbRcbRebRcbLobLobRebRg
bRebLsbLobRobLobLobRebLibRobLgbRcbLobRibLcbRcbLsbLcbRsbLibRibRobLobLcb
RcbRgbLebLcbRcbRgbLobRobRibLebLcbLibRebRcbLcbLcbLobLebLsbLobRebRobLcbL
cbLobLebRobRobLobLcbLgbLebRebRebLcbRsbLibRcbLobRjbLcbRibLobLobLibLobRe
bLcbRobLobRsbLcbLgbRobRcbLibLebLobRibLobLobRobRebLebLibRcbRhbLobRebLgb
RobRebLcbLsbRobLebLobLobRibRcbRobLsbLhbRcbRobLobRobLebRgbLebRebRgbRobR
obRobRobRibRobRobLcbRhbLebRcbLobLobLebRibLobRgbLobRgbRobRcbLobLhbLebRo
bRobLcbRebLebRgbLobRobRgbLebLcbRobRobLcbRebRobRebLobRibRcbLebRibRibRib
RibRgbRcbRsbRibLcbLobLebLobRebLebLobLobLhbRcbRebLobLcbLebLcbRobLibLgbR
obRhbRobLebRobRibRgbRgbRobRsbRobRibLebLcbLobLobRgbRobRobLobLobRsbRobRe
bLobRobLobRobRobLcbLobLobRobRobLgbRobLobRhbRcbRebLibLobLebRobLobLobRob
LcbLcbRcbRcbLobLobRibLobLcbRsbLgbRebRcbLibLcbLcbLcbLobRobLcbRcbRebLibR
ebRebRobRebLobRobRobRobRobRgbLcbRobRibLebRibRsbLebLobRcbLcbRobRgbRcbLo
bRebRebLobRcbRebLobLsbRcbRcbRobLobRobRebLebRcbRcbLhbLsbRebLibRcbLebRcb
RobRobRibLobLobLcbLebRcbLebRobRobLobLebRebRgbRcbLobLebLobRsbRgbLebLobL
obLcbRobLcbRebRobRcbRebRebLcbRobRgbLebRcbRibLebLcbRebLebLobLobRobLobLe
bLobLgbRcbRcbLobLebLcbRobRobLobLcbRebLobLobRobRcbLcbRobLobLobRcbLgbLcb
RebLebRobRobLobRobRsbLobRgbLobRobRcbLcbRebRibRobRibRgbLebLobLobRebLobR
sbRobLibLhbRobLsbRobRobRobRebRobLobLobLobRsbRibLhbRhbRhbLebLcbRobRobRo
bRgbLobRobRobLobLebRgbLebRebLibRobLebRgbRebRobRobLobLcbLobRgbLobRobRob
LobRcbRsbLibLsbRcbLibLobLgbRsbLebRobRobRebLebRsbLebRcbLgbRobRibLhbRebL
ebLobLcbLebLobLobLobLebLcbRcbRsbLcbRcbRgbRobLobRebRebLebRibRgbLobRobLg
bRgbRobLobLibLcbLobLobLobLobLebLibRobRobRebRcbRebRobLobLobLebLobLebReb
LibLobLebRibLcbLebLebRebLebRobLebRebLobLgbLobRobLebRobRebLobLobLsbLebR
sbLsbLsbLobRobLobRibLobRobRebLobRobRobLibRobRebRhbRebRobRobRobLobRsbRe
bLcbRebRsbRobLebRobRibRibLobRobLobLobRcbRobRcbRobRebLgbRsbLebLebLsbLeb
RhbRcbLebLobRebRgbRcbRsbLobRobRebRobRobLobLebLebLibLibLobLcbLobLobLobR
cbRobLobRobRobRgbLobRsbRobLibLcbLebRgbLebLobRobLgbLcbRobLebRcbRobLobLo
bRebRobRobRgbRcbLebRebRebRobLobLcbRcbRobLobLsbRobRibLobRgbRgbLebLebLob
RgbRobLebLibLebLibRcbRibLobLobRobLcbLsbRsbRobRgbRcbLsbLebRobRsbLobRobL
obLibLebLobLobLobLibRebRgbRobRobRebRcbLibRobLcbRebLcbRsbLgbRcbLobLobRe
bLobRebLcbLobRebRcbLcbRsbLebLgbLebRcbLebLobLgbLebRgbLebLobLsbLebRobRob
RebLcbRobLcbLhbLobRcbLobLebLibRibLibLebLobLobRcbLebLcbRgbRebLebLobLobL
ebLsbRebLhbLobLobLobLebLobRsbLebLcbLebLebLcbLhbLibLobRjbLcbRobLibRebRe
bLgbLibRobRobRobLobLcbLobLibRobRcbLobRgbLcbRebRcbRobLobRcbLcbLcbRhbRob
LsbRebRcbRibRobRobRebLibRobRhbLgbRebRobLibLobLobRibRsbLobLobRebLebLebR
obRebRgbRibLebRjbLgbRobLobLebRcbLgbRibLebLobLhbLobLibRobRebLobRgbLob

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 47; Drug: Haloperidol 10 然 Apo 0.5 然
bRgbRgRsmbLsbLgLgbLiLgLsLsmbLibLiLgLgLsLsLsLiLsmmbLsLsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 162511; End: 163011;
Recording: 12-1; Individual: 48; Drug: Haloperidol 10 然 Apo 0.5 然
bRgbsbRsbLsRsbRsbLsbLgbLsLgbLsbLgbLsbLsLsmbLsbLsbLsbsbRsbRsbsbLsbLgbRs
bLsbLsbRsLsbLsLsmbLgbRsbLsbLsbLsbRsLsbRsLsLsmbLsbLsbRsRsmbRsRsmbLsLsmb
LsbLsbLsLsmbLsbLsLsLsmmbLsbLsbLsbLsbLsbLsLsLsLsmmmbLsbLsLsLsLgmmbLsbLg
RsbRsLsLgbLsLsmbsbLgbLsbLsbLsLsmbLgbRsbsbLsbLgLsLsLsLsLsLsmmmmmbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 1; Drug: Control Apo 0.5 然
bLcRsbLobLcbLjbLebRobRoRsmbLibLib

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 2; Drug: Control Apo 0.5 然
bRsRsmbRsbsbsb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 3; Drug: Control Apo 0.5 然
bLebLjbLebLsbRgbRsbRsbRsbRjbLsbLsLobRsbRsbLjbRsbRsLsbRgbLjbRsbLsRsLjbL
sLgbRsLsbLsRsbRsbRsLgbRjbLgbRsbRsLgbsbLsRsbLsbLsLsmbRsbRgbRgbLsbRebRsR
obRobsbLsRgbRsRsRsmmbLobRsbLobLsLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 4; Drug: Control Apo 0.5 然
bLsbLhbLsbRcbLjbRobLgRsbLsbLsbRgbLcbLsbLcbLsbRoLsbLgbLibLsbRsbLsbLsbLo
bRsbLsbLhb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 5; Drug: Control Apo 0.5 然
bLjRsbLgbLgbRib

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 6; Drug: Control Apo 0.5 然
bLcb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 7; Drug: Haloperidol 1 然 Apo 0.5 然
bRibRgbLibLcbLibLibLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 8; Drug: Haloperidol 1 然 Apo 0.5 然
bRiLsbRsbRiRsmbRsLsbLsbRsbLjLsmbRibLjLsLsmmbLgbLsbLsbLsRibRjbLgLsbRsbR
gRsmbRsbLsLoLsmbLsLsmbLsLgbRsbsbRcRibRibRgbRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 9; Drug: Haloperidol 1 然 Apo 0.5 然
bRjbRcbRibRibLibLgbRjRsmbRsbRcbRsbRibRcbLcbRsRsmbRsbRibLibRibRhbLgbLsb
RibLhbRibRsRsmbRsbRobRjbLcbRsbLobLibLsbLsbLcRsbLibLgbRibRgbRsbRebRcbRi
bRgbRsRsRsmmb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 10; Drug: Haloperidol 1 然 Apo 0.5 然
bRsbLibLibRsbLiLsbRsRsmbLcbLebRibRgRsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 11; Drug: Haloperidol 1 然 Apo 0.5 然
bsbLsLsmbRsbRsbRsRsmbRsRsmbRsRsmbRibRsbLsbRsbRgbRcbsbsbsbRsRsmbRsbRjRs
mbsbRsbLebRsbRebRcbLibRibLsbLsLsLsmmbRibRiRsmbRsbRibLibRsbLjbRsbRibLgL
sLsmbRsbRgbLjbLibRjRsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 12; Drug: Haloperidol 1 然 Apo 0.5 然
bRibRjRsmbRsRsRsLsmmbRoRsRsmmbRiLsbRgbLsbRsRjbRcRsmbRsLgLsbRsbLcbRobRg
bLcRsbRibRhRsRsmmbRsbRsRibLjbLcbLsLsmbLcbRcbsbLibLcbLibRsbRsbLibLsbRsb
LgbLobLsbRhbRjbLcRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 13; Drug: Haloperidol 3 然 Apo 0.5 然
bRcLsbLgLsbLsLsLsmmbRibRhbLsbRgbRhbLibRsbLcbLsbRsbRsbLsLibRsbRsLsbLsbL
ibRsbRsRsmbLibRsbLhbLsbRsbsbLgbLgbLgbRsbLsbLibRsbLgLsbLiLsbLsbRsRsRsmm
bsbsbLebLsbLsbRsbLsLsmbLiLsbLsbLsbLsbLiLsbLibRsRsRsLsmmbLcbRsRsRsmmbRi
bRibRsbRhRsmbRsbRsbLsRsbRibRsbRsbLgbsbRjRsmbsbLsbRibRibLsbLsbLsbRcbRgR
smbLsbRsLsbLsbRiRsmbLsbsbRsRsmbRgbRsbRgbRsbLsbLgbLsbRcbRsRsmbLjbRibRib
LsLsmbLsbLsLsmbLsLsRsmbLsbLsbRibLgRsbRhbRgbsbLgLsbRsLsbRhbRsbRsbRsRsRs
mmbLsRsbLcbLgLsbLsbLcLsmbRsbRsbLcbRgLsbLgbLibLsbLsbRsbRebRibRsbRibLsbL
sLgRsbRjLsbRibLgbRcbLgLsbLgLgRsbRcbRsbLjLgbLgbLgbLsLcbLsRsbRsLsbRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 14; Drug: Haloperidol 3 然 Apo 0.5 然
bRhbLgbRcbLcRsbLibRsbLhbLibLobRiLsbLsbRobLsbLsbLsbLsbLgRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 15; Drug: Haloperidol 3 然 Apo 0.5 然
bLiLsbRsbRsbLobsbRcbLebLiLsbLgLsLsmbLjLsmbRibLsbsbsbsbRsbsbsbLsLsmbRsb
RjRsmbRoLsbRsbLsbLsbLcbLsbLibLsbRsRsmbRsLsbsbRsbLoRcbRsbRsbLibLibLsLsm
bRsbLhLsLsmbRsbRgbLsLsmbRsLsbLsbRsbRsbsbRsbRsbLsLsmbRsRsmbLsbLsRsbLsbL
sbLsbLsbRsbLsRsbLhbLsbRsbRsbLibLsRsbLcbLiLsbRibLsRiRsmbRsbRibLgbRibRsR
smbRgbRsbRgbRgRsmbLsbRsRsmbRgbRsRsmbsbRgRsLsmbRsRsmbLsbRsRsmbRsbsbLgbR
gbLibLsbLhbRgbLjLsmbRsbLcbRgbLeLsbRsbLsbRibLhbLgbRsbLebRsbRibRibRsbRsL
sLsmbRsbsbsbRsbRsbsbLsbLsbsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 16; Drug: Haloperidol 3 然 Apo 0.5 然
bLebLsbLsbLgbLsbLsLgLsbLcLsmbLgbLsbRgbLsbLgbLibLsbRsbLcbRsbLsbLsbLibRs
bLsbLsbLsLsmbLsbLobLsRsbLsbRebLjbRhbLgbLobLibLsbLgbLsbRsbLgbLgRsbRsbRe
bLebLebLsbLgLsbLgbLsbRsbLsbLgLsbRsbLibLibLebLibLsbRcbLsbLcLsmbLobLibLi
bRibRsbRibLebLibRsbRjbLsbLibLiLsbLgbLhLsbLsbLsbLsbLsbLcbLsbLsLsmbLibLg
bLcLsmbRgLsbLsRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 17; Drug: Haloperidol 3 然 Apo 0.5 然
bLiRsbsbsbsbLebRsRsmbLcbLgbLgLsbRsbLgbLibLiLsbLsbLgRsbRsRsmbLobRsRsmbR
ibRsRgbRsbsbRsbsbsbsbsbsbRsbRsRsmbsbRsRsmbsbLsbLsbRgbLsbLsRsLsRsRsmbsb
sbRsLsRsRsmbsbsbLgbRibRsbLcLsmbLsbLsbLcbLjLsmbRsRgbRgbLsRsbLibRsbRsRsm
bsbsbRsbsbLibsbsbsbsbLsbRsbsbsbsbsbLjLsmbLsRsbLsRsLsbRsbRsRsLsmbsbLibL
sLgLsbLsbLsbLsbLsbLsbLsbRsLsbLsRsRsLsmbLsbRsbRsRsmbLgbsbLgbRsbLsbLibLg
bLibLsLsmbRhbLsbRobRgbRsRsmbLhbLjbLjLsmbRsbsbsbsbsbsbLsbsbsbRsbsbRsbsb
LsLsmbRsbLsRsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 18; Drug: Haloperidol 3 然 Apo 0.5 然
bRgbRgLsbRjbLsbLsbRsbLhbRgbRsLsbsbRsbRsbLsbLsLsLsmmbLsbsbsbsbsbLsRsRsm
bsbRgRsmbRgRibLsbRibRibRsLsbsbLjbLibLjLsmbRsbRsbRsbLgbRsbRiRsmbRcb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 19; Drug: Haloperidol 10 然 Apo 0.5 然
bLebRsRsmbLiRsLsbRsbLsRsbLgbLsbLgRsbLgLsLsLgLgmbLsbRsbLgbLsbLsbLsbLsRs
bRgbRsbLsbRsLsbLsbRsbLsbLsbLsbLsbsbsbsbsbLsLsLsLsmmmbLsbRsbLgLsRsbRiRs
RgmbLiLgRsbLsbLgbLgbLjbLsbLgbLgbLsLsLsmmbLsbLgbLgbsbLgLsbLgbsbLsbLsbLs
bLsLsmbLsLsRsmbRsRsmbLsbLsRsbLsbLsRsbLsLsmbLsbLsRsLsLsRsmbLsLsmbLgbLsb
LsLsmbLsbLsbLsbLgbRsbRsbLsbLsbLsbLibLsbsbRsbLsbRsbLsbLgLsbLgbLiLibLgRs
LsbLgLsLsLsmmbLgbRobLcbLjbLhbLibRsbRsbRsbLsbLsbLgbRsbLebRsbRcbRjRiRhRj
bLibLsRsbRsLgbLsLsmbLsLsmbLobLsbRibRsbRgbLsbLsbLjLsmbLibLebLsbRgbRgbLs
RsLsbLsbLgRsbLsbLsRsbLjRsbRsbRsbRsbRsRsmbRsbRsRsRsmmbRsRsmbRsbRgbRgbRg
bRgbRiRsmbRibRebRobRsbRjRsmbRgbRgRsmbRiRsmbRsbLsbsb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 20; Drug: Haloperidol 10 然 Apo 0.5 然
bLoLsmbRsLsbRsbLobRebLsbRsbLcLsLsRgmmbRgRibRgRsRsmmbRebRgRsmbRiRsRsmmb
LsbRgbLsbLiRsbLsbRgbLibLebLgLsLsmbRsbLgbLgbLsbLsbLjbLgbLsbLsLsmbLsbLsL
smbLsbLsbRsLsbRsbRcRsLsLsLsRsmmmbLsRgbLoRsbRgbRsRsmbRgRgLsbRgRgbRsbRiR
smbLgbRobLsbRebLeRsbRgRsRsRgRsmmmbLibRhRsRsmmbRgbRgLgbLsbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 21; Drug: Haloperidol 10 然 Apo 0.5 然
bLebLebLsbLsRsbLsbLhb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 22; Drug: Haloperidol 10 然 Apo 0.5 然
bsbRsbRibLgbRsbRsbRibLcbLgRsRsRsmmbRiRsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 23; Drug: Haloperidol 10 然 Apo 0.5 然
bLgbLsRsRsLgmbLsbLgbLgbLgRsbLgbLgbRsbLsRsRsmbLgLsbLibRsbLsbLgbRiLsbLsb
LgLsbsbLsbLsLsmbLgbsbLsbLgbLsbLsLsmbLsLgbRsbLgLsbLgRsLsbLsbRsbLgbLsLsm
bLhbLgbLgRsbRsRsmbLgLsbLsbLgLsbLsLsmbLsbLgbRibRgbRgRsmbRgbsbLsbRobLgbL
gRsbLgbLgbLgbLgbLobLebRgLsbRgbRgLsbRgbRjbLebRebRgbRgLsbLsRsbLgbRobRoRg
bLcLsmbRsLsbLsbLiRsbRebLeRsbRsbLsbLsLsLsLsmmmbRsbRsbLebRgbRsLsRsLsbRsb
LjLsmbLgbLsbLsbLsbLsbLsLsmbLsbsbLgbLgLsLsmbRjRhRsmbLjbLgbLsbLsbLsbLsbR
sbLsRsbLsbRibRgbRsbRgbRsbRsbRgbRsbRsbRsLsbRsRsmbRsbLsbLsLsmbRjbRgbRibR
gbRgbRgRsmbLsRsbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 24; Drug: Haloperidol 10 然 Apo 0.5 然
bRgbRoLsbRsLsbLibLgbLgbLsbLgLsbLsbLsbRibRhbLebLibRcbRgRsLsmbLsLsmbLsRj
bReLsbLiLsbRgbRebLoRsRsmbLsRibLsbsbLibLebLiRsbLsRcbRoRsmbLibRobRebRgLs
bRsLsRsbRsbLcbRjRsmbRebLsbRibRibRgRsRsmmbLiLsLsLiLimbLibRgbRobRcbRcbsb
sbLsbRsbRibLgLsbLgLsbRgbLsLsRsmbRjbRgbRgbLsbLgLsbLsbLcbRjbLcLsLsRsmmbR
sLgLsLsLsmmbLsbRobRsRcbRebLsbRobsbRgRsmbRobsbRgbsbRsRhRsRsmmbRoRsRcRgR
sRsmmmbRgbRsLsbLsbRgbRsbsbRsRsmbLgbRsLsbRsbRsbRsLsbRjbLsbLjbLgRsbRgbLg
bLsbLiLcLcbLcbLiLcbLgbLgbLgLsbLgRcbLsbRsbLjbLsbLgLsbLgbLiLsbLgbLgLgbLg
bLsbsbLsbLsbLgLsbsbLgbLsLhLcLsLcmbLcLsLiLsmbLcLibLsbsbLcbRsRgbLcbLiRsb
RsbRsRsLsmbLsbRsbRsbRibLiLsbRsbsbLoRsbLsbLsLsmbRjbsbRjbLibLsReLsbLsbRg
LsbRsbRsbRiRgRobsb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 25; Drug: Control Apo 0.5 然
bRsRsmbRsbRsbLgbLgLsbRcbLibRsbRgLsbLobRibRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 26; Drug: Control Apo 0.5 然
bRsLsbRgbLsbRibLgbLsbLoRsbLsbLsLsmbLgbLcbRcbLgbRsRsRsmmbsb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 27; Drug: Control Apo 0.5 然
bLcbRjRsmbRsbRsRsmbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 28; Drug: Control Apo 0.5 然
bRoRibLsbRibLibLcRsbRhbRsbRsbsbLsbLgbLsbLsbLgbLibLibRcbRsbLcbRgbLsbLsb
LcbLcbLsRsbLsbLibLsRsbRobRcRsmbRsbRsbRibRsbRsbRsbLsbRibRiLsbRsbLsRsbLs
RsbRiLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 29; Drug: Control Apo 0.5 然
bRsbRebLjLgbLobRcRsmbLib

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 30; Drug: Control Apo 0.5 然
bLjbLiLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 31; Drug: Haloperidol 1 然 Apo 0.5 然
bRsRsmbLobLcbLsLsLsmmbLhbRobLsLsmbLsbLgbLibLjLsmbRsbRsbLsLsLsmmbLsbRhR
smbRgbRhbLgRsbLcbRcLsLsRsmbRcbLsbLcbLgbLsbLiRsbRjbRobLsbLeRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 32; Drug: Haloperidol 1 然 Apo 0.5 然
bRgbLgLsbRsLsbLgbRcLoRsbLgbLcbRgRsmbRjbLobLgbLgLsbRcLsbRibRsbLgRsbLhbL
sbLsbLsbRsLsbLsLsmbRobRgbsbRsbLsbRsbRsbRibsbLsbLsbLgbRsbRgbLgbRiRsmbLs
bLsRsLsbLsbLsbLgbRoLsbLcbLgbLgbLibRsLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 33; Drug: Haloperidol 1 然 Apo 0.5 然
bLgbLsbRsRsmbRsbLsbLibLsbLibLhLsbLibLgbRsbRsbLsLsmbLsbLsbLsRsbsbLgbLsb
LgbLsbLsbLsbLsbLsbLsbLsbLibLgbLsbLsbLsbLsbLsbLgbLcbLsbLsbLsbLhLgLsLsRs
mbLsbLibLsbLgbLsRsLsbRsbRsbLsbLgbLsbLsbLsbLsbLsbLsbLsbLgbLgbRsbLgbLgbL
ibRsbLgbRsbLgbLsbRsbLgbRsbLsbLgbLsbRsbRsbLgbRgbRjbLgbLgbLsbLsbLgbLibRg
bRgbRsbLibLsbLgLsbLibLibRgbLgbLsbLgLsbLsbLsbLsbLgLsbLgbRibLgbRsbRsbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 34; Drug: Haloperidol 1 然 Apo 0.5 然
bLibRgbLibLsbRsbRsbLgbLibRgbLsbLjbLgbRgbRgbRgbLhbRcbRgbRsbLsbLsbLibLgb
RsbLjbRibRibLsbRibLsbLsbRibLsLsmbLsbLebLsbLgbRsbLsbLgbRsbLsLsmbLsbLsbL
sRsbLgbLsbLgbLsbRcbRib

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 35; Drug: Haloperidol 1 然 Apo 0.5 然
bLhbRcbRsbRcbLgbLsbRibLsbLgLsbLhbLsRsbLgbsbLgbsbLsbLsLsmbLobRobRjb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 36; Drug: Haloperidol 1 然 Apo 0.5 然
bRsbLhLsbLsbRsRsRsmmbRsRsmbLgbRibLcbLcbRobRibRibsbLsbRcbLsbLsLsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 37; Drug: Haloperidol 3 然 Apo 0.5 然
bRgRsmbLsbLgbLgbLibLibLsbLsbLsbLgbLsLsmbsbRsRsmbRsRsmbLgbLgbLibLibLgRs
bLgRsbLsbLsLsmbLgbLsbLsLsmbLgbLibRibRgRsRsmmbRgbRsbsbsbRsbRsLsbRibLsLs
mbLgbLibLgbRsbLgbLsbLsbLsLsmbLsbLsLsmbLsbLsbRsbLsLsLsmmbLsbLsbLibLsbRj
RsmbLcbLibLiLsbLsbLibLiLsbLgLsLsLsmmbLgLsbLgbLcbRgbRgbRiLsbRsbLebLgbLs
bLgbRsLsbRgbLibRjbLsbLsbRjbLiLsbLsbLjbLiRsbRgbRgbLibLiLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 38; Drug: Haloperidol 3 然 Apo 0.5 然
bLjbLsbLjLsmbRjbRobRsRsmbRibRibLsbLcbLcbLibRgbRsbLgbLibLgbLcbLhbLibLob
LcbRcbRibLsbLgbRsbRobRsbLibLsbRcbLjbLcbLibLibLgRsbRsbRibRcbRjbLgbLgbLi
bLsbLsbLibLibLsbLcLsmbLibLgbLsbLsbLsLsmbLibLgRsbRjbLibLsbLibLsbLgbLibL
sbLibLgbLjbRibRsbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 39; Drug: Haloperidol 3 然 Apo 0.5 然
bLsbRiLsbLhLsbLibRsbRsbRsRsmbsbLgbLgbRsbLiLsbLcbLibLsRsbLibLiLsbLibRgb
RibRibRobLsbLgbLibRibRibRibRebRiLsbRiRsmbRsbLcbRjbRebRibLjbLibLibLiRsL
sbRsbLhbLsbLsbLgbLsbLibRgbLibLibRsbLibLibLibRsbLgbRsLsbsbsbRsbsbLibRsb
LibRsbLiLsbLiLsbRiLsRsbRjRsmbRibLsbRgbLsbLsbLsbLsRsLsbRhbRibRsbRibRgbR
gRsRsmmbLsbRgbRibRsbRgb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 40; Drug: Haloperidol 3 然 Apo 0.5 然
bLoRsbRgRsmbRgbRsbLjLsmbLgbLsLsmbRsLsbLgbLsLsmbLsbLgbRobRebRiRsmbLsbLo
bLgbRsbRsbLjLsmbsbsbLibLgbLsbRsbRsbLsbLgLsbLsbRsbRsbLibLgLsbRsbRsLsbRs
bLjLsLsmmbLgbLgLsbLjbRcbLhbLibLsbLgbRibRcbRcbRhLsRsbRsbRsRsmbRsbRsbLcb
LgLsbLsLsmbRsbRsbLhbLibRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 41; Drug: Haloperidol 3 然 Apo 0.5 然
bLsLsLsLsmmmbRsLsbRcbRsbLsbLgbRcbLgbLgLsbLcbRcbRobLibLibLgbLsbLsRsbRsb
LibLgbLibLgLsbLgbLgbLibLgLsbLgbLgbLsbLgLsbLgLsbLgbLgLsbRsbLgbLgLsbLgbL
gbLgbLgbLsLsmbLsLsmbLgbLgbLgbLgbLgbLsLsmbLsbLgbLgLsbLgLsbLgbLgRsbLsbLs
bLgbRsbRsRsmbRsbLjbLebLeLsbLgbLgbLgbLgbLiLsbLgLsbRsbRsbRsbRsbRiLsLsmbL
ibLgbLjbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 42; Drug: Haloperidol 3 然 Apo 0.5 然
bRsbRgbRibLsbRsRsmbRgbsbRcbRsbRsRsmbRcbRibRhbRsbRsbLjbLgLsbRsLibsbRsbL
sLsmbsbLsLgbLsLsmbRcbRcbRsbLgbLsbLgLsLsLsmmbRsbLhbLgLsLgbLsLsmbLgLsbLo
RsbRsbLoLsmbRebRibLcbLsbLsbRsbLsbRcbRsbLsbLjbLsLsLsmmbLsbReRsmbRgbRibL
sbRsbRgRsmbRgbLsbRgbRsbRgbRsRsmbRgbLsLsmbRsbRgbsb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 43; Drug: Haloperidol 10 然 Apo 0.5 然
bsbsbRsRgbLsbLsbRibLcbLhbRibRgbRsLsLsLsmmbLgbLsbLibLgLsbLgLsbLgbLgLsRs
bRsbLsbLgbLsbLibLgbLgbLgLsbLgbLsbLsbRsbRsbLgbLsbLsbLsbLsbLsbLsbLsbLsbL
sbLsbLsbLsLsmbLsbLsRsbLgRsLsLsmbLsLsmbLsbLsbLsbLsbLsLsmbLsLsmbLsbLsRsb
LgbLsLsRsmbLgbLsbLsbLgbLgRsbLgbRsbLibLsbRsbsbRsLsbRsLsbLgbLsLsmbLsbLgb
LsbLsLsmbsbsbLsLsLsmmbLsbLsbLsbLsbLsbRgbLgbRgRsRsRsmmmbLsbLgbLsRsbRsbR
sbRgbLgbsbLsbLsbLsLsmbLsLsmbLsbLsbLsbLsRsbLsbLgbLgbLsbLsbLgbLsbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 44; Drug: Haloperidol 10 然 Apo 0.5 然
bRsRsmbRsbRsbLiLsbLgbLgbLgb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 45; Drug: Haloperidol 10 然 Apo 0.5 然
bRgbLibRsbLibRsbLibLgbLsbLiLsRsbLgbLibLgRsbLsLsmbLgbLsbLsbLsbLgbLgLsbL
gbLsLsLsLsmmmbLgLsLsLsmmbLsLsmbLsRsLsbLsbLgLsLsmbLhbRsbLgbLgbLgbRsbLhL
sbLibLgbLgRsbLsRsbRcbLsbRgRsmbsbsbLsbsbsbRsbRsLsbLsbLjbLgLsbLgbLgRsbLs
LsmbLiRsLsbLsLsmbRsb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 46; Drug: Haloperidol 10 然 Apo 0.5 然
bRsbRsLsbRsLsbLsbRsbLsbLgLsbLsbLgbLsLsmbLsbLsbLsLsmbRsbLgLsLsmbRsbLsbL
iLsbRsbLsbLgLsLsmb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 47; Drug: Haloperidol 10 然 Apo 0.5 然
bLcLsmbRsRsRiRgmbRebLcbLgRsbRsRsmbRjLsRgbLebLgLsRsRsRsmmbRhbRgRsmbRgRs
RsRsmmmbRsbRgbRiLsbRgbRgRgbRcRsRsmmbRiLiRsLsLsmbLgbLebLebRhLsbRiRgRgRs
mbRsRgbRgbRgLsbRgRsmbRsRsmbRsRgbRgRgRsRiRgRimbRhRsmbRgbLebLsLsmbLibRgL
sbLebLibRobLgbRsbRsRsRsmmbLsLsLsmmbRsRiRgbRgRgbRgbRgRsmbRgbRibRgbRsLsb
RiLgbRgbRgRsmbRgbLsbLcbLeLsbLsLsmbsbsbLsLsmbLsb

>ZF Recording 2016-07-04; tW: 300s; Start: 163013; End: 163513;
Recording: 13-1; Individual: 48; Drug: Haloperidol 10 然 Apo 0.5 然
bLsLsRsLgRsmbLsLsmbLsbRjbLhLsbRsbRibRsbRsRsRsmmbRsbRibLgLsLsLsmmbRsRsR
smmbRsbRgLsbRsRsmbRsRsmbRsbRgbRgbRgbRcRsmbLsbRsLsRsbLsRsbLsbsbLgLsbRsb
RjbLjbRsLsLiLgLsLsmbLgbLgbLgbLgbLsbLsLgLsbLsbLgLsLgbLgLgLsbLgbLsbRgbLs
bLsbLsLsLgLimbLgbRsbLgbLiLiLsLiLsbRebRjbRgbLibRsbRiRsmbRsRsmbRgbLgbLsb
RjbLsbLsbRsbRsbLsbRsbRgLsbsbRoLgbLiLgbLjbRcbLiLgbLgLsbLibLsbLgbLgbLsbL
sbLsbsbLgLsbLebRiLsbRsRsmbLsbRsbRgbRcbLsLsRsLsLgLimbLibLhbRebRiRiRsmbR
gbLsbLsLsmbRcRsmbRsbRsbLsRsRsmbRjbRobRjRsmbRgRsmbRibRsbLsbLgbRsbRibRiR
smbLsbLgLsbsbRsLgbRsRsmbLsLsmbRsLgbLgbRsbRibLcbLibReRsmbLsLsmbLibLebLg
bRsLsLsmbLgLsbRibsbRsbRgLsbRsb

